|
a |
|
b/R-scripts/data/clinical/ovarian |
|
|
1 |
sampleID _EVENT _INTEGRATION _OS _OS_IND _OS_UNIT _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_PANCAN _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_miRNA_PANCAN _PANCAN_mirna_OV _PANCAN_mutation_PANCAN _PATIENT _RFS _RFS_IND _RFS_UNIT _TIME_TO_EVENT _TIME_TO_EVENT_UNIT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis anatomic_neoplasm_subdivision bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode clinical_stage days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment eastern_cancer_oncology_group followup_case_report_form_submission_reason followup_treatment_success form_completion_date gender histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_pathologic_diagnosis_method initial_weight intermediate_dimension is_ffpe karnofsky_performance_score longest_dimension lost_follow_up lymphatic_invasion neoplasm_histologic_grade new_neoplasm_event_type new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment oct_embedded other_dx pathology_report_file_name patient_id performance_status_scale_timing person_neoplasm_cancer_status postoperative_rx_tx primary_therapy_outcome_success progression_determined_by radiation_therapy residual_tumor sample_type sample_type_id shortest_dimension tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_residual_disease tumor_tissue_site venous_invasion vial_number vital_status year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_OV_PDMRNAseq _GENOMIC_ID_data/public/TCGA/OV/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_OV_mutation_bcm_solid_gene _GENOMIC_ID_TCGA_OV_exp_u133a _GENOMIC_ID_TCGA_OV_hMethyl450 _GENOMIC_ID_TCGA_OV_miRNA_HiSeq _GENOMIC_ID_TCGA_OV_mutation_curated_bcm_solid_gene _GENOMIC_ID_TCGA_OV_hMethyl27 _GENOMIC_ID_TCGA_OV_mutation_wustl_hiseq_gene _GENOMIC_ID_TCGA_OV_RPPA_RBN _GENOMIC_ID_TCGA_OV_mutation_wustl_gene _GENOMIC_ID_TCGA_OV_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_OV_gistic2thd _GENOMIC_ID_TCGA_OV_PDMarray _GENOMIC_ID_TCGA_OV_RPPA _GENOMIC_ID_TCGA_OV_exp_HiSeq _GENOMIC_ID_TCGA_OV_gistic2 _GENOMIC_ID_TCGA_OV_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_OV_exp_HiSeq_exon _GENOMIC_ID_TCGA_OV_exp_HiSeqV2 _GENOMIC_ID_TCGA_OV_mutation_broad_gene _GENOMIC_ID_TCGA_OV_PDMarrayCNV _GENOMIC_ID_TCGA_OV_PDMRNAseqCNV _GENOMIC_ID_TCGA_OV_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_OV_mutation _GENOMIC_ID_TCGA_OV_G4502A_07_3 _GENOMIC_ID_TCGA_OV_G4502A_07_2 |
|
|
2 |
TCGA-01-0628-11 NA TCGA-01-0628-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0628 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-01-0628-11A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.4 NO NA 0.4 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 0.4 NA NA NA NA NA NA A NA NA NA NA NA 78fc9d0c-7cb2-475b-bd98-e36f04d16358 NA NA NA TCGA-01-0628-11A-01D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0628-11A-01R-0363-07 |
|
|
3 |
TCGA-01-0629-11 NA TCGA-01-0629-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0629 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0629-11A-01D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0629-11A-01R-0363-07 |
|
|
4 |
TCGA-01-0630-11 NA TCGA-01-0630-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0630 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-01-0630-11A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.4 NO NA 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 0.4 NA NA NA NA NA NA A NA NA NA NA NA a87c0a4d-bb41-412c-abd4-7fa010fb18d8 NA NA NA TCGA-01-0630-11A-01D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0630-11A-01R-0363-07 |
|
|
5 |
TCGA-01-0631-11 NA TCGA-01-0631-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0631 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-01-0631-11A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.8 NO NA 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 0.8 NA NA NA NA NA NA A NA NA NA NA NA 0c490ce9-9178-4dfe-8384-208d3d2d46c5 NA NA NA TCGA-01-0631-11A-01D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0631-11A-01R-0363-07 |
|
|
6 |
TCGA-01-0633-11 NA TCGA-01-0633-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0633 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-01-0633-11A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.4 NO NA 0.8 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 0.3 NA NA NA NA NA NA A NA NA NA NA NA eb14ef88-0adc-424d-b0a7-dd449f0907c6 NA NA NA TCGA-01-0633-11A-01D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0633-11A-01R-0363-07 |
|
|
7 |
TCGA-01-0636-11 NA TCGA-01-0636-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0636 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-01-0636-11A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.8 NO NA 1.1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 0.8 NA NA NA NA NA NA A NA NA NA NA NA f17680d1-12eb-45ad-83bc-ba3d14485d10 NA NA NA TCGA-01-0636-11A-01D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0636-11A-01R-0363-07 |
|
|
8 |
TCGA-01-0637-11 NA TCGA-01-0637-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0637 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-01-0637-11A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.7 NO NA 0.7 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 0.3 NA NA NA NA NA NA A NA NA NA NA NA c22da589-1714-4d0c-aa00-e16b466e8a64 NA NA NA TCGA-01-0637-11A-01D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0637-11A-01R-0363-07 |
|
|
9 |
TCGA-01-0638-11 NA TCGA-01-0638-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0638 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0638-11A-02D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0638-11A-02R-0363-07 |
|
|
10 |
TCGA-01-0639-11 NA TCGA-01-0639-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0639 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-01-0639-11A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.8 NO NA 0.9 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 0.5 NA NA NA NA NA NA A NA NA NA NA NA c417e63f-8714-4777-af37-5b39e34492c9 NA NA NA TCGA-01-0639-11A-01D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0639-11A-01R-0363-07 |
|
|
11 |
TCGA-01-0642-11 NA TCGA-01-0642-11 NA NA days NA NA NA NA NA NA NA NA TCGA-01-0642 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-01-0642-11A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.8 NO NA 0.8 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 0.4 NA NA NA NA NA NA A NA NA NA NA NA 4a42ad28-e3d0-4ec8-9c54-40179a2e2953 NA NA NA TCGA-01-0642-11A-02D-0383-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-01-0642-11A-02R-0363-07 |
|
|
12 |
TCGA-04-1331-01 1 TCGA-04-1331-01 1336 1 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1331 NA NA days 1336 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 78 Bilateral TCGA-04-1331-F23906 TCGA-04-1331 TCGA-04-1331-01A Stage IIIC -28848 NA 1336 0 1224 NA 459 NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.5 NA YES G3 Recurrence NA NA NA NA TCGA-04-1331.2CF541C5-B56A-4946-A5C4-DBB4D71D7908.pdf 1331 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 04 1-10 mm Ovary NO A DECEASED 2004 NA TCGA-04-1331-01 NA 96db4ec8-524f-4a9a-a23c-30fade0992b7 NA TCGA-04-1331-01 NA TCGA-04-1331-01A-01D-0432-05 NA NA NA NA TCGA-04-1331-01A-01D-0428-01 TCGA-04-1331-01 NA NA TCGA-04-1331-01A-01D-0428-01 NA NA NA TCGA-04-1331-01A-01W-0486-08 TCGA-04-1331-01 NA NA TCGA-04-1331-01A-01W-0486-08 TCGA-04-1331-01A-01R-0436-07 |
|
|
13 |
TCGA-04-1332-01 1 TCGA-04-1332-01 1247 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1332 NA NA days 1247 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Bilateral TCGA-04-1332-F23911 TCGA-04-1332 NA Stage IIIC -25786 NA 1247 0 1247 NA 393 1 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NO G3 Recurrence NA NA NA NA NA 1332 Preoperative WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 NA NA NA 04 1-10 mm Ovary NA NA DECEASED 2002 NA NA NA e984c174-f724-49b0-84bf-788ff370d89f NA NA NA TCGA-04-1332-01A-01D-0432-05 TCGA-04-1332-01A-01W-0488-09 NA TCGA-04-1332-01A-01W-0488-09 NA TCGA-04-1332-01A-01D-0428-01 TCGA-04-1332-01 NA NA TCGA-04-1332-01A-01D-0428-01 NA NA NA NA TCGA-04-1332-01 NA NA TCGA-04-1332-01A-01W-0488-09 TCGA-04-1332-01A-01R-0436-07 |
|
|
14 |
TCGA-04-1335-01 1 TCGA-04-1335-01 55 1 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-04-1335 NA NA days 55 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Bilateral TCGA-04-1335-F23924 TCGA-04-1335 TCGA-04-1335-01A Stage IB -21963 NA 55 0 NA NA NA NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NO G2 NA NA NA NA NA TCGA-04-1335.A3CEAB60-287E-41D1-A0BD-12B6626BA574.pdf 1335 Preoperative WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.4 NA NA 04 NA Ovary NO A DECEASED 2005 NA NA NA 51038814-3401-4377-a815-92b9ce678f3d NA NA NA TCGA-04-1335-01A-01D-0432-05 NA TCGA-04-1335-01A-21-20 NA NA TCGA-04-1335-01A-01D-0428-01 TCGA-04-1335-01 b1473202-11db-484b-8896-56abe5a3296e NA TCGA-04-1335-01A-01D-0428-01 NA NA NA NA TCGA-04-1335-01 NA NA NA TCGA-04-1335-01A-01R-0436-07 |
|
|
15 |
TCGA-04-1336-01 0 TCGA-04-1336-01 1495 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1336 NA NA days 1495 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Bilateral TCGA-04-1336-F23926 TCGA-04-1336 TCGA-04-1336-01A Stage IIIB -20271 NA NA 0 1495 NA NA NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA NO G3 NA NA NA NA NA TCGA-04-1336.D66DA590-83E1-4607-8806-6402DF3F3385.pdf 1336 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 04 No Macroscopic disease Ovary NA A LIVING 2005 NA TCGA-04-1336-01 NA e53eba00-2869-4168-98aa-a6c491b69fc6 NA TCGA-04-1336-01 NA TCGA-04-1336-01A-01D-0432-05 TCGA-04-1336-01A-01W-0488-09 TCGA-04-1336-01A-21-20 TCGA-04-1336-01A-01W-0488-09 NA TCGA-04-1336-01A-01D-0428-01 TCGA-04-1336-01 7892f3fd-fdb3-43a0-8fd9-390927061f7a NA TCGA-04-1336-01A-01D-0428-01 NA NA NA NA TCGA-04-1336-01 NA NA TCGA-04-1336-01A-01W-0488-09 TCGA-04-1336-01A-01R-0436-07 |
|
|
16 |
TCGA-04-1337-01 1 TCGA-04-1337-01 61 1 days BRCA-LUAD+ NA UCEC Serous c4 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1337 NA NA days 61 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Bilateral TCGA-04-1337-F23931 TCGA-04-1337 TCGA-04-1337-01A Stage IIIC -28626 NA 61 0 NA NA NA 1 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NO G2 NA NA NA NA NA TCGA-04-1337.BA3A3AFD-9687-4FD3-B43A-2A5E623E3B31.pdf 1337 Preoperative WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.3 NA NA 04 No Macroscopic disease Ovary NA A DECEASED 2005 NA TCGA-04-1337-01 TCGA-04-1337-01A-01W-0484-10 543cc1e4-76ee-4e0a-80fa-7ad8477d8d40 NA TCGA-04-1337-01 TCGA-04-1337-01A-01W-0484-10 TCGA-04-1337-01A-01D-0432-05 NA NA NA NA TCGA-04-1337-01A-01D-0428-01 TCGA-04-1337-01 NA NA TCGA-04-1337-01A-01D-0428-01 NA NA NA NA TCGA-04-1337-01 NA NA TCGA-04-1337-01A-01W-0484-10 TCGA-04-1337-01A-01R-0436-07 |
|
|
17 |
TCGA-04-1338-01 0 TCGA-04-1338-01 1418 0 days High C9-OV OV-like c1 OV-like c4 NA NA NA mutation cluster 5 TCGA-04-1338 NA NA days 1418 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 78 Bilateral TCGA-04-1338-F23933 TCGA-04-1338 TCGA-04-1338-01A Stage IIIC -28789 NA NA 0 1418 NA 380 1 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-04-1338.889AF2DB-7FF9-45B1-8FD4-28D57CF870A7.pdf 1338 Preoperative WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 0.4 NA NA 04 1-10 mm Ovary NA A LIVING 2005 NA NA TCGA-04-1338-01A-01W-0484-10 17aa44c9-3071-4184-9692-4c04fabb5a4b NA NA TCGA-04-1338-01A-01W-0484-10 TCGA-04-1338-01A-01D-0432-05 NA TCGA-04-1338-01A-21-20 NA NA TCGA-04-1338-01A-01D-0428-01 TCGA-04-1338-01 ee14145d-2ec8-4323-804e-c0a15371559b NA TCGA-04-1338-01A-01D-0428-01 NA NA NA NA TCGA-04-1338-01 NA NA TCGA-04-1338-01A-01W-0484-10 TCGA-04-1338-01A-01R-0436-07 |
|
|
18 |
TCGA-04-1341-01 0 TCGA-04-1341-01 33 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 NA TCGA-04-1341 NA NA days 33 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 85 NA TCGA-04-1341-F23940 TCGA-04-1341 TCGA-04-1341-01A NA -31215 NA NA 0 33 NA NA NA Scheduled Follow-up Submission NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-04-1341.9DB095E5-19F0-4ECE-9E54-2F030190FDB5.pdf 1341 NA WITH TUMOR NA Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NO YES 04 NA Ovary NA A LIVING 2006 NA TCGA-04-1341-01 NA a9e75af6-31c2-4d32-8c4e-ee9538e77b0e NA TCGA-04-1341-01 NA TCGA-04-1341-01A-01D-0432-05 NA TCGA-04-1341-01A-21-20 NA NA TCGA-04-1341-01A-01D-0428-01 TCGA-04-1341-01 9e5cf025-e667-4a73-94a3-e45255194ec3 NA TCGA-04-1341-01A-01D-0428-01 NA NA NA NA TCGA-04-1341-01 NA NA NA TCGA-04-1341-01A-01R-0436-07 |
|
|
19 |
TCGA-04-1342-01 1 TCGA-04-1342-01 563 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1342 NA NA days 563 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 80 Bilateral TCGA-04-1342-F23942 TCGA-04-1342 TCGA-04-1342-01A Stage IV -29501 NA 563 0 NA NA NA 2 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 2 NA NA G2 NA NA NA NA NA TCGA-04-1342.B296EAFA-9EE4-4611-888A-FA0B58EC2A88.pdf 1342 Preoperative WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.2 NA NA 04 >20 mm Ovary NA A DECEASED 2006 NA TCGA-04-1342-01 NA 3cfa7f01-3d75-4c1a-8e7f-ac849f5fde70 NA TCGA-04-1342-01 NA TCGA-04-1342-01A-01D-0432-05 NA TCGA-04-1342-01A-21-20 NA NA TCGA-04-1342-01A-01D-0428-01 TCGA-04-1342-01 e79f6986-9f15-4826-901b-1a97c2b8ae42 NA TCGA-04-1342-01A-01D-0428-01 NA NA NA TCGA-04-1342-01A-01W-0486-08 TCGA-04-1342-01 NA NA TCGA-04-1342-01A-01W-0486-08 TCGA-04-1342-01A-01R-0436-07 |
|
|
20 |
TCGA-04-1343-01 1 TCGA-04-1343-01 361 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1343 NA NA days 361 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 72 Bilateral TCGA-04-1343-F23949 TCGA-04-1343 TCGA-04-1343-01A Stage IV -26428 NA 361 0 NA NA NA 3 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NA G3 NA NA NA NA NA TCGA-04-1343.E62828D9-A46C-498F-9976-CC430D16057E.pdf 1343 Preoperative WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.4 NA NA 04 >20 mm Ovary NA A DECEASED 2002 NA TCGA-04-1343-01 NA ecfe5ba4-b146-4757-894e-ee6e44f4ba5c NA TCGA-04-1343-01 NA TCGA-04-1343-01A-01D-0432-05 TCGA-04-1343-01A-01W-0488-09 TCGA-04-1343-01A-21-20 TCGA-04-1343-01A-01W-0488-09 NA TCGA-04-1343-01A-01D-0428-01 TCGA-04-1343-01 58f649ec-b1cd-4775-8c03-4ebdfe0ad072 NA TCGA-04-1343-01A-01D-0428-01 NA NA NA NA TCGA-04-1343-01 NA NA TCGA-04-1343-01A-01W-0488-09 TCGA-04-1343-01A-01R-0436-07 |
|
|
21 |
TCGA-04-1346-01 0 TCGA-04-1346-01 1993 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-04-1346 NA NA days 1993 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 Bilateral TCGA-04-1346-F23959 TCGA-04-1346 TCGA-04-1346-01A Stage IIIC -26865 NA NA 0 1993 NA NA NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO 100 2 NA YES G2 NA NA NA NA NA TCGA-04-1346.40C05C93-8968-4FF0-855F-09E2F7FAAB68.pdf 1346 NA TUMOR FREE NO Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 04 NA Ovary NA A LIVING 2003 NA TCGA-04-1346-01 NA 3b372510-9632-40d8-a82b-d58e0a0c0ba6 NA TCGA-04-1346-01 NA TCGA-04-1346-01A-01D-0432-05 TCGA-04-1346-01A-01W-0488-09 NA TCGA-04-1346-01A-01W-0488-09 NA TCGA-04-1346-01A-01D-0428-01 TCGA-04-1346-01 NA NA TCGA-04-1346-01A-01D-0428-01 NA NA NA NA TCGA-04-1346-01 NA NA TCGA-04-1346-01A-01W-0488-09 TCGA-04-1346-01A-01R-0436-07 |
|
|
22 |
TCGA-04-1347-01 0 TCGA-04-1347-01 1919 0 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1347 NA NA days 1919 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 81 Bilateral TCGA-04-1347-F23961 TCGA-04-1347 TCGA-04-1347-01A Stage IV -29695 NA NA 0 1919 NA NA 0 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO 100 1.1 NA NO G3 NA NA NA NA NA TCGA-04-1347.18BFB10C-5EDC-4253-A2A8-93533CB4B471.pdf 1347 Preoperative TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.1 NA NA 04 No Macroscopic disease Ovary NO A LIVING 2004 NA TCGA-04-1347-01 NA 886f150b-23d2-4000-b550-e0fda444ca61 NA TCGA-04-1347-01 NA TCGA-04-1347-01A-01D-0432-05 TCGA-04-1347-01A-01W-0488-09 NA TCGA-04-1347-01A-01W-0488-09 NA TCGA-04-1347-01A-01D-0428-01 TCGA-04-1347-01 NA NA TCGA-04-1347-01A-01D-0428-01 NA NA NA NA TCGA-04-1347-01 NA NA TCGA-04-1347-01A-01W-0488-09 TCGA-04-1347-01A-01R-0436-07 |
|
|
23 |
TCGA-04-1348-01 1 TCGA-04-1348-01 1483 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1348 NA NA days 1483 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-04-1348-F23967 TCGA-04-1348 TCGA-04-1348-01A Stage IIIB -16236 NA 1483 0 NA NA 575 NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA YES G3 Recurrence NA NA NA NA TCGA-04-1348.51B558EF-C11B-41A7-A7BF-15D201506006.pdf 1348 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 0.4 NA NA 04 1-10 mm Ovary NA A DECEASED 2004 TCGA-04-1348-01 TCGA-04-1348-01 NA 6b5e9411-a6df-45a9-8281-75228283c4f4 NA TCGA-04-1348-01 NA TCGA-04-1348-01A-01D-0460-05 TCGA-04-1348-01A-01W-0494-09 TCGA-04-1348-01A-21-20 TCGA-04-1348-01A-01W-0494-09 1465139e-d1b2-4026-a532-08513fe0ad4d TCGA-04-1348-01A-01D-0452-01 TCGA-04-1348-01 21a891e7-6da2-4d9e-a1e3-e760605d9dee NA TCGA-04-1348-01A-01D-0452-01 1465139e-d1b2-4026-a532-08513fe0ad4d NA 1465139e-d1b2-4026-a532-08513fe0ad4d NA TCGA-04-1348-01 TCGA-04-1348-01 1465139e-d1b2-4026-a532-08513fe0ad4d TCGA-04-1348-01A-01W-0494-09 TCGA-04-1348-01A-01R-0456-07 |
|
|
24 |
TCGA-04-1349-01 1 TCGA-04-1349-01 656 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1349 NA NA days 656 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 69 Bilateral TCGA-04-1349-F23977 TCGA-04-1349 TCGA-04-1349-01A Stage IV -25213 NA 656 0 NA NA 428 NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.1 NA YES G3 Recurrence NA NA NA NA TCGA-04-1349.8D470D24-17DD-4180-987E-F33FA31535AE.pdf 1349 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.2 NA NA 04 NA Ovary NA A DECEASED 2004 NA TCGA-04-1349-01 NA 83332db9-57b5-40ce-ad30-cf81d48a7cd6 NA TCGA-04-1349-01 NA TCGA-04-1349-01A-01D-0460-05 TCGA-04-1349-01A-01W-0494-09 TCGA-04-1349-01A-21-20 TCGA-04-1349-01A-01W-0494-09 NA TCGA-04-1349-01A-01D-0452-01 TCGA-04-1349-01 2a143727-7310-4103-beec-3522534165fe NA TCGA-04-1349-01A-01D-0452-01 NA NA NA NA TCGA-04-1349-01 NA NA TCGA-04-1349-01A-01W-0494-09 TCGA-04-1349-01A-01R-0456-07 |
|
|
25 |
TCGA-04-1350-01 1 TCGA-04-1350-01 1946 1 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-04-1350 NA NA days 1946 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 46 Bilateral TCGA-04-1350-F23988 TCGA-04-1350 TCGA-04-1350-01A Stage IIIC -16942 NA 1946 0 NA NA 111 0 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-04-1350.C4BB615C-ABBA-4136-AAB4-52EA1FE88D14.pdf 1350 Preoperative WITH TUMOR NO Stable Disease Imaging Study NO NA Primary Tumor 01 0.4 NA NA 04 >20 mm Ovary NA A DECEASED 2003 NA TCGA-04-1350-01 TCGA-04-1350-01A-01W-0490-10 339c6cc0-96b2-4225-b3bc-6cac497c7b92 NA TCGA-04-1350-01 TCGA-04-1350-01A-01W-0490-10 TCGA-04-1350-01A-01D-0460-05 NA NA NA NA TCGA-04-1350-01A-01D-0452-01 TCGA-04-1350-01 NA NA TCGA-04-1350-01A-01D-0452-01 NA NA NA NA TCGA-04-1350-01 NA NA TCGA-04-1350-01A-01W-0490-10 TCGA-04-1350-01A-01R-0456-07 |
|
|
26 |
TCGA-04-1351-01 0 TCGA-04-1351-01 1991 0 days High NA OV-like c1 NA NA NA NA NA TCGA-04-1351 NA NA days 1991 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 NA TCGA-04-1351-F24001 TCGA-04-1351 NA Stage IIIC -28045 NA NA 0 1991 NA 1658 NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA NA NA 100 NA NA NA G2 Recurrence NA NA NA NA NA 1351 NA TUMOR FREE YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 04 NA Ovary NA NA LIVING 2004 NA NA TCGA-04-1351-01A-01W-0490-10 a8c3bbb4-24aa-4975-916a-50c6ba1f7eac NA NA TCGA-04-1351-01A-01W-0490-10 TCGA-04-1351-01A-01D-0460-05 NA NA NA NA TCGA-04-1351-01A-01D-0452-01 TCGA-04-1351-01 NA NA TCGA-04-1351-01A-01D-0452-01 NA NA NA NA TCGA-04-1351-01 NA NA NA TCGA-04-1351-01A-01R-0456-07 |
|
|
27 |
TCGA-04-1353-01 0 TCGA-04-1353-01 16 0 days High NA OV-like c1 NA NA NA NA NA TCGA-04-1353 NA NA days 16 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 64 NA TCGA-04-1353-F65201 TCGA-04-1353 NA Stage IIIC -23611 NA NA 0 16 NA NA NA Scheduled Follow-up Submission NA 2014-9-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA NA NA NA NA NO NA NA NA NA NA NA No NA 1353 NA NA NA NA NA NA NA Primary Tumor 01 NA NO YES 04 NA Ovary NA NA LIVING 2003 NA NA NA b4d1d595-41fa-4b9d-9f01-e820fdace4f6 NA NA NA TCGA-04-1353-01A-01D-1047-05 NA NA TCGA-04-1353-01A-01D-1526-09 NA TCGA-04-1353-01A-01D-1043-01 TCGA-04-1353-01 NA NA TCGA-04-1353-01A-01D-1043-01 NA NA NA NA TCGA-04-1353-01 NA NA NA TCGA-04-1353-01A-01R-1050-07 |
|
|
28 |
TCGA-04-1353-11 0 TCGA-04-1353-11 16 0 days NA NA NA NA NA NA NA NA TCGA-04-1353 NA NA days 16 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 64 NA TCGA-04-1353-F65201 TCGA-04-1353 TCGA-04-1353-11B Stage IIIC -23611 NA NA 0 16 NA NA NA Scheduled Follow-up Submission NA 2014-9-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA 0.4 NO NA 1.5 NO NA NA NA NA NA NA No NA 1353 NA NA NA NA NA NA NA Solid Tissue Normal 11 0.2 NO YES 04 NA Ovary NA B LIVING 2003 NA NA NA NA NA NA NA TCGA-04-1353-11B-01D-1047-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
29 |
TCGA-04-1356-01 1 TCGA-04-1356-01 1499 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-04-1356 NA NA days 1499 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 62 Bilateral TCGA-04-1356-F24005 TCGA-04-1356 TCGA-04-1356-01A Stage IIC -22855 NA 1499 0 NA NA 156 NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO 80 1.2 NA YES G3 Recurrence NA NA NA NA TCGA-04-1356.7D26B212-1DE7-43CC-A0DC-A9071C3A534F.pdf 1356 Preoperative WITH TUMOR NO Progressive Disease Physical Examination NO NA Primary Tumor 01 0.4 NA NA 04 NA Ovary YES A DECEASED 2004 NA TCGA-04-1356-01 NA 9e919b59-a80e-4165-ba65-02ae5c35e910 NA TCGA-04-1356-01 NA TCGA-04-1356-01A-01D-0460-05 NA TCGA-04-1356-01A-21-20 NA NA TCGA-04-1356-01A-01D-0452-01 TCGA-04-1356-01 6b9482bd-967a-447e-8f6f-324c7ec41b4d NA TCGA-04-1356-01A-01D-0452-01 NA NA NA TCGA-04-1356-01A-01W-0492-08 TCGA-04-1356-01 NA NA TCGA-04-1356-01A-01W-0492-08 TCGA-04-1356-01A-01R-0456-07 |
|
|
30 |
TCGA-04-1357-01 NA TCGA-04-1357-01 NA NA days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-04-1357 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 NA TCGA-04-1357-F24009 TCGA-04-1357 NA Stage IIIB -18999 NA NA 0 NA NA NA NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 1357 NA NA YES NA NA NO NA Primary Tumor 01 NA NA NA 04 NA Ovary NA NA LIVING 2005 TCGA-04-1357-01 TCGA-04-1357-01 NA ab3d12c9-29b5-41b0-98dd-56670fe303d9 NA TCGA-04-1357-01 NA TCGA-04-1357-01A-01D-0460-05 NA TCGA-04-1357-01A-21-20 NA ec1fc406-d1c4-4eba-ab6b-6cfb460f0862 TCGA-04-1357-01A-01D-0452-01 TCGA-04-1357-01 fcbf9267-5e2a-4a94-8851-9f7151aee4a0 NA TCGA-04-1357-01A-01D-0452-01 ec1fc406-d1c4-4eba-ab6b-6cfb460f0862 NA ec1fc406-d1c4-4eba-ab6b-6cfb460f0862 TCGA-04-1357-01A-01W-0492-08 TCGA-04-1357-01 TCGA-04-1357-01 ec1fc406-d1c4-4eba-ab6b-6cfb460f0862 TCGA-04-1357-01A-01W-0492-08 TCGA-04-1357-01A-01R-0456-07 |
|
|
31 |
TCGA-04-1360-01 NA TCGA-04-1360-01 NA NA days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-04-1360 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 65 NA TCGA-04-1360-F24011 TCGA-04-1360 TCGA-04-1360-01A Stage IA -23993 NA NA 0 NA NA NA NA NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA 0.8 NO NA 1 NA NA G3 NA NA NA NA NA TCGA-04-1360.D215D37F-D04B-44BC-AF17-D3B8C804A3E9.pdf 1360 NA NA YES NA NA NO NA Primary Tumor 01 0.4 NA NA 04 NA Ovary NA A LIVING 2005 NA NA NA 09afddf6-c527-4561-b476-cbc9bcc7ca24 NA NA NA TCGA-04-1360-01A-01D-0460-05 NA TCGA-04-1360-01A-21-20 NA NA TCGA-04-1360-01A-01D-0452-01 TCGA-04-1360-01 e470041a-5d0c-4818-8246-bd4530cc81e0 NA TCGA-04-1360-01A-01D-0452-01 NA NA NA NA TCGA-04-1360-01 NA NA NA TCGA-04-1360-01A-01R-0456-07 |
|
|
32 |
TCGA-04-1361-01 0 TCGA-04-1361-01 989 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1361 NA NA days 989 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-04-1361-F24013 TCGA-04-1361 TCGA-04-1361-01A Stage IIIB -20860 NA NA 0 989 NA 927 1 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.8 NA NA G3 Recurrence NA NA NA NA TCGA-04-1361.5116FD62-7A2C-425A-A99E-D47C1B456961.pdf 1361 NA NA YES Stable Disease Imaging Study NO NA Primary Tumor 01 0.3 NA NA 04 No Macroscopic disease Ovary NA A LIVING 2005 NA TCGA-04-1361-01 NA 874772d1-76e5-4480-9fb5-0130d66f1b3a NA TCGA-04-1361-01 NA TCGA-04-1361-01A-01D-0460-05 TCGA-04-1361-01A-01W-0494-09 TCGA-04-1361-01A-21-20 TCGA-04-1361-01A-01W-0494-09 NA TCGA-04-1361-01A-01D-0452-01 TCGA-04-1361-01 62d06e8a-aed1-4904-8651-c9912e5b1eae NA TCGA-04-1361-01A-01D-0452-01 NA NA NA NA TCGA-04-1361-01 NA NA TCGA-04-1361-01A-01W-0494-09 TCGA-04-1361-01A-01R-0456-07 |
|
|
33 |
TCGA-04-1362-01 1 TCGA-04-1362-01 1348 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-04-1362 NA NA days 1348 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-04-1362-F24020 TCGA-04-1362 TCGA-04-1362-01A Stage IIC -21745 NA 1348 0 NA NA 223 1 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-04-1362.D3757F96-E669-4D0E-BBCB-41696AB72004.pdf 1362 Pre-Adjuvant Therapy WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 0.6 NA NA 04 1-10 mm Ovary NA A DECEASED 2002 TCGA-04-1362-01 TCGA-04-1362-01 NA 9dcb2e40-d569-439e-8359-4178124447b5 NA TCGA-04-1362-01 NA TCGA-04-1362-01A-01D-0460-05 TCGA-04-1362-01A-01W-0494-09 TCGA-04-1362-01A-21-20 TCGA-04-1362-01A-01W-0494-09 802ea3c6-e07f-49a1-a1c2-8f90e3197e62 TCGA-04-1362-01A-01D-0452-01 TCGA-04-1362-01 e6a03e2b-8fcf-4ad5-9b40-be38c0b08786 NA TCGA-04-1362-01A-01D-0452-01 802ea3c6-e07f-49a1-a1c2-8f90e3197e62 NA 802ea3c6-e07f-49a1-a1c2-8f90e3197e62 NA TCGA-04-1362-01 TCGA-04-1362-01 802ea3c6-e07f-49a1-a1c2-8f90e3197e62 TCGA-04-1362-01A-01W-0494-09 TCGA-04-1362-01A-01R-0456-07 |
|
|
34 |
TCGA-04-1364-01 1 TCGA-04-1364-01 1024 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1364 NA NA days 1024 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-04-1364-F24028 TCGA-04-1364 TCGA-04-1364-01A Stage IIIC -22294 NA 1024 0 NA NA 288 1 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.2 NA NO G3 Recurrence NA NA NA NA TCGA-04-1364.CA87C9DF-D4ED-41BD-AEC9-B41C4FEC54A4.pdf 1364 Preoperative WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 0.3 NA NA 04 1-10 mm Ovary NA A DECEASED 2003 TCGA-04-1364-01 TCGA-04-1364-01 TCGA-04-1364-01A-01W-0490-10 0e23070a-25c9-49b4-8c4a-a9994de3a312 NA TCGA-04-1364-01 TCGA-04-1364-01A-01W-0490-10 TCGA-04-1364-01A-01D-0460-05 NA NA NA 2fadaf5a-402b-483d-bc26-08feb3dc162d TCGA-04-1364-01A-01D-0452-01 TCGA-04-1364-01 NA NA TCGA-04-1364-01A-01D-0452-01 2fadaf5a-402b-483d-bc26-08feb3dc162d NA 2fadaf5a-402b-483d-bc26-08feb3dc162d NA TCGA-04-1364-01 TCGA-04-1364-01 2fadaf5a-402b-483d-bc26-08feb3dc162d TCGA-04-1364-01A-01W-0490-10 TCGA-04-1364-01A-01R-0456-07 |
|
|
35 |
TCGA-04-1365-01 0 TCGA-04-1365-01 2329 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-04-1365 NA NA days 2329 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 87 Left TCGA-04-1365-F24044 TCGA-04-1365 TCGA-04-1365-01A Stage IIIB -31925 NA NA 0 2329 NA 1328 1 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.2 NA NO G3 Recurrence NA NA NA NA TCGA-04-1365.049FC54E-4D17-4B68-9E41-268529C9F18F.pdf 1365 Preoperative WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 0.6 NA NA 04 NA Ovary NA A LIVING 2003 TCGA-04-1365-01 TCGA-04-1365-01 TCGA-04-1365-01A-01W-0490-10 a64bec02-eddf-4723-90a8-6742267b4f51 NA TCGA-04-1365-01 TCGA-04-1365-01A-01W-0490-10 TCGA-04-1365-01A-01D-0460-05 NA NA NA 2535da6b-39f0-41de-afd3-82cb37916b95 TCGA-04-1365-01A-01D-0452-01 TCGA-04-1365-01 NA NA TCGA-04-1365-01A-01D-0452-01 2535da6b-39f0-41de-afd3-82cb37916b95 NA 2535da6b-39f0-41de-afd3-82cb37916b95 NA TCGA-04-1365-01 TCGA-04-1365-01 2535da6b-39f0-41de-afd3-82cb37916b95 TCGA-04-1365-01A-01W-0490-10 TCGA-04-1365-01A-01R-0456-07 |
|
|
36 |
TCGA-04-1367-01 0 TCGA-04-1367-01 3145 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-04-1367 3145 0 days 3145 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-04-1367-F62486 TCGA-04-1367 TCGA-04-1367-01A Stage IIIC -18577 NA NA 0 3145 NA 2997 0 Scheduled Follow-up Submission Progressive Disease 2014-7-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO 100 0.7 NO NO G3 Progression of Disease NA NO NA NA TCGA-04-1367.78E00062-0996-45A9-80FC-125409EE370A.pdf 1367 Preoperative WITH TUMOR NO Progressive Disease Molecular Markers NO NA Primary Tumor 01 0.5 NO YES 04 No Macroscopic disease Ovary NO A LIVING 2003 NA TCGA-04-1367-01 NA 69b2dded-5eff-448b-8220-8163c264e63b NA TCGA-04-1367-01 NA TCGA-04-1367-01A-01D-0460-05 NA NA NA NA TCGA-04-1367-01A-01D-0452-01 TCGA-04-1367-01 NA NA TCGA-04-1367-01A-01D-0452-01 NA NA NA TCGA-04-1367-01A-01W-0492-08 TCGA-04-1367-01 NA NA TCGA-04-1367-01A-01W-0492-08 TCGA-04-1367-01A-01R-0456-07 |
|
|
37 |
TCGA-04-1369-01 1 TCGA-04-1369-01 642 1 days NA NA OV-like c1 OV-like c4 NA NA NA NA TCGA-04-1369 NA NA days 642 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-04-1369-F24056 TCGA-04-1369 TCGA-04-1369-01A Stage IIIC -19571 NA 642 0 NA NA 315 0 NA NA 2010-8-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA NA G2 Progression of Disease NA NA NA NA TCGA-04-1369.5C54C779-C561-4625-B8F0-029BE2D3C91B.pdf 1369 Pre-Adjuvant Therapy WITH TUMOR YES NA Imaging Study NO R1 Primary Tumor 01 0.2 NA NA 04 1-10 mm Ovary NA A DECEASED 2004 NA NA NA 940c48c2-f75f-498a-9c40-a33d65dfbce1 NA NA NA TCGA-04-1369-01A-02D-1047-05 NA TCGA-04-1369-01A-11-1562-20 TCGA-04-1369-01A-02D-1526-09 NA NA TCGA-04-1369-01 40f6f0ca-e0e0-4c0b-96b1-3d305aa93f95 NA NA NA NA NA NA NA NA NA NA TCGA-04-1369-01A-02R-1050-07 |
|
|
38 |
TCGA-04-1369-11 1 TCGA-04-1369-11 642 1 days NA NA NA NA NA NA NA NA TCGA-04-1369 NA NA days 642 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-04-1369-F24056 TCGA-04-1369 TCGA-04-1369-11A Stage IIIC -19571 NA 642 0 NA NA 315 0 NA NA 2010-8-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.5 NA NA G2 Progression of Disease NA NA NA NA NA 1369 Pre-Adjuvant Therapy WITH TUMOR YES NA Imaging Study NO R1 Solid Tissue Normal 11 0.3 NA NA 04 1-10 mm Ovary NA A DECEASED 2004 NA NA NA NA NA NA NA TCGA-04-1369-11A-01D-1047-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
39 |
TCGA-04-1370-01 0 TCGA-04-1370-01 1824 0 days NA NA NA OV-like c4 NA NA NA NA TCGA-04-1370 NA NA days 1824 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Bilateral TCGA-04-1370-F24062 TCGA-04-1370 TCGA-04-1370-01A Stage IIIC -19329 NA NA 0 1824 NA NA 1 NA NA 2010-8-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2 NO NA 2 NA NA G3 NA NA NA NA NA TCGA-04-1370.6E990DE9-ED0A-4152-A862-866FBF8A41DE.pdf 1370 Pre-Adjuvant Therapy NA YES NA NA NO R1 Primary Tumor 01 0.3 NA NA 04 1-10 mm Ovary NA A LIVING 2004 NA NA NA NA NA NA NA NA NA TCGA-04-1370-01A-21-1562-20 NA NA NA NA 4234f147-09cf-480f-bfca-5ae6c5d338f9 NA NA NA NA NA NA NA NA NA NA NA |
|
|
40 |
TCGA-04-1371-01 0 TCGA-04-1371-01 2506 0 days High NA OV-like c1 NA NA NA NA NA TCGA-04-1371 NA NA days 2506 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-04-1371-F24066 TCGA-04-1371 NA Stage IIIC -21243 NA NA 0 2506 NA NA 0 NA NA 2009-3-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 1371 Pre-Adjuvant Therapy TUMOR FREE YES NA NA NO NA Primary Tumor 01 NA NA NA 04 1-10 mm Ovary NA NA LIVING 2001 NA NA NA bf67f8d7-e33c-4b18-9801-4b78ce0b41bb NA NA NA TCGA-04-1371-01A-01D-0460-05 NA NA NA NA TCGA-04-1371-01A-01D-0452-01 TCGA-04-1371-01 NA NA TCGA-04-1371-01A-01D-0452-01 NA NA NA NA TCGA-04-1371-01 NA NA NA TCGA-04-1371-01A-01R-0456-07 |
|
|
41 |
TCGA-04-1514-01 1 TCGA-04-1514-01 1720 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-04-1514 NA NA days 1720 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Bilateral TCGA-04-1514-F24071 TCGA-04-1514 TCGA-04-1514-01A Stage IIIA -16725 NA 1720 0 NA NA 1221 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.1 NA NO G2 Recurrence NA NA NA NA TCGA-04-1514.A0487B93-029F-48EB-AF5C-06A2F5A3FAAA.pdf 1514 Preoperative TUMOR FREE YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 04 No Macroscopic disease Ovary NA A DECEASED 2004 TCGA-04-1514-01 TCGA-04-1514-01 TCGA-04-1514-01A-01W-0552-10 c7e3fccc-4e03-4914-874c-e5034bcc6941 NA TCGA-04-1514-01 TCGA-04-1514-01A-01W-0552-10 TCGA-04-1514-01A-01D-0501-05 NA TCGA-04-1514-01A-21-1558-20 NA cc5e2498-a9e6-48be-bbda-9aa101546ca4 TCGA-04-1514-01A-01D-0497-01 TCGA-04-1514-01 8fcd1179-3170-4ca1-b961-dbaa7a391ea4 NA TCGA-04-1514-01A-01D-0497-01 cc5e2498-a9e6-48be-bbda-9aa101546ca4 NA cc5e2498-a9e6-48be-bbda-9aa101546ca4 NA TCGA-04-1514-01 TCGA-04-1514-01 cc5e2498-a9e6-48be-bbda-9aa101546ca4 TCGA-04-1514-01A-01W-0552-10 TCGA-04-1514-01A-01R-0504-07 |
|
|
42 |
TCGA-04-1516-01 0 TCGA-04-1516-01 1265 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-04-1516 NA NA days 1265 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Left TCGA-04-1516-F24087 TCGA-04-1516 TCGA-04-1516-01A Stage IA -17768 NA NA 0 1265 NA NA 0 NA NA 2010-6-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.6 NA NA G3 NA NA NA NA NA TCGA-04-1516.434BDC72-1BE6-4235-AFBA-10ADE94C8901.pdf 1516 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO R0 Primary Tumor 01 0.3 NA NA 04 No Macroscopic disease Ovary NA A LIVING 2006 NA NA NA 0c2520a9-0937-40b7-a09f-9f21a4726876 NA NA NA TCGA-04-1516-01A-01D-1047-05 NA TCGA-04-1516-01A-21-1558-20 TCGA-04-1516-01A-01D-1526-09 NA TCGA-04-1516-01A-01D-1043-01 TCGA-04-1516-01 556a186c-d6ab-4f84-9cac-2b237c3bb4fc NA TCGA-04-1516-01A-01D-1043-01 NA NA NA NA TCGA-04-1516-01 NA NA NA TCGA-04-1516-01A-01R-1050-07 |
|
|
43 |
TCGA-04-1516-11 0 TCGA-04-1516-11 1265 0 days NA NA NA NA NA NA NA NA TCGA-04-1516 NA NA days 1265 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Left TCGA-04-1516-F24087 TCGA-04-1516 TCGA-04-1516-11B Stage IA -17768 NA NA 0 1265 NA NA 0 NA NA 2010-6-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1 NA NA G3 NA NA NA NA NA NA 1516 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO R0 Solid Tissue Normal 11 0.5 NA NA 04 No Macroscopic disease Ovary NA B LIVING 2006 NA NA NA NA NA NA NA TCGA-04-1516-11B-01D-1047-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
44 |
TCGA-04-1517-01 1 TCGA-04-1517-01 608 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-04-1517 NA NA days 608 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 79 Bilateral TCGA-04-1517-F24092 TCGA-04-1517 TCGA-04-1517-01A Stage IIIC -29045 NA 608 0 NA NA 349 NA NA NA 2009-6-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.5 NA NO G3 Recurrence NA NA NA NA TCGA-04-1517.ED992763-74E1-466F-A71A-AC0455AD40F6.pdf 1517 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 04 >20 mm Ovary NO A DECEASED 2006 NA TCGA-04-1517-01 TCGA-04-1517-01A-01W-0615-10 663aa6bd-30d1-47fb-8aec-2baece0cbb87 NA TCGA-04-1517-01 TCGA-04-1517-01A-01W-0615-10 TCGA-04-1517-01A-01D-0536-05 NA TCGA-04-1517-01A-21-1558-20 NA NA TCGA-04-1517-01A-01D-0533-01 TCGA-04-1517-01 9e4ae9f4-e1ef-40a6-af24-7ea99c9beccd NA TCGA-04-1517-01A-01D-0533-01 NA NA NA NA TCGA-04-1517-01 NA NA TCGA-04-1517-01A-01W-0615-10 TCGA-04-1517-01A-01R-0540-07 |
|
|
45 |
TCGA-04-1519-01 0 TCGA-04-1519-01 24 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 NA TCGA-04-1519 NA NA days 24 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 NA TCGA-04-1519-F58470 TCGA-04-1519 TCGA-04-1519-01A Stage IIIC -17671 NA NA 0 24 NA NA NA Scheduled Follow-up Submission NA 2014-4-10 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA 0.4 NO NA 1.3 YES NA G3 NA NA NA NA NA TCGA-04-1519.53840C6E-E1AA-415E-BB85-8E1B8976F45C.pdf 1519 NA NA NA NA NA NA NA Primary Tumor 01 0.4 NA NA 04 NA Ovary NA A LIVING 2007 TCGA-04-1519-01 TCGA-04-1519-01 TCGA-04-1519-01A-01W-0615-10 87caa261-28f0-4d9d-bec5-3842c715d23a NA TCGA-04-1519-01 TCGA-04-1519-01A-01W-0615-10 TCGA-04-1519-01A-01D-0536-05 NA TCGA-04-1519-01A-21-1558-20 NA 193d3e7f-ec7f-453a-9c2a-77b240c4ba19 TCGA-04-1519-01A-01D-0533-01 TCGA-04-1519-01 0ed2d853-f94d-49d0-856b-85d54e4817f5 NA TCGA-04-1519-01A-01D-0533-01 193d3e7f-ec7f-453a-9c2a-77b240c4ba19 NA 193d3e7f-ec7f-453a-9c2a-77b240c4ba19 NA TCGA-04-1519-01 TCGA-04-1519-01 193d3e7f-ec7f-453a-9c2a-77b240c4ba19 NA TCGA-04-1519-01A-01R-0540-07 |
|
|
46 |
TCGA-04-1525-01 1 TCGA-04-1525-01 1167 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-04-1525 NA NA days 1167 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-04-1525-F24099 TCGA-04-1525 TCGA-04-1525-01A Stage IIIC -17469 NA 1167 0 1167 NA 213 NA NA NA 2009-6-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 2 NA NO G3 Recurrence NA NA NA NA TCGA-04-1525.B84E0C8B-B383-453F-9099-92B5445691D6.pdf 1525 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.2 NA NA 04 1-10 mm Ovary NO A DECEASED 2005 NA TCGA-04-1525-01 TCGA-04-1525-01A-01W-0615-10 9fffbdac-8e68-4ea7-ba2f-b2f6156e9f15 NA TCGA-04-1525-01 TCGA-04-1525-01A-01W-0615-10 TCGA-04-1525-01A-01D-0536-05 NA TCGA-04-1525-01A-21-1558-20 NA NA TCGA-04-1525-01A-01D-0533-01 TCGA-04-1525-01 1ea5f6bb-950e-4383-b76b-f3918c0a0366 NA TCGA-04-1525-01A-01D-0533-01 NA NA NA NA TCGA-04-1525-01 NA NA TCGA-04-1525-01A-01W-0615-10 TCGA-04-1525-01A-01R-0540-07 |
|
|
47 |
TCGA-04-1530-01 1 TCGA-04-1530-01 3622 1 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-04-1530 NA NA days 3622 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Bilateral TCGA-04-1530-F24104 TCGA-04-1530 TCGA-04-1530-01A Stage IIIC -25013 NA 3622 0 NA NA 350 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.4 NA NO G3 Recurrence NA NA NA NA TCGA-04-1530.6CB3AECE-ADBB-4AED-A036-2E2D28D68369.pdf 1530 NA WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 0.4 NA NA 04 1-10 mm Ovary NO A DECEASED 1995 NA TCGA-04-1530-01 TCGA-04-1530-01A-02W-0552-10 4271a8fa-e416-4274-8a37-49673f212605 NA TCGA-04-1530-01 TCGA-04-1530-01A-02W-0552-10 TCGA-04-1530-01A-02D-0501-05 NA NA NA NA TCGA-04-1530-01A-02D-0497-01 TCGA-04-1530-01 NA NA TCGA-04-1530-01A-02D-0497-01 NA NA NA NA TCGA-04-1530-01 NA NA TCGA-04-1530-01A-02W-0552-10 TCGA-04-1530-01A-02R-0504-07 |
|
|
48 |
TCGA-04-1536-01 1 TCGA-04-1536-01 885 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 4 NA TCGA-04-1536 NA NA days 885 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-04-1536-F24110 TCGA-04-1536 NA Stage IV -21939 NA 885 0 NA NA 498 0 NA NA 2009-6-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1536 NA WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 NA NA NA 04 1-10 mm Ovary NA NA DECEASED 2001 NA TCGA-04-1536-01 NA f2c0342a-1302-47ff-8615-8d3eb700e3a5 NA TCGA-04-1536-01 NA TCGA-04-1536-01A-01D-0536-05 NA NA NA NA TCGA-04-1536-01A-01D-0533-01 TCGA-04-1536-01 NA NA TCGA-04-1536-01A-01D-0533-01 NA NA NA NA TCGA-04-1536-01 NA NA NA TCGA-04-1536-01A-01R-0540-07 |
|
|
49 |
TCGA-04-1542-01 1 TCGA-04-1542-01 2561 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-04-1542 NA NA days 2561 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 Bilateral TCGA-04-1542-F24118 TCGA-04-1542 TCGA-04-1542-01A Stage IIIB -19263 NA 2561 0 NA NA 1020 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1 NA NO G2 Recurrence NA NA NA NA TCGA-04-1542.E3103C8A-50CB-43FE-9670-2BFB5D1DC318.pdf 1542 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 04 1-10 mm Ovary NA A DECEASED 2001 NA TCGA-04-1542-01 NA 7a29ab3a-5d05-47e9-bd87-2cf0285fc8a6 NA TCGA-04-1542-01 NA TCGA-04-1542-01A-01D-0501-05 TCGA-04-1542-01A-01W-0553-09 TCGA-04-1542-01A-21-1558-20 TCGA-04-1542-01A-01W-0553-09 NA TCGA-04-1542-01A-01D-0497-01 TCGA-04-1542-01 abafb551-fa90-465c-8122-6a8c2793c2d8 NA TCGA-04-1542-01A-01D-0497-01 NA NA NA NA TCGA-04-1542-01 NA NA TCGA-04-1542-01A-01W-0553-09 TCGA-04-1542-01A-01R-0504-07 |
|
|
50 |
TCGA-04-1638-01 1 TCGA-04-1638-01 1686 1 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 NA TCGA-04-1638 NA NA days 1686 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 57 NA TCGA-04-1638-F24136 TCGA-04-1638 TCGA-04-1638-01A Stage IV -20987 NA 1686 0 NA NA 298 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.6 NA NA G3 Recurrence NA NA NA NA TCGA-04-1638.5CA47F76-8E99-4594-B84C-FAC31BB42269.pdf 1638 Pre-Adjuvant Therapy TUMOR FREE YES NA Other Method NO NA Primary Tumor 01 0.3 NA NA 04 No Macroscopic disease Ovary NA A DECEASED 2002 NA TCGA-04-1638-01 NA 11e368d8-9506-45d7-90e6-3ddf23c9e903 NA TCGA-04-1638-01 NA TCGA-04-1638-01A-01D-0581-05 NA TCGA-04-1638-01A-21-1558-20 TCGA-04-1638-01A-01W-0639-09 NA TCGA-04-1638-01A-01D-0577-01 TCGA-04-1638-01 66049405-6d0c-4409-a9be-166eda4f96b6 NA TCGA-04-1638-01A-01D-0577-01 NA NA NA NA TCGA-04-1638-01 NA NA NA TCGA-04-1638-01A-01R-0584-07 |
|
|
51 |
TCGA-04-1644-01 1 TCGA-04-1644-01 1487 1 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-04-1644 NA NA days 1487 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-04-1644-F24145 TCGA-04-1644 TCGA-04-1644-01A Stage IIIC -17725 NA 1487 0 NA NA 634 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.2 NA NA G3 Progression of Disease NA NA NA NA TCGA-04-1644.7AA7FF0A-C1C4-42A1-A340-A1E03CED8DEB.pdf 1644 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 0.4 NA NA 04 >20 mm Ovary NA A DECEASED 2002 NA NA NA 5c14dcb5-1dd3-4eaa-a71a-e7b62d4698ee NA NA NA TCGA-04-1644-01B-01D-1047-05 NA TCGA-04-1644-01A-11-1562-20 TCGA-04-1644-01B-01D-1526-09 NA TCGA-04-1644-01B-01D-1043-01 TCGA-04-1644-01 3fa1c199-830d-486c-859f-2179bb86e5bf NA TCGA-04-1644-01B-01D-1043-01 NA NA NA NA TCGA-04-1644-01 NA NA NA TCGA-04-1644-01B-01R-1050-07 |
|
|
52 |
TCGA-04-1644-11 1 TCGA-04-1644-11 1487 1 days NA NA NA NA NA NA NA NA TCGA-04-1644 NA NA days 1487 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-04-1644-F24145 TCGA-04-1644 TCGA-04-1644-11A Stage IIIC -17725 NA 1487 0 NA NA 634 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.1 NA NA G3 Progression of Disease NA NA NA NA NA 1644 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Solid Tissue Normal 11 0.4 NA NA 04 >20 mm Ovary NA A DECEASED 2002 NA NA NA NA NA NA NA TCGA-04-1644-11A-01D-1047-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
53 |
TCGA-04-1646-01 1 TCGA-04-1646-01 848 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-04-1646 NA NA days 848 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-04-1646-F24152 TCGA-04-1646 NA Stage IIIC -22207 NA 848 0 NA NA 508 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1646 Pre-Adjuvant Therapy WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 NA NA NA 04 1-10 mm Ovary NA NA DECEASED 2003 NA TCGA-04-1646-01 NA d6a1fffb-cecf-4137-865c-95d7d95fae2d NA TCGA-04-1646-01 NA TCGA-04-1646-01A-01D-0581-05 NA TCGA-04-1646-01A-21-1558-20 TCGA-04-1646-01A-01W-0639-09 NA TCGA-04-1646-01A-01D-0577-01 TCGA-04-1646-01 c278e930-af50-4be7-a706-48a80e58b24f NA TCGA-04-1646-01A-01D-0577-01 NA NA NA NA TCGA-04-1646-01 NA NA NA TCGA-04-1646-01A-01R-0584-07 |
|
|
54 |
TCGA-04-1648-01 1 TCGA-04-1648-01 871 1 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-04-1648 NA NA days 871 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 NA TCGA-04-1648-F24159 TCGA-04-1648 NA Stage IIIC -21113 NA 871 0 NA NA 412 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G2 Recurrence NA NA NA NA NA 1648 Pre-Adjuvant Therapy NA YES NA Molecular Markers NO NA Primary Tumor 01 NA NA NA 04 1-10 mm Ovary NA NA DECEASED 2003 NA TCGA-04-1648-01 NA b145279e-8242-4087-9584-0519d4639d31 NA TCGA-04-1648-01 NA TCGA-04-1648-01A-01D-0581-05 NA TCGA-04-1648-01A-21-1558-20 TCGA-04-1648-01A-01W-0639-09 NA TCGA-04-1648-01A-01D-0577-01 TCGA-04-1648-01 f904c338-e425-42f1-a15e-b5eb2dcfe829 NA TCGA-04-1648-01A-01D-0577-01 NA NA NA NA TCGA-04-1648-01 NA NA NA TCGA-04-1648-01A-01R-0584-07 |
|
|
55 |
TCGA-04-1649-01 0 TCGA-04-1649-01 1966 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 NA TCGA-04-1649 NA NA days 1966 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-04-1649-F24168 TCGA-04-1649 TCGA-04-1649-01A Stage IIIC -27165 NA NA 0 1966 NA 1672 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.7 NA NA G3 Recurrence NA NA NA NA TCGA-04-1649.C0A1166D-7233-4843-A007-DDF16A45A5E8.pdf 1649 Preoperative NA NO NA Imaging Study NO NA Primary Tumor 01 0.3 NA NA 04 1-10 mm Ovary NA A LIVING 2003 NA TCGA-04-1649-01 NA 3ae3b762-3f04-450d-86db-44daec23ca9f NA TCGA-04-1649-01 NA TCGA-04-1649-01A-01D-0581-05 NA TCGA-04-1649-01A-21-1558-20 TCGA-04-1649-01A-01W-0639-09 NA TCGA-04-1649-01A-01D-0577-01 TCGA-04-1649-01 fd9ff078-e2fe-4ab6-9e62-445caba9e611 NA TCGA-04-1649-01A-01D-0577-01 NA NA NA NA TCGA-04-1649-01 NA NA NA TCGA-04-1649-01A-01R-0584-07 |
|
|
56 |
TCGA-04-1651-01 1 TCGA-04-1651-01 1102 1 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 5 NA TCGA-04-1651 NA NA days 1102 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-04-1651-F24172 TCGA-04-1651 TCGA-04-1651-01A Stage IIIC -19628 NA 1102 0 NA NA 990 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.4 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-04-1651.703BEFE1-07E0-48AE-826E-133A59F97068.pdf 1651 Pre-Adjuvant Therapy NA YES NA Imaging Study NO NA Primary Tumor 01 0.3 NA NA 04 1-10 mm Ovary NA A DECEASED 2004 NA TCGA-04-1651-01 NA 797b7d36-42e2-4f9d-9f8f-7d3fb52219ff NA TCGA-04-1651-01 NA TCGA-04-1651-01A-01D-0581-05 NA TCGA-04-1651-01A-21-1558-20 TCGA-04-1651-01A-01W-0639-09 NA TCGA-04-1651-01A-01D-0577-01 TCGA-04-1651-01 5c0f2819-0ecd-43de-aa9b-6073e34779e5 NA TCGA-04-1651-01A-01D-0577-01 NA NA NA NA TCGA-04-1651-01 NA NA NA TCGA-04-1651-01A-01R-0584-07 |
|
|
57 |
TCGA-04-1652-01 1 TCGA-04-1652-01 969 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 2 NA TCGA-04-1652 NA NA days 969 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Right TCGA-04-1652-F24179 TCGA-04-1652 NA Stage IIIC -28101 NA 969 0 NA NA 880 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NO G2 Recurrence NA NA NA NA NA 1652 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 NA NA NA 04 NA Ovary NO NA DECEASED 2004 NA TCGA-04-1652-01 NA dd1addbf-ba25-418f-98d9-efe155026fdd NA TCGA-04-1652-01 NA TCGA-04-1652-01A-01D-0581-05 NA NA TCGA-04-1652-01A-01W-0639-09 NA TCGA-04-1652-01A-01D-0577-01 TCGA-04-1652-01 NA NA TCGA-04-1652-01A-01D-0577-01 NA NA NA NA TCGA-04-1652-01 NA NA NA TCGA-04-1652-01A-01R-0584-07 |
|
|
58 |
TCGA-04-1654-01 1 TCGA-04-1654-01 1451 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-04-1654 NA NA days 1451 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 69 Bilateral TCGA-04-1654-F24185 TCGA-04-1654 TCGA-04-1654-01A Stage IIIC -25387 NA 1451 0 NA NA 808 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.8 NO NA 1.2 NA NA G2 Recurrence NA NA NA NA TCGA-04-1654.E6F4CDD1-DD1B-4C69-8A9F-0DCA88F8C539.pdf 1654 Pre-Adjuvant Therapy NA YES NA Imaging Study NO NA Primary Tumor 01 0.3 NA NA 04 1-10 mm Ovary NA A DECEASED 1999 NA TCGA-04-1654-01 NA bf9a9a62-9471-41f7-b10f-35a1316f63c3 NA TCGA-04-1654-01 NA TCGA-04-1654-01A-02D-0652-05 NA TCGA-04-1654-01A-11-1562-20 NA NA TCGA-04-1654-01A-02D-0648-01 TCGA-04-1654-01 2b44138a-955e-46f3-bf8e-c8ace62e6389 NA TCGA-04-1654-01A-02D-0648-01 NA NA NA NA TCGA-04-1654-01 NA NA NA TCGA-04-1654-01A-02R-0655-07 |
|
|
59 |
TCGA-04-1655-01 1 TCGA-04-1655-01 1380 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 NA TCGA-04-1655 NA NA days 1380 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-04-1655-F24191 TCGA-04-1655 TCGA-04-1655-01A Stage IIIB -17988 NA 1380 0 NA NA 819 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO NA 1.1 NA NA G2 Recurrence NA NA NA NA TCGA-04-1655.D808763E-D67C-460C-B5D6-85CC5C1C05BC.pdf 1655 Pre-Adjuvant Therapy NA YES NA Physical Examination NO NA Primary Tumor 01 0.4 NA NA 04 No Macroscopic disease Ovary NA A DECEASED 1999 NA TCGA-04-1655-01 NA 461a33bb-1055-403e-b7e0-7f16d1c10f7b NA TCGA-04-1655-01 NA TCGA-04-1655-01A-01D-0563-05 NA NA TCGA-04-1655-01A-01W-0633-09 NA TCGA-04-1655-01A-01D-0559-01 TCGA-04-1655-01 NA NA TCGA-04-1655-01A-01D-0559-01 NA NA NA NA TCGA-04-1655-01 NA NA NA TCGA-04-1655-01A-01R-0566-07 |
|
|
60 |
TCGA-09-0364-01 1 TCGA-09-0364-01 887 1 days Squamous NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-09-0364 NA NA days 887 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 80 Right TCGA-09-0364-F24198 TCGA-09-0364 TCGA-09-0364-01A Stage IIC -29262 NA 887 0 NA NA 395 NA NA NA 2009-3-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NO NA NA NA NO G3 Recurrence NA NA NA NA TCGA-09-0364.27b9efd3-7748-4deb-96a2-3869a19bfa6f.pdf 0364 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 09 11-20 mm Ovary NO A DECEASED 1998 TCGA-09-0364-01 TCGA-09-0364-01 TCGA-09-0364-01A-02W-0370-10 0ba4e8de-0013-421a-8605-efb4f3ebfc0a NA TCGA-09-0364-01 TCGA-09-0364-01A-02W-0370-10 TCGA-09-0364-01A-02D-0359-05 NA NA NA 2d0702a8-bf85-458e-879c-ebc03a2aa3d1 TCGA-09-0364-01A-02D-0356-01 TCGA-09-0364-01 NA NA TCGA-09-0364-01A-02D-0356-01 2d0702a8-bf85-458e-879c-ebc03a2aa3d1 NA 2d0702a8-bf85-458e-879c-ebc03a2aa3d1 NA TCGA-09-0364-01 TCGA-09-0364-01 2d0702a8-bf85-458e-879c-ebc03a2aa3d1 NA NA TCGA-09-0364-01A-02R-0363-07 |
|
|
61 |
TCGA-09-0365-01 1 TCGA-09-0365-01 288 1 days GBM NA OV-like c1 NA NA NA NA NA TCGA-09-0365 NA NA days 288 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Left TCGA-09-0365-F24203 TCGA-09-0365 TCGA-09-0365-01A Stage IIIC -25703 NA 288 0 NA NA 251 NA NA NA 2009-3-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NO NA NA NA NO G3 Recurrence NA NA NA NA TCGA-09-0365.459f8df7-b386-47c6-bf17-73af831441d4.pdf 0365 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 09 No Macroscopic disease Ovary NO A DECEASED 1999 NA NA NA 16f6b497-da7d-4156-9b83-dda375a1c04f NA NA NA TCGA-09-0365-01A-02D-0359-05 NA NA NA NA TCGA-09-0365-01A-02D-0356-01 TCGA-09-0365-01 NA NA TCGA-09-0365-01A-02D-0356-01 NA NA NA NA TCGA-09-0365-01 NA NA NA NA TCGA-09-0365-01A-02R-0363-07 |
|
|
62 |
TCGA-09-0366-01 1 TCGA-09-0366-01 1757 1 days BRCA-LUAD+ C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-09-0366 NA NA days 1757 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-09-0366-F24207 TCGA-09-0366 NA Stage IIIC -20440 NA 1757 0 NA NA 190 NA NA NA 2009-3-4 FEMALE Serous Cystadenocarcinoma No C48.1 8441/3 C48.1 YES Tumor resection NA NA NA NA NA NA NO G3 Recurrence NA NA NA NA NA 0366 NA WITH TUMOR YES Stable Disease Imaging Study NO NA Primary Tumor 01 NA NA NA 09 1-10 mm Ovary NO NA DECEASED 1999 TCGA-09-0366-01 TCGA-09-0366-01 NA e091ea57-ec3e-4357-8929-b4e149dfa3f5 NA TCGA-09-0366-01 NA TCGA-09-0366-01A-01D-0359-05 TCGA-09-0366-01A-01W-0372-09 NA TCGA-09-0366-01A-01W-0372-09 cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7 TCGA-09-0366-01A-01D-0356-01 TCGA-09-0366-01 NA NA TCGA-09-0366-01A-01D-0356-01 cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7 NA cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7 NA TCGA-09-0366-01 TCGA-09-0366-01 cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7 TCGA-09-0366-01A-01W-0372-09 NA TCGA-09-0366-01A-01R-0363-07 |
|
|
63 |
TCGA-09-0367-01 1 TCGA-09-0367-01 547 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-09-0367 NA NA days 547 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 67 Bilateral TCGA-09-0367-F24212 TCGA-09-0367 TCGA-09-0367-01A Stage IIIC -24473 NA 547 0 NA NA NA NA NA NA 2009-3-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NO NA NA NA YES G3 NA NA NA NA NA TCGA-09-0367.8a24fe8a-9f7f-4fbf-86c7-704427ccaf89.pdf 0367 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 NA NA NA 09 1-10 mm Ovary YES A DECEASED 2001 TCGA-09-0367-01 TCGA-09-0367-01 NA 129c93c0-eb2f-47c5-acdc-4fd083e9dc8a NA TCGA-09-0367-01 NA TCGA-09-0367-01A-01D-0359-05 NA NA NA 047e04aa-6a91-4535-b279-50430098e638 TCGA-09-0367-01A-01D-0356-01 TCGA-09-0367-01 NA NA TCGA-09-0367-01A-01D-0356-01 047e04aa-6a91-4535-b279-50430098e638 NA 047e04aa-6a91-4535-b279-50430098e638 NA TCGA-09-0367-01 TCGA-09-0367-01 047e04aa-6a91-4535-b279-50430098e638 NA NA TCGA-09-0367-01A-01R-0363-07 |
|
|
64 |
TCGA-09-0369-01 1 TCGA-09-0369-01 1082 1 days High C9-OV OV-like c1 NA OV-like c16 NA NA mutation cluster 5 TCGA-09-0369 NA NA days 1082 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Left TCGA-09-0369-F24217 TCGA-09-0369 TCGA-09-0369-01A Stage IIIC -20705 NA 1082 0 NA NA 274 NA NA NA 2009-3-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NO NA NA NA YES G3 Recurrence NA NA NA NA TCGA-09-0369.c052e190-b5c2-44bf-b5b0-2b37cde18cee.pdf 0369 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 09 No Macroscopic disease Ovary YES A DECEASED 2003 TCGA-09-0369-01 NA NA 11197914-6f55-4542-9138-ad6b451c3350 NA NA NA TCGA-09-0369-01A-01D-0359-05 TCGA-09-0369-01A-01W-0372-09 NA TCGA-09-0369-01A-01W-0372-09 1f972766-2f58-4d41-b84c-3493ef2dd0c4 TCGA-09-0369-01A-01D-0356-01 TCGA-09-0369-01 NA NA TCGA-09-0369-01A-01D-0356-01 1f972766-2f58-4d41-b84c-3493ef2dd0c4 NA 1f972766-2f58-4d41-b84c-3493ef2dd0c4 NA TCGA-09-0369-01 TCGA-09-0369-01 1f972766-2f58-4d41-b84c-3493ef2dd0c4 TCGA-09-0369-01A-01W-0372-09 NA TCGA-09-0369-01A-01R-0363-07 |
|
|
65 |
TCGA-09-1659-01 1 TCGA-09-1659-01 304 1 days High NA OV-like c1 NA NA NA NA mutation cluster 5 TCGA-09-1659 NA NA days 304 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-09-1659-F24226 TCGA-09-1659 TCGA-09-1659-01B Stage IIIC -18733 NA 304 0 NA NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA YES G3 NA NA NA NA NA TCGA-09-1659.f10b2e12-02b2-42e0-a5b2-a02c1daabbdf.pdf 1659 NA WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.4 NA NA 09 >20 mm Ovary NO B DECEASED 1997 TCGA-09-1659-01 NA TCGA-09-1659-01B-01W-0615-10 5203ba2e-518a-4492-8f15-25182bff1dec NA NA TCGA-09-1659-01B-01W-0615-10 TCGA-09-1659-01B-01D-0536-05 NA NA NA 32d5209e-2ef2-4ef0-b902-585542d7d16b TCGA-09-1659-01B-01D-0533-01 TCGA-09-1659-01 NA NA TCGA-09-1659-01B-01D-0533-01 32d5209e-2ef2-4ef0-b902-585542d7d16b NA 32d5209e-2ef2-4ef0-b902-585542d7d16b NA TCGA-09-1659-01 TCGA-09-1659-01 32d5209e-2ef2-4ef0-b902-585542d7d16b TCGA-09-1659-01B-01W-0615-10 TCGA-09-1659-01B-01R-0540-07 |
|
|
66 |
TCGA-09-1661-01 1 TCGA-09-1661-01 1169 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-09-1661 NA NA days 1169 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 75 Right TCGA-09-1661-F24233 TCGA-09-1661 TCGA-09-1661-01B Stage IIIC -27486 NA 1169 0 NA NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.6 NA NO G3 NA NA NA NA NA TCGA-09-1661.1910251f-8c5c-4067-91dc-87bfdaf77283.pdf 1661 NA WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.1 NA NA 09 1-10 mm Ovary NO B DECEASED 2000 NA TCGA-09-1661-01 TCGA-09-1661-01B-01W-0615-10 956ee2ec-8a47-417a-a82b-dc4c91f9cf46 NA TCGA-09-1661-01 TCGA-09-1661-01B-01W-0615-10 TCGA-09-1661-01B-01D-0536-05 NA NA NA NA TCGA-09-1661-01B-01D-0533-01 TCGA-09-1661-01 NA NA TCGA-09-1661-01B-01D-0533-01 NA NA NA NA TCGA-09-1661-01 NA NA TCGA-09-1661-01B-01W-0615-10 TCGA-09-1661-01B-01R-0540-07 |
|
|
67 |
TCGA-09-1662-01 1 TCGA-09-1662-01 2717 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-09-1662 NA NA days 2717 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Left TCGA-09-1662-F24243 TCGA-09-1662 TCGA-09-1662-01A Stage IV -21246 NA 2717 0 NA NA 1046 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.5 NA YES G3 Recurrence NA NA NA NA TCGA-09-1662.8e2676a4-2ac3-42af-be7d-cf74b6d82f2f.pdf 1662 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 09 1-10 mm Ovary YES A DECEASED 2001 TCGA-09-1662-01 TCGA-09-1662-01 TCGA-09-1662-01A-01W-0615-10 0fc0fc51-c5b7-428e-92c6-d55c8514b689 NA TCGA-09-1662-01 TCGA-09-1662-01A-01W-0615-10 TCGA-09-1662-01A-01D-0536-05 NA TCGA-09-1662-01A-21-1558-20 NA 759060d9-af2e-4098-b4ee-7aa2214acba8 TCGA-09-1662-01A-01D-0533-01 TCGA-09-1662-01 253b785e-f10b-4d0e-88cb-4db4a3610c7c NA TCGA-09-1662-01A-01D-0533-01 759060d9-af2e-4098-b4ee-7aa2214acba8 NA 759060d9-af2e-4098-b4ee-7aa2214acba8 NA TCGA-09-1662-01 TCGA-09-1662-01 759060d9-af2e-4098-b4ee-7aa2214acba8 TCGA-09-1662-01A-01W-0615-10 TCGA-09-1662-01A-01R-0540-07 |
|
|
68 |
TCGA-09-1664-01 1 TCGA-09-1664-01 2279 1 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-09-1664 NA NA days 2279 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 37 Bilateral TCGA-09-1664-F24268 TCGA-09-1664 NA Stage IIIC -13739 NA 2279 0 NA NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NO G1 NA NA NA NA NA NA 1664 NA NA YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 09 1-10 mm Ovary NO NA DECEASED 2002 NA NA NA ab246047-1519-4cd8-b1c5-abb4ef58697a NA NA NA TCGA-09-1664-01A-01D-0581-05 NA TCGA-09-1664-01A-21-1558-20 TCGA-09-1664-01A-01W-0639-09 NA TCGA-09-1664-01A-01D-0577-01 TCGA-09-1664-01 e2007adb-55b1-4b8b-99c0-4e6a61a2da29 NA TCGA-09-1664-01A-01D-0577-01 NA NA NA NA TCGA-09-1664-01 NA NA NA TCGA-09-1664-01A-01R-0584-07 |
|
|
69 |
TCGA-09-1665-01 1 TCGA-09-1665-01 1266 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-09-1665 NA NA days 1266 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 73 Left TCGA-09-1665-F24272 TCGA-09-1665 TCGA-09-1665-01B Stage IIIC -27010 NA 1266 0 NA NA 468 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA YES G2 Recurrence NA NA NA NA TCGA-09-1665.0e311879-9b25-453d-b41a-7cc3048bb05e.pdf 1665 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 09 No Macroscopic disease Ovary YES B DECEASED 2002 NA TCGA-09-1665-01 TCGA-09-1665-01B-01W-0615-10 5b880786-e40d-41ff-9fee-f542f1b5a27c NA TCGA-09-1665-01 TCGA-09-1665-01B-01W-0615-10 TCGA-09-1665-01B-01D-0536-05 NA TCGA-09-1665-01B-21-1558-20 NA NA TCGA-09-1665-01B-01D-0533-01 TCGA-09-1665-01 a565c52a-a226-47db-b68c-d579055e4c06 NA TCGA-09-1665-01B-01D-0533-01 NA NA NA NA TCGA-09-1665-01 NA NA TCGA-09-1665-01B-01W-0615-10 TCGA-09-1665-01B-01R-0540-07 |
|
|
70 |
TCGA-09-1666-01 0 TCGA-09-1666-01 1752 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-09-1666 NA NA days 1752 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-09-1666-F24279 TCGA-09-1666 TCGA-09-1666-01A Stage IIIC -21066 NA NA 0 1752 NA 480 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA NO G3 Recurrence NA NA NA NA TCGA-09-1666.2de50dd9-b607-4a87-baae-468c4bf43205.pdf 1666 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 09 No Macroscopic disease Ovary NO A LIVING 2003 TCGA-09-1666-01 TCGA-09-1666-01 TCGA-09-1666-01A-01W-0615-10 fc1d50d5-b097-41f0-a9b2-0efd207d6ebd NA TCGA-09-1666-01 TCGA-09-1666-01A-01W-0615-10 TCGA-09-1666-01A-01D-0536-05 NA TCGA-09-1666-01A-21-1558-20 NA 529b7dd2-075c-4e93-b8c8-6990d3297c30 TCGA-09-1666-01A-01D-0533-01 TCGA-09-1666-01 aa4fad88-9a21-4085-9ac7-21b349113168 NA TCGA-09-1666-01A-01D-0533-01 529b7dd2-075c-4e93-b8c8-6990d3297c30 NA 529b7dd2-075c-4e93-b8c8-6990d3297c30 NA TCGA-09-1666-01 TCGA-09-1666-01 529b7dd2-075c-4e93-b8c8-6990d3297c30 TCGA-09-1666-01A-01W-0615-10 TCGA-09-1666-01A-01R-0540-07 |
|
|
71 |
TCGA-09-1667-01 0 TCGA-09-1667-01 1882 0 days High NA OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-09-1667 NA NA days 1882 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Bilateral TCGA-09-1667-F24292 TCGA-09-1667 TCGA-09-1667-01C Stage IIC -22306 NA NA 0 1882 NA 460 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1 NA NO G2 Recurrence NA NA NA NA TCGA-09-1667.0f3fbc34-6dce-467f-a837-442815ebc159.pdf 1667 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 09 No Macroscopic disease Ovary NO C LIVING 2004 TCGA-09-1667-01 TCGA-09-1667-01 NA 64fbf0df-6693-4ea5-a868-925636d9d20f NA TCGA-09-1667-01 NA TCGA-09-1667-01C-01D-0536-05 NA NA NA 9b7a1eb0-014f-4cd6-bde8-fd96131fac3e TCGA-09-1667-01C-01D-0533-01 TCGA-09-1667-01 NA NA TCGA-09-1667-01C-01D-0533-01 9b7a1eb0-014f-4cd6-bde8-fd96131fac3e NA 9b7a1eb0-014f-4cd6-bde8-fd96131fac3e NA TCGA-09-1667-01 TCGA-09-1667-01 9b7a1eb0-014f-4cd6-bde8-fd96131fac3e NA TCGA-09-1667-01C-01R-0540-07 |
|
|
72 |
TCGA-09-1668-01 0 TCGA-09-1668-01 1684 0 days Squamous NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-09-1668 NA NA days 1684 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Right TCGA-09-1668-F24300 TCGA-09-1668 TCGA-09-1668-01B Stage IIIC -20972 NA NA 0 1684 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 0.7 NA NO G3 NA NA NA NA NA TCGA-09-1668.7740b3ec-1d81-4408-be9e-45ccd7e91b3a.pdf 1668 NA WITH TUMOR YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 09 NA Ovary NO B LIVING 2004 TCGA-09-1668-01 TCGA-09-1668-01 NA fe849a8b-cfb0-44a3-a264-75ccef069be3 NA TCGA-09-1668-01 NA TCGA-09-1668-01B-01D-0536-05 NA NA NA 66894abe-8af5-4fd9-9a59-cf24e57fc07f TCGA-09-1668-01B-01D-0533-01 TCGA-09-1668-01 NA NA TCGA-09-1668-01B-01D-0533-01 66894abe-8af5-4fd9-9a59-cf24e57fc07f NA 66894abe-8af5-4fd9-9a59-cf24e57fc07f NA TCGA-09-1668-01 TCGA-09-1668-01 66894abe-8af5-4fd9-9a59-cf24e57fc07f NA TCGA-09-1668-01B-01R-0540-07 |
|
|
73 |
TCGA-09-1669-01 0 TCGA-09-1669-01 928 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-09-1669 NA NA days 928 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 54 Right TCGA-09-1669-F24305 TCGA-09-1669 TCGA-09-1669-01A Stage IIIA -20052 NA NA 0 928 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.9 NA NO G3 NA NA NA NA NA TCGA-09-1669.7870b5a7-a96c-4e55-b56f-8eca45918251.pdf 1669 NA WITH TUMOR YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 09 No Macroscopic disease Ovary NO A LIVING 2004 TCGA-09-1669-01 TCGA-09-1669-01 TCGA-09-1669-01A-01W-0615-10 01119e56-c4b0-4d4f-876c-fd34e4185af3 NA TCGA-09-1669-01 TCGA-09-1669-01A-01W-0615-10 TCGA-09-1669-01A-01D-0536-05 NA NA NA a56ccd4c-1959-44a9-968d-57e6c5bc0cf8 TCGA-09-1669-01A-01D-0533-01 TCGA-09-1669-01 NA NA TCGA-09-1669-01A-01D-0533-01 a56ccd4c-1959-44a9-968d-57e6c5bc0cf8 NA a56ccd4c-1959-44a9-968d-57e6c5bc0cf8 NA TCGA-09-1669-01 TCGA-09-1669-01 a56ccd4c-1959-44a9-968d-57e6c5bc0cf8 TCGA-09-1669-01A-01W-0615-10 TCGA-09-1669-01A-01R-0540-07 |
|
|
74 |
TCGA-09-1670-01 0 TCGA-09-1670-01 547 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 NA TCGA-09-1670 NA NA days 547 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-09-1670-F24309 TCGA-09-1670 TCGA-09-1670-01A Stage IIIA -21147 NA NA 0 547 NA 547 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.6 NA NO G3 Recurrence NA NA NA NA TCGA-09-1670.5cc85cd9-99c4-4087-bdc5-8039b0369538.pdf 1670 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 09 No Macroscopic disease Ovary NO A LIVING 2005 TCGA-09-1670-01 TCGA-09-1670-01 NA 99b305e7-c4d7-4174-955d-7618d91f84d0 NA TCGA-09-1670-01 NA TCGA-09-1670-01A-01D-0563-05 NA TCGA-09-1670-01A-21-1558-20 TCGA-09-1670-01A-01W-0633-09 eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4 TCGA-09-1670-01A-01D-0559-01 TCGA-09-1670-01 950ea36f-87d6-4730-b11d-e8eae3e0fe79 NA TCGA-09-1670-01A-01D-0559-01 eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4 NA eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4 NA TCGA-09-1670-01 TCGA-09-1670-01 eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4 NA TCGA-09-1670-01A-01R-0566-07 |
|
|
75 |
TCGA-09-1672-01 0 TCGA-09-1672-01 178 0 days BRCA-LUAD+ NA OV-like c1 NA NA NA NA NA TCGA-09-1672 NA NA days 178 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Right TCGA-09-1672-F24314 TCGA-09-1672 TCGA-09-1672-01A Stage IIIC -28556 NA NA 0 178 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA YES G1 NA NA NA NA NA TCGA-09-1672.103ad514-77dc-42fd-8cf2-31e9de128a74.pdf 1672 NA TUMOR FREE YES NA NA NO NA Primary Tumor 01 0.3 NA NA 09 NA Ovary YES A LIVING 2008 NA NA NA 67029a85-41d6-41a6-844e-cecf63941f3e NA NA NA TCGA-09-1672-01A-01D-0563-05 NA NA TCGA-09-1672-01A-01W-0633-09 NA TCGA-09-1672-01A-01D-0559-01 TCGA-09-1672-01 NA NA TCGA-09-1672-01A-01D-0559-01 NA NA NA NA TCGA-09-1672-01 NA NA NA TCGA-09-1672-01A-01R-0566-07 |
|
|
76 |
TCGA-09-1673-01 0 TCGA-09-1673-01 92 0 days High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-09-1673 NA NA days 92 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 50 Bilateral TCGA-09-1673-F24318 TCGA-09-1673 TCGA-09-1673-01A Stage IV -18599 NA NA 0 92 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 3 NA YES G3 NA NA NA NA NA TCGA-09-1673.d4f7aa96-11e8-4d66-a1be-595ec22de450.pdf 1673 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.6 NA NA 09 >20 mm Ovary YES A LIVING 2008 TCGA-09-1673-01 TCGA-09-1673-01 NA f45664bd-409f-4819-bb3f-b16ce74e7d9c NA TCGA-09-1673-01 NA TCGA-09-1673-01A-01D-0563-05 NA TCGA-09-1673-01A-21-1558-20 TCGA-09-1673-01A-01W-0633-09 37037dcf-fa69-4cd3-b83d-e474d69059b4 TCGA-09-1673-01A-01D-0559-01 TCGA-09-1673-01 ca0ee85f-6e38-447b-b232-49812c6e2a97 NA TCGA-09-1673-01A-01D-0559-01 37037dcf-fa69-4cd3-b83d-e474d69059b4 NA 37037dcf-fa69-4cd3-b83d-e474d69059b4 NA TCGA-09-1673-01 TCGA-09-1673-01 37037dcf-fa69-4cd3-b83d-e474d69059b4 NA TCGA-09-1673-01A-01R-0566-07 |
|
|
77 |
TCGA-09-1674-01 0 TCGA-09-1674-01 260 0 days High C9-OV OV-like c1 UCEC-like c5 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-09-1674 NA NA days 260 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 79 Bilateral TCGA-09-1674-F24322 TCGA-09-1674 TCGA-09-1674-01A Stage IIIC -28878 NA NA 0 260 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 2.1 NA NO G3 NA NA NA NA NA TCGA-09-1674.d8e0ddd2-304d-4f5e-9225-2cd88ae9984e.pdf 1674 NA WITH TUMOR YES Complete Remission/Response NA NO NA Primary Tumor 01 0.7 NA NA 09 1-10 mm Ovary NO A LIVING 2008 TCGA-09-1674-01 TCGA-09-1674-01 NA 995f3a5f-4e3d-4e69-a473-4b53da943923 NA TCGA-09-1674-01 NA TCGA-09-1674-01A-01D-0563-05 NA TCGA-09-1674-01A-21-1558-20 TCGA-09-1674-01A-01W-0633-09 3a81f083-56dc-48a5-be8d-b69a146db93b TCGA-09-1674-01A-01D-0559-01 TCGA-09-1674-01 872b7aec-febf-4104-8269-bfb0c72fbeec NA TCGA-09-1674-01A-01D-0559-01 3a81f083-56dc-48a5-be8d-b69a146db93b NA 3a81f083-56dc-48a5-be8d-b69a146db93b NA TCGA-09-1674-01 TCGA-09-1674-01 3a81f083-56dc-48a5-be8d-b69a146db93b NA TCGA-09-1674-01A-01R-0566-07 |
|
|
78 |
TCGA-09-1675-01 0 TCGA-09-1675-01 2967 0 days Squamous NA OV-like c1 NA NA NA NA NA TCGA-09-1675 NA NA days 2967 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 50 Left TCGA-09-1675-F24326 TCGA-09-1675 TCGA-09-1675-01B Stage IC -18596 NA NA 0 2967 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1.1 NA NO G2 NA NA NA NA NA TCGA-09-1675.f981f103-fc2d-4f41-9f71-015f194391f5.pdf 1675 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.1 NA NA 09 No Macroscopic disease Ovary NO B LIVING 2001 NA NA NA 690beb52-7ca9-448a-a134-7317be4f8289 NA NA NA TCGA-09-1675-01B-01D-0563-05 NA NA TCGA-09-1675-01B-01W-0633-09 NA TCGA-09-1675-01B-01D-0559-01 TCGA-09-1675-01 NA NA TCGA-09-1675-01B-01D-0559-01 NA NA NA NA TCGA-09-1675-01 NA NA NA TCGA-09-1675-01B-01R-0566-07 |
|
|
79 |
TCGA-09-2043-01 0 TCGA-09-2043-01 188 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-09-2043 NA NA days 188 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 69 Left TCGA-09-2043-F24332 TCGA-09-2043 TCGA-09-2043-01A Stage IC -25480 NA NA 0 188 NA NA NA NA NA 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 2 NA NO G3 NA NA NA NA NA TCGA-09-2043.1fa4e0b8-344f-4ebb-b150-c3ace0ec4a00.pdf 2043 NA TUMOR FREE NO Complete Remission/Response NA NO NA Primary Tumor 01 0.1 NA NA 09 No Macroscopic disease Ovary NO A LIVING 2009 NA NA NA dec0d15f-9489-4987-83ff-3613cf21c379 NA NA NA TCGA-09-2043-01A-01D-0708-05 NA TCGA-09-2043-01A-21-1560-20 NA NA TCGA-09-2043-01A-01D-0704-01 TCGA-09-2043-01 066f35fb-d0a8-4968-acf1-1da9ec81748e NA TCGA-09-2043-01A-01D-0704-01 NA NA NA NA TCGA-09-2043-01 NA NA NA TCGA-09-2043-01A-01R-0711-07 |
|
|
80 |
TCGA-09-2044-01 0 TCGA-09-2044-01 186 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 13 TCGA-09-2044 NA NA days 186 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 77 Right TCGA-09-2044-F24334 TCGA-09-2044 TCGA-09-2044-01B Stage IIB -28231 NA NA 0 186 NA NA NA NA NA 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.4 NO NA 1.8 NA NO G3 NA NA NA NA NA TCGA-09-2044.42d7c4ad-b379-4dc0-ba67-16aa6ead89d9.pdf 2044 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 09 No Macroscopic disease Ovary NO B LIVING 2009 TCGA-09-2044-01 TCGA-09-2044-01 NA 0b4c7448-2729-45db-b1b2-0fba79016c76 NA TCGA-09-2044-01 NA TCGA-09-2044-01B-01D-0708-05 NA TCGA-09-2044-01B-21-1560-20 NA 658b4847-33bc-414c-a2bb-ce9379ef57bd TCGA-09-2044-01B-01D-0704-01 TCGA-09-2044-01 32c1a264-b1dd-4307-ab4d-f710ea9692cc NA TCGA-09-2044-01B-01D-0704-01 658b4847-33bc-414c-a2bb-ce9379ef57bd NA 658b4847-33bc-414c-a2bb-ce9379ef57bd TCGA-09-2044-01B-01W-0799-08 TCGA-09-2044-01 TCGA-09-2044-01 658b4847-33bc-414c-a2bb-ce9379ef57bd TCGA-09-2044-01B-01W-0799-08 TCGA-09-2044-01B-01R-0711-07 |
|
|
81 |
TCGA-09-2045-01 1 TCGA-09-2045-01 1069 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 8 TCGA-09-2045 NA NA days 1069 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-09-2045-F24338 TCGA-09-2045 TCGA-09-2045-01A Stage IV -18285 NA 1069 0 NA NA 631 NA NA NA 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.5 NA YES G2 Recurrence NA NA NA NA TCGA-09-2045.6c826e9d-b1aa-4c84-b294-c8fb41818da1.pdf 2045 NA WITH TUMOR YES Stable Disease Physical Examination NO NA Primary Tumor 01 0.4 NA NA 09 1-10 mm Ovary YES A DECEASED 1996 TCGA-09-2045-01 TCGA-09-2045-01 NA 4456d296-bac1-461d-bda9-d3c52aba590c NA TCGA-09-2045-01 NA TCGA-09-2045-01A-01D-0708-05 NA TCGA-09-2045-01A-21-1560-20 NA 7b412fd9-4414-440f-b768-70666037c768 TCGA-09-2045-01A-01D-0704-01 TCGA-09-2045-01 51c5bf06-26be-471c-927c-1cb07bf10a2b NA TCGA-09-2045-01A-01D-0704-01 7b412fd9-4414-440f-b768-70666037c768 NA 7b412fd9-4414-440f-b768-70666037c768 TCGA-09-2045-01A-01W-0799-08 TCGA-09-2045-01 TCGA-09-2045-01 7b412fd9-4414-440f-b768-70666037c768 TCGA-09-2045-01A-01W-0799-08 TCGA-09-2045-01A-01R-0711-07 |
|
|
82 |
TCGA-09-2048-01 1 TCGA-09-2048-01 138 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-09-2048 NA NA days 138 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Bilateral TCGA-09-2048-F24351 TCGA-09-2048 TCGA-09-2048-01A Stage IIIC -23043 NA 138 0 NA NA NA NA NA NA 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1 NA YES G3 NA NA NA NA NA TCGA-09-2048.0755D708-ADF5-4219-ABC6-BCD9C2BCA089.pdf 2048 NA WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.2 NA NA 09 1-10 mm Ovary YES A DECEASED 1999 TCGA-09-2048-01 TCGA-09-2048-01 NA 8d5f3a67-69eb-49b0-a1bc-f626eb70c76f NA TCGA-09-2048-01 NA TCGA-09-2048-01A-01D-0708-05 NA NA NA d3220bce-1bf3-47c4-951f-937dac7581be TCGA-09-2048-01A-01D-0704-01 TCGA-09-2048-01 NA NA TCGA-09-2048-01A-01D-0704-01 d3220bce-1bf3-47c4-951f-937dac7581be NA d3220bce-1bf3-47c4-951f-937dac7581be NA TCGA-09-2048-01 TCGA-09-2048-01 d3220bce-1bf3-47c4-951f-937dac7581be NA TCGA-09-2048-01A-01R-0711-07 |
|
|
83 |
TCGA-09-2049-01 0 TCGA-09-2049-01 3419 0 days High C9-OV OV-like c1 OV-like c4 NA NA NA mutation cluster 8 TCGA-09-2049 NA NA days 3419 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Left TCGA-09-2049-F24354 TCGA-09-2049 TCGA-09-2049-01D Stage IIIC -23410 NA NA 0 3419 NA 953 NA NA NA 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-09-2049.17564604-ce57-4087-887a-f97a5b280b26.pdf 2049 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 09 >20 mm Ovary NO D LIVING 1999 NA NA NA 870e7182-fd31-4863-b19b-001fb9a2a11d NA NA NA TCGA-09-2049-01D-01D-0708-05 NA TCGA-09-2049-01D-21-1560-20 NA NA TCGA-09-2049-01D-01D-0704-01 TCGA-09-2049-01 ccaa932c-805b-4a2c-825f-d742a9fddb2c NA TCGA-09-2049-01D-01D-0704-01 NA NA NA TCGA-09-2049-01D-01W-0799-08 TCGA-09-2049-01 NA NA TCGA-09-2049-01D-01W-0799-08 TCGA-09-2049-01D-01R-0711-07 |
|
|
84 |
TCGA-09-2050-01 0 TCGA-09-2050-01 2163 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-09-2050 NA NA days 2163 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 65 Bilateral TCGA-09-2050-F24367 TCGA-09-2050 TCGA-09-2050-01A Stage IIA -23987 NA NA 0 2163 NA NA NA NA NA 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.6 NA NO G2 NA NA NA NA NA TCGA-09-2050.fb343129-010d-430b-aae4-f7beb7122279.pdf 2050 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 09 No Macroscopic disease Ovary NO A LIVING 2003 NA TCGA-09-2050-01 NA 968defb5-7701-4ec8-9c4f-7b73a13b0411 NA TCGA-09-2050-01 NA TCGA-09-2050-01A-01D-0708-05 NA NA NA NA TCGA-09-2050-01A-01D-0704-01 TCGA-09-2050-01 NA NA TCGA-09-2050-01A-01D-0704-01 NA NA NA TCGA-09-2050-01A-01W-0799-08 TCGA-09-2050-01 NA NA TCGA-09-2050-01A-01W-0799-08 TCGA-09-2050-01A-01R-0711-07 |
|
|
85 |
TCGA-09-2051-01 0 TCGA-09-2051-01 1919 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-09-2051 NA NA days 1919 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Bilateral TCGA-09-2051-F24373 TCGA-09-2051 TCGA-09-2051-01A Stage IIIC -15650 NA NA 0 1919 NA 583 NA NA NA 2009-11-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.8 NA YES G3 Recurrence NA NA NA NA TCGA-09-2051.242a1ff3-05ad-4623-b5aa-9bb556e2cfa9.pdf 2051 NA TUMOR FREE YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 09 No Macroscopic disease Ovary YES A LIVING 2004 TCGA-09-2051-01 TCGA-09-2051-01 NA 34b0a38d-33f0-436f-a30b-4c730a37e27c NA TCGA-09-2051-01 NA TCGA-09-2051-01A-01D-0708-05 NA TCGA-09-2051-01A-21-1560-20 NA 6bc296b8-ac74-4ff9-872d-5f7e4a3d011a TCGA-09-2051-01A-01D-0704-01 TCGA-09-2051-01 5bcc9755-b429-47c1-9a00-af84edd803aa NA TCGA-09-2051-01A-01D-0704-01 6bc296b8-ac74-4ff9-872d-5f7e4a3d011a NA 6bc296b8-ac74-4ff9-872d-5f7e4a3d011a TCGA-09-2051-01A-01W-0799-08 TCGA-09-2051-01 TCGA-09-2051-01 6bc296b8-ac74-4ff9-872d-5f7e4a3d011a TCGA-09-2051-01A-01W-0799-08 TCGA-09-2051-01A-01R-0711-07 |
|
|
86 |
TCGA-09-2053-01 0 TCGA-09-2053-01 1209 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-09-2053 NA NA days 1209 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 72 Left TCGA-09-2053-F24384 TCGA-09-2053 TCGA-09-2053-01C Stage IIIC -26433 NA NA 0 1209 NA NA NA NA NA 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.7 NA NO G3 NA NA NA NA NA TCGA-09-2053.0d28e549-3ed0-4a22-bac7-9cbe24e44f53.pdf 2053 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 09 No Macroscopic disease Ovary NO C LIVING 2005 NA TCGA-09-2053-01 NA 00fdb098-d819-43f1-995d-a43f2499afe7 NA TCGA-09-2053-01 NA TCGA-09-2053-01C-01D-0667-05 NA NA NA NA TCGA-09-2053-01C-01D-0663-01 TCGA-09-2053-01 NA NA TCGA-09-2053-01C-01D-0663-01 NA NA NA TCGA-09-2053-01C-01W-0722-08 TCGA-09-2053-01 NA NA TCGA-09-2053-01C-01W-0722-08 TCGA-09-2053-01C-01R-0670-07 |
|
|
87 |
TCGA-09-2054-01 1 TCGA-09-2054-01 637 1 days High C9-OV OV-like c1 KIRC-like c1 OV-like c16 miRNA cluster 2 cluster 3 NA TCGA-09-2054 NA NA days 637 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-09-2054-F24388 TCGA-09-2054 TCGA-09-2054-01A Stage IIIC -21285 NA 637 0 637 NA NA NA NA NA 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 2 NA YES G3 NA NA NA NA NA TCGA-09-2054.4f0eb2a1-996c-4816-a956-835ce5085438.pdf 2054 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.4 NA NA 09 1-10 mm Ovary YES A DECEASED 2005 TCGA-09-2054-01 TCGA-09-2054-01 NA f6aa28c5-b1f6-4552-82a7-a6a170814534 NA TCGA-09-2054-01 NA TCGA-09-2054-01A-01D-0667-05 NA TCGA-09-2054-01A-21-1560-20 NA 5cd7faa0-323a-4ea3-a658-859d0336e0ac TCGA-09-2054-01A-01D-0663-01 TCGA-09-2054-01 3b31fec3-6dd6-4ef7-bcb4-8c67007f6937 NA TCGA-09-2054-01A-01D-0663-01 5cd7faa0-323a-4ea3-a658-859d0336e0ac NA 5cd7faa0-323a-4ea3-a658-859d0336e0ac NA TCGA-09-2054-01 TCGA-09-2054-01 5cd7faa0-323a-4ea3-a658-859d0336e0ac NA TCGA-09-2054-01A-01R-0670-07 |
|
|
88 |
TCGA-09-2055-01 0 TCGA-09-2055-01 819 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-09-2055 NA NA days 819 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Left TCGA-09-2055-F24395 TCGA-09-2055 TCGA-09-2055-01B Stage IC -17545 NA NA 0 819 NA NA NA NA NA 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.8 NA NO G3 NA NA NA NA NA TCGA-09-2055.4cff882a-1ce5-4586-a808-a7f00e319743.pdf 2055 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 09 No Macroscopic disease Ovary NO B LIVING 2007 NA NA NA 7c240854-d066-4ecd-905d-1f6dea67d509 NA NA NA TCGA-09-2055-01B-01D-0708-05 NA TCGA-09-2055-01A-11-1563-20 NA NA TCGA-09-2055-01B-01D-0704-01 TCGA-09-2055-01 b02ef957-7893-4222-983a-3784ee59dfdd NA TCGA-09-2055-01B-01D-0704-01 NA NA NA NA TCGA-09-2055-01 NA NA NA TCGA-09-2055-01B-01R-0711-07 |
|
|
89 |
TCGA-09-2056-01 0 TCGA-09-2056-01 379 0 days BRCA-LUAD+ C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation c1uster 9 TCGA-09-2056 NA NA days 379 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Bilateral TCGA-09-2056-F24399 TCGA-09-2056 TCGA-09-2056-01B Stage IIIC -22864 NA NA 0 379 NA NA NA NA NA 2009-11-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.6 NA NO G3 NA NA NA NA NA TCGA-09-2056.67bdb457-cfb8-4052-bd33-bff86c736910.pdf 2056 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 09 No Macroscopic disease Ovary NO B LIVING 2008 TCGA-09-2056-01 NA NA 6c194f10-5bf3-4331-b035-f50e93536dda NA NA NA TCGA-09-2056-01B-01D-0667-05 NA TCGA-09-2056-01B-21-1560-20 NA 67670628-ad07-41ef-8977-890080616900 TCGA-09-2056-01B-01D-0663-01 TCGA-09-2056-01 568718ea-3d9d-4d09-b155-0b8467a10bbe NA TCGA-09-2056-01B-01D-0663-01 67670628-ad07-41ef-8977-890080616900 NA 67670628-ad07-41ef-8977-890080616900 TCGA-09-2056-01B-01W-0722-08 TCGA-09-2056-01 TCGA-09-2056-01 67670628-ad07-41ef-8977-890080616900 TCGA-09-2056-01B-01W-0722-08 TCGA-09-2056-01B-01R-0670-07 |
|
|
90 |
TCGA-10-0925-01 1 TCGA-10-0925-01 1652 1 days BRCA-LUAD+ NA OV-like c1 OV-like c4 NA NA NA NA TCGA-10-0925 NA NA days 1652 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-10-0925-F24403 TCGA-10-0925 TCGA-10-0925-01B Stage IIIB -21498 NA 1652 0 1652 NA 558 NA NA NA 2010-2-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO 80 0.7 NA NA G1 Recurrence NA NA NA NA TCGA-10-0925.96f0f453-84f9-401a-9fd0-0a8712a87be5.pdf 0925 Preoperative WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 10 1-10 mm Ovary NA B DECEASED 2000 NA NA NA 54016305-6747-489d-b09b-8db5be8409dc NA NA NA TCGA-10-0925-01B-01D-0652-05 NA TCGA-10-0925-01A-11-20 NA NA TCGA-10-0925-01B-01D-0648-01 TCGA-10-0925-01 ee2bb61b-4b7c-4cb4-b9e8-381285ad51f7 NA TCGA-10-0925-01B-01D-0648-01 NA NA NA NA TCGA-10-0925-01 NA NA NA TCGA-10-0925-01B-01R-0655-07 |
|
|
91 |
TCGA-10-0926-01 1 TCGA-10-0926-01 788 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-10-0926 NA NA days 788 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Bilateral TCGA-10-0926-F24413 TCGA-10-0926 TCGA-10-0926-01A Stage IIIC -23307 NA 788 0 788 NA 287 NA NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO 80 1 NA NO G3 Recurrence NA NA NA NA TCGA-10-0926.b940b1b3-8278-400e-b43a-e7897e0361b7.pdf 0926 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study YES NA Primary Tumor 01 0.6 NA NA 10 11-20 mm Ovary NO A DECEASED 2000 NA NA NA 892ce3d6-a97f-480f-85fb-5491e5ab9afa NA NA NA TCGA-10-0926-01A-01D-0402-05 NA TCGA-10-0926-01A-21-20 NA NA TCGA-10-0926-01A-01D-0399-01 TCGA-10-0926-01 fb5e42c3-de28-4dc9-8e33-c56685b72e5e NA TCGA-10-0926-01A-01D-0399-01 NA NA NA TCGA-10-0926-01A-01W-0420-08 TCGA-10-0926-01 NA NA TCGA-10-0926-01A-01W-0420-08 TCGA-10-0926-01A-01R-0406-07 |
|
|
92 |
TCGA-10-0927-01 1 TCGA-10-0927-01 2490 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-10-0927 NA NA days 2490 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-10-0927-F24420 TCGA-10-0927 NA Stage IIIC -23982 NA 2490 0 2478 NA 1001 NA NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G2 Recurrence NA NA NA NA NA 0927 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 10 1-10 mm Ovary NA NA DECEASED 2000 NA TCGA-10-0927-01 TCGA-10-0927-01A-02W-0419-10 c4ec4774-a95e-4097-bd99-7b0862020450 NA TCGA-10-0927-01 TCGA-10-0927-01A-02W-0419-10 TCGA-10-0927-01A-02D-0402-05 NA NA NA NA TCGA-10-0927-01A-02D-0399-01 TCGA-10-0927-01 NA NA TCGA-10-0927-01A-02D-0399-01 NA NA NA NA TCGA-10-0927-01 NA NA TCGA-10-0927-01 TCGA-10-0927-01A-02R-0406-07 |
|
|
93 |
TCGA-10-0928-01 1 TCGA-10-0928-01 563 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 2 TCGA-10-0928 NA NA days 563 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 71 Bilateral TCGA-10-0928-F24430 TCGA-10-0928 TCGA-10-0928-01A Stage IIIC -26066 NA 563 0 563 NA NA 0 NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1 NA NO G3 NA NA NA NA NA TCGA-10-0928.859b2662-493a-4ead-9ac7-0aa8d0a7a3d8.pdf 0928 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.4 NA NA 10 1-10 mm Ovary NO A DECEASED 2000 TCGA-10-0928-01 TCGA-10-0928-01 TCGA-10-0928-01A-02W-0419-10 3534ce20-56e1-409a-a438-50513c622602 NA TCGA-10-0928-01 TCGA-10-0928-01A-02W-0419-10 TCGA-10-0928-01A-02D-0402-05 NA NA NA 9aa3ae15-1033-46f1-a304-993f5d41cd50 TCGA-10-0928-01A-02D-0399-01 TCGA-10-0928-01 NA NA TCGA-10-0928-01A-02D-0399-01 9aa3ae15-1033-46f1-a304-993f5d41cd50 NA 9aa3ae15-1033-46f1-a304-993f5d41cd50 NA TCGA-10-0928-01 TCGA-10-0928-01 9aa3ae15-1033-46f1-a304-993f5d41cd50 TCGA-10-0928-01A-02W-0419-10 TCGA-10-0928-01A-02R-0406-07 |
|
|
94 |
TCGA-10-0930-01 1 TCGA-10-0930-01 1040 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation c1uster 9 TCGA-10-0930 NA NA days 1040 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Left TCGA-10-0930-F24432 TCGA-10-0930 TCGA-10-0930-01A Stage IIIC -25737 NA 1040 0 1011 NA 680 NA NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 0.8 NA NA G3 Recurrence NA NA NA NA TCGA-10-0930.89034658-e10d-47d3-9ad8-d79aa51cf234.pdf 0930 NA WITH TUMOR YES Complete Remission/Response Physical Examination NO NA Primary Tumor 01 0.3 NA NA 10 1-10 mm Ovary NA A DECEASED 2002 NA TCGA-10-0930-01 NA 36457b1f-1ee7-4bdc-82f4-75f3fccceb66 NA TCGA-10-0930-01 NA TCGA-10-0930-01A-02D-0402-05 TCGA-10-0930-01A-02W-0421-09 NA TCGA-10-0930-01A-02W-0421-09 NA TCGA-10-0930-01A-02D-0399-01 TCGA-10-0930-01 NA NA TCGA-10-0930-01A-02D-0399-01 NA NA NA NA TCGA-10-0930-01 NA NA TCGA-10-0930-01A-02W-0421-09 TCGA-10-0930-01A-02R-0406-07 |
|
|
95 |
TCGA-10-0931-01 1 TCGA-10-0931-01 1000 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-10-0931 NA NA days 1000 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-10-0931-F24440 TCGA-10-0931 TCGA-10-0931-01A Stage IIIC -16262 NA 1000 0 982 NA 300 1 NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.5 NA NA G3 Recurrence NA NA NA NA TCGA-10-0931.45d8f828-6dfb-4e68-8282-f2ee74671461.pdf 0931 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 10 1-10 mm Ovary NO A DECEASED 2002 NA TCGA-10-0931-01 NA 3d021366-16ec-4c18-8ce6-17beebce1e9c NA TCGA-10-0931-01 NA TCGA-10-0931-01A-01D-0402-05 NA TCGA-10-0931-01A-21-20 NA NA TCGA-10-0931-01A-01D-0399-01 TCGA-10-0931-01 25a69746-6f70-41eb-9805-6299ea0a4728 NA TCGA-10-0931-01A-01D-0399-01 NA NA NA TCGA-10-0931-01A-01W-0420-08 TCGA-10-0931-01 NA NA TCGA-10-0931-01A-01W-0420-08 TCGA-10-0931-01A-01R-0406-07 |
|
|
96 |
TCGA-10-0933-01 1 TCGA-10-0933-01 446 1 days High C9-OV UCEC Serous c4 OV-like c4 NA miRNA cluster 1 cluster 3 mutation c1uster 9 TCGA-10-0933 NA NA days 446 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 77 Bilateral TCGA-10-0933-F24454 TCGA-10-0933 TCGA-10-0933-01A Stage IIIC -28433 NA 446 0 356 NA 356 1 NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-10-0933.f973309d-55dd-489b-a7ca-9348666a9129.pdf 0933 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 10 No Macroscopic disease Ovary NA A DECEASED 2003 NA TCGA-10-0933-01 NA 99221367-1f21-45c5-944f-f734178e1468 NA TCGA-10-0933-01 NA TCGA-10-0933-01A-01D-0402-05 TCGA-10-0933-01A-01W-0421-09 TCGA-10-0933-01A-21-20 TCGA-10-0933-01A-01W-0421-09 NA TCGA-10-0933-01A-01D-0399-01 TCGA-10-0933-01 7c7459b2-2a24-4866-a4fc-e960ef606d39 NA TCGA-10-0933-01A-01D-0399-01 NA NA NA NA TCGA-10-0933-01 NA NA TCGA-10-0933-01A-01W-0421-09 TCGA-10-0933-01A-01R-0406-07 |
|
|
97 |
TCGA-10-0934-01 1 TCGA-10-0934-01 204 1 days High NA UCEC non-CIMP c3 NA NA miRNA cluster 6 cluster 4 mutation cluster 5 TCGA-10-0934 NA NA days 204 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-10-0934-F24458 TCGA-10-0934 NA Stage IIIC -18602 NA 204 0 119 NA 111 NA NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NO G3 Recurrence NA NA NA NA NA 0934 NA WITH TUMOR YES Progressive Disease First Seen At Further Surgery NO NA Primary Tumor 01 NA NA NA 10 1-10 mm Ovary NA NA DECEASED 2003 NA NA NA cb990c79-c1bf-45d1-88ff-04a916bf3a16 NA NA NA TCGA-10-0934-01A-02D-0402-05 NA NA NA NA TCGA-10-0934-01A-02D-0399-01 TCGA-10-0934-01 NA NA TCGA-10-0934-01A-02D-0399-01 NA NA NA TCGA-10-0934-01A-02W-0420-08 TCGA-10-0934-01 NA NA TCGA-10-0934-01A-02W-0420-08 TCGA-10-0934-01A-02R-0406-07 |
|
|
98 |
TCGA-10-0935-01 1 TCGA-10-0935-01 1078 1 days BRCA-LUAD+ NA OV-like c1 NA NA NA NA mutation cluster 5 TCGA-10-0935 NA NA days 1078 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 68 Bilateral TCGA-10-0935-F24462 TCGA-10-0935 NA Stage IIIC -25098 NA 1078 0 1078 NA NA NA NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 NA NA NA NA NA NA 0935 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 NA NA NA 10 1-10 mm Ovary YES NA DECEASED 2003 NA NA NA da4b7cf0-830b-42de-9bd5-fa065c331362 NA NA NA TCGA-10-0935-01A-03D-0402-05 TCGA-10-0935-01A-03W-0421-09 NA TCGA-10-0935-01A-03W-0421-09 NA TCGA-10-0935-01A-03D-0399-01 TCGA-10-0935-01 NA NA TCGA-10-0935-01A-03D-0399-01 NA NA NA NA TCGA-10-0935-01 NA NA TCGA-10-0935-01A-03W-0421-09 TCGA-10-0935-01A-02R-0406-07 |
|
|
99 |
TCGA-10-0936-01 1 TCGA-10-0936-01 1123 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 2 NA TCGA-10-0936 NA NA days 1123 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 69 Bilateral TCGA-10-0936-F24466 TCGA-10-0936 TCGA-10-0936-01A Stage IIIC -25454 NA 1123 0 1089 NA NA 0 NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA YES G3 NA NA NA NA NA TCGA-10-0936.6b9a13e4-760e-476f-a0a7-fb42ab7c63c5.pdf 0936 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 10 >20 mm Ovary NA A DECEASED 2005 TCGA-10-0936-01 TCGA-10-0936-01 NA 8492ae5a-2139-4159-8b99-133e01b12568 NA TCGA-10-0936-01 NA TCGA-10-0936-01A-01D-0402-05 NA TCGA-10-0936-01A-21-20 NA 04112b9c-6ef4-49cd-bed8-43151b5bbe1f TCGA-10-0936-01A-01D-0399-01 TCGA-10-0936-01 5e8ac787-50cc-45ea-9fc4-efe67b6d05ff NA TCGA-10-0936-01A-01D-0399-01 04112b9c-6ef4-49cd-bed8-43151b5bbe1f NA 04112b9c-6ef4-49cd-bed8-43151b5bbe1f NA TCGA-10-0936-01 TCGA-10-0936-01 04112b9c-6ef4-49cd-bed8-43151b5bbe1f NA TCGA-10-0936-01A-01R-0406-07 |
|
|
100 |
TCGA-10-0937-01 1 TCGA-10-0937-01 608 1 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-10-0937 NA NA days 608 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-10-0937-F24476 TCGA-10-0937 NA Stage IIIC -16222 NA 608 0 460 NA 235 0 NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 0937 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 10 1-10 mm Ovary NA NA DECEASED 2005 NA NA TCGA-10-0937-01A-02W-0419-10 a104dfcb-8b29-4ab3-99ad-9ccbac4b2d4d NA NA TCGA-10-0937-01A-02W-0419-10 TCGA-10-0937-01A-02D-0402-05 NA NA NA NA TCGA-10-0937-01A-02D-0399-01 TCGA-10-0937-01 NA NA TCGA-10-0937-01A-02D-0399-01 NA NA NA NA TCGA-10-0937-01 NA NA TCGA-10-0937-01A-02W-0419-10 TCGA-10-0937-01A-02R-0406-07 |
|
|
101 |
TCGA-10-0938-01 1 TCGA-10-0938-01 636 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-10-0938 NA NA days 636 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 80 Bilateral TCGA-10-0938-F24483 TCGA-10-0938 TCGA-10-0938-01A Stage IIIC -29558 NA 636 0 604 NA 362 2 NA NA 2009-3-6 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA 0.6 NO NA 1 NA NA G3 Progression of Disease NA NA NA NA TCGA-10-0938.faa8920a-3b4a-4767-bdb1-5d086e51fe92.pdf 0938 NA WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 0.6 NA NA 10 >20 mm Ovary NA A DECEASED 2002 NA TCGA-10-0938-01 TCGA-10-0938-01A-02W-0419-10 02e1cf40-826f-451a-bb3c-a3c7c94e8104 NA TCGA-10-0938-01 TCGA-10-0938-01A-02W-0419-10 TCGA-10-0938-01A-02D-0402-05 NA NA NA NA TCGA-10-0938-01A-02D-0399-01 TCGA-10-0938-01 NA NA TCGA-10-0938-01A-02D-0399-01 NA NA NA NA TCGA-10-0938-01 NA NA TCGA-10-0938-01A-02W-0419-10 TCGA-10-0938-01A-02R-0406-07 |
|
|
102 |
TCGA-13-0714-01 1 TCGA-13-0714-01 189 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0714 NA NA days 189 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-13-0714-F24489 TCGA-13-0714 TCGA-13-0714-01A Stage IV -20109 NA 189 0 189 NA 110 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO 80 1.2 NA NA G3 Progression of Disease NA NA NA NA TCGA-13-0714.96EB4BD1-CE3B-44D8-8095-076712A3E082.pdf 0714 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA A DECEASED 2000 NA TCGA-13-0714-01 TCGA-13-0714-01A-01W-0370-10 408156df-a8fa-4068-9b87-f92bd60ca873 NA TCGA-13-0714-01 TCGA-13-0714-01A-01W-0370-10 TCGA-13-0714-01A-01D-0359-05 NA NA NA NA TCGA-13-0714-01A-01D-0356-01 TCGA-13-0714-01 NA NA TCGA-13-0714-01A-01D-0356-01 NA NA NA NA TCGA-13-0714-01 NA NA TCGA-13-0714-01A-01W-0370-10 NA TCGA-13-0714-01A-01R-0363-07 |
|
|
103 |
TCGA-13-0717-01 1 TCGA-13-0717-01 748 1 days High NA OV-like c1 NA NA NA NA mutation cluster 8 TCGA-13-0717 NA NA days 748 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-13-0717-F24494 TCGA-13-0717 NA Stage IIIC -20042 NA 748 0 748 NA 294 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 0717 NA WITH TUMOR YES Complete Remission/Response Physical Examination NO NA Primary Tumor 01 NA NA NA 13 >20 mm Ovary NA NA DECEASED 2000 NA NA TCGA-13-0717-01A-01W-0370-10 d6012831-3668-402e-8be1-849c011767a6 NA NA TCGA-13-0717-01A-01W-0370-10 TCGA-13-0717-01A-01D-0359-05 NA NA NA NA TCGA-13-0717-01A-01D-0356-01 TCGA-13-0717-01 NA NA TCGA-13-0717-01A-01D-0356-01 NA NA NA NA TCGA-13-0717-01 NA NA TCGA-13-0717-01A-01W-0370-10 NA TCGA-13-0717-01A-01R-0363-07 |
|
|
104 |
TCGA-13-0720-01 1 TCGA-13-0720-01 1355 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-13-0720 NA NA days 1355 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-13-0720-F24498 TCGA-13-0720 TCGA-13-0720-01A Stage IIIC -17799 NA 1355 0 1355 NA 292 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO 80 8 NA NA G3 Recurrence NA NA NA NA TCGA-13-0720.0A196866-A083-40AC-90E3-5ECA3B141645.pdf 0720 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA A DECEASED 2001 NA TCGA-13-0720-01 TCGA-13-0720-01A-01W-0370-10 595dacaa-2763-4482-998c-eb748907f146 NA TCGA-13-0720-01 TCGA-13-0720-01A-01W-0370-10 TCGA-13-0720-01A-01D-0359-05 NA TCGA-13-0720-01A-21-20 NA NA TCGA-13-0720-01A-01D-0356-01 TCGA-13-0720-01 5864cd1e-a0da-4553-b12b-75f8941ecbab NA TCGA-13-0720-01A-01D-0356-01 NA NA NA NA TCGA-13-0720-01 NA NA TCGA-13-0720-01A-01W-0370-10 TCGA-13-0720-01A-01R-0363-07 |
|
|
105 |
TCGA-13-0723-01 1 TCGA-13-0723-01 1204 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-13-0723 NA NA days 1204 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 63 Bilateral TCGA-13-0723-F24503 TCGA-13-0723 TCGA-13-0723-01A Stage IIIC -23094 NA 1204 0 1204 NA 210 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.3 NA NA G3 Progression of Disease NA NA NA NA TCGA-13-0723.0A628FDD-EDDF-48BA-A083-8E2676DD9B5C.pdf 0723 NA WITH TUMOR YES Progressive Disease Molecular Markers NO NA Primary Tumor 01 0.3 NA NA 13 >20 mm Ovary NA A DECEASED 2002 NA TCGA-13-0723-01 NA 95906f3c-8c5d-4eb9-8183-a444efde2a18 NA TCGA-13-0723-01 NA TCGA-13-0723-01A-02D-0359-05 TCGA-13-0723-01A-02W-0372-09 NA TCGA-13-0723-01A-02W-0372-09 NA TCGA-13-0723-01A-02D-0356-01 TCGA-13-0723-01 NA NA TCGA-13-0723-01A-02D-0356-01 NA NA NA NA TCGA-13-0723-01 NA NA TCGA-13-0723-01A-02W-0372-09 NA TCGA-13-0723-01A-02R-0363-07 |
|
|
106 |
TCGA-13-0724-01 1 TCGA-13-0724-01 83 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-0724 NA NA days 83 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 72 Right TCGA-13-0724-F24507 TCGA-13-0724 NA Stage IV -26342 NA 83 0 83 NA 83 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy NA NA NA 80 NA NA NA G3 Progression of Disease NA NA NA NA NA 0724 Preoperative WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2002 NA TCGA-13-0724-01 NA fb6ffde7-3b9f-4f28-845c-e2bb245db90b NA TCGA-13-0724-01 NA TCGA-13-0724-01A-01D-0359-05 TCGA-13-0724-01A-01W-0372-09 NA TCGA-13-0724-01A-01W-0372-09 NA TCGA-13-0724-01A-01D-0356-01 TCGA-13-0724-01 NA NA TCGA-13-0724-01A-01D-0356-01 NA NA NA NA TCGA-13-0724-01 NA NA TCGA-13-0724-01A-01W-0372-09 NA TCGA-13-0724-01A-01R-0363-07 |
|
|
107 |
TCGA-13-0725-01 1 TCGA-13-0725-01 377 1 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 NA TCGA-13-0725 NA NA days 377 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-13-0725-F24510 TCGA-13-0725 TCGA-13-0725-01A Stage IIIC -16086 NA 377 0 377 NA 190 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-13-0725.A6CD74F2-47A0-4790-BB81-6C636DA16ADC.pdf 0725 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA A DECEASED 2002 NA TCGA-13-0725-01 NA c030245e-982a-40d5-a03d-c7896105b062 NA TCGA-13-0725-01 NA TCGA-13-0725-01A-01D-0359-05 NA TCGA-13-0725-01A-21-20 NA NA TCGA-13-0725-01A-01D-0356-01 TCGA-13-0725-01 6701705e-cbfb-4af1-b1ab-898298de7c02 NA TCGA-13-0725-01A-01D-0356-01 NA NA NA NA TCGA-13-0725-01 NA NA NA NA TCGA-13-0725-01A-01R-0363-07 |
|
|
108 |
TCGA-13-0726-01 1 TCGA-13-0726-01 949 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-0726 NA NA days 949 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-13-0726-F24515 TCGA-13-0726 NA Stage IIIC -20134 NA 949 0 946 NA 392 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA GX Recurrence NA NA NA NA NA 0726 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2002 NA TCGA-13-0726-01 NA ec64c4e0-8c79-4161-bc31-56abd101de2c NA TCGA-13-0726-01 NA TCGA-13-0726-01A-01D-0359-05 TCGA-13-0726-01A-01W-0372-09 NA TCGA-13-0726-01A-01W-0372-09 NA TCGA-13-0726-01A-01D-0356-01 TCGA-13-0726-01 NA NA TCGA-13-0726-01A-01D-0356-01 NA NA NA NA TCGA-13-0726-01 NA NA TCGA-13-0726-01A-01W-0372-09 NA TCGA-13-0726-01A-01R-0363-07 |
|
|
109 |
TCGA-13-0727-01 1 TCGA-13-0727-01 462 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation c1uster 9 TCGA-13-0727 NA NA days 462 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-13-0727-F24519 TCGA-13-0727 NA Stage IIIC -26185 NA 462 0 462 NA 253 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 0727 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2003 NA TCGA-13-0727-01 TCGA-13-0727-01A-01W-0370-10 ccf2280b-6308-40ad-bf39-f222aa67a91b NA TCGA-13-0727-01 TCGA-13-0727-01A-01W-0370-10 TCGA-13-0727-01A-01D-0359-05 NA NA NA NA TCGA-13-0727-01A-01D-0356-01 TCGA-13-0727-01 NA NA TCGA-13-0727-01A-01D-0356-01 NA NA NA NA TCGA-13-0727-01 NA NA TCGA-13-0727-01A-01W-0370-10 NA TCGA-13-0727-01A-01R-0363-07 |
|
|
110 |
TCGA-13-0730-01 1 TCGA-13-0730-01 542 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-0730 NA NA days 542 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 71 Bilateral TCGA-13-0730-F60695 TCGA-13-0730 TCGA-13-0730-01A Stage IIIC -26086 NA 542 0 NA NA NA NA Scheduled Follow-up Submission NA 2014-6-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 0.6 NO NA 1.1 NO NA G3 NA NA NA NA NA TCGA-13-0730.2AF2844E-F1DC-4938-85D3-08B07BB9DCFF.pdf 0730 NA NA NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 >20 mm Ovary NA A DECEASED 2003 TCGA-13-0730-01 TCGA-13-0730-01 TCGA-13-0730-01A-01W-0370-10 1bd423e8-af33-4277-8ded-7d8c3f675f4b NA TCGA-13-0730-01 TCGA-13-0730-01A-01W-0370-10 TCGA-13-0730-01A-01D-0359-05 NA NA NA 754dfe07-22f4-4070-bbcb-10bfbb649def TCGA-13-0730-01A-01D-0356-01 TCGA-13-0730-01 NA NA TCGA-13-0730-01A-01D-0356-01 754dfe07-22f4-4070-bbcb-10bfbb649def NA 754dfe07-22f4-4070-bbcb-10bfbb649def NA TCGA-13-0730-01 TCGA-13-0730-01 754dfe07-22f4-4070-bbcb-10bfbb649def TCGA-13-0730-01A-01W-0370-10 NA TCGA-13-0730-01A-01R-0363-07 |
|
|
111 |
TCGA-13-0751-01 1 TCGA-13-0751-01 1678 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0751 NA NA days 1678 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-13-0751-F24525 TCGA-13-0751 TCGA-13-0751-01A Stage IIIC -16304 NA 1678 0 1678 NA 653 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA NA GX Recurrence NA NA NA NA TCGA-13-0751.61280768-69DF-4601-BED6-E78C1F82E5BC.pdf 0751 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 1999 NA TCGA-13-0751-01 NA 625f1703-3f6c-4434-b30d-8bf174c438d7 NA TCGA-13-0751-01 NA TCGA-13-0751-01A-01D-0359-05 NA NA NA NA TCGA-13-0751-01A-01D-0356-01 TCGA-13-0751-01 NA NA TCGA-13-0751-01A-01D-0356-01 NA NA NA TCGA-13-0751-01A-01D-0446-08 TCGA-13-0751-01 NA NA TCGA-13-0751-01 TCGA-13-0751-01A-01R-0363-07 |
|
|
112 |
TCGA-13-0755-01 1 TCGA-13-0755-01 76 1 days Squamous NA OV-like c1 NA NA miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-13-0755 NA NA days 76 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 75 Bilateral TCGA-13-0755-F24531 TCGA-13-0755 NA Stage IV -27438 NA 76 0 76 NA 34 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA 40 NA NA NA G3 Progression of Disease NA NA NA NA NA 0755 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2003 NA TCGA-13-0755-01 NA b14fdd08-b406-4db3-ac74-d1fdb6b213a2 NA TCGA-13-0755-01 NA TCGA-13-0755-01A-01D-0359-05 TCGA-13-0755-01A-01W-0372-09 NA TCGA-13-0755-01A-01W-0372-09 NA TCGA-13-0755-01A-01D-0356-01 TCGA-13-0755-01 NA NA TCGA-13-0755-01A-01D-0356-01 NA NA NA NA TCGA-13-0755-01 NA NA TCGA-13-0755-01A-01W-0372-09 TCGA-13-0755-01A-01R-0363-07 |
|
|
113 |
TCGA-13-0757-01 1 TCGA-13-0757-01 340 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 NA TCGA-13-0757 NA NA days 340 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-13-0757-F24534 TCGA-13-0757 TCGA-13-0757-01A Stage IIIC -25999 NA 340 0 340 NA 293 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO 60 0.9 NA NA G3 Recurrence NA NA NA NA TCGA-13-0757.81F1B0FB-CEB7-4313-AA0D-71DA495AEABE.pdf 0757 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 2005 NA TCGA-13-0757-01 NA 69337aad-1fe3-4b0e-943e-ca5ac6dc6076 NA TCGA-13-0757-01 NA TCGA-13-0757-01A-01D-0359-05 NA NA NA NA TCGA-13-0757-01A-01D-0356-01 TCGA-13-0757-01 NA NA TCGA-13-0757-01A-01D-0356-01 NA NA NA NA TCGA-13-0757-01 NA NA NA NA TCGA-13-0757-01A-01R-0363-07 |
|
|
114 |
TCGA-13-0758-01 1 TCGA-13-0758-01 346 1 days Squamous NA OV-like c1 NA NA NA NA NA TCGA-13-0758 NA NA days 346 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-13-0758-F24539 TCGA-13-0758 TCGA-13-0758-01A Stage IV -22088 NA 346 0 346 NA 212 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO 60 1.3 NA NA G3 Progression of Disease NA NA NA NA TCGA-13-0758.37B557BB-D2C4-42A9-B224-F1DFFC9B8FE3.pdf 0758 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 2005 NA NA NA 4d8ca9f7-21f4-49d8-b985-53a096e48428 NA NA NA TCGA-13-0758-01A-01D-0359-05 NA NA NA NA TCGA-13-0758-01A-01D-0356-01 TCGA-13-0758-01 NA NA TCGA-13-0758-01A-01D-0356-01 NA NA NA NA TCGA-13-0758-01 NA NA NA NA TCGA-13-0758-01A-01R-0363-07 |
|
|
115 |
TCGA-13-0760-01 1 TCGA-13-0760-01 351 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0760 NA NA days 351 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Bilateral TCGA-13-0760-F24543 TCGA-13-0760 NA Stage IV -23036 NA 351 0 351 NA NA NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA NA NA 80 NA NA NA G3 NA NA NA NA NA NA 0760 Pre-Adjuvant Therapy NA YES NA NA NO NA Primary Tumor 01 NA NA NA 13 No Macroscopic disease Ovary NA NA DECEASED 2006 NA TCGA-13-0760-01 NA NA NA TCGA-13-0760-01 NA TCGA-13-0760-01A-01D-0359-05 TCGA-13-0760-01A-01W-0372-09 NA TCGA-13-0760-01A-01W-0372-09 NA TCGA-13-0760-01A-01D-0356-01 TCGA-13-0760-01 NA NA TCGA-13-0760-01A-01D-0356-01 NA NA NA NA TCGA-13-0760-01 NA NA TCGA-13-0760-01A-01W-0372-09 NA TCGA-13-0760-01A-01R-0363-07 |
|
|
116 |
TCGA-13-0761-01 1 TCGA-13-0761-01 1156 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-13-0761 424 1 days 1156 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-13-0761-F72596 TCGA-13-0761 TCGA-13-0761-01A Stage IV -18697 NA 1156 0 1036 NA 424 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA NA G3 NA NA YES NA NA TCGA-13-0761.9609319A-2534-4753-9C71-3F59BFD20F15.pdf 0761 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2006 NA TCGA-13-0761-01 TCGA-13-0761-01A-01W-0370-10 31361f65-a9de-4272-9de7-d884d15db3f0 NA TCGA-13-0761-01 TCGA-13-0761-01A-01W-0370-10 TCGA-13-0761-01A-01D-0359-05 NA NA NA NA TCGA-13-0761-01A-01D-0356-01 TCGA-13-0761-01 NA NA TCGA-13-0761-01A-01D-0356-01 NA NA NA NA TCGA-13-0761-01 NA NA TCGA-13-0761-01A-01W-0370-10 NA TCGA-13-0761-01A-01R-0363-07 |
|
|
117 |
TCGA-13-0762-01 0 TCGA-13-0762-01 3400 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 2 TCGA-13-0762 1003 1 days 3400 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 65 Bilateral TCGA-13-0762-F72597 TCGA-13-0762 NA Stage IIIC -23960 NA NA 0 3400 NA 1003 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA 80 NA NA NA G3 NA NA YES NA NA NA 0762 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 No Macroscopic disease Ovary NA NA LIVING 2006 NA TCGA-13-0762-01 TCGA-13-0762-01A-01W-0370-10 f33f5749-bed4-403d-b311-176f59fb32bc NA TCGA-13-0762-01 TCGA-13-0762-01A-01W-0370-10 TCGA-13-0762-01A-01D-0359-05 NA NA NA NA TCGA-13-0762-01A-01D-0356-01 TCGA-13-0762-01 NA NA TCGA-13-0762-01A-01D-0356-01 NA NA NA NA TCGA-13-0762-01 NA NA TCGA-13-0762-01A-01W-0370-10 NA TCGA-13-0762-01A-01R-0363-07 |
|
|
118 |
TCGA-13-0764-01 1 TCGA-13-0764-01 1881 1 days High NA OV-like c1 NA NA NA NA NA TCGA-13-0764 272 1 days 1881 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Bilateral TCGA-13-0764-F72599 TCGA-13-0764 NA Stage IV -22965 NA 1881 0 944 NA 272 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA NA NA 80 NA NA NA G3 NA NA YES NA NA NA 0764 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2006 NA NA NA b72f0610-8aaa-48ac-afed-333e5f4159cd NA NA NA TCGA-13-0764-01A-03D-0359-05 NA NA NA NA TCGA-13-0764-01A-03D-0356-01 TCGA-13-0764-01 NA NA TCGA-13-0764-01A-03D-0356-01 NA NA NA NA TCGA-13-0764-01 NA NA NA NA TCGA-13-0764-01A-03R-0363-07 |
|
|
119 |
TCGA-13-0765-01 1 TCGA-13-0765-01 1389 1 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-0765 668 1 days 1389 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 50 Bilateral TCGA-13-0765-F72600 TCGA-13-0765 TCGA-13-0765-01A Stage IIIC -18574 NA 1389 0 869 NA 668 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.2 NA NA G3 NA NA YES NA NA TCGA-13-0765.96588189-C273-4095-88C5-9E22368813C0.pdf 0765 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 2006 NA TCGA-13-0765-01 NA 17962695-e9c2-45f2-b4a2-00b7bfd1ffd6 NA TCGA-13-0765-01 NA TCGA-13-0765-01A-01D-0359-05 TCGA-13-0765-01A-01W-0372-09 NA TCGA-13-0765-01A-01W-0372-09 NA NA TCGA-13-0765-01 NA NA NA NA NA NA NA NA NA NA TCGA-13-0765-01A-01W-0372-09 TCGA-13-0765-01A-01R-0363-07 |
|
|
120 |
TCGA-13-0766-01 1 TCGA-13-0766-01 1725 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 NA TCGA-13-0766 628 1 days 1725 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 42 Bilateral TCGA-13-0766-F72601 TCGA-13-0766 TCGA-13-0766-01A Stage IIIC -15571 NA 1725 0 651 NA 628 NA NA NA 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.7 NA NA G3 NA NA YES NA NA TCGA-13-0766.7F283E4B-70F9-4834-866C-B91024C74EA3.pdf 0766 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 2006 NA TCGA-13-0766-01 NA 2b1e48b5-b8f4-4f57-8089-8293f470f466 NA TCGA-13-0766-01 NA TCGA-13-0766-01A-02D-0359-05 NA NA NA NA TCGA-13-0766-01A-02D-0356-01 TCGA-13-0766-01 NA NA TCGA-13-0766-01A-02D-0356-01 NA NA NA NA TCGA-13-0766-01 NA NA NA TCGA-13-0766-01A-02R-0363-07 |
|
|
121 |
TCGA-13-0768-01 1 TCGA-13-0768-01 1784 1 days High NA OV-like c1 NA NA miRNA cluster 3 cluster 5 NA TCGA-13-0768 398 1 days 1784 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 Bilateral TCGA-13-0768-F72603 TCGA-13-0768 TCGA-13-0768-01A Stage IIIC -26999 NA 1784 0 257 NA 398 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO 60 0.8 NA NA G3 NA NA YES NA NA TCGA-13-0768.7D67D0D3-105C-4A00-B104-106BE26FEE2D.pdf 0768 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A DECEASED 2008 NA TCGA-13-0768-01 NA 282e4c72-a430-4a70-9393-c259a90d9ee3 NA TCGA-13-0768-01 NA TCGA-13-0768-01A-01D-0359-05 NA NA NA NA TCGA-13-0768-01A-01D-0356-01 TCGA-13-0768-01 NA NA TCGA-13-0768-01A-01D-0356-01 NA NA NA NA TCGA-13-0768-01 NA NA NA NA TCGA-13-0768-01A-01R-0363-07 |
|
|
122 |
TCGA-13-0791-01 1 TCGA-13-0791-01 1224 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0791 281 1 days 1224 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-13-0791-F72604 TCGA-13-0791 TCGA-13-0791-01A Stage IIIC -21380 NA 1224 0 1184 NA 281 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO 80 1.8 NA NA G3 NA NA YES NA NA TCGA-13-0791.BDF98098-6E0F-4387-9C2C-30CF1812073A.pdf 0791 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2005 NA TCGA-13-0791-01 NA 7290ea9e-baf6-4777-b512-ab1da9bf62cd NA TCGA-13-0791-01 NA TCGA-13-0791-01A-01D-0359-05 TCGA-13-0791-01A-01W-0372-09 NA TCGA-13-0791-01A-01W-0372-09 NA TCGA-13-0791-01A-01D-0356-01 TCGA-13-0791-01 NA NA TCGA-13-0791-01A-01D-0356-01 NA NA NA NA TCGA-13-0791-01 NA NA TCGA-13-0791-01A-01W-0372-09 NA TCGA-13-0791-01A-01R-0363-07 |
|
|
123 |
TCGA-13-0791-02 1 TCGA-13-0791-02 1224 1 days NA NA OV-like c1 NA NA miRNA cluster 2 NA mutation cluster 5 TCGA-13-0791 281 1 days 1224 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-13-0791-F72604 TCGA-13-0791 TCGA-13-0791-02A Stage IIIC -21380 NA 1224 0 1184 NA 281 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO 80 1 NA NA G3 NA NA YES NA NA TCGA-13-0791.60B0A7B2-179E-47CE-908C-A1360EA6BB6B.pdf 0791 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Recurrent Tumor 02 0.1 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2005 NA TCGA-13-0791-02 NA 3038dbe5-a4fd-4ebf-b582-503b3041822b NA TCGA-13-0791-02 NA TCGA-13-0791-02A-01D-0807-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-13-0791-02A-01R-0810-07 |
|
|
124 |
TCGA-13-0792-01 0 TCGA-13-0792-01 3602 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-0792 816 1 days 3602 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 40 Bilateral TCGA-13-0792-F72605 TCGA-13-0792 TCGA-13-0792-01A Stage IIIC -14729 NA NA 0 3602 NA 816 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO 80 1.2 NA NA G3 NA NA YES NA NA TCGA-13-0792.3FBB8BEC-64D0-4AC8-9E15-C8FA9627E451.pdf 0792 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2005 NA TCGA-13-0792-01 TCGA-13-0792-01A-01W-0370-10 3a6c89bc-5db4-4816-b7f4-d77cf1d8eb0b NA TCGA-13-0792-01 TCGA-13-0792-01A-01W-0370-10 TCGA-13-0792-01A-01D-0359-05 NA NA NA NA TCGA-13-0792-01A-01D-0356-01 TCGA-13-0792-01 NA NA TCGA-13-0792-01A-01D-0356-01 NA NA NA NA TCGA-13-0792-01 NA NA TCGA-13-0792-01A-01W-0370-10 NA TCGA-13-0792-01A-01R-0363-07 |
|
|
125 |
TCGA-13-0793-01 0 TCGA-13-0793-01 3263 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0793 351 1 days 3263 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 40 Left TCGA-13-0793-F72606 TCGA-13-0793 TCGA-13-0793-01A Stage IV -14708 NA NA 0 3263 NA 351 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO 80 1.6 NA NA G3 NA NA YES NA NA TCGA-13-0793.43781B94-0865-4824-94B9-1476AC2F8677.pdf 0793 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A LIVING 2006 NA TCGA-13-0793-01 TCGA-13-0793-01A-01W-0370-10 447c38c0-ac42-4a58-ad55-c1c68258cdf4 NA TCGA-13-0793-01 TCGA-13-0793-01A-01W-0370-10 TCGA-13-0793-01A-01D-0359-05 NA TCGA-13-0793-01A-03-20 NA NA TCGA-13-0793-01A-01D-0356-01 TCGA-13-0793-01 7a9e7c44-9e41-4f1c-bf87-3faa086b0306 NA TCGA-13-0793-01A-01D-0356-01 NA NA NA NA TCGA-13-0793-01 NA NA TCGA-13-0793-01A-01W-0370-10 NA TCGA-13-0793-01A-01R-0363-07 |
|
|
126 |
TCGA-13-0794-01 1 TCGA-13-0794-01 1919 1 days BRCA-LUAD+ NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 3 NA TCGA-13-0794 845 1 days 1919 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Bilateral TCGA-13-0794-F72607 TCGA-13-0794 NA Stage IIIC -21945 NA 1919 0 923 NA 845 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA 60 NA NA NA G3 NA NA YES NA NA NA 0794 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2006 NA TCGA-13-0794-01 NA c9dd6b81-e436-410c-abe3-aefea5b82103 NA TCGA-13-0794-01 NA TCGA-13-0794-01A-01D-0359-05 NA TCGA-13-0794-01A-03-20 NA NA TCGA-13-0794-01A-01D-0356-01 TCGA-13-0794-01 fde6d311-beb0-4efa-92af-36b426444dd4 NA TCGA-13-0794-01A-01D-0356-01 NA NA NA NA TCGA-13-0794-01 NA NA NA NA TCGA-13-0794-01A-01R-0363-07 |
|
|
127 |
TCGA-13-0795-01 1 TCGA-13-0795-01 619 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-13-0795 325 1 days 619 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 66 Bilateral TCGA-13-0795-F72608 TCGA-13-0795 TCGA-13-0795-01A Stage IIIC -24403 NA 619 0 596 NA 325 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 0.9 NO 80 1.4 NA NA G3 NA NA YES NA NA TCGA-13-0795.B98206EC-73D1-404F-B497-BAD6C817D9B7.pdf 0795 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 >20 mm Ovary NA A DECEASED 2007 NA TCGA-13-0795-01 NA 8a90ef9c-f444-4bff-92df-7356ec1c07ad NA TCGA-13-0795-01 NA TCGA-13-0795-01A-01D-0359-05 TCGA-13-0795-01A-01W-0372-09 NA TCGA-13-0795-01A-01W-0372-09 NA TCGA-13-0795-01A-01D-0356-01 TCGA-13-0795-01 NA NA TCGA-13-0795-01A-01D-0356-01 NA NA NA NA TCGA-13-0795-01 NA NA TCGA-13-0795-01A-01W-0372-09 NA TCGA-13-0795-01A-01R-0363-07 |
|
|
128 |
TCGA-13-0797-01 0 TCGA-13-0797-01 2121 0 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 5 NA TCGA-13-0797 525 1 days 2121 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Bilateral TCGA-13-0797-F72609 TCGA-13-0797 TCGA-13-0797-01A Stage IIIC -18051 NA NA 0 2121 NA 525 NA NA Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO 80 1.6 NA NA G3 NA NA YES NA NA TCGA-13-0797.84ED21CA-E018-44C5-86E4-57927ABBCC9A.pdf 0797 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A LIVING 2008 NA TCGA-13-0797-01 NA 9efea7f4-e521-4520-8abb-c764fa2a6a8c NA TCGA-13-0797-01 NA TCGA-13-0797-01A-01D-0359-05 NA TCGA-13-0797-01A-03-20 NA NA TCGA-13-0797-01A-01D-0356-01 TCGA-13-0797-01 0a64d08c-7d28-4c74-ab75-2ff02f1a4de0 NA TCGA-13-0797-01A-01D-0356-01 NA NA NA NA TCGA-13-0797-01 NA NA NA TCGA-13-0797-01A-01R-0363-07 |
|
|
129 |
TCGA-13-0799-01 0 TCGA-13-0799-01 2535 0 days BRCA-LUAD+ C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-13-0799 1262 1 days 2535 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 44 Bilateral TCGA-13-0799-F72611 TCGA-13-0799 TCGA-13-0799-01A Stage IIIC -16171 NA NA 0 2535 NA 1262 NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO 80 1.6 NA NA G3 NA NA YES NA NA TCGA-13-0799.CBB83CF3-9846-409B-858B-C8A7E74CDFF1.pdf 0799 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2008 TCGA-13-0799-01 TCGA-13-0799-01 NA 1197c1db-5ef3-475a-bbdb-c81da71b6ccf NA TCGA-13-0799-01 NA TCGA-13-0799-01A-01D-0359-05 NA TCGA-13-0799-01A-03-1562-20 NA a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3 TCGA-13-0799-01A-01D-0356-01 TCGA-13-0799-01 c91f1247-0579-4c10-8da1-2d62d276e58e NA TCGA-13-0799-01A-01D-0356-01 a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3 NA a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3 NA TCGA-13-0799-01 TCGA-13-0799-01 a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3 NA TCGA-13-0799-01A-01R-0363-07 |
|
|
130 |
TCGA-13-0800-01 0 TCGA-13-0800-01 2661 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 3 TCGA-13-0800 1396 1 days 2661 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Bilateral TCGA-13-0800-F72612 TCGA-13-0800 TCGA-13-0800-01A Stage IIIC -19087 NA NA 0 2661 NA 1396 NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.5 NA NA G3 NA NA YES NA NA TCGA-13-0800.E3206F00-3BC6-44B4-848E-F2ED70E094BD.pdf 0800 NA TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2008 TCGA-13-0800-01 TCGA-13-0800-01 NA b637c4e1-2685-4843-9d5f-f63db155b468 NA TCGA-13-0800-01 NA TCGA-13-0800-01A-01D-0359-05 TCGA-13-0800-01A-01W-0372-09 TCGA-13-0800-01A-03-1562-20 TCGA-13-0800-01A-01W-0372-09 cd93531b-4d92-4be3-95e5-032636dd1ad8 TCGA-13-0800-01A-01D-0356-01 TCGA-13-0800-01 81737798-92c9-46d7-a85c-751fc5b102e8 NA TCGA-13-0800-01A-01D-0356-01 cd93531b-4d92-4be3-95e5-032636dd1ad8 NA cd93531b-4d92-4be3-95e5-032636dd1ad8 NA TCGA-13-0800-01 TCGA-13-0800-01 cd93531b-4d92-4be3-95e5-032636dd1ad8 TCGA-13-0800-01A-01W-0372-09 NA TCGA-13-0800-01A-01R-0363-07 |
|
|
131 |
TCGA-13-0801-01 1 TCGA-13-0801-01 1399 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-13-0801 345 1 days 1399 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 46 Bilateral TCGA-13-0801-F72613 TCGA-13-0801 TCGA-13-0801-01A Stage IIIC -16812 NA 1399 0 252 NA 345 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO 80 1.5 NA NA G3 NA NA YES NA NA TCGA-13-0801.FA63535E-7499-41E3-AFB1-98EB18DA7371.pdf 0801 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2008 TCGA-13-0801-01 TCGA-13-0801-01 TCGA-13-0801-01A-01W-0370-10 98d97019-658a-4493-bea0-5c571e196889 NA TCGA-13-0801-01 TCGA-13-0801-01A-01W-0370-10 TCGA-13-0801-01A-01D-0359-05 NA TCGA-13-0801-01A-03-20 NA c51dee3c-5047-4dde-b454-2474de5cf025 TCGA-13-0801-01A-01D-0356-01 TCGA-13-0801-01 1c4d4161-a528-4601-b512-eb2d5ed8d992 NA TCGA-13-0801-01A-01D-0356-01 c51dee3c-5047-4dde-b454-2474de5cf025 NA c51dee3c-5047-4dde-b454-2474de5cf025 NA TCGA-13-0801-01 TCGA-13-0801-01 c51dee3c-5047-4dde-b454-2474de5cf025 NA NA TCGA-13-0801-01A-01R-0363-07 |
|
|
132 |
TCGA-13-0802-01 1 TCGA-13-0802-01 1552 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 3 NA TCGA-13-0802 510 1 days 1552 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 79 Bilateral TCGA-13-0802-F72615 TCGA-13-0802 NA Stage IIIC -29075 NA 1552 0 249 NA 510 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA 60 NA NA NA G3 NA NA YES NA NA NA 0802 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 No Macroscopic disease Ovary NA NA DECEASED 2008 NA TCGA-13-0802-01 TCGA-13-0802-01A-01W-0370-10 eb96b8fd-6402-434d-9b98-bfa40b4be522 NA TCGA-13-0802-01 TCGA-13-0802-01A-01W-0370-10 TCGA-13-0802-01A-01D-0359-05 NA TCGA-13-0802-01A-03-1562-20 NA NA TCGA-13-0802-01A-01D-0356-01 TCGA-13-0802-01 e8448d63-f837-4512-89bf-06201938b152 NA TCGA-13-0802-01A-01D-0356-01 NA NA NA NA TCGA-13-0802-01 NA NA NA NA TCGA-13-0802-01A-01R-0363-07 |
|
|
133 |
TCGA-13-0803-01 1 TCGA-13-0803-01 1334 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 NA TCGA-13-0803 NA NA days 1334 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 81 Bilateral TCGA-13-0803-F24629 TCGA-13-0803 NA Stage IIIC -29685 NA 1334 0 1334 NA 337 NA NA NA 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 0803 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 NA NA NA 13 No Macroscopic disease Ovary NA NA DECEASED 2001 NA TCGA-13-0803-01 NA f17806bc-e184-49dc-99aa-cd5547ebb032 NA TCGA-13-0803-01 NA TCGA-13-0803-01A-01D-0359-05 NA NA NA NA TCGA-13-0803-01A-01D-0356-01 TCGA-13-0803-01 NA NA TCGA-13-0803-01A-01D-0356-01 NA NA NA NA TCGA-13-0803-01 NA NA NA NA TCGA-13-0803-01A-01R-0363-07 |
|
|
134 |
TCGA-13-0804-01 1 TCGA-13-0804-01 1073 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-0804 NA NA days 1073 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 73 Bilateral TCGA-13-0804-F24633 TCGA-13-0804 TCGA-13-0804-01A Stage IIIC -27021 NA 1073 0 1073 NA 329 NA NA NA 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.3 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-13-0804.34870541-DEE9-4B39-A292-117E443B1CBF.pdf 0804 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 2003 NA NA NA a7711b62-2471-4ee7-8461-279e9732e83b NA NA NA TCGA-13-0804-01A-01D-0359-05 TCGA-13-0804-01A-01W-0372-09 TCGA-13-0804-01A-03-20 TCGA-13-0804-01A-01W-0372-09 NA TCGA-13-0804-01A-01D-0356-01 TCGA-13-0804-01 50ffbcf0-99c5-4528-bd60-8a054b3566a8 NA TCGA-13-0804-01A-01D-0356-01 NA NA NA NA TCGA-13-0804-01 NA NA TCGA-13-0804-01A-01W-0372-09 NA TCGA-13-0804-01A-01R-0363-07 |
|
|
135 |
TCGA-13-0805-01 1 TCGA-13-0805-01 1074 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 NA TCGA-13-0805 NA NA days 1074 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-13-0805-F24638 TCGA-13-0805 NA Stage IIIC -21014 NA 1074 0 1073 NA 177 NA NA NA 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Progression of Disease NA NA NA NA NA 0805 NA WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2005 NA TCGA-13-0805-01 NA fbd0a639-044c-453b-a29c-3d914f431bd9 NA TCGA-13-0805-01 NA TCGA-13-0805-01A-01D-0359-05 NA NA NA NA TCGA-13-0805-01A-01D-0356-01 TCGA-13-0805-01 NA NA TCGA-13-0805-01A-01D-0356-01 NA NA NA NA TCGA-13-0805-01 NA NA NA NA TCGA-13-0805-01A-01R-0363-07 |
|
|
136 |
TCGA-13-0807-01 1 TCGA-13-0807-01 414 1 days Squamous NA OV-like c1 NA NA NA NA mutation cluster 5 TCGA-13-0807 NA NA days 414 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 54 NA TCGA-13-0807-F24642 TCGA-13-0807 TCGA-13-0807-01B Stage IIIC -19890 NA 414 0 414 NA NA NA NA NA 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NO NA NA NA NA G3 NA NA NA NA NA TCGA-13-0807.E28B5574-1AC3-4E5E-BDD5-5B548E450F28.pdf 0807 NA NA YES NA NA NO R1 Primary Tumor 01 NA NA NA 13 >20 mm Ovary NA B DECEASED 2005 NA NA NA 8fee0dca-afdb-46a8-b7b3-e16ed7ba4e32 NA NA NA TCGA-13-0807-01B-02D-0402-05 TCGA-13-0807-01B-02W-0421-09 NA TCGA-13-0807-01B-02W-0421-09 NA TCGA-13-0807-01B-02D-0399-01 TCGA-13-0807-01 NA NA TCGA-13-0807-01B-02D-0399-01 NA NA NA NA TCGA-13-0807-01 NA NA TCGA-13-0807-01B-02W-0421-09 TCGA-13-0807-01B-01R-0406-07 |
|
|
137 |
TCGA-13-0883-01 1 TCGA-13-0883-01 2097 1 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-0883 NA NA days 2097 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-13-0883-F24646 TCGA-13-0883 TCGA-13-0883-01A Stage IIIC -22395 NA 2097 0 2097 NA 819 NA NA NA 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.1 NO NA 1.4 NA NA G3 Recurrence NA NA NA NA TCGA-13-0883.7AC6471C-1BA0-4AA5-9A2E-70413C9768F8.pdf 0883 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A DECEASED 2002 NA TCGA-13-0883-01 NA 8b92a7da-e2b2-41c4-9ea2-8c3f87c2f5e9 NA TCGA-13-0883-01 NA TCGA-13-0883-01A-02D-0402-05 NA NA NA NA TCGA-13-0883-01A-02D-0399-01 TCGA-13-0883-01 NA NA TCGA-13-0883-01A-02D-0399-01 NA NA NA TCGA-13-0883-01A-02W-0420-08 TCGA-13-0883-01 NA NA TCGA-13-0883-01A-02W-0420-08 TCGA-13-0883-01A-02R-0406-07 |
|
|
138 |
TCGA-13-0884-01 1 TCGA-13-0884-01 3260 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-0884 NA NA days 3260 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 39 Bilateral TCGA-13-0884-F24651 TCGA-13-0884 TCGA-13-0884-01B Stage IIIC -14538 NA 3260 0 3260 NA 1251 NA NA NA 2009-3-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.7 NO NA 1.3 NA NA G3 Recurrence NA NA NA NA TCGA-13-0884.D15552F3-1407-4C01-9B59-DFAC5D4EF095.pdf 0884 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA B DECEASED 1999 NA TCGA-13-0884-01 NA 3b4e9ec5-9001-40af-8397-8802341611ad NA TCGA-13-0884-01 NA TCGA-13-0884-01B-01D-0460-05 TCGA-13-0884-01B-01W-0494-09 TCGA-13-0884-01B-21-1562-20 TCGA-13-0884-01B-01W-0494-09 NA TCGA-13-0884-01B-01D-0452-01 TCGA-13-0884-01 2185ae8b-2257-4cc5-b08d-cf91dffa760d NA TCGA-13-0884-01B-01D-0452-01 NA NA NA NA TCGA-13-0884-01 NA NA TCGA-13-0884-01B-01W-0494-09 TCGA-13-0884-01B-01R-0456-07 |
|
|
139 |
TCGA-13-0885-01 0 TCGA-13-0885-01 3388 0 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-13-0885 NA NA days 3388 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 70 Left TCGA-13-0885-F72616 TCGA-13-0885 TCGA-13-0885-01A Stage IIIC -25763 NA NA 0 3388 NA NA NA NA NA 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO 80 1.2 NA NA G3 NA NA NA NA NA TCGA-13-0885.81DFFD49-45F0-4A20-AC27-B8316B2E0289.pdf 0885 Pre-Adjuvant Therapy NA NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 11-20 mm Ovary NA A LIVING 2000 NA TCGA-13-0885-01 NA 22d268ea-7e43-46f4-8d1c-7a557d2f1664 NA TCGA-13-0885-01 NA TCGA-13-0885-01A-02D-0402-05 TCGA-13-0885-01A-02W-0421-09 NA TCGA-13-0885-01A-02W-0421-09 NA TCGA-13-0885-01A-02D-0399-01 TCGA-13-0885-01 NA NA TCGA-13-0885-01A-02D-0399-01 NA NA NA NA TCGA-13-0885-01 NA NA TCGA-13-0885-01A-02W-0421-09 TCGA-13-0885-01A-02R-0406-07 |
|
|
140 |
TCGA-13-0886-01 0 TCGA-13-0886-01 4665 0 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-0886 4665 0 days 4665 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 67 Bilateral TCGA-13-0886-F72617 TCGA-13-0886 TCGA-13-0886-01A Stage IIIC -24724 NA NA 0 4665 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NA G3 NA NA NO NA NA TCGA-13-0886.2FB5824C-F30B-4E0B-B787-CBF93A6A48AE.pdf 0886 NA TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA A LIVING 2002 NA TCGA-13-0886-01 NA de22b463-bc0e-4f81-9a06-0e55353b1412 NA TCGA-13-0886-01 NA TCGA-13-0886-01A-01D-0402-05 NA TCGA-13-0886-01A-21-20 NA NA TCGA-13-0886-01A-01D-0399-01 TCGA-13-0886-01 97f40569-5280-4c67-831d-dc8fa952e0f8 NA TCGA-13-0886-01A-01D-0399-01 NA NA NA TCGA-13-0886-01A-01W-0420-08 TCGA-13-0886-01 NA NA TCGA-13-0886-01A-01W-0420-08 TCGA-13-0886-01A-01R-0406-07 |
|
|
141 |
TCGA-13-0887-01 1 TCGA-13-0887-01 2028 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0887 NA NA days 2028 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Bilateral TCGA-13-0887-F24668 TCGA-13-0887 TCGA-13-0887-01A Stage IIIC -15669 NA 2028 0 2028 NA 514 NA NA NA 2009-2-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO 80 1.3 NA NA G3 Recurrence NA NA NA NA TCGA-13-0887.AAEBFF3C-EA12-4D58-A424-2463307484A3.pdf 0887 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A DECEASED 2002 NA TCGA-13-0887-01 NA 3bc498df-2e02-4182-87f5-381fbde2f225 NA TCGA-13-0887-01 NA TCGA-13-0887-01A-01D-0402-05 TCGA-13-0887-01A-01W-0421-09 TCGA-13-0887-01A-21-20 TCGA-13-0887-01A-01W-0421-09 NA TCGA-13-0887-01A-01D-0399-01 TCGA-13-0887-01 0226becf-0ff4-4457-a446-0ed079324b0d NA TCGA-13-0887-01A-01D-0399-01 NA NA NA NA TCGA-13-0887-01 NA NA TCGA-13-0887-01A-01W-0421-09 TCGA-13-0887-01A-01R-0406-07 |
|
|
142 |
TCGA-13-0888-01 1 TCGA-13-0888-01 2811 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 NA TCGA-13-0888 2811 0 days 2811 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Right TCGA-13-0888-F72618 TCGA-13-0888 TCGA-13-0888-01A Stage IIIC -28498 NA 2811 0 2141 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO 80 1.2 NA NA G3 NA NA NO NA NA TCGA-13-0888.DFDEBDE5-C16E-4B29-9986-8EB557648AC5.pdf 0888 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2003 NA TCGA-13-0888-01 NA 2b24ddb3-3774-46ac-aa6f-48abfec30a81 NA TCGA-13-0888-01 NA TCGA-13-0888-01A-01D-0402-05 NA TCGA-13-0888-01A-21-20 NA NA TCGA-13-0888-01A-01D-0399-01 TCGA-13-0888-01 bb0f85fb-5126-4934-89bc-39e1044dee03 NA TCGA-13-0888-01A-01D-0399-01 NA NA NA NA TCGA-13-0888-01 NA NA NA TCGA-13-0888-01A-01R-0406-07 |
|
|
143 |
TCGA-13-0889-01 1 TCGA-13-0889-01 2894 1 days Squamous NA UCEC Serous c4 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0889 NA NA days 2894 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 75 Right TCGA-13-0889-F72619 TCGA-13-0889 TCGA-13-0889-01A Stage IV -27674 NA 2894 0 1881 NA NA NA NA NA 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.5 NO 60 1.5 NA NA GX NA NA NA NA NA TCGA-13-0889.262B6A57-D2DF-47E3-BDB2-1FB956D8ABE9.pdf 0889 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 2003 NA TCGA-13-0889-01 TCGA-13-0889-01A-01W-0419-10 8f64648c-7481-4814-865a-c392da1968bd NA TCGA-13-0889-01 TCGA-13-0889-01A-01W-0419-10 TCGA-13-0889-01A-01D-0402-05 NA NA NA NA TCGA-13-0889-01A-01D-0399-01 TCGA-13-0889-01 NA NA TCGA-13-0889-01A-01D-0399-01 NA NA NA NA TCGA-13-0889-01 NA NA TCGA-13-0889-01A-01W-0419-10 TCGA-13-0889-01A-01R-0406-07 |
|
|
144 |
TCGA-13-0890-01 0 TCGA-13-0890-01 4424 0 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0890 4424 0 days 4424 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 56 Bilateral TCGA-13-0890-F72620 TCGA-13-0890 TCGA-13-0890-01A Stage IIIC -20770 NA NA 0 4424 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 1.5 NA NA G3 NA NA NO NA NA TCGA-13-0890.78888517-0ADC-4A78-B7FA-9ACE201795AB.pdf 0890 NA TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A LIVING 2003 TCGA-13-0890-01 TCGA-13-0890-01 NA 9b5c97b8-eba5-431b-96cc-c60f5ee91a62 NA TCGA-13-0890-01 NA TCGA-13-0890-01A-01D-0402-05 TCGA-13-0890-01A-01W-0421-09 NA TCGA-13-0890-01A-01W-0421-09 65cc3a15-cfa9-48fb-b9e4-801398b073b8 TCGA-13-0890-01A-01D-0399-01 TCGA-13-0890-01 NA NA TCGA-13-0890-01A-01D-0399-01 65cc3a15-cfa9-48fb-b9e4-801398b073b8 NA 65cc3a15-cfa9-48fb-b9e4-801398b073b8 NA TCGA-13-0890-01 TCGA-13-0890-01 65cc3a15-cfa9-48fb-b9e4-801398b073b8 TCGA-13-0890-01A-01W-0421-09 TCGA-13-0890-01A-01R-0406-07 |
|
|
145 |
TCGA-13-0891-01 1 TCGA-13-0891-01 3128 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-13-0891 762 1 days 3128 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 Bilateral TCGA-13-0891-F72621 TCGA-13-0891 TCGA-13-0891-01A Stage IV -26886 NA 3128 0 2099 NA 762 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 1.2 NO 80 1.4 NA NA G3 NA NA YES NA NA TCGA-13-0891.7DF79B3C-8CD7-446D-A13A-BBB69DFE2394.pdf 0891 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2003 NA TCGA-13-0891-01 NA 7d27ea62-19e6-4032-9e7f-799be4d3eaef NA TCGA-13-0891-01 NA TCGA-13-0891-01A-01D-0402-05 NA TCGA-13-0891-01A-21-20 NA NA TCGA-13-0891-01A-01D-0399-01 TCGA-13-0891-01 f305890a-3b48-4e7b-8f31-f2653a5582b8 NA TCGA-13-0891-01A-01D-0399-01 NA NA NA TCGA-13-0891-01A-01W-0420-08 TCGA-13-0891-01 NA NA TCGA-13-0891-01A-01W-0420-08 TCGA-13-0891-01A-01R-0406-07 |
|
|
146 |
TCGA-13-0893-01 1 TCGA-13-0893-01 1319 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-0893 NA NA days 1319 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-13-0893-F24690 TCGA-13-0893 TCGA-13-0893-01B Stage IIIC -17573 NA 1319 0 1319 NA 461 NA NA NA 2009-3-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-13-0893.0648E74B-766C-4AB7-BEEE-D45895413E5E.pdf 0893 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 13 11-20 mm Ovary NA B DECEASED 2003 TCGA-13-0893-01 TCGA-13-0893-01 NA 901a306b-6a5b-4f94-aac0-6eb7c767bb2e NA TCGA-13-0893-01 NA TCGA-13-0893-01B-01D-0460-05 TCGA-13-0893-01B-01W-0494-09 NA TCGA-13-0893-01B-01W-0494-09 2b2d5fc7-b109-4d11-a632-db8016268840 TCGA-13-0893-01B-01D-0452-01 TCGA-13-0893-01 NA NA TCGA-13-0893-01B-01D-0452-01 2b2d5fc7-b109-4d11-a632-db8016268840 NA 2b2d5fc7-b109-4d11-a632-db8016268840 NA TCGA-13-0893-01 TCGA-13-0893-01 2b2d5fc7-b109-4d11-a632-db8016268840 TCGA-13-0893-01B-01W-0494-09 TCGA-13-0893-01B-01R-0456-07 |
|
|
147 |
TCGA-13-0894-01 1 TCGA-13-0894-01 1509 1 days High C9-OV Low purity c2 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0894 NA NA days 1509 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-13-0894-F24695 TCGA-13-0894 TCGA-13-0894-01B Stage IIIC -19466 NA 1509 0 1509 NA 565 NA NA NA 2009-3-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.1 NO 80 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-13-0894.305FFF39-3453-49A4-8ED6-0532C9119AF0.pdf 0894 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA B DECEASED 2003 NA TCGA-13-0894-01 NA 2f62cd27-7bac-44c6-baa8-7e8593962402 NA TCGA-13-0894-01 NA TCGA-13-0894-01B-01D-0460-05 TCGA-13-0894-01B-01W-0494-09 TCGA-13-0894-01B-03-1562-20 TCGA-13-0894-01B-01W-0494-09 NA NA TCGA-13-0894-01 7e63800a-f2db-4a2a-82ab-2867707caf14 NA NA NA NA NA NA NA NA NA TCGA-13-0894-01B-01W-0494-09 TCGA-13-0894-01B-01R-0456-07 |
|
|
148 |
TCGA-13-0897-01 1 TCGA-13-0897-01 2182 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-0897 554 1 days 2182 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 54 Right TCGA-13-0897-F72622 TCGA-13-0897 TCGA-13-0897-01A Stage IIIC -19894 NA 2182 0 1748 NA 554 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.5 NO 80 1.1 NA NA G3 NA NA YES NA NA TCGA-13-0897.058A5354-D36C-4398-AC2C-12447FDB0966.pdf 0897 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA A DECEASED 2004 TCGA-13-0897-01 TCGA-13-0897-01 NA 5ae3b33e-162f-4784-b007-cce51fdcfa5e NA TCGA-13-0897-01 NA TCGA-13-0897-01A-01D-0402-05 TCGA-13-0897-01A-01W-0421-09 TCGA-13-0897-01A-21-20 TCGA-13-0897-01A-01W-0421-09 479b74bf-5003-45e1-9505-687146a5fc45 TCGA-13-0897-01A-01D-0399-01 TCGA-13-0897-01 7a6431cb-6461-4534-89e9-fc15b639bfac NA TCGA-13-0897-01A-01D-0399-01 479b74bf-5003-45e1-9505-687146a5fc45 NA 479b74bf-5003-45e1-9505-687146a5fc45 NA TCGA-13-0897-01 TCGA-13-0897-01 479b74bf-5003-45e1-9505-687146a5fc45 TCGA-13-0897-01A-01W-0421-09 TCGA-13-0897-01A-01R-0406-07 |
|
|
149 |
TCGA-13-0899-01 1 TCGA-13-0899-01 2012 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-0899 547 1 days 2012 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Bilateral TCGA-13-0899-F72623 TCGA-13-0899 TCGA-13-0899-01A Stage IIIC -22031 NA 2012 0 1708 NA 547 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 1.6 NA NA G3 NA NA YES NA NA TCGA-13-0899.AB15D325-CCD6-452F-8662-158E3153AFC4.pdf 0899 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA A DECEASED 2004 TCGA-13-0899-01 TCGA-13-0899-01 NA f5878d06-b37c-49fd-8a70-aaaaa270a14c NA TCGA-13-0899-01 NA TCGA-13-0899-01A-01D-0402-05 NA TCGA-13-0899-01A-21-20 NA 605d0aed-4637-4a09-82dd-eedd1aa76ca0 TCGA-13-0899-01A-01D-0399-01 TCGA-13-0899-01 eacc42b9-bd6e-468c-8560-6d699ae97737 NA TCGA-13-0899-01A-01D-0399-01 605d0aed-4637-4a09-82dd-eedd1aa76ca0 NA 605d0aed-4637-4a09-82dd-eedd1aa76ca0 TCGA-13-0899-01A-01W-0420-08 TCGA-13-0899-01 TCGA-13-0899-01 605d0aed-4637-4a09-82dd-eedd1aa76ca0 TCGA-13-0899-01A-01W-0420-08 TCGA-13-0899-01A-01R-0406-07 |
|
|
150 |
TCGA-13-0900-01 0 TCGA-13-0900-01 4077 0 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 11 TCGA-13-0900 4077 0 days 4077 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Bilateral TCGA-13-0900-F72637 TCGA-13-0900 TCGA-13-0900-01B Stage IIIC -21698 NA NA 0 4077 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO 60 1.5 NA NA G3 NA NA NO NA NA TCGA-13-0900.27A4B579-9123-431C-95B6-FBC5CB5142C9.pdf 0900 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.1 NA NA 13 NA Ovary NA B LIVING 2004 NA TCGA-13-0900-01 TCGA-13-0900-01B-01W-0490-10 443f369f-d9cf-433a-a115-7934c20bf98a NA TCGA-13-0900-01 TCGA-13-0900-01B-01W-0490-10 TCGA-13-0900-01B-01D-0460-05 NA NA NA NA TCGA-13-0900-01B-01D-0452-01 TCGA-13-0900-01 NA NA TCGA-13-0900-01B-01D-0452-01 NA NA NA NA TCGA-13-0900-01 NA NA TCGA-13-0900-01B-01W-0490-10 TCGA-13-0900-01B-01R-0456-07 |
|
|
151 |
TCGA-13-0901-01 0 TCGA-13-0901-01 589 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 5 NA TCGA-13-0901 NA NA days 589 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 41 Bilateral TCGA-13-0901-F24712 TCGA-13-0901 TCGA-13-0901-01A Stage IIIC -15333 NA NA 0 589 NA 390 NA NA NA 2009-3-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO 80 1.3 NA NA G3 Recurrence NA NA NA NA TCGA-13-0901.5613318C-D3D4-436D-B22F-BE8FC36D9686.pdf 0901 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 13 >20 mm Ovary NA A LIVING 2004 NA TCGA-13-0901-01 TCGA-13-0901-01B-01W-0490-10 9a07f778-ddd0-4290-af0b-9cf85da4b123 NA TCGA-13-0901-01 TCGA-13-0901-01B-01W-0490-10 TCGA-13-0901-01B-01D-0460-05 NA TCGA-13-0901-01A-21-20 NA NA TCGA-13-0901-01B-01D-0452-01 TCGA-13-0901-01 0f0ae870-f5a7-4572-998d-d39403507fbe NA TCGA-13-0901-01B-01D-0452-01 NA NA NA NA TCGA-13-0901-01 NA NA NA TCGA-13-0901-01B-01R-0456-07 |
|
|
152 |
TCGA-13-0903-01 0 TCGA-13-0903-01 3887 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0903 3887 0 days 3887 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 42 Bilateral TCGA-13-0903-F72624 TCGA-13-0903 TCGA-13-0903-01A Stage IV -15705 NA NA 0 3887 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO 80 1 NA NA G3 NA NA NO NA NA TCGA-13-0903.A0EC0825-B2E7-40A0-868C-8C93A5D01AD8.pdf 0903 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2004 NA TCGA-13-0903-01 NA 0931f0af-d4ff-4d49-9671-44f7f972ad49 NA TCGA-13-0903-01 NA TCGA-13-0903-01A-01D-0402-05 TCGA-13-0903-01A-01W-0421-09 TCGA-13-0903-01A-21-20 TCGA-13-0903-01A-01W-0421-09 NA TCGA-13-0903-01A-01D-0399-01 TCGA-13-0903-01 1eb38ad5-a108-4461-8d9c-2246c4e5174c NA TCGA-13-0903-01A-01D-0399-01 NA NA NA NA TCGA-13-0903-01 NA NA TCGA-13-0903-01A-01W-0421-09 TCGA-13-0903-01A-01R-0406-07 |
|
|
153 |
TCGA-13-0904-01 1 TCGA-13-0904-01 1532 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 2 TCGA-13-0904 330 1 days 1532 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Bilateral TCGA-13-0904-F72625 TCGA-13-0904 TCGA-13-0904-01A Stage IIIC -23278 NA 1532 0 1470 NA 330 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 0.7 NO 80 1.5 NA NA G3 NA NA YES NA NA TCGA-13-0904.4355BCD7-7A04-4F75-9415-83D3D6E18A24.pdf 0904 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 >20 mm Ovary NA A DECEASED 2004 NA TCGA-13-0904-01 NA 8db1ce50-4f8c-40a6-a56b-8266f0a16d28 NA TCGA-13-0904-01 NA TCGA-13-0904-01A-02D-0402-05 NA NA NA NA TCGA-13-0904-01A-02D-0399-01 TCGA-13-0904-01 NA NA TCGA-13-0904-01A-02D-0399-01 NA NA NA TCGA-13-0904-01A-02W-0420-08 TCGA-13-0904-01 NA NA TCGA-13-0904-01A-02W-0420-08 TCGA-13-0904-01A-02R-0406-07 |
|
|
154 |
TCGA-13-0905-01 0 TCGA-13-0905-01 3746 0 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0905 1535 1 days 3746 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Left TCGA-13-0905-F72638 TCGA-13-0905 TCGA-13-0905-01B Stage IIIC -18757 NA NA 0 3746 NA 1535 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO 80 1.2 NA NA G3 NA NA YES NA NA TCGA-13-0905.4EC6E47F-60BD-413E-9371-D70E1E89D0CA.pdf 0905 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 NA Ovary NA B LIVING 2005 NA TCGA-13-0905-01 NA 05762312-1eb7-48bd-b497-97e2f94a86ff NA TCGA-13-0905-01 NA TCGA-13-0905-01B-01D-0460-05 NA NA NA NA TCGA-13-0905-01B-01D-0452-01 TCGA-13-0905-01 NA NA TCGA-13-0905-01B-01D-0452-01 NA NA NA TCGA-13-0905-01B-01W-0492-08 TCGA-13-0905-01 NA NA TCGA-13-0905-01B-01W-0492-08 TCGA-13-0905-01B-01R-0456-07 |
|
|
155 |
TCGA-13-0906-01 0 TCGA-13-0906-01 3619 0 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-0906 3619 0 days 3619 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 50 Bilateral TCGA-13-0906-F72626 TCGA-13-0906 TCGA-13-0906-01A Stage IIIC -18383 NA NA 0 3619 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO 60 1.1 NA NA G3 NA NA NO NA NA TCGA-13-0906.D75790B2-C93F-4723-B691-84EE94656FF1.pdf 0906 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A LIVING 2005 NA TCGA-13-0906-01 TCGA-13-0906-01A-01W-0419-10 8cba78d8-365d-4f21-9024-b1c65e7aebd9 NA TCGA-13-0906-01 TCGA-13-0906-01A-01W-0419-10 TCGA-13-0906-01A-01D-0402-05 NA TCGA-13-0906-01A-21-20 NA NA TCGA-13-0906-01A-01D-0399-01 TCGA-13-0906-01 80aaf315-cf54-47e5-b82a-1343e25938ca NA TCGA-13-0906-01A-01D-0399-01 NA NA NA NA TCGA-13-0906-01 NA NA TCGA-13-0906-01A-01W-0419-10 TCGA-13-0906-01A-01R-0406-07 |
|
|
156 |
TCGA-13-0908-01 1 TCGA-13-0908-01 1843 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 6 NA TCGA-13-0908 552 1 days 1843 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-13-0908-F72639 TCGA-13-0908 TCGA-13-0908-01B Stage IV -21422 NA 1843 0 1364 NA 552 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.3 NO NA 1.4 NA NA G3 NA NA YES NA NA TCGA-13-0908.AE735D44-31EA-4345-9B3E-E92C7F236569.pdf 0908 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA B DECEASED 2005 NA TCGA-13-0908-01 NA 1a0d9712-cc09-46fa-a588-2d9db23c751b NA TCGA-13-0908-01 NA TCGA-13-0908-01B-01D-0460-05 NA NA NA NA TCGA-13-0908-01B-01D-0452-01 TCGA-13-0908-01 NA NA TCGA-13-0908-01B-01D-0452-01 NA NA NA NA TCGA-13-0908-01 NA NA NA TCGA-13-0908-01B-01R-0456-07 |
|
|
157 |
TCGA-13-0910-01 0 TCGA-13-0910-01 3548 0 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0910 1212 1 days 3548 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-13-0910-F72627 TCGA-13-0910 NA Stage IIIC -21473 NA NA 0 3548 NA 1212 NA NA Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA 60 NA NA NA G3 NA NA YES NA NA NA 0910 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA LIVING 2005 NA TCGA-13-0910-01 NA c86a6b6b-046a-46c9-a89d-d365adafedd7 NA TCGA-13-0910-01 NA TCGA-13-0910-01A-01D-0402-05 TCGA-13-0910-01A-01W-0421-09 TCGA-13-0910-01A-21-20 TCGA-13-0910-01A-01W-0421-09 NA TCGA-13-0910-01A-01D-0399-01 TCGA-13-0910-01 a7d2bac8-709d-455d-8613-e87b8fd8fe19 NA TCGA-13-0910-01A-01D-0399-01 NA NA NA NA TCGA-13-0910-01 NA NA TCGA-13-0910-01A-01W-0421-09 TCGA-13-0910-01A-01R-0406-07 |
|
|
158 |
TCGA-13-0911-01 1 TCGA-13-0911-01 1355 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0911 279 1 days 1355 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Bilateral TCGA-13-0911-F72628 TCGA-13-0911 TCGA-13-0911-01A Stage IV -20276 NA 1355 0 843 NA 279 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO 80 1.5 NA NA G3 NA NA YES NA NA TCGA-13-0911.0DE80BC5-8AA8-423A-B99B-9CD9883F27C2.pdf 0911 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA R1 Primary Tumor 01 0.8 NA NA 13 1-10 mm Ovary NA A DECEASED 2005 NA TCGA-13-0911-01 NA 68069103-49df-4246-8858-31d6b3571145 NA TCGA-13-0911-01 NA TCGA-13-0911-01A-01D-0402-05 NA TCGA-13-0911-01A-21-20 NA NA TCGA-13-0911-01A-01D-0399-01 TCGA-13-0911-01 c2fbc465-c862-412d-8966-d88e0e414316 NA TCGA-13-0911-01A-01D-0399-01 NA NA NA TCGA-13-0911-01A-01W-0420-08 TCGA-13-0911-01 NA NA TCGA-13-0911-01A-01W-0420-08 TCGA-13-0911-01A-01R-0406-07 |
|
|
159 |
TCGA-13-0912-01 1 TCGA-13-0912-01 1145 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0912 469 1 days 1145 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-13-0912-F72629 TCGA-13-0912 TCGA-13-0912-01A Stage IIIC -21427 NA 1145 0 1036 NA 469 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO 80 1.2 NA NA G3 NA NA YES NA NA TCGA-13-0912.E6BF50DE-3E1D-447C-88B6-497B3C4C835F.pdf 0912 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2006 NA TCGA-13-0912-01 NA 1daa5008-c4db-41ea-8e40-e551632f8bec NA TCGA-13-0912-01 NA TCGA-13-0912-01A-01D-0402-05 TCGA-13-0912-01A-01W-0421-09 NA TCGA-13-0912-01A-01W-0421-09 NA TCGA-13-0912-01A-01D-0399-01 TCGA-13-0912-01 NA NA TCGA-13-0912-01A-01D-0399-01 NA NA NA NA TCGA-13-0912-01 NA NA TCGA-13-0912-01A-01W-0421-09 TCGA-13-0912-01A-01R-0406-07 |
|
|
160 |
TCGA-13-0913-01 0 TCGA-13-0913-01 3325 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0913 871 1 days 3325 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 53 Bilateral TCGA-13-0913-F72630 TCGA-13-0913 TCGA-13-0913-01A Stage IIIC -19573 NA NA 0 3325 NA 871 NA NA Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO 80 1.3 NA NA G3 NA NA YES NA NA TCGA-13-0913.E8FB6EA9-586A-452F-B6A6-0746F16B51DB.pdf 0913 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2006 TCGA-13-0913-01 TCGA-13-0913-01 NA e993c6b2-05c7-4404-b8d8-a4e3ce8a8253 NA TCGA-13-0913-01 NA TCGA-13-0913-01A-01D-0402-05 NA TCGA-13-0913-01A-21-20 NA cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9 TCGA-13-0913-01A-01D-0399-01 TCGA-13-0913-01 8887c7f4-1bc4-4ec6-874f-453c17e1646e,0c76e11e-e654-49d5-9469-aec43bc8eb96 NA TCGA-13-0913-01A-01D-0399-01 cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9 NA cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9 TCGA-13-0913-01A-01W-0420-08 TCGA-13-0913-01 TCGA-13-0913-01 cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9 TCGA-13-0913-01A-01W-0420-08 TCGA-13-0913-01A-01R-0406-07 |
|
|
161 |
TCGA-13-0913-02 0 TCGA-13-0913-02 3325 0 days NA C9-OV OV-like c1 NA NA miRNA cluster 2 NA mutation cluster 5 TCGA-13-0913 871 1 days 3325 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 53 Bilateral TCGA-13-0913-F72630 TCGA-13-0913 TCGA-13-0913-02A Stage IIIC -19573 NA NA 0 3325 NA 871 NA NA Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO 80 1.4 NA NA G3 NA NA YES NA NA TCGA-13-0913.61FBF10C-A508-4D83-971D-5A48BA81F08A.pdf 0913 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Recurrent Tumor 02 0.3 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2006 NA TCGA-13-0913-02 NA b9367a1a-2b4b-4beb-a02f-743f826bf85d NA TCGA-13-0913-02 NA TCGA-13-0913-02A-01D-0807-05 NA NA NA NA NA NA 8c5c67e0-0a80-43b4-b35f-ddd51163b452 NA NA NA NA NA NA NA NA NA NA TCGA-13-0913-02A-01R-0810-07 |
|
|
162 |
TCGA-13-0916-01 0 TCGA-13-0916-01 1785 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0916 1785 0 days 1785 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Bilateral TCGA-13-0916-F72631 TCGA-13-0916 TCGA-13-0916-01A Stage IIIC -18189 NA NA 0 1785 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 NA NA NO NA NA TCGA-13-0916.28A2A65C-70A2-40D2-A03A-F68884457C14.pdf 0916 NA TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.6 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2006 TCGA-13-0916-01 TCGA-13-0916-01 NA 468b249e-69a0-4728-a0a3-cbe7fad18499 NA TCGA-13-0916-01 NA TCGA-13-0916-01A-01D-0402-05 NA TCGA-13-0916-01A-21-20 NA 63c52e46-68cf-4dac-9bd7-37081daa4474 TCGA-13-0916-01A-01D-0399-01 TCGA-13-0916-01 3a88bad5-3325-409f-8023-5e2df3ba1bf4 NA TCGA-13-0916-01A-01D-0399-01 63c52e46-68cf-4dac-9bd7-37081daa4474 NA 63c52e46-68cf-4dac-9bd7-37081daa4474 TCGA-13-0916-01A-01W-0420-08 TCGA-13-0916-01 TCGA-13-0916-01 63c52e46-68cf-4dac-9bd7-37081daa4474 TCGA-13-0916-01A-01W-0420-08 TCGA-13-0916-01A-01R-0406-07 |
|
|
163 |
TCGA-13-0919-01 0 TCGA-13-0919-01 2571 0 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 8 TCGA-13-0919 2571 0 days 2571 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Bilateral TCGA-13-0919-F72632 TCGA-13-0919 NA Stage IIIC -19337 NA NA 0 2571 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA 80 NA NA NA G3 NA NA NO NA NA NA 0919 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 NA NA NA 13 No Macroscopic disease Ovary NA NA LIVING 2007 NA TCGA-13-0919-01 TCGA-13-0919-01A-01W-0419-10 f00f1225-2b6a-4d61-a3e1-909fd595b624 NA TCGA-13-0919-01 TCGA-13-0919-01A-01W-0419-10 TCGA-13-0919-01A-01D-0402-05 NA NA NA NA TCGA-13-0919-01A-01D-0399-01 TCGA-13-0919-01 NA NA TCGA-13-0919-01A-01D-0399-01 NA NA NA NA TCGA-13-0919-01 NA NA TCGA-13-0919-01A-01W-0419-10 TCGA-13-0919-01A-01R-0406-07 |
|
|
164 |
TCGA-13-0920-01 1 TCGA-13-0920-01 1484 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-0920 297 1 days 1484 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 65 Bilateral TCGA-13-0920-F72633 TCGA-13-0920 TCGA-13-0920-01A Stage IIIC -24064 NA 1484 0 420 NA 297 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1 NA NA G3 NA NA YES NA NA TCGA-13-0920.6880B406-08B2-43CE-9274-5826B1BE9114.pdf 0920 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A DECEASED 2007 TCGA-13-0920-01 TCGA-13-0920-01 NA f109f013-990a-4e2d-9bce-b3dce60e5b0f NA TCGA-13-0920-01 NA TCGA-13-0920-01A-01D-0402-05 TCGA-13-0920-01A-01W-0421-09 TCGA-13-0920-01A-21-20 TCGA-13-0920-01A-01W-0421-09 2d8e1b4d-85d0-4bfd-99f7-59559dabe978 TCGA-13-0920-01A-01D-0399-01 TCGA-13-0920-01 1aaaee17-5206-42cc-b678-f4a4e712ae54 NA TCGA-13-0920-01A-01D-0399-01 2d8e1b4d-85d0-4bfd-99f7-59559dabe978 NA 2d8e1b4d-85d0-4bfd-99f7-59559dabe978 NA TCGA-13-0920-01 TCGA-13-0920-01 2d8e1b4d-85d0-4bfd-99f7-59559dabe978 TCGA-13-0920-01A-01W-0421-09 TCGA-13-0920-01A-01R-0406-07 |
|
|
165 |
TCGA-13-0921-01 1 TCGA-13-0921-01 1483 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 3 NA TCGA-13-0921 NA NA days 1483 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 72 Bilateral TCGA-13-0921-F72634 TCGA-13-0921 TCGA-13-0921-01A Stage IIIC -26606 NA 1483 0 141 NA NA NA NA NA 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-13-0921.307EC276-EE89-45D3-8B61-4F217C0F61C4.pdf 0921 NA TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.2 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2008 NA TCGA-13-0921-01 NA d4b09b28-c890-406a-97d4-3354bb5484c6 NA TCGA-13-0921-01 NA TCGA-13-0921-01A-01D-0402-05 NA TCGA-13-0921-01A-21-20 NA NA TCGA-13-0921-01A-01D-0399-01 TCGA-13-0921-01 56e2b31e-e133-45fa-a38c-9f1c8825194c NA TCGA-13-0921-01A-01D-0399-01 NA NA NA NA TCGA-13-0921-01 NA NA NA TCGA-13-0921-01A-01R-0406-07 |
|
|
166 |
TCGA-13-0923-01 0 TCGA-13-0923-01 2547 0 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0923 1719 1 days 2547 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 74 Right TCGA-13-0923-F72635 TCGA-13-0923 TCGA-13-0923-01A Stage IIIC -27081 NA NA 0 2547 NA 1719 NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NO NA NA NA NA G3 NA NA YES NA NA TCGA-13-0923.06AB5B8C-7B57-43B0-8376-7A05C58AFC1A.pdf 0923 NA TUMOR FREE NA NA NA NA NA Primary Tumor 01 NA NA NA 13 No Macroscopic disease Ovary NA A LIVING 2008 NA TCGA-13-0923-01 NA 5e88feda-6485-4934-9c79-2c5c88e908de NA TCGA-13-0923-01 NA TCGA-13-0923-01A-01D-0402-05 NA NA NA NA TCGA-13-0923-01A-01D-0399-01 TCGA-13-0923-01 NA NA TCGA-13-0923-01A-01D-0399-01 NA NA NA TCGA-13-0923-01A-01W-0420-08 TCGA-13-0923-01 NA NA TCGA-13-0923-01A-01W-0420-08 TCGA-13-0923-01A-01R-0406-07 |
|
|
167 |
TCGA-13-0924-01 0 TCGA-13-0924-01 2614 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-0924 962 1 days 2614 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 45 Bilateral TCGA-13-0924-F72636 TCGA-13-0924 TCGA-13-0924-01A Stage IV -16670 NA NA 0 2614 NA 962 NA NA Stable Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NO NA NA NA NA G3 NA NA YES NA NA TCGA-13-0924.2EA17F21-1594-430A-97E3-29C5F49CB3BC.pdf 0924 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA A LIVING 2008 TCGA-13-0924-01 TCGA-13-0924-01 NA b0dae9c4-1401-4b88-94cb-bef931901b94 NA TCGA-13-0924-01 NA TCGA-13-0924-01A-01D-0402-05 TCGA-13-0924-01A-01W-0421-09 NA TCGA-13-0924-01A-01W-0421-09 85a4c41b-9829-48f8-9c7a-a9de870332b6 TCGA-13-0924-01A-01D-0399-01 TCGA-13-0924-01 NA NA TCGA-13-0924-01A-01D-0399-01 85a4c41b-9829-48f8-9c7a-a9de870332b6 NA 85a4c41b-9829-48f8-9c7a-a9de870332b6 NA TCGA-13-0924-01 TCGA-13-0924-01 85a4c41b-9829-48f8-9c7a-a9de870332b6 TCGA-13-0924-01A-01W-0421-09 TCGA-13-0924-01A-01R-0406-07 |
|
|
168 |
TCGA-13-1403-01 1 TCGA-13-1403-01 2345 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1403 418 1 days 2345 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Left TCGA-13-1403-F72653 TCGA-13-1403 TCGA-13-1403-01A Stage IIIC -17697 NA 2345 0 331 NA 418 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.9 NO NA 1.2 NA NA G3 NA NA YES NA NA TCGA-13-1403.435619AB-01F5-4AC3-8D28-A8CC0054699F.pdf 1403 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 NA Ovary NA A DECEASED 2008 TCGA-13-1403-01 TCGA-13-1403-01 NA 88424970-6ba5-4c0f-ac01-f06513be5b42 NA TCGA-13-1403-01 NA TCGA-13-1403-01A-01D-0460-05 TCGA-13-1403-01A-01W-0494-09 NA TCGA-13-1403-01A-01W-0494-09 3217dd54-d41c-4c63-8bab-ff2c4baaee10 TCGA-13-1403-01A-01D-0452-01 TCGA-13-1403-01 NA NA TCGA-13-1403-01A-01D-0452-01 3217dd54-d41c-4c63-8bab-ff2c4baaee10 NA 3217dd54-d41c-4c63-8bab-ff2c4baaee10 NA TCGA-13-1403-01 TCGA-13-1403-01 3217dd54-d41c-4c63-8bab-ff2c4baaee10 TCGA-13-1403-01A-01W-0494-09 TCGA-13-1403-01A-01R-0456-07 |
|
|
169 |
TCGA-13-1404-01 0 TCGA-13-1404-01 2469 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1404 1581 1 days 2469 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Bilateral TCGA-13-1404-F72655 TCGA-13-1404 TCGA-13-1404-01A Stage IIIC -17784 NA NA 0 2469 NA 1581 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO 60 1.5 NA NA G3 NA NA YES NA NA TCGA-13-1404.39B73962-A374-4521-BFBB-F10D117979F9.pdf 1404 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A LIVING 2008 NA TCGA-13-1404-01 NA 454548ae-a10c-4811-a88b-5e893ffe1caa NA TCGA-13-1404-01 NA TCGA-13-1404-01A-01D-0460-05 TCGA-13-1404-01A-01W-0494-09 TCGA-13-1404-01A-21-1562-20 TCGA-13-1404-01A-01W-0494-09 NA TCGA-13-1404-01A-01D-0452-01 TCGA-13-1404-01 b9dd3b0f-e45a-400a-8078-5d421d257726 NA TCGA-13-1404-01A-01D-0452-01 NA NA NA NA TCGA-13-1404-01 NA NA TCGA-13-1404-01A-01W-0494-09 TCGA-13-1404-01A-01R-0456-07 |
|
|
170 |
TCGA-13-1405-01 1 TCGA-13-1405-01 868 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1405 228 1 days 868 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Bilateral TCGA-13-1405-F72656 TCGA-13-1405 TCGA-13-1405-01A Stage IV -18218 NA 868 0 224 NA 228 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.3 NO 80 1.3 NA NA G3 NA NA YES NA NA TCGA-13-1405.DFB9F8B2-986C-4963-B2D2-837E54174CF0.pdf 1405 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA A DECEASED 2008 TCGA-13-1405-01 TCGA-13-1405-01 NA 04d8cf12-0689-4e2d-a8e9-771920563560 NA TCGA-13-1405-01 NA TCGA-13-1405-01A-01D-0460-05 TCGA-13-1405-01A-01W-0494-09 TCGA-13-1405-01A-21-1562-20 TCGA-13-1405-01A-01W-0494-09 044d949f-0eb4-44c9-8327-90226936fc7c TCGA-13-1405-01A-01D-0452-01 TCGA-13-1405-01 79cd114a-31d2-468d-92e6-5ea925e61918 NA TCGA-13-1405-01A-01D-0452-01 044d949f-0eb4-44c9-8327-90226936fc7c NA 044d949f-0eb4-44c9-8327-90226936fc7c NA TCGA-13-1405-01 TCGA-13-1405-01 044d949f-0eb4-44c9-8327-90226936fc7c TCGA-13-1405-01A-01W-0494-09 TCGA-13-1405-01A-01R-0456-07 |
|
|
171 |
TCGA-13-1407-01 0 TCGA-13-1407-01 2534 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-13-1407 1333 1 days 2534 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-13-1407-F72657 TCGA-13-1407 NA Stage IIIC -18896 NA NA 0 2534 NA 1333 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G3 NA NA YES NA NA NA 1407 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 NA Ovary NA NA LIVING 2008 NA TCGA-13-1407-01 TCGA-13-1407-01A-01W-0490-10 ba5b2281-2b96-47e8-92b9-0221c434b4e9 NA TCGA-13-1407-01 TCGA-13-1407-01A-01W-0490-10 TCGA-13-1407-01A-01D-0460-05 NA NA NA NA TCGA-13-1407-01A-01D-0452-01 TCGA-13-1407-01 NA NA TCGA-13-1407-01A-01D-0452-01 NA NA NA NA TCGA-13-1407-01 NA NA TCGA-13-1407-01A-01W-0490-10 TCGA-13-1407-01A-01R-0456-07 |
|
|
172 |
TCGA-13-1408-01 1 TCGA-13-1408-01 1680 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 mutation cluster 14 TCGA-13-1408 765 1 days 1680 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 NA TCGA-13-1408-F72659 TCGA-13-1408 TCGA-13-1408-01A Stage IIIC -21635 NA 1680 0 180 NA 765 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.8 NA NA G3 NA NA YES NA NA TCGA-13-1408.39435FCB-699F-4A2F-9005-E67C9A41C766.pdf 1408 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 >20 mm Ovary NA A DECEASED 2008 NA TCGA-13-1408-01 TCGA-13-1408-01A-01W-0490-10 3f056922-bdb4-4a8f-8a4d-9116cae32ae8 NA TCGA-13-1408-01 TCGA-13-1408-01A-01W-0490-10 TCGA-13-1408-01A-01D-0460-05 NA TCGA-13-1408-01A-21-1562-20 NA NA TCGA-13-1408-01A-01D-0452-01 TCGA-13-1408-01 c9dc89ec-e887-4acc-90a5-6fd20f4a1483 NA TCGA-13-1408-01A-01D-0452-01 NA NA NA NA TCGA-13-1408-01 NA NA TCGA-13-1408-01A-01W-0490-10 TCGA-13-1408-01A-01R-0456-07 |
|
|
173 |
TCGA-13-1409-01 1 TCGA-13-1409-01 1742 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1409 690 1 days 1742 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 NA TCGA-13-1409-F72660 TCGA-13-1409 TCGA-13-1409-01A Stage IIIC -26836 NA 1742 0 208 NA 690 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 1 NO 60 1.6 NA NA G3 NA NA YES NA NA TCGA-13-1409.3F18B612-EE50-4459-8CAF-61A12157DD8A.pdf 1409 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.6 NA NA 13 1-10 mm Ovary NA A DECEASED 2008 NA TCGA-13-1409-01 NA c4293c0c-8d5d-40b4-9f84-42633383f950 NA TCGA-13-1409-01 NA TCGA-13-1409-01A-01D-0460-05 NA TCGA-13-1409-01A-21-20 NA NA TCGA-13-1409-01A-01D-0452-01 TCGA-13-1409-01 8c0c5cc9-dbb0-49ed-96c4-7fde7d37fd25 NA TCGA-13-1409-01A-01D-0452-01 NA NA NA TCGA-13-1409-01A-01W-0492-08 TCGA-13-1409-01 NA NA TCGA-13-1409-01A-01W-0492-08 TCGA-13-1409-01A-01R-0456-07 |
|
|
174 |
TCGA-13-1410-01 0 TCGA-13-1410-01 2464 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-1410 319 1 days 2464 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Bilateral TCGA-13-1410-F72661 TCGA-13-1410 TCGA-13-1410-01A Stage IV -20950 NA NA 0 2464 NA 319 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO 60 1.9 NA NA GX NA NA YES NA NA TCGA-13-1410.0F641D88-673B-48C4-97F5-730DA3FD343C.pdf 1410 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.5 NA NA 13 NA Ovary NA A LIVING 2008 TCGA-13-1410-01 TCGA-13-1410-01 NA e8da901b-05d8-4448-8e0c-52c558fe2ea8 NA TCGA-13-1410-01 NA TCGA-13-1410-01A-01D-0460-05 NA TCGA-13-1410-01A-21-20 NA fdda1428-ad6b-4337-a959-83bae1f9664b TCGA-13-1410-01A-01D-0452-01 TCGA-13-1410-01 3f2151ce-1e04-4a0e-8ded-e59696b705cb NA TCGA-13-1410-01A-01D-0452-01 fdda1428-ad6b-4337-a959-83bae1f9664b NA fdda1428-ad6b-4337-a959-83bae1f9664b TCGA-13-1410-01A-01W-0492-08 TCGA-13-1410-01 TCGA-13-1410-01 fdda1428-ad6b-4337-a959-83bae1f9664b TCGA-13-1410-01A-01W-0492-08 TCGA-13-1410-01A-01R-0456-07 |
|
|
175 |
TCGA-13-1411-01 1 TCGA-13-1411-01 531 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-13-1411 238 1 days 531 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 81 NA TCGA-13-1411-F72662 TCGA-13-1411 TCGA-13-1411-01A Stage IIIC -29874 NA 531 0 128 NA 238 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 1.7 NA NA G3 NA NA YES NA NA TCGA-13-1411.F73F2D6F-3FD9-4457-921A-9EE0E47A6470.pdf 1411 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 >20 mm Ovary NA A DECEASED 2008 TCGA-13-1411-01 TCGA-13-1411-01 NA 88a02ee5-0e09-4181-ad62-88ec7f877f45 NA TCGA-13-1411-01 NA TCGA-13-1411-01A-01D-0460-05 TCGA-13-1411-01A-01W-0494-09 TCGA-13-1411-01A-21-20 TCGA-13-1411-01A-01W-0494-09 0069c63d-f699-41d4-9798-9a109d1c09df TCGA-13-1411-01A-01D-0452-01 TCGA-13-1411-01 438d9016-0b99-46f7-b8ad-21c125f4bedd NA TCGA-13-1411-01A-01D-0452-01 0069c63d-f699-41d4-9798-9a109d1c09df NA 0069c63d-f699-41d4-9798-9a109d1c09df NA TCGA-13-1411-01 TCGA-13-1411-01 0069c63d-f699-41d4-9798-9a109d1c09df TCGA-13-1411-01A-01W-0494-09 TCGA-13-1411-01A-01R-0456-07 |
|
|
176 |
TCGA-13-1412-01 1 TCGA-13-1412-01 984 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1412 409 1 days 984 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 41 Bilateral TCGA-13-1412-F72669 TCGA-13-1412 TCGA-13-1412-01A Stage IV -15119 NA 984 0 162 NA 409 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO 80 1.1 NA NA G3 NA NA YES NA NA TCGA-13-1412.D36FA0B4-9605-498F-B815-1BE4BF64E100.pdf 1412 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 2008 NA TCGA-13-1412-01 NA 54620fb3-d7d9-4d00-a77b-4d8dcfee4d55 NA TCGA-13-1412-01 NA TCGA-13-1412-01A-01D-0460-05 TCGA-13-1412-01A-01W-0494-09 TCGA-13-1412-01A-21-20 TCGA-13-1412-01A-01W-0494-09 NA TCGA-13-1412-01A-01D-0452-01 TCGA-13-1412-01 b22eb00b-8fcc-4fd5-b396-1169f7f025fd NA TCGA-13-1412-01A-01D-0452-01 NA NA NA NA TCGA-13-1412-01 NA NA TCGA-13-1412-01A-01W-0494-09 TCGA-13-1412-01A-01R-0456-07 |
|
|
177 |
TCGA-13-1477-01 1 TCGA-13-1477-01 1662 1 days Iq C9-OV OV-like c1 OV-like c4 NA miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-13-1477 NA NA days 1662 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 49 Bilateral TCGA-13-1477-F24839 TCGA-13-1477 TCGA-13-1477-01A Stage IV -18111 NA 1662 0 1662 NA 235 NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 1.3 NO NA 1.3 NA NA G2 Progression of Disease NA NA NA NA TCGA-13-1477.2507FA0F-9709-4B5D-9EC1-907637FB373A.pdf 1477 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A DECEASED 2000 NA TCGA-13-1477-01 NA 7bc1d947-f625-418c-b577-c66aea3e33c4 NA TCGA-13-1477-01 NA TCGA-13-1477-01A-01D-0475-05 NA TCGA-13-1477-01A-21-1562-20 NA NA TCGA-13-1477-01A-01D-0472-01 TCGA-13-1477-01 fa473bf9-b927-4d17-ac77-ad0e52f01cac NA TCGA-13-1477-01A-01D-0472-01 NA NA NA TCGA-13-1477-01A-01D-0472-08 TCGA-13-1477-01 NA NA TCGA-13-1477-01A-01D-0472-08 TCGA-13-1477-01A-01R-0479-07 |
|
|
178 |
TCGA-13-1479-01 NA TCGA-13-1479-01 NA NA days NA NA NA NA NA NA NA NA TCGA-13-1479 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-13-1479-01A-01D-0475-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-13-1479-01A-01R-0479-07 |
|
|
179 |
TCGA-13-1481-01 1 TCGA-13-1481-01 2648 1 days High C9-OV OV-like c1 KIRC-like c1 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-1481 NA NA days 2648 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 76 Right TCGA-13-1481-F24843 TCGA-13-1481 TCGA-13-1481-01A Stage IIIC -27898 NA 2648 0 2648 NA NA NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.3 NO NA 1.4 NA NA G2 NA NA NA NA NA TCGA-13-1481.4832CBA4-9482-4A2A-A9E1-4E8489B0F157.pdf 1481 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A DECEASED 2000 TCGA-13-1481-01 TCGA-13-1481-01 NA 2b0cdd7b-9556-4bd5-bf80-1daa495b38e3 NA TCGA-13-1481-01 NA TCGA-13-1481-01A-01D-0475-05 TCGA-13-1481-01A-01W-0549-09 TCGA-13-1481-01A-21-1562-20 TCGA-13-1481-01A-01W-0549-09 761f9668-304f-4e22-87cd-2005aa86152c TCGA-13-1481-01A-01D-0472-01 TCGA-13-1481-01 8b7b0f6e-4f3b-40f2-8ca0-7de1000f473a NA TCGA-13-1481-01A-01D-0472-01 761f9668-304f-4e22-87cd-2005aa86152c NA 761f9668-304f-4e22-87cd-2005aa86152c NA TCGA-13-1481-01 TCGA-13-1481-01 761f9668-304f-4e22-87cd-2005aa86152c TCGA-13-1481-01A-01W-0549-09 TCGA-13-1481-01A-01R-0479-07 |
|
|
180 |
TCGA-13-1482-01 1 TCGA-13-1482-01 1877 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1482 NA NA days 1877 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 NA TCGA-13-1482-F24848 TCGA-13-1482 NA Stage IV -19178 NA 1877 0 1877 NA 602 NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA 80 NA NA NA G2 Recurrence NA NA NA NA NA 1482 Preoperative WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 13 >20 mm Ovary NA NA DECEASED 2000 NA TCGA-13-1482-01 NA c2b1ef9b-a1b3-4fe9-b35f-841893a6092d NA TCGA-13-1482-01 NA TCGA-13-1482-01A-01D-0475-05 TCGA-13-1482-01A-01W-0549-09 TCGA-13-1482-01A-21-1562-20 TCGA-13-1482-01A-01W-0549-09 NA TCGA-13-1482-01A-01D-0472-01 TCGA-13-1482-01 db641a43-1973-4213-a4ed-42fa9ff8e8ec NA TCGA-13-1482-01A-01D-0472-01 NA NA NA NA TCGA-13-1482-01 NA NA TCGA-13-1482-01A-01W-0549-09 TCGA-13-1482-01A-01R-0479-07 |
|
|
181 |
TCGA-13-1483-01 1 TCGA-13-1483-01 895 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 8 TCGA-13-1483 NA NA days 895 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 NA TCGA-13-1483-F24852 TCGA-13-1483 TCGA-13-1483-01A Stage IIIC -22342 NA 895 0 895 NA 297 NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 1.4 NO 60 1.8 NA NA G3 Recurrence NA NA NA NA TCGA-13-1483.c5f81fb7-5cdc-4c0a-8d5a-74e93a11b7db.pdf 1483 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Molecular Markers NO NA Primary Tumor 01 0.4 NA NA 13 >20 mm Ovary NA A DECEASED 2000 NA TCGA-13-1483-01 NA ba90cac1-6c52-4111-99f5-8cb3cb11faeb NA TCGA-13-1483-01 NA TCGA-13-1483-01A-01D-0475-05 TCGA-13-1483-01A-01W-0549-09 TCGA-13-1483-01A-21-1562-20 TCGA-13-1483-01A-01W-0549-09 NA TCGA-13-1483-01A-01D-0472-01 TCGA-13-1483-01 3ab7ed23-61b4-4c74-8668-25b7ee186bf7 NA TCGA-13-1483-01A-01D-0472-01 NA NA NA NA TCGA-13-1483-01 NA NA TCGA-13-1483-01A-01W-0549-09 TCGA-13-1483-01A-01R-0479-07 |
|
|
182 |
TCGA-13-1484-01 1 TCGA-13-1484-01 3785 1 days High C9-OV OV-like c1 BRCA basal-like c6 NA miRNA cluster 1 cluster 6 mutation cluster 8 TCGA-13-1484 497 1 days 3785 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 NA TCGA-13-1484-F72640 TCGA-13-1484 TCGA-13-1484-01A Stage IIIC -22698 NA 3785 0 2982 NA 497 NA NA Progressive Disease 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 0.6 NO 80 1.5 NA NA G3 NA NA YES NA NA TCGA-13-1484.CF223E16-1613-4FAB-A4DA-86D5ECE7B55E.pdf 1484 Preoperative WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 NA Ovary NA A DECEASED 2000 NA TCGA-13-1484-01 NA 53f117b0-5e33-4abf-9720-e3358f62ed9a NA TCGA-13-1484-01 NA TCGA-13-1484-01A-01D-0475-05 NA TCGA-13-1484-01A-21-1562-20 NA NA TCGA-13-1484-01A-01D-0472-01 TCGA-13-1484-01 d48335c8-f1dd-472d-a4d6-6ad7eb5d081d NA TCGA-13-1484-01A-01D-0472-01 NA NA NA TCGA-13-1484-01A-01W-0545-08 TCGA-13-1484-01 NA NA TCGA-13-1484-01A-01W-0545-08 TCGA-13-1484-01A-01R-0479-07 |
|
|
183 |
TCGA-13-1485-01 1 TCGA-13-1485-01 629 1 days High NA OV-like c1 NA NA miRNA cluster 3 cluster 6 NA TCGA-13-1485 NA NA days 629 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-13-1485-F24861 TCGA-13-1485 NA Stage IV -17642 NA 629 0 629 NA 170 NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA NA NA 80 NA NA NA G2 Progression of Disease NA NA NA NA NA 1485 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2001 NA TCGA-13-1485-01 NA a1378617-e3ff-4bfa-adef-03e4c07512fa NA TCGA-13-1485-01 NA TCGA-13-1485-01A-02D-0475-05 NA NA NA NA TCGA-13-1485-01A-02D-0472-01 TCGA-13-1485-01 NA NA TCGA-13-1485-01A-02D-0472-01 NA NA NA NA TCGA-13-1485-01 NA NA NA TCGA-13-1485-01A-02R-0479-07 |
|
|
184 |
TCGA-13-1487-01 1 TCGA-13-1487-01 681 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-1487 NA NA days 681 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 NA TCGA-13-1487-F24865 TCGA-13-1487 NA Stage IV -27176 NA 681 0 681 NA 412 NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA GX Recurrence NA NA NA NA NA 1487 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 NA NA NA 13 NA Ovary NA NA DECEASED 2002 NA TCGA-13-1487-01 NA a7c48735-a4be-424a-a3cd-125cf2e2a274 NA TCGA-13-1487-01 NA TCGA-13-1487-01A-01D-0475-05 NA TCGA-13-1487-01A-21-1562-20 NA NA TCGA-13-1487-01A-01D-0472-01 TCGA-13-1487-01 f10389e0-3564-4067-b82a-d0be5d5eec92 NA TCGA-13-1487-01A-01D-0472-01 NA NA NA TCGA-13-1487-01A-01D-0472-08 TCGA-13-1487-01 NA NA TCGA-13-1487-01A-01D-0472-08 TCGA-13-1487-01A-01R-0479-07 |
|
|
185 |
TCGA-13-1488-01 1 TCGA-13-1488-01 2154 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1488 NA NA days 2154 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-13-1488-F24871 TCGA-13-1488 TCGA-13-1488-01A Stage IV -21726 NA 2154 0 2154 NA 351 NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO 80 2.3 NA NA G3 Recurrence NA NA NA NA TCGA-13-1488.79A91E41-0B59-4328-B7BB-2B4EEAD46A89.pdf 1488 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 13 11-20 mm Ovary NA A DECEASED 2002 NA TCGA-13-1488-01 NA 6b1d30b6-321c-4d55-bf9f-dfb4be92210b NA TCGA-13-1488-01 NA TCGA-13-1488-01A-01D-0475-05 TCGA-13-1488-01A-01W-0549-09 TCGA-13-1488-01A-21-1562-20 TCGA-13-1488-01A-01W-0549-09 NA TCGA-13-1488-01A-01D-0472-01 TCGA-13-1488-01 1ec3bf38-f06e-4789-a298-cde202cf3649 NA TCGA-13-1488-01A-01D-0472-01 NA NA NA NA TCGA-13-1488-01 NA NA TCGA-13-1488-01A-01W-0549-09 TCGA-13-1488-01A-01R-0479-07 |
|
|
186 |
TCGA-13-1489-01 1 TCGA-13-1489-01 2553 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-13-1489 806 1 days 2553 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 70 Bilateral TCGA-13-1489-F72641 TCGA-13-1489 NA Stage IIIC -25768 NA 2553 0 2521 NA 806 NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA 80 NA NA NA G2 NA NA YES NA NA NA 1489 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 NA NA NA 13 NA Ovary NA NA DECEASED 2002 NA TCGA-13-1489-01 NA aeb47cad-0087-4bf3-aa09-3751a6dcb269 NA TCGA-13-1489-01 NA TCGA-13-1489-01A-01D-0475-05 TCGA-13-1489-01A-01W-0549-09 TCGA-13-1489-01A-21-1562-20 TCGA-13-1489-01A-01W-0549-09 NA TCGA-13-1489-01A-01D-0472-01 TCGA-13-1489-01 f99befac-a46e-43a1-91b7-e4a492dae82f,c35fe897-f2eb-4dcb-a571-89f2c27ffa6a NA TCGA-13-1489-01A-01D-0472-01 NA NA NA NA TCGA-13-1489-01 NA NA TCGA-13-1489-01A-01W-0549-09 TCGA-13-1489-01A-01R-0479-07 |
|
|
187 |
TCGA-13-1489-02 1 TCGA-13-1489-02 2553 1 days NA C9-OV OV-like c1 NA OV-like c16 miRNA cluster 3 NA mutation cluster 5 TCGA-13-1489 806 1 days 2553 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 70 Bilateral TCGA-13-1489-F72641 TCGA-13-1489 TCGA-13-1489-02A Stage IIIC -25768 NA 2553 0 2521 NA 806 NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO 80 1 NA NA G2 NA NA YES NA NA TCGA-13-1489.639712E8-5C63-433C-8F23-4C78FF37D8FC.pdf 1489 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Recurrent Tumor 02 0.4 NA NA 13 NA Ovary NA A DECEASED 2002 NA TCGA-13-1489-02 NA 141d2716-c6c3-4495-b30f-12dc204d77a3 NA TCGA-13-1489-02 NA TCGA-13-1489-02A-01D-0807-05 NA NA NA d8cd1ca1-dc00-4a48-ab81-5d23daed6fce NA NA d95612da-1768-4b34-bb28-607208c05c38 NA NA d8cd1ca1-dc00-4a48-ab81-5d23daed6fce NA d8cd1ca1-dc00-4a48-ab81-5d23daed6fce NA NA NA d8cd1ca1-dc00-4a48-ab81-5d23daed6fce NA TCGA-13-1489-02A-01R-0810-07 |
|
|
188 |
TCGA-13-1491-01 1 TCGA-13-1491-01 1595 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1491 NA NA days 1595 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-13-1491-F24884 TCGA-13-1491 TCGA-13-1491-01A Stage IIIC -20262 NA 1595 0 1595 NA 508 NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 0.6 NO 60 2 NA NA G3 Recurrence NA NA NA NA TCGA-13-1491.051EAB19-C9CF-407E-A0C3-19CB76368C22.pdf 1491 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 13 NA Ovary NA A DECEASED 2002 NA TCGA-13-1491-01 NA 7ae5754b-5508-416e-96ec-fe3221d6e2ff NA TCGA-13-1491-01 NA TCGA-13-1491-01A-01D-0475-05 TCGA-13-1491-01A-01W-0549-09 TCGA-13-1491-01A-21-1562-20 TCGA-13-1491-01A-01W-0549-09 NA TCGA-13-1491-01A-01D-0472-01 TCGA-13-1491-01 a2142ff2-fb53-4517-b0d5-9f25ba91ea1a NA TCGA-13-1491-01A-01D-0472-01 NA NA NA NA TCGA-13-1491-01 NA NA TCGA-13-1491-01A-01W-0549-09 TCGA-13-1491-01A-01R-0479-07 |
|
|
189 |
TCGA-13-1492-01 1 TCGA-13-1492-01 3819 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1492 3819 0 days 3819 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 66 NA TCGA-13-1492-F72643 TCGA-13-1492 TCGA-13-1492-01A Stage IIIC -24332 NA 3819 0 2237 NA NA NA NA Complete Remission/Response 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 1.2 NO 80 2.5 NA NA G3 NA NA NO NA NA TCGA-13-1492.566BE185-8A2E-43C4-9762-65216AB9AC44.pdf 1492 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 NA Ovary NA A DECEASED 2002 NA TCGA-13-1492-01 NA c37d0090-3b9a-4832-934a-299d8a7f6a2d NA TCGA-13-1492-01 NA TCGA-13-1492-01A-01D-0475-05 NA TCGA-13-1492-01A-21-1562-20 NA NA TCGA-13-1492-01A-01D-0472-01 TCGA-13-1492-01 943e741f-3371-4167-99e0-fd795663874c NA TCGA-13-1492-01A-01D-0472-01 NA NA NA TCGA-13-1492-01A-01D-0472-08 TCGA-13-1492-01 NA NA TCGA-13-1492-01A-01D-0472-08 TCGA-13-1492-01A-01R-0479-07 |
|
|
190 |
TCGA-13-1494-01 1 TCGA-13-1494-01 2856 1 days Squamous C9-OV OV-like c1 KIRC-like c1 NA miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-13-1494 693 1 days 2856 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 43 Bilateral TCGA-13-1494-F72644 TCGA-13-1494 NA Stage IV -15993 NA 2856 0 1162 NA 693 NA NA NA 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA NA NA NA NA NA NA G3 NA NA YES NA NA NA 1494 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 NA Ovary NA NA DECEASED 2004 NA TCGA-13-1494-01 NA d8a57388-6e4e-4865-a68f-7485dec8304f NA TCGA-13-1494-01 NA TCGA-13-1494-01A-01D-0475-05 NA TCGA-13-1494-01A-21-1562-20 NA NA TCGA-13-1494-01A-01D-0472-01 TCGA-13-1494-01 af9b3f69-ef63-4303-85c6-8f6936dc6b6e NA TCGA-13-1494-01A-01D-0472-01 NA NA NA TCGA-13-1494-01A-01W-0545-08 TCGA-13-1494-01 NA NA TCGA-13-1494-01A-01W-0545-08 TCGA-13-1494-01A-01R-0479-07 |
|
|
191 |
TCGA-13-1495-01 1 TCGA-13-1495-01 2749 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-13-1495 977 1 days 2749 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Bilateral TCGA-13-1495-F72645 TCGA-13-1495 TCGA-13-1495-01A Stage IIIC -22046 NA 2749 0 1498 NA 977 NA NA NA 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.5 NO 80 2.1 NA NA G2 NA NA YES NA NA TCGA-13-1495.51F0A8BF-0E86-402D-BE9F-D41771ED98A3.pdf 1495 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A DECEASED 2004 NA TCGA-13-1495-01 NA 2476b238-9e59-49ae-ac0d-456ad4fe4ffc NA TCGA-13-1495-01 NA TCGA-13-1495-01A-01D-0475-05 NA TCGA-13-1495-01A-21-1562-20 NA NA TCGA-13-1495-01A-01D-0472-01 TCGA-13-1495-01 15443f5b-51c9-496d-bf7a-99693ca3b943 NA TCGA-13-1495-01A-01D-0472-01 NA NA NA TCGA-13-1495-01A-01W-0545-08 TCGA-13-1495-01 NA NA TCGA-13-1495-01A-01W-0545-08 TCGA-13-1495-01A-01R-0479-07 |
|
|
192 |
TCGA-13-1496-01 1 TCGA-13-1496-01 129 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1496 NA NA days 129 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 65 Bilateral TCGA-13-1496-F24904 TCGA-13-1496 TCGA-13-1496-01A Stage IIIC -23993 NA 129 0 129 NA NA NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 1.1 NA NA G3 NA NA NA NA NA TCGA-13-1496.BCDD1BDE-689B-455D-81A7-C2522417E055.pdf 1496 NA NA YES NA NA NO NA Primary Tumor 01 0.3 NA NA 13 >20 mm Ovary NA A DECEASED 2004 NA TCGA-13-1496-01 NA e75a75ac-204d-48b0-891e-c3d6e979d4d4 NA TCGA-13-1496-01 NA TCGA-13-1496-01A-01D-0475-05 NA TCGA-13-1496-01A-21-1562-20 NA NA TCGA-13-1496-01A-01D-0472-01 TCGA-13-1496-01 35781069-501d-45c3-b3f0-7292b0186211 NA TCGA-13-1496-01A-01D-0472-01 NA NA NA TCGA-13-1496-01A-01W-0545-08 TCGA-13-1496-01 NA NA TCGA-13-1496-01A-01W-0545-08 TCGA-13-1496-01A-01R-0479-07 |
|
|
193 |
TCGA-13-1497-01 0 TCGA-13-1497-01 3871 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1497 813 1 days 3871 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 47 NA TCGA-13-1497-F72646 TCGA-13-1497 NA Stage IIIC -17528 NA NA 0 3871 NA 813 NA NA Complete Remission/Response 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA 80 NA NA NA G3 NA NA YES NA NA NA 1497 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 NA NA NA 13 NA Ovary NA NA LIVING 2004 TCGA-13-1497-01 TCGA-13-1497-01 NA d53c30c7-126f-40ec-9e02-4a1d2a3e2681 NA TCGA-13-1497-01 NA TCGA-13-1497-01A-01D-0475-05 TCGA-13-1497-01A-01W-0549-09 NA TCGA-13-1497-01A-01W-0549-09 eb61bd52-e5fa-4c33-a2e4-1353a42184d9 TCGA-13-1497-01A-01D-0472-01 TCGA-13-1497-01 NA NA TCGA-13-1497-01A-01D-0472-01 eb61bd52-e5fa-4c33-a2e4-1353a42184d9 NA eb61bd52-e5fa-4c33-a2e4-1353a42184d9 NA TCGA-13-1497-01 TCGA-13-1497-01 eb61bd52-e5fa-4c33-a2e4-1353a42184d9 TCGA-13-1497-01A-01W-0549-09 TCGA-13-1497-01A-01R-0479-07 |
|
|
194 |
TCGA-13-1498-01 1 TCGA-13-1498-01 2012 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-1498 534 1 days 2012 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 NA TCGA-13-1498-F72647 TCGA-13-1498 TCGA-13-1498-01A Stage IIIC -26820 NA 2012 0 1144 NA 534 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO 60 1.1 NA NA G3 NA NA YES NA NA TCGA-13-1498.0B03A4B9-61B9-43EA-9E7A-8EE1FF3B31F1.pdf 1498 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 >20 mm Ovary NA A DECEASED 2006 TCGA-13-1498-01 TCGA-13-1498-01 NA 0fe423b7-115f-48a2-bc4a-9eec87f319e2 NA TCGA-13-1498-01 NA TCGA-13-1498-01A-01D-0475-05 TCGA-13-1498-01A-01W-0549-09 TCGA-13-1498-01A-21-1562-20 TCGA-13-1498-01A-01W-0549-09 176d1ca2-eb1d-4f49-9b10-c129c822fa5a TCGA-13-1498-01A-01D-0472-01 TCGA-13-1498-01 17dca857-f830-4be9-9f2b-5619ae7eb73f NA TCGA-13-1498-01A-01D-0472-01 176d1ca2-eb1d-4f49-9b10-c129c822fa5a NA 176d1ca2-eb1d-4f49-9b10-c129c822fa5a NA TCGA-13-1498-01 TCGA-13-1498-01 176d1ca2-eb1d-4f49-9b10-c129c822fa5a TCGA-13-1498-01A-01W-0549-09 TCGA-13-1498-01A-01R-0479-07 |
|
|
195 |
TCGA-13-1499-01 0 TCGA-13-1499-01 3500 0 days Squamous C9-OV Low purity c2 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1499 583 1 days 3500 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 56 NA TCGA-13-1499-F72649 TCGA-13-1499 TCGA-13-1499-01A Stage IIIC -20668 NA NA 0 3500 NA 583 NA NA Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 1.1 NO 80 2.1 NA NA G3 NA NA YES NA NA TCGA-13-1499.3FC4A433-FAD1-4CC1-9BD6-A45E2707F6D0.pdf 1499 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 NA Ovary NA A LIVING 2005 NA TCGA-13-1499-01 NA f54b35ad-c934-4df9-ba57-089c4c9d5c1e NA TCGA-13-1499-01 NA TCGA-13-1499-01A-01D-0475-05 TCGA-13-1499-01A-01W-0549-09 TCGA-13-1499-01A-21-1562-20 TCGA-13-1499-01A-01W-0549-09 NA TCGA-13-1499-01A-01D-0472-01 TCGA-13-1499-01 21c833c6-d2bc-4308-a233-894c7a6636f1 NA TCGA-13-1499-01A-01D-0472-01 NA NA NA NA TCGA-13-1499-01 NA NA TCGA-13-1499-01A-01W-0549-09 TCGA-13-1499-01A-01R-0479-07 |
|
|
196 |
TCGA-13-1500-01 1 TCGA-13-1500-01 425 1 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 NA TCGA-13-1500 NA NA days 425 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-13-1500-F24926 TCGA-13-1500 TCGA-13-1500-01A Stage IIIC -26172 NA 425 0 425 NA 253 NA NA NA 2009-3-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.2 NO 80 1.7 NA NA G3 Recurrence NA NA NA NA TCGA-13-1500.BFC92139-677F-4AD6-93D4-B479B8121449.pdf 1500 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Molecular Markers NO NA Primary Tumor 01 0.4 NA NA 13 11-20 mm Ovary NA A DECEASED 2006 NA TCGA-13-1500-01 NA 6bd685eb-c19d-404d-bb70-0d7590034653 NA TCGA-13-1500-01 NA TCGA-13-1500-01A-01D-0475-05 NA TCGA-13-1500-01A-21-1562-20 NA NA TCGA-13-1500-01A-01D-0472-01 TCGA-13-1500-01 639afc90-9b92-45f2-a350-6b7e355bbcbc NA TCGA-13-1500-01A-01D-0472-01 NA NA NA NA TCGA-13-1500-01 NA NA NA TCGA-13-1500-01A-01R-0479-07 |
|
|
197 |
TCGA-13-1501-01 1 TCGA-13-1501-01 1314 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 8 TCGA-13-1501 392 1 days 1314 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 50 Bilateral TCGA-13-1501-F72651 TCGA-13-1501 TCGA-13-1501-01A Stage IV -18393 NA 1314 0 999 NA 392 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.2 NO 80 1.5 NA NA G3 NA NA YES NA NA TCGA-13-1501.7D27D441-D069-4674-A761-299E315D67C1.pdf 1501 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 >20 mm Ovary NA A DECEASED 2006 NA TCGA-13-1501-01 NA cf8ec1d5-56c7-45b7-8208-58fc6f5d6aa6 NA TCGA-13-1501-01 NA TCGA-13-1501-01A-01D-0475-05 NA TCGA-13-1501-01A-21-1562-20 NA NA TCGA-13-1501-01A-01D-0472-01 TCGA-13-1501-01 9f507427-22ed-408e-807f-39a90244bef4 NA TCGA-13-1501-01A-01D-0472-01 NA NA NA TCGA-13-1501-01A-01W-0545-08 TCGA-13-1501-01 NA NA TCGA-13-1501-01A-01W-0545-08 TCGA-13-1501-01A-01R-0479-07 |
|
|
198 |
TCGA-13-1504-01 1 TCGA-13-1504-01 1059 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1504 548 1 days 1059 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 68 Bilateral TCGA-13-1504-F72652 TCGA-13-1504 TCGA-13-1504-01A Stage IIIC -25008 NA 1059 0 504 NA 548 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO 60 1.6 NA NA G3 NA NA YES NA NA TCGA-13-1504.DB8A8258-9893-4968-A91B-5D9D319D0585.pdf 1504 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 NA Ovary NA A DECEASED 2007 NA TCGA-13-1504-01 NA 6ad70118-653d-4476-b26c-4e276f556aaf NA TCGA-13-1504-01 NA TCGA-13-1504-01A-01D-0475-05 NA TCGA-13-1504-01A-21-1562-20 NA NA TCGA-13-1504-01A-01D-0472-01 TCGA-13-1504-01 f1e3f6ff-3c3d-4045-9ab3-bf5803828428 NA TCGA-13-1504-01A-01D-0472-01 NA NA NA TCGA-13-1504-01A-01W-0545-08 TCGA-13-1504-01 NA NA TCGA-13-1504-01A-01W-0545-08 TCGA-13-1504-01A-01R-0479-07 |
|
|
199 |
TCGA-13-1505-01 0 TCGA-13-1505-01 1998 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-13-1505 1561 1 days 1998 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Bilateral TCGA-13-1505-F72674 TCGA-13-1505 TCGA-13-1505-01A Stage IIIC -23238 NA NA 0 1998 NA 1561 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 1.2 NA NA G3 NA NA YES NA NA TCGA-13-1505.ACD1E3CC-53FC-4615-B31B-0AFDF4B259BF.pdf 1505 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 1-10 mm Ovary NA A LIVING 2008 TCGA-13-1505-01 TCGA-13-1505-01 NA 3237c7be-aa7d-47d1-8c46-8d6b4ce5d1c4 NA TCGA-13-1505-01 NA TCGA-13-1505-01A-01D-0475-05 NA TCGA-13-1505-01A-21-1562-20 NA 7774b7d4-2935-4b9b-bf76-312a625629e1 TCGA-13-1505-01A-01D-0472-01 TCGA-13-1505-01 d15e55f3-d7f1-4276-9fe1-17cc18dc2515 NA TCGA-13-1505-01A-01D-0472-01 7774b7d4-2935-4b9b-bf76-312a625629e1 NA 7774b7d4-2935-4b9b-bf76-312a625629e1 TCGA-13-1505-01A-01D-0472-08 TCGA-13-1505-01 TCGA-13-1505-01 7774b7d4-2935-4b9b-bf76-312a625629e1 TCGA-13-1505-01A-01D-0472-08 TCGA-13-1505-01A-01R-0479-07 |
|
|
200 |
TCGA-13-1506-01 1 TCGA-13-1506-01 1039 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-13-1506 666 1 days 1039 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 45 Bilateral TCGA-13-1506-F72675 TCGA-13-1506 TCGA-13-1506-01A Stage IIIC -16734 NA 1039 0 134 NA 666 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO 80 1.1 NA NA G3 NA NA YES NA NA TCGA-13-1506.88E423FF-4070-4F01-A0B0-41B45443E762.pdf 1506 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.2 NA NA 13 NA Ovary NA A DECEASED 2008 TCGA-13-1506-01 TCGA-13-1506-01 NA e9c25372-66bb-4c51-9b0f-8fb53262f48b NA TCGA-13-1506-01 NA TCGA-13-1506-01A-01D-0475-05 TCGA-13-1506-01A-01W-0549-09 TCGA-13-1506-01A-21-1562-20 TCGA-13-1506-01A-01W-0549-09 927c7b6d-3997-453b-81b1-b947341d5819 TCGA-13-1506-01A-01D-0472-01 TCGA-13-1506-01 6bdc5656-6cff-48e4-9625-e953d683aed5 NA TCGA-13-1506-01A-01D-0472-01 927c7b6d-3997-453b-81b1-b947341d5819 NA 927c7b6d-3997-453b-81b1-b947341d5819 NA TCGA-13-1506-01 TCGA-13-1506-01 927c7b6d-3997-453b-81b1-b947341d5819 TCGA-13-1506-01A-01W-0549-09 TCGA-13-1506-01A-01R-0479-07 |
|
|
201 |
TCGA-13-1507-01 1 TCGA-13-1507-01 1993 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1507 324 1 days 1993 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 77 Bilateral TCGA-13-1507-F72677 TCGA-13-1507 TCGA-13-1507-01A Stage IIIC -28445 NA 1993 0 145 NA 324 1 NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.1 NO 60 2 NA NA G3 NA NA YES NA NA TCGA-13-1507.0B6D1513-8119-459C-8D5A-8942B8C31179.pdf 1507 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A DECEASED 2008 TCGA-13-1507-01 TCGA-13-1507-01 NA c374d509-5dff-45a7-bb49-b7e273b6f229 NA TCGA-13-1507-01 NA TCGA-13-1507-01A-01D-0475-05 TCGA-13-1507-01A-01W-0549-09 TCGA-13-1507-01A-21-1562-20 TCGA-13-1507-01A-01W-0549-09 41a5fa6b-4594-4ef8-b841-fe75c17a13c2 TCGA-13-1507-01A-01D-0472-01 TCGA-13-1507-01 307d0834-99b0-416a-aafb-60d7ec74406f NA TCGA-13-1507-01A-01D-0472-01 41a5fa6b-4594-4ef8-b841-fe75c17a13c2 NA 41a5fa6b-4594-4ef8-b841-fe75c17a13c2 NA TCGA-13-1507-01 TCGA-13-1507-01 41a5fa6b-4594-4ef8-b841-fe75c17a13c2 TCGA-13-1507-01A-01W-0549-09 TCGA-13-1507-01A-01R-0479-07 |
|
|
202 |
TCGA-13-1509-01 0 TCGA-13-1509-01 2438 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-13-1509 578 1 days 2438 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 64 Bilateral TCGA-13-1509-F72678 TCGA-13-1509 TCGA-13-1509-01A Stage IV -23481 NA NA 0 2438 NA 578 NA NA Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.5 NO 40 1.7 NA NA G3 NA NA YES NA NA TCGA-13-1509.5FB47FA9-299B-4466-A324-20D44C788F8B.pdf 1509 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A LIVING 2008 NA TCGA-13-1509-01 NA 36181328-ff8f-4ad6-9521-7020c689acfe NA TCGA-13-1509-01 NA TCGA-13-1509-01A-01D-0475-05 TCGA-13-1509-01A-01W-0549-09 TCGA-13-1509-01A-21-1562-20 TCGA-13-1509-01A-01W-0549-09 NA TCGA-13-1509-01A-01D-0472-01 TCGA-13-1509-01 a35cc137-a072-4287-8248-dbc4df213144 NA TCGA-13-1509-01A-01D-0472-01 NA NA NA NA TCGA-13-1509-01 NA NA TCGA-13-1509-01A-01W-0549-09 TCGA-13-1509-01A-01R-0479-07 |
|
|
203 |
TCGA-13-1510-01 1 TCGA-13-1510-01 1359 1 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-13-1510 1189 1 days 1359 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Left TCGA-13-1510-F72679 TCGA-13-1510 TCGA-13-1510-01A Stage IIIC -22708 NA 1359 0 78 NA 1189 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 2 NA NA G3 NA NA YES NA NA TCGA-13-1510.D6FA84A0-0DE4-42F8-9D15-9EDA4115AE4D.pdf 1510 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2008 NA TCGA-13-1510-01 NA 614859a5-6f16-4f6b-8c26-60646708c1ba NA TCGA-13-1510-01 NA TCGA-13-1510-01A-02D-0475-05 NA NA NA NA TCGA-13-1510-01A-02D-0472-01 TCGA-13-1510-01 NA NA TCGA-13-1510-01A-02D-0472-01 NA NA NA TCGA-13-1510-01A-02D-0472-08 TCGA-13-1510-01 NA NA TCGA-13-1510-01A-02D-0472-08 TCGA-13-1510-01A-02R-0479-07 |
|
|
204 |
TCGA-13-1511-01 1 TCGA-13-1511-01 1650 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-13-1511 459 1 days 1650 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Bilateral TCGA-13-1511-F72680 TCGA-13-1511 TCGA-13-1511-01A Stage IV -19258 NA 1650 0 119 NA 459 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.6 NO 60 2.2 NA NA G3 NA NA YES NA NA TCGA-13-1511.CD73F0B8-0B90-40D1-B6FE-6046F84E9AB0.pdf 1511 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 >20 mm Ovary NA A DECEASED 2008 TCGA-13-1511-01 TCGA-13-1511-01 NA 96a8f10e-4b72-4262-9ad7-3ba062ce7f85 NA TCGA-13-1511-01 NA TCGA-13-1511-01A-01D-0475-05 NA TCGA-13-1511-01A-21-1562-20 NA ccd83080-7a51-4952-b4af-d13e9c182bc0 TCGA-13-1511-01A-01D-0472-01 TCGA-13-1511-01 a5d23561-577b-4b73-979e-8908b15b223e NA TCGA-13-1511-01A-01D-0472-01 ccd83080-7a51-4952-b4af-d13e9c182bc0 NA ccd83080-7a51-4952-b4af-d13e9c182bc0 NA TCGA-13-1511-01 TCGA-13-1511-01 ccd83080-7a51-4952-b4af-d13e9c182bc0 NA TCGA-13-1511-01A-01R-0479-07 |
|
|
205 |
TCGA-13-1512-01 0 TCGA-13-1512-01 442 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-13-1512 427 1 days 442 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Bilateral TCGA-13-1512-F72681 TCGA-13-1512 TCGA-13-1512-01A Stage IIIC -18134 NA NA 0 442 NA 427 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 1.4 NO 60 2 NA NA G3 NA NA YES NA NA TCGA-13-1512.66DC098E-9ADD-4446-AB6D-FEA35D5FD33B.pdf 1512 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2008 TCGA-13-1512-01 TCGA-13-1512-01 NA 59b113ee-0571-4e46-b437-9c48e04697eb NA TCGA-13-1512-01 NA TCGA-13-1512-01A-01D-0475-05 NA TCGA-13-1512-01A-21-1558-20 NA 67e85198-4b8c-45db-b433-683b1899f3ea TCGA-13-1512-01A-01D-0472-01 TCGA-13-1512-01 70bd95ea-f6ca-4b5a-b744-e174576d1063 NA TCGA-13-1512-01A-01D-0472-01 67e85198-4b8c-45db-b433-683b1899f3ea NA 67e85198-4b8c-45db-b433-683b1899f3ea TCGA-13-1512-01A-01W-0545-08 TCGA-13-1512-01 TCGA-13-1512-01 67e85198-4b8c-45db-b433-683b1899f3ea TCGA-13-1512-01A-01W-0545-08 TCGA-13-1512-01A-01R-0479-07 |
|
|
206 |
TCGA-13-1817-01 1 TCGA-13-1817-01 1024 1 days High NA Cluster 6 OV-like c4 NA NA NA NA TCGA-13-1817 NA NA days 1024 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-13-1817-F24974 TCGA-13-1817 TCGA-13-1817-01A Stage IIIC -20771 NA 1024 0 1024 NA 541 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.4 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-13-1817.76F55E61-714E-4C20-A9BD-2ECF28E5444F.pdf 1817 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 13 >20 mm Ovary NA A DECEASED 2001 NA NA NA aad798d8-5b4a-4f23-8ebe-fb68cb37fd51 NA NA NA TCGA-13-1817-01A-01D-0807-05 NA TCGA-13-1817-01A-21-1559-20 NA NA TCGA-13-1817-01A-01D-2069-01 TCGA-13-1817-01 82a5bb6f-81aa-4ba2-9a74-c0a7ea48cabc,cfa86d7b-f1c9-42b9-8d0e-dc7366aec542 NA TCGA-13-1817-01A-01D-2069-01 NA NA NA NA TCGA-13-1817-01 NA NA NA TCGA-13-1817-01A-01R-0810-07 |
|
|
207 |
TCGA-13-1817-02 1 TCGA-13-1817-02 1024 1 days NA NA Cluster 6 NA NA NA NA NA TCGA-13-1817 NA NA days 1024 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-13-1817-F24974 TCGA-13-1817 TCGA-13-1817-02A Stage IIIC -20771 NA 1024 0 1024 NA 541 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-13-1817.AF88642C-B18E-4C22-A8B7-C6B2D259B4E9.pdf 1817 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Recurrent Tumor 02 0.4 NA NA 13 >20 mm Ovary NA A DECEASED 2001 NA NA NA 29cf6928-081b-4498-89b3-89bd24b61608 NA NA NA TCGA-13-1817-02A-01D-0807-05 NA NA NA NA NA NA 5823971e-18e2-4fec-8872-a309b1a6914f NA NA NA NA NA NA NA NA NA NA TCGA-13-1817-02A-01R-0810-07 |
|
|
208 |
TCGA-13-1819-01 1 TCGA-13-1819-01 2025 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-13-1819 429 1 days 2025 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Right TCGA-13-1819-F72642 TCGA-13-1819 TCGA-13-1819-01A Stage IIC -21635 NA 2025 0 1946 NA 429 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.5 NA NA G3 NA NA YES NA NA TCGA-13-1819.27225767-34C2-48F2-A347-867FDDC907E9.pdf 1819 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2004 NA NA NA 3816ef10-585d-4480-bee6-d3d3fe9cbef5 NA NA NA TCGA-13-1819-01A-01D-0807-05 NA TCGA-13-1819-01A-21-1559-20 NA NA TCGA-13-1819-01A-01D-2069-01 TCGA-13-1819-01 249b311f-42e8-4ae2-88a1-11e80c3c02f9,6b5c65d5-0279-43ca-80fb-ef142bf820b7 NA TCGA-13-1819-01A-01D-2069-01 NA NA NA NA TCGA-13-1819-01 NA NA NA TCGA-13-1819-01A-01R-0810-07 |
|
|
209 |
TCGA-13-1819-02 1 TCGA-13-1819-02 2025 1 days NA NA OV-like c1 NA NA NA NA NA TCGA-13-1819 429 1 days 2025 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Right TCGA-13-1819-F72642 TCGA-13-1819 TCGA-13-1819-02A Stage IIC -21635 NA 2025 0 1946 NA 429 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2 NO NA 2.1 NA NA G3 NA NA YES NA NA TCGA-13-1819.EABB4610-CCE8-4DC5-A416-0FABFA634056.pdf 1819 NA WITH TUMOR NA NA NA NA NA Recurrent Tumor 02 0.3 NA NA 13 No Macroscopic disease Ovary NA A DECEASED 2004 NA NA NA 71492b0a-c202-4688-bb17-1828ed1d9d97 NA NA NA TCGA-13-1819-02A-01D-0807-05 NA NA NA NA NA NA f3945f2a-3281-446e-b8b9-d65ac2c770a9 NA NA NA NA NA NA NA NA NA NA TCGA-13-1819-02A-01R-0810-07 |
|
|
210 |
TCGA-13-2057-01 0 TCGA-13-2057-01 2434 0 days High NA UCEC Serous c4 NA NA NA NA NA TCGA-13-2057 897 1 days 2434 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Bilateral TCGA-13-2057-F72682 TCGA-13-2057 TCGA-13-2057-01A Stage IIIC -21554 NA NA 0 2434 NA 897 NA NA Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 1.5 NO 60 3 NA NA G3 NA NA YES NA NA TCGA-13-2057.112EC7A2-A410-4D98-A974-BD6BF75E156F.pdf 2057 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.3 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2008 NA NA NA 0b1c95cf-0eb2-4297-956e-85702b3bbbc3 NA NA NA TCGA-13-2057-01A-02D-1047-05 NA NA TCGA-13-2057-01A-02D-1526-09 NA TCGA-13-2057-01A-02D-1043-01 TCGA-13-2057-01 NA NA TCGA-13-2057-01A-02D-1043-01 NA NA NA NA TCGA-13-2057-01 NA NA NA TCGA-13-2057-01A-02R-1050-07 |
|
|
211 |
TCGA-13-2059-01 0 TCGA-13-2059-01 2387 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-13-2059 1005 1 days 2387 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 50 Bilateral TCGA-13-2059-F72684 TCGA-13-2059 TCGA-13-2059-01A Stage IIIC -18449 NA NA 0 2387 NA 1005 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO 80 2 NA NA G3 NA NA YES NA NA TCGA-13-2059.E3673116-F004-4011-A609-D8E1693DBA62.pdf 2059 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NA NA 13 1-10 mm Ovary NA A LIVING 2009 NA NA NA 96ef4c4d-9292-4281-b23d-8e29fe47119f NA NA NA TCGA-13-2059-01A-01D-1047-05 NA TCGA-13-2059-01A-03-1563-20 TCGA-13-2059-01A-01D-1526-09 NA TCGA-13-2059-01A-01D-1043-01 TCGA-13-2059-01 6af82345-1327-40dc-bbe3-1a4b5feb1da5 NA TCGA-13-2059-01A-01D-1043-01 NA NA NA NA TCGA-13-2059-01 NA NA NA TCGA-13-2059-01A-01R-1050-07 |
|
|
212 |
TCGA-13-2060-01 0 TCGA-13-2060-01 2369 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-13-2060 1475 1 days 2369 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-13-2060-F72683 TCGA-13-2060 TCGA-13-2060-01A Stage IV -18635 NA NA 0 2369 NA 1475 NA NA Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.5 NO 80 2.5 NA NA G3 NA NA YES NA NA TCGA-13-2060.F6986C14-4627-424E-81C5-74E1CE38D52D.pdf 2060 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.5 NA NA 13 1-10 mm Ovary NA A LIVING 2009 TCGA-13-2060-01 TCGA-13-2060-01 NA 60beab4b-53c5-4c97-af8f-21f4076b4850 NA TCGA-13-2060-01 NA TCGA-13-2060-01A-01D-0708-05 NA TCGA-13-2060-01A-21-1560-20 NA 32de1e4d-198a-4616-8227-4d633c80124b TCGA-13-2060-01A-01D-0704-01 TCGA-13-2060-01 19465a94-b5e9-4700-8f19-0724f72dd3a4 NA TCGA-13-2060-01A-01D-0704-01 32de1e4d-198a-4616-8227-4d633c80124b NA 32de1e4d-198a-4616-8227-4d633c80124b TCGA-13-2060-01A-01W-0799-08 TCGA-13-2060-01 TCGA-13-2060-01 32de1e4d-198a-4616-8227-4d633c80124b TCGA-13-2060-01A-01W-0799-08 TCGA-13-2060-01A-01R-0711-07 |
|
|
213 |
TCGA-13-2061-01 0 TCGA-13-2061-01 2339 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-13-2061 2339 0 days 2339 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-13-2061-F72686 TCGA-13-2061 TCGA-13-2061-01A Stage IIIC -21543 NA NA 0 2339 NA NA NA NA Complete Remission/Response 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.5 NO 80 1.9 NA NA G3 NA NA NO NA NA TCGA-13-2061.57D9D913-A6F9-4406-BF4D-0770004131D5.pdf 2061 Pre-Adjuvant Therapy TUMOR FREE NA NA NA NA NA Primary Tumor 01 0.5 NA NA 13 No Macroscopic disease Ovary NA A LIVING 2009 NA NA NA 7183ed35-46c8-49c5-b247-09d01df7f6de NA NA NA TCGA-13-2061-01A-01D-1047-05 NA TCGA-13-2061-01A-03-1563-20 TCGA-13-2061-01A-01D-1526-09 NA TCGA-13-2061-01A-01D-1043-01 TCGA-13-2061-01 7fd07232-c71d-43b3-8f05-8855c8028871 NA TCGA-13-2061-01A-01D-1043-01 NA NA NA NA TCGA-13-2061-01 NA NA NA TCGA-13-2061-01A-01R-1050-07 |
|
|
214 |
TCGA-13-2065-01 0 TCGA-13-2065-01 1993 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-13-2065 946 1 days 1993 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 71 Bilateral TCGA-13-2065-F72688 TCGA-13-2065 NA Stage IIIC -25973 NA NA 0 1993 NA 946 NA NA Stable Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G3 NA NA YES NA NA NA 2065 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA LIVING 2009 NA NA NA d020829d-93e8-4b1d-9b6e-006efc029547 NA NA NA TCGA-13-2065-01A-01D-1047-05 NA TCGA-13-2065-01A-03-1563-20 TCGA-13-2065-01A-01D-1526-09 NA TCGA-13-2065-01A-01D-1043-01 TCGA-13-2065-01 c8f40939-b3f0-4392-bad8-38608d23f320 NA TCGA-13-2065-01A-01D-1043-01 NA NA NA NA TCGA-13-2065-01 NA NA NA TCGA-13-2065-01A-01R-1050-07 |
|
|
215 |
TCGA-13-2066-01 1 TCGA-13-2066-01 2133 1 days NA NA OV-like c1 UCEC-like c5 NA NA NA NA TCGA-13-2066 1028 1 days 2133 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Bilateral TCGA-13-2066-F72687 TCGA-13-2066 NA Stage IV -18170 NA 2133 0 295 NA 1028 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA 80 NA NA NA G3 NA NA YES NA NA NA 2066 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 NA NA NA 13 1-10 mm Ovary NA NA DECEASED 2009 NA NA NA bfe15bbc-6ec4-4c49-b86d-4b01aa23093a NA NA NA TCGA-13-2066-01A-01D-1047-05 NA TCGA-13-2066-01A-03-1562-20 TCGA-13-2066-01A-01D-1526-09 NA NA TCGA-13-2066-01 f2fa59a1-7ceb-4483-9925-3b2707f18d51 NA NA NA NA NA NA NA NA NA NA TCGA-13-2066-01A-01R-1050-07 |
|
|
216 |
TCGA-13-2071-01 1 TCGA-13-2071-01 773 1 days Squamous NA OV-like c1 NA NA NA NA NA TCGA-13-2071 322 1 days 773 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Bilateral TCGA-13-2071-F72689 TCGA-13-2071 TCGA-13-2071-01A Stage IV -23367 NA 773 0 191 NA 322 NA NA Progressive Disease 2015-7-31 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 2 NO 80 2.5 NA NA G3 NA NA YES NA NA TCGA-13-2071.882BE278-9263-466C-BF61-E30543690FD7.pdf 2071 Pre-Adjuvant Therapy WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.6 NA NA 13 1-10 mm Ovary NA A DECEASED 2009 NA NA NA 97c72a04-f6a3-4f0e-89ca-8b6a47ee6d25 NA NA NA TCGA-13-2071-01A-02D-1047-05 NA NA TCGA-13-2071-01A-02D-1526-09 NA TCGA-13-2071-01A-02D-1043-01 TCGA-13-2071-01 NA NA TCGA-13-2071-01A-02D-1043-01 NA NA NA NA TCGA-13-2071-01 NA NA NA TCGA-13-2071-01A-02R-1050-07 |
|
|
217 |
TCGA-13-A5FT-01 0 TCGA-13-A5FT-01 2143 0 days NA NA NA NA NA NA NA NA TCGA-13-A5FT 2143 0 days 2143 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 67 Bilateral TCGA-13-A5FT-F72595 TCGA-13-A5FT TCGA-13-A5FT-01A Stage IIIC -24743 1211 NA 0 2143 NA NA NA NA Complete Remission/Response 2015-7-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 230 NA NO 70 NA NA NA G3 NA NA NO true No TCGA-13-A5FT.B67517DE-A483-4563-8698-51CB95DC5CF1.pdf A5FT Pre-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO RX Primary Tumor 01 NA NO YES 13 No Macroscopic disease Ovary NA A LIVING 2009 TCGA-13-A5FT-01 TCGA-13-A5FT-01 NA NA TCGA-13-A5FT-01A-11D-A409-05 TCGA-13-A5FT-01 NA NA NA NA NA 819ce36b-9256-4ea0-947f-694029850c9d TCGA-13-A5FT-01A-11D-A402-01 NA 2066E3C1-00C3-4264-AA5A-A441AA209F55 TCGA-13-A5FT-01A-11R-A406-31 TCGA-13-A5FT-01A-11D-A402-01 819ce36b-9256-4ea0-947f-694029850c9d TCGA-13-A5FT-01A-11R-A406-31 819ce36b-9256-4ea0-947f-694029850c9d NA NA TCGA-13-A5FT-01 819ce36b-9256-4ea0-947f-694029850c9d NA NA |
|
|
218 |
TCGA-13-A5FU-01 1 TCGA-13-A5FU-01 256 1 days NA NA NA NA NA NA NA NA TCGA-13-A5FU 256 0 days 256 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Bilateral NA TCGA-13-A5FU TCGA-13-A5FU-01A Stage IV -22256 1151 256 0 NA NA NA NA NA NA 2013-5-26 FEMALE Serous Cystadenocarcinoma No C48.0 8441/3 C48.0 YES Tumor resection 210 NA NO 50 NA NA NA G3 NA NA NO true No TCGA-13-A5FU.81DED60F-76BC-47E8-A15C-4488C6FDA1A5.pdf A5FU Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response NA NO R2 Primary Tumor 01 NA NO YES 13 1-10 mm Ovary NA A DECEASED 2009 NA TCGA-13-A5FU-01 NA NA TCGA-13-A5FU-01A-11D-A409-05 TCGA-13-A5FU-01 NA NA NA NA NA NA TCGA-13-A5FU-01A-11D-A402-01 NA 71773ABF-D6B1-46D1-BE6D-95F3B01E04A4 NA TCGA-13-A5FU-01A-11D-A402-01 NA NA NA NA NA NA NA NA NA |
|
|
219 |
TCGA-20-0987-01 1 TCGA-20-0987-01 701 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-20-0987 NA NA days 701 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-20-0987-F25518 TCGA-20-0987 NA Stage IIIC -22287 NA 701 0 NA NA 442 NA NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 0987 NA WITH TUMOR YES NA Physical Examination NO NA Primary Tumor 01 NA NA NA 20 1-10 mm Ovary NA NA DECEASED 2004 NA NA NA e770e1d2-f6bc-4fc0-87c5-15f0939a189b NA NA NA TCGA-20-0987-01A-02D-0432-05 NA NA NA NA TCGA-20-0987-01A-02D-0428-01 TCGA-20-0987-01 NA NA TCGA-20-0987-01A-02D-0428-01 NA NA NA TCGA-20-0987-01A-02W-0486-08 TCGA-20-0987-01 NA NA TCGA-20-0987-01A-02W-0486-08 TCGA-20-0987-01A-02R-0436-07 |
|
|
220 |
TCGA-20-0990-01 0 TCGA-20-0990-01 789 0 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-20-0990 NA NA days 789 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-20-0990-F25523 TCGA-20-0990 TCGA-20-0990-01A Stage IIIC -27170 NA NA 0 789 NA 871 1 NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 0.6 NO NA 0.7 NA NA G3 Recurrence NA NA NA NA TCGA-20-0990.2380A6A4-8F10-40BE-BEE6-DCC116803763.pdf 0990 Post-Adjuvant Therapy WITH TUMOR YES NA Molecular Markers NO NA Primary Tumor 01 0.3 NA NA 20 NA Ovary NA A LIVING 2005 NA TCGA-20-0990-01 NA 8179bb45-deba-42a6-9306-73030e4aa5d8 NA TCGA-20-0990-01 NA TCGA-20-0990-01A-01D-0432-05 NA NA NA NA TCGA-20-0990-01A-01D-0428-01 TCGA-20-0990-01 NA NA TCGA-20-0990-01A-01D-0428-01 NA NA NA TCGA-20-0990-01A-01W-0486-08 TCGA-20-0990-01 NA NA TCGA-20-0990-01A-01W-0486-08 TCGA-20-0990-01A-01R-0436-07 |
|
|
221 |
TCGA-20-0991-01 0 TCGA-20-0991-01 797 0 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-20-0991 NA NA days 797 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Right TCGA-20-0991-F25530 TCGA-20-0991 NA Stage IIB -28694 NA NA 0 797 NA NA 0 NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 0991 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 20 No Macroscopic disease Ovary NA NA LIVING 2006 NA TCGA-20-0991-01 NA bc5c2691-a35b-4548-99ed-7a3e6e95153f NA TCGA-20-0991-01 NA TCGA-20-0991-01A-03D-0432-05 NA NA NA NA TCGA-20-0991-01A-03D-0428-01 TCGA-20-0991-01 NA NA TCGA-20-0991-01A-03D-0428-01 NA NA NA TCGA-20-0991-01A-03D-0428-08 TCGA-20-0991-01 NA NA TCGA-20-0991-01A-03D-0428-08 TCGA-20-0991-01A-01R-0436-07 |
|
|
222 |
TCGA-20-0996-01 0 TCGA-20-0996-01 2196 0 days Kirc+ NA OV-like c1 NA NA NA NA NA TCGA-20-0996 NA NA days 2196 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Bilateral TCGA-20-0996-F25533 TCGA-20-0996 NA Stage IIIC -21572 NA NA 0 2196 NA NA 0 NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G2 NA NA NA NA NA NA 0996 Post-Adjuvant Therapy WITH TUMOR YES NA NA NO NA Primary Tumor 01 NA NA NA 20 1-10 mm Ovary NA NA LIVING 2001 NA NA NA c1396756-4582-49ae-ac88-857ff11b377d NA NA NA TCGA-20-0996-01A-03D-0432-05 NA NA NA NA TCGA-20-0996-01A-03D-0428-01 TCGA-20-0996-01 NA NA TCGA-20-0996-01A-03D-0428-01 NA NA NA NA TCGA-20-0996-01 NA NA NA TCGA-20-0996-01A-02R-0436-07 |
|
|
223 |
TCGA-20-1682-01 0 TCGA-20-1682-01 837 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-20-1682 NA NA days 837 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 56 Bilateral TCGA-20-1682-F25540 TCGA-20-1682 TCGA-20-1682-01A Stage IIIC -20583 NA NA 0 837 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1 NA YES GX NA NA NA NA NA TCGA-20-1682.cf49ea4d-478c-469d-ace2-7ef52b66a332.pdf 1682 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 20 11-20 mm Ovary YES A LIVING 2007 TCGA-20-1682-01 TCGA-20-1682-01 NA 3feadfdb-a932-4ead-8a20-59698a0655ae NA TCGA-20-1682-01 NA TCGA-20-1682-01A-01D-0563-05 NA TCGA-20-1682-01A-21-1558-20 TCGA-20-1682-01A-01W-0633-09 f03d023b-cba8-413d-a88d-0378ee7b7748 TCGA-20-1682-01A-01D-0559-01 TCGA-20-1682-01 a999220b-fed5-446d-8bba-c4c59428d473 NA TCGA-20-1682-01A-01D-0559-01 f03d023b-cba8-413d-a88d-0378ee7b7748 NA f03d023b-cba8-413d-a88d-0378ee7b7748 NA TCGA-20-1682-01 TCGA-20-1682-01 f03d023b-cba8-413d-a88d-0378ee7b7748 NA TCGA-20-1682-01A-01R-0566-07 |
|
|
224 |
TCGA-20-1683-01 0 TCGA-20-1683-01 772 0 days High C9-OV Cluster 6 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 NA TCGA-20-1683 NA NA days 772 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Right TCGA-20-1683-F25544 TCGA-20-1683 TCGA-20-1683-01A Stage IIIC -24006 NA NA 0 772 NA 618 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-20-1683.5a83e4b3-8be2-4628-bd4b-93d040b43856.pdf 1683 Post-Adjuvant Therapy TUMOR FREE YES Stable Disease Molecular Markers NO NA Primary Tumor 01 0.4 NA NA 20 No Macroscopic disease Ovary NA A LIVING 2007 TCGA-20-1683-01 TCGA-20-1683-01 NA f44d8a5e-bb22-4961-bfa5-be4ba92c8729 NA TCGA-20-1683-01 NA TCGA-20-1683-01A-01D-0563-05 NA TCGA-20-1683-01A-21-1558-20 TCGA-20-1683-01A-01W-0633-09 e78c6cd7-67f2-4ac8-9dd9-c46392459835 TCGA-20-1683-01A-01D-0559-01 TCGA-20-1683-01 78abd251-6a19-4b51-bd1d-7c8dba5f324e NA TCGA-20-1683-01A-01D-0559-01 e78c6cd7-67f2-4ac8-9dd9-c46392459835 NA e78c6cd7-67f2-4ac8-9dd9-c46392459835 NA TCGA-20-1683-01 TCGA-20-1683-01 e78c6cd7-67f2-4ac8-9dd9-c46392459835 NA TCGA-20-1683-01A-01R-0566-07 |
|
|
225 |
TCGA-20-1684-01 0 TCGA-20-1684-01 581 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-20-1684 NA NA days 581 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-20-1684-F25549 TCGA-20-1684 TCGA-20-1684-01A Stage IIIC -18755 NA NA 0 581 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA NO G3 NA NA NA NA NA TCGA-20-1684.3ce61823-9e89-424f-9ce2-a8987420b2a9.pdf 1684 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 20 1-10 mm Ovary NO A LIVING 2007 TCGA-20-1684-01 TCGA-20-1684-01 NA c0d9b7e3-7c05-4db3-a77e-ae8a6a4ab4e7 NA TCGA-20-1684-01 NA TCGA-20-1684-01A-01D-0563-05 NA TCGA-20-1684-01A-21-1558-20 TCGA-20-1684-01A-01W-0633-09 91b2872a-73bc-4f52-a8f6-96ce81cbef8a TCGA-20-1684-01A-01D-0559-01 TCGA-20-1684-01 8ba9a6e5-3dc8-4e7b-80ca-17470663b495 NA TCGA-20-1684-01A-01D-0559-01 91b2872a-73bc-4f52-a8f6-96ce81cbef8a NA 91b2872a-73bc-4f52-a8f6-96ce81cbef8a NA TCGA-20-1684-01 TCGA-20-1684-01 91b2872a-73bc-4f52-a8f6-96ce81cbef8a NA TCGA-20-1684-01A-01R-0566-07 |
|
|
226 |
TCGA-20-1685-01 0 TCGA-20-1685-01 508 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-20-1685 NA NA days 508 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 45 Bilateral TCGA-20-1685-F25554 TCGA-20-1685 TCGA-20-1685-01A Stage IIIC -16745 NA NA 0 508 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.8 NA NO G3 NA NA NA NA NA TCGA-20-1685.09b7c163-7ad3-42a2-bc06-32bd55f80327.pdf 1685 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 20 1-10 mm Ovary NO A LIVING 2008 TCGA-20-1685-01 TCGA-20-1685-01 NA 923bc90c-b380-4710-b062-5c3deb27de44 NA TCGA-20-1685-01 NA TCGA-20-1685-01A-01D-0563-05 NA TCGA-20-1685-01A-21-1558-20 TCGA-20-1685-01A-01W-0633-09 9f6dd4ad-0130-46fe-9c49-72f378a753fe TCGA-20-1685-01A-01D-0559-01 TCGA-20-1685-01 b1b57151-ff27-4b55-bf89-6e25a61f1060 NA TCGA-20-1685-01A-01D-0559-01 9f6dd4ad-0130-46fe-9c49-72f378a753fe NA 9f6dd4ad-0130-46fe-9c49-72f378a753fe NA TCGA-20-1685-01 TCGA-20-1685-01 9f6dd4ad-0130-46fe-9c49-72f378a753fe NA TCGA-20-1685-01A-01R-0566-07 |
|
|
227 |
TCGA-20-1686-01 0 TCGA-20-1686-01 89 0 days High NA OV-like c1 BRCA basal-like c6 NA miRNA cluster 2 cluster 2 NA TCGA-20-1686 NA NA days 89 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 75 Bilateral TCGA-20-1686-F25559 TCGA-20-1686 TCGA-20-1686-01A Stage IIIC -27588 NA NA 0 89 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.8 NA NO G3 NA NA NA NA NA TCGA-20-1686.c87ff195-1793-455a-bb19-e495a915befe.pdf 1686 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 20 No Macroscopic disease Ovary NA A LIVING 2008 NA TCGA-20-1686-01 NA 91fb24d3-6a1d-4fd1-9bf3-d891ab25017c NA TCGA-20-1686-01 NA TCGA-20-1686-01A-01D-0563-05 NA TCGA-20-1686-01A-21-1558-20 TCGA-20-1686-01A-01W-0633-09 NA TCGA-20-1686-01A-01D-0559-01 TCGA-20-1686-01 92c3ac1c-3e84-4448-8587-8c95329d0549 NA TCGA-20-1686-01A-01D-0559-01 NA NA NA NA TCGA-20-1686-01 NA NA NA TCGA-20-1686-01A-01R-0566-07 |
|
|
228 |
TCGA-20-1687-01 0 TCGA-20-1687-01 81 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 NA TCGA-20-1687 NA NA days 81 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 46 Bilateral TCGA-20-1687-F25563 TCGA-20-1687 TCGA-20-1687-01A Stage IV -16961 NA NA 0 81 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.8 NO NA 1.8 NA YES G3 NA NA NA NA NA TCGA-20-1687.e966d90f-0e5f-42e6-b487-1f10fbef204f.pdf 1687 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 20 No Macroscopic disease Ovary NA A LIVING 2008 TCGA-20-1687-01 TCGA-20-1687-01 NA 7221f0cf-2235-4717-938b-425c949730e3 NA TCGA-20-1687-01 NA TCGA-20-1687-01A-01D-0563-05 NA TCGA-20-1687-01A-21-1558-20 TCGA-20-1687-01A-01W-0633-09 ad7529aa-47f7-4207-b0a9-8684ff1e6e80 TCGA-20-1687-01A-01D-0559-01 TCGA-20-1687-01 a3332b9e-1a9c-4a7e-81c0-e19de968609b NA TCGA-20-1687-01A-01D-0559-01 ad7529aa-47f7-4207-b0a9-8684ff1e6e80 NA ad7529aa-47f7-4207-b0a9-8684ff1e6e80 NA TCGA-20-1687-01 TCGA-20-1687-01 ad7529aa-47f7-4207-b0a9-8684ff1e6e80 NA TCGA-20-1687-01A-01R-0566-07 |
|
|
229 |
TCGA-23-1021-01 1 TCGA-23-1021-01 1446 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-23-1021 NA NA days 1446 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Right TCGA-23-1021-F25567 TCGA-23-1021 NA Stage IV -16484 NA 1446 0 1446 1181 NA NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 Locoregional Disease YES NA NA NA NA 1021 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 NA NA NA 23 >20 mm Ovary YES NA DECEASED 2004 NA TCGA-23-1021-01 NA eb55cb66-59d1-4b7c-a99e-3dd5e38cca85 NA TCGA-23-1021-01 NA TCGA-23-1021-01B-01D-0432-05 TCGA-23-1021-01B-01W-0488-09 NA TCGA-23-1021-01B-01W-0488-09 NA TCGA-23-1021-01B-01D-0428-01 TCGA-23-1021-01 NA NA TCGA-23-1021-01B-01D-0428-01 NA NA NA NA TCGA-23-1021-01 NA NA TCGA-23-1021-01B-01W-0488-09 TCGA-23-1021-01B-01R-0436-07 |
|
|
230 |
TCGA-23-1022-01 1 TCGA-23-1022-01 1511 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-23-1022 NA NA days 1511 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Left TCGA-23-1022-F25576 TCGA-23-1022 TCGA-23-1022-01A Stage IIIC -24798 NA 1511 0 NA NA 450 NA NA NA 2009-2-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.7 NA YES G3 Recurrence NA NA NA NA TCGA-23-1022.1A674838-E992-4E9B-82AE-FAFA0AD3BF56.pdf 1022 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 23 1-10 mm Ovary YES A DECEASED 2003 NA TCGA-23-1022-01 NA 430ab09f-2d3f-4a3d-9aac-d6c678e983db NA TCGA-23-1022-01 NA TCGA-23-1022-01A-02D-0432-05 TCGA-23-1022-01A-02W-0488-09 NA TCGA-23-1022-01A-02W-0488-09 NA TCGA-23-1022-01A-02D-0428-01 TCGA-23-1022-01 NA NA TCGA-23-1022-01A-02D-0428-01 NA NA NA NA TCGA-23-1022-01 NA NA TCGA-23-1022-01A-02W-0488-09 TCGA-23-1022-01A-01R-0436-07 |
|
|
231 |
TCGA-23-1023-01 0 TCGA-23-1023-01 1233 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-23-1023 NA NA days 1233 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Right TCGA-23-1023-F25587 TCGA-23-1023 TCGA-23-1023-01R Stage IIIC -23826 NA NA 0 1233 NA 490 NA NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-23-1023.98EBC356-C54E-4C1E-9726-BA61397DDA38.pdf 1023 NA WITH TUMOR YES Complete Remission/Response Other Method NO NA Recurrent Tumor 02 0.3 NA NA 23 1-10 mm Ovary YES R LIVING 2005 TCGA-23-1023-01 TCGA-23-1023-01 TCGA-23-1023-01A-03W-0484-10 fcd199f1-6a2a-4b56-977a-6e0959335ca9,d00090cb-c5e2-427f-bdee-5602808ec406 NA TCGA-23-1023-01 TCGA-23-1023-01A-03W-0484-10 TCGA-23-1023-01A-03D-0432-05,TCGA-23-1023-01R-01D-0807-05 NA NA NA 1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf TCGA-23-1023-01A-03D-0428-01 TCGA-23-1023-01 NA NA TCGA-23-1023-01A-03D-0428-01 1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf NA 1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf NA TCGA-23-1023-01 TCGA-23-1023-01 69bec2db-02c3-46ca-b17b-60eae9a1e0bf,1c88dde8-4fe6-49e9-8d76-40668ed783ff TCGA-23-1023-01A-03W-0484-10 TCGA-23-1023-01R-01R-0810-07,TCGA-23-1023-01A-02R-0436-07 |
|
|
232 |
TCGA-23-1024-01 0 TCGA-23-1024-01 468 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-23-1024 NA NA days 468 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Right TCGA-23-1024-F25604 TCGA-23-1024 TCGA-23-1024-01A Stage IV -19052 NA NA 0 468 NA NA NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.8 NA NA G3 NA NA NA NA NA TCGA-23-1024.1CCE5978-6A4D-427A-9875-47617F6A4258.pdf 1024 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.2 NA NA 23 1-10 mm Ovary NA A LIVING 2007 NA TCGA-23-1024-01 TCGA-23-1024-01A-02W-0484-10 15e969ea-df91-4ade-9f5f-91f317ac7573 NA TCGA-23-1024-01 TCGA-23-1024-01A-02W-0484-10 TCGA-23-1024-01A-02D-0432-05 NA NA NA NA TCGA-23-1024-01A-02D-0428-01 TCGA-23-1024-01 NA NA TCGA-23-1024-01A-02D-0428-01 NA NA NA NA TCGA-23-1024-01 NA NA TCGA-23-1024-01A-02W-0484-10 TCGA-23-1024-01A-02R-0436-07 |
|
|
233 |
TCGA-23-1026-01 0 TCGA-23-1026-01 816 0 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-23-1026 NA NA days 816 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Left TCGA-23-1026-F25610 TCGA-23-1026 TCGA-23-1026-01B Stage IIIC -16442 NA NA 0 816 NA 797 NA NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.8 NA NA G3 Recurrence NA NA NA NA TCGA-23-1026.E41E1018-422B-4B4A-8732-C9389847830D.pdf 1026 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 23 1-10 mm Ovary NA B LIVING 2004 TCGA-23-1026-01 TCGA-23-1026-01 TCGA-23-1026-01B-01W-0484-10 fca7646c-094b-4720-a550-f3e066f24431 NA TCGA-23-1026-01 TCGA-23-1026-01B-01W-0484-10 TCGA-23-1026-01B-01D-0432-05 NA NA NA 973907c7-f259-4d1a-b9df-68db1837af91 TCGA-23-1026-01B-01D-0428-01 TCGA-23-1026-01 NA NA TCGA-23-1026-01B-01D-0428-01 973907c7-f259-4d1a-b9df-68db1837af91 NA 973907c7-f259-4d1a-b9df-68db1837af91 NA TCGA-23-1026-01 TCGA-23-1026-01 973907c7-f259-4d1a-b9df-68db1837af91 TCGA-23-1026-01B-01W-0484-10 TCGA-23-1026-01B-01R-0436-07 |
|
|
234 |
TCGA-23-1027-01 1 TCGA-23-1027-01 976 1 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-23-1027 NA NA days 976 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Right TCGA-23-1027-F25616 TCGA-23-1027 NA Stage IIIC -17588 NA 976 0 966 NA 114 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 Recurrence NA NA NA NA NA 1027 NA NA YES Progressive Disease NA NO NA Primary Tumor 01 NA NA NA 23 1-10 mm Ovary YES NA DECEASED 2005 TCGA-23-1027-01 TCGA-23-1027-01 NA acb73086-38dd-4ed6-9d1c-d14dcd155936 NA TCGA-23-1027-01 NA TCGA-23-1027-01A-02D-0432-05 NA NA NA edbc81a6-2593-45c5-8131-3c4615d1807f TCGA-23-1027-01A-02D-0428-01 TCGA-23-1027-01 NA NA TCGA-23-1027-01A-02D-0428-01 edbc81a6-2593-45c5-8131-3c4615d1807f NA edbc81a6-2593-45c5-8131-3c4615d1807f TCGA-23-1027-01A-02W-0486-08 TCGA-23-1027-01 TCGA-23-1027-01 edbc81a6-2593-45c5-8131-3c4615d1807f TCGA-23-1027-01A-02W-0486-08 TCGA-23-1027-01A-02R-0436-07 |
|
|
235 |
TCGA-23-1028-01 0 TCGA-23-1028-01 1503 0 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-23-1028 NA NA days 1503 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 43 Left TCGA-23-1028-F25624 TCGA-23-1028 TCGA-23-1028-01A Stage IIIC -16018 NA NA 0 1503 NA 133 NA NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 0.8 NA YES G3 Recurrence NA NA NA NA TCGA-23-1028.CCD0A1B3-DE92-473C-AA1B-8EE25DE408A2.pdf 1028 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 23 1-10 mm Ovary YES A LIVING 2004 NA TCGA-23-1028-01 TCGA-23-1028-01A-01W-0484-10 511adb99-1cae-481e-8da7-f4cdc4d5f385 NA TCGA-23-1028-01 TCGA-23-1028-01A-01W-0484-10 TCGA-23-1028-01A-01D-0432-05 NA NA NA NA TCGA-23-1028-01A-01D-0428-01 TCGA-23-1028-01 NA NA TCGA-23-1028-01A-01D-0428-01 NA NA NA NA TCGA-23-1028-01 NA NA TCGA-23-1028-01A-01W-0484-10 TCGA-23-1028-01A-01R-0436-07 |
|
|
236 |
TCGA-23-1029-01 0 TCGA-23-1029-01 268 0 days Squamous NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-23-1029 NA NA days 268 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 46 Right TCGA-23-1029-F25639 TCGA-23-1029 TCGA-23-1029-01B Stage IIIC -16889 NA NA 0 268 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 0.8 NA NA G3 NA NA NA NA NA TCGA-23-1029.89E1F403-12CB-442A-9588-CF5C0AC0E0A6.pdf 1029 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 23 1-10 mm Ovary NA B LIVING 2007 TCGA-23-1029-01 TCGA-23-1029-01 NA fcd48515-450a-4a24-b92d-8fb4eb4890b3 NA TCGA-23-1029-01 NA TCGA-23-1029-01B-01D-0581-05 NA NA TCGA-23-1029-01B-01W-0639-09 9a54d0fe-f998-4866-bb1f-92be472d843a TCGA-23-1029-01B-01D-0577-01 TCGA-23-1029-01 NA NA TCGA-23-1029-01B-01D-0577-01 9a54d0fe-f998-4866-bb1f-92be472d843a NA 9a54d0fe-f998-4866-bb1f-92be472d843a NA TCGA-23-1029-01 TCGA-23-1029-01 9a54d0fe-f998-4866-bb1f-92be472d843a NA TCGA-23-1029-01B-01R-0584-07 |
|
|
237 |
TCGA-23-1030-01 0 TCGA-23-1030-01 886 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-23-1030 NA NA days 886 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Left TCGA-23-1030-F25643 TCGA-23-1030 NA Stage IIIC -23416 NA NA 0 886 NA 544 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 Recurrence NA NA NA NA NA 1030 NA TUMOR FREE YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 23 1-10 mm Ovary YES NA LIVING 2006 NA TCGA-23-1030-01 NA b1f62bf0-8681-4b6d-ab78-a7c5757770a4 NA TCGA-23-1030-01 NA TCGA-23-1030-01A-02D-0432-05 NA NA NA NA TCGA-23-1030-01A-02D-0428-01 TCGA-23-1030-01 NA NA TCGA-23-1030-01A-02D-0428-01 NA NA NA TCGA-23-1030-01A-02W-0486-08 TCGA-23-1030-01 NA NA TCGA-23-1030-01A-02W-0486-08 TCGA-23-1030-01A-02R-0436-07 |
|
|
238 |
TCGA-23-1031-01 1 TCGA-23-1031-01 575 1 days High NA OV-like c1 NA NA NA NA mutation cluster 5 TCGA-23-1031 NA NA days 575 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Left TCGA-23-1031-F25649 TCGA-23-1031 NA Stage IV -22225 NA 575 0 575 NA NA NA NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 1031 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 NA NA NA 23 1-10 mm Ovary NA NA DECEASED 2003 NA NA NA c85b3936-20a5-41cb-ad0d-d184c2c1f6d9 NA NA NA TCGA-23-1031-01A-01D-0432-05 NA NA NA NA TCGA-23-1031-01A-01D-0428-01 TCGA-23-1031-01 NA NA TCGA-23-1031-01A-01D-0428-01 NA NA NA TCGA-23-1031-01A-01W-0486-08 TCGA-23-1031-01 NA NA TCGA-23-1031-01A-01W-0486-08 TCGA-23-1031-01A-01R-0436-07 |
|
|
239 |
TCGA-23-1032-01 1 TCGA-23-1032-01 84 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-23-1032 NA NA days 84 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 Right TCGA-23-1032-F25659 TCGA-23-1032 TCGA-23-1032-01A Stage IV -26715 NA 84 0 68 NA NA NA NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1 NA NA G3 NA NA NA NA NA TCGA-23-1032.6E8A5413-EB7E-49D8-8E11-8CA6A912ED50.pdf 1032 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.6 NA NA 23 1-10 mm Ovary NA A DECEASED 2002 NA TCGA-23-1032-01 NA 986863dd-b61b-48c2-a37c-af21fed7e778 NA TCGA-23-1032-01 NA TCGA-23-1032-01A-02D-0432-05 NA NA NA NA TCGA-23-1032-01A-02D-0428-01 TCGA-23-1032-01 NA NA TCGA-23-1032-01A-02D-0428-01 NA NA NA TCGA-23-1032-01A-02W-0486-08 TCGA-23-1032-01 NA NA TCGA-23-1032-01A-02W-0486-08 TCGA-23-1032-01A-02R-0436-07 |
|
|
240 |
TCGA-23-1107-01 1 TCGA-23-1107-01 9 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 NA TCGA-23-1107 NA NA days 9 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Left TCGA-23-1107-F25661 TCGA-23-1107 TCGA-23-1107-01A Stage IV -21561 NA 9 0 9 NA NA NA NA NA 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NA G3 NA NA NA NA NA TCGA-23-1107.700802e6-8058-4485-8210-3e5b8f10bbf3.pdf 1107 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.6 NA NA 23 >20 mm Ovary NA A DECEASED 1999 NA TCGA-23-1107-01 TCGA-23-1107-01A-01W-0484-10 7f426322-5acf-4d04-8bd6-93ec56bffd0f NA TCGA-23-1107-01 TCGA-23-1107-01A-01W-0484-10 TCGA-23-1107-01A-01D-0432-05 NA NA NA NA NA TCGA-23-1107-01 NA NA NA NA NA NA NA NA NA NA NA TCGA-23-1107-01A-01R-0436-07 |
|
|
241 |
TCGA-23-1109-01 1 TCGA-23-1109-01 1562 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 NA TCGA-23-1109 NA NA days 1562 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 62 Right TCGA-23-1109-F25663 TCGA-23-1109 NA Stage IIIC -23002 NA 1562 0 1562 NA 987 NA NA NA 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1109 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 23 1-10 mm Ovary NA NA DECEASED 1999 TCGA-23-1109-01 TCGA-23-1109-01 TCGA-23-1109-01A-01W-0484-10 ef6ecfd8-badc-4863-a3d5-fc20161f09dc NA TCGA-23-1109-01 TCGA-23-1109-01A-01W-0484-10 TCGA-23-1109-01A-01D-0432-05 NA TCGA-23-1109-01A-21-1562-20 NA d47e074a-f78e-40c5-8af4-f737ce010041 TCGA-23-1109-01A-01D-0428-01 TCGA-23-1109-01 b8d71b4b-6d11-47da-b15d-a3eac835a9a9 NA TCGA-23-1109-01A-01D-0428-01 d47e074a-f78e-40c5-8af4-f737ce010041 NA d47e074a-f78e-40c5-8af4-f737ce010041 NA TCGA-23-1109-01 TCGA-23-1109-01 d47e074a-f78e-40c5-8af4-f737ce010041 NA TCGA-23-1109-01A-01R-0436-07 |
|
|
242 |
TCGA-23-1110-01 0 TCGA-23-1110-01 1658 0 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-23-1110 NA NA days 1658 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Right TCGA-23-1110-F25666 TCGA-23-1110 TCGA-23-1110-01A Stage IIIC -15383 NA NA 0 1658 NA 326 NA NA NA 2009-2-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 0.8 NA YES G3 Recurrence NA NA NA NA TCGA-23-1110.07361efd-0b7d-4dcb-afe3-464200f59ac0.pdf 1110 NA TUMOR FREE YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 23 No Macroscopic disease Ovary YES A LIVING 2003 NA TCGA-23-1110-01 NA 811e848e-6289-4821-8640-c645e2b3f57e NA TCGA-23-1110-01 NA TCGA-23-1110-01A-01D-0432-05 NA TCGA-23-1110-01A-11-1562-20 NA NA TCGA-23-1110-01A-01D-0428-01 TCGA-23-1110-01 e36ba512-a711-4e42-80ce-94edb0be836e NA TCGA-23-1110-01A-01D-0428-01 NA NA NA TCGA-23-1110-01A-01D-0428-08 TCGA-23-1110-01 NA NA TCGA-23-1110-01A-01D-0428-08 TCGA-23-1110-01A-01R-0436-07 |
|
|
243 |
TCGA-23-1111-01 0 TCGA-23-1111-01 98 0 days High C9-OV OV-like c1 BRCA basal-like c6 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-23-1111 NA NA days 98 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Right TCGA-23-1111-F25672 TCGA-23-1111 TCGA-23-1111-01A Stage IIIC -23171 NA NA 0 98 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 0.9 NA YES G3 NA NA NA NA NA TCGA-23-1111.ba3ae03c-74d4-4b5f-849f-71466bae7c0e.pdf 1111 NA NA YES NA NA NO NA Primary Tumor 01 0.4 NA NA 23 >20 mm Ovary NA A LIVING 2008 TCGA-23-1111-01 TCGA-23-1111-01 NA 190f5d18-230f-417f-b10c-992c28dcf418 NA TCGA-23-1111-01 NA TCGA-23-1111-01A-01D-0581-05 NA TCGA-23-1111-01A-21-20 TCGA-23-1111-01A-01W-0639-09 f38e46dc-67b9-448a-8d24-507291e55bca TCGA-23-1111-01A-01D-0577-01 TCGA-23-1111-01 8e14b0f8-af54-486f-9ecc-8b62eb434ad4 NA TCGA-23-1111-01A-01D-0577-01 f38e46dc-67b9-448a-8d24-507291e55bca NA f38e46dc-67b9-448a-8d24-507291e55bca NA TCGA-23-1111-01 TCGA-23-1111-01 f38e46dc-67b9-448a-8d24-507291e55bca NA TCGA-23-1111-01A-01R-0584-07 |
|
|
244 |
TCGA-23-1113-01 1 TCGA-23-1113-01 949 1 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 1 NA TCGA-23-1113 NA NA days 949 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Left TCGA-23-1113-F25677 TCGA-23-1113 NA Stage IV -17791 NA 949 0 NA NA NA NA NA NA 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 NA NA NA NA NA NA 1113 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 NA NA NA 23 1-10 mm Ovary NA NA DECEASED 2002 NA TCGA-23-1113-01 NA a418120d-175f-4f72-b81f-02528d563418 NA TCGA-23-1113-01 NA TCGA-23-1113-01A-01D-0432-05 NA NA NA NA TCGA-23-1113-01A-01D-0428-01 TCGA-23-1113-01 NA NA TCGA-23-1113-01A-01D-0428-01 NA NA NA NA TCGA-23-1113-01 NA NA NA TCGA-23-1113-01A-01R-0436-07 |
|
|
245 |
TCGA-23-1114-01 1 TCGA-23-1114-01 2089 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-23-1114 NA NA days 2089 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Left TCGA-23-1114-F25685 TCGA-23-1114 TCGA-23-1114-01B Stage IIIC -20409 NA 2089 0 2089 NA 634 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-23-1114.d5c00586-d7e4-4909-be2b-ffc4f9ef2e82.pdf 1114 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 23 No Macroscopic disease Ovary NA B DECEASED 2000 TCGA-23-1114-01 TCGA-23-1114-01 NA 7ee203ae-339a-4534-9e72-0dd723890ad1 NA TCGA-23-1114-01 NA TCGA-23-1114-01B-01D-0563-05 NA NA TCGA-23-1114-01B-01W-0633-09 7cfe1419-65be-4860-9f99-75f4a139d9ac TCGA-23-1114-01B-01D-0559-01 TCGA-23-1114-01 NA NA TCGA-23-1114-01B-01D-0559-01 7cfe1419-65be-4860-9f99-75f4a139d9ac NA 7cfe1419-65be-4860-9f99-75f4a139d9ac NA TCGA-23-1114-01 TCGA-23-1114-01 7cfe1419-65be-4860-9f99-75f4a139d9ac NA TCGA-23-1114-01B-01R-0566-07 |
|
|
246 |
TCGA-23-1116-01 1 TCGA-23-1116-01 592 1 days High NA OV-like c1 NA NA NA NA mutation cluster 8 TCGA-23-1116 286 1 days 592 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 83 Left TCGA-23-1116-F72416 TCGA-23-1116 NA Stage IIIC -30464 NA 592 0 139 NA 286 NA Additional New Tumor Event Progressive Disease 2015-6-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NO YES G3 Recurrence NA YES NA NA NA 1116 NA WITH TUMOR YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 23 >20 mm Ovary YES NA DECEASED 2008 NA NA NA e7a2e1cf-9175-4d4b-9f6a-ccace71a5267 NA NA NA TCGA-23-1116-01A-01D-0432-05 NA NA NA NA TCGA-23-1116-01A-01D-0428-01 TCGA-23-1116-01 NA NA TCGA-23-1116-01A-01D-0428-01 NA NA NA TCGA-23-1116-01A-01W-0486-08 TCGA-23-1116-01 NA NA TCGA-23-1116-01A-01W-0486-08 TCGA-23-1116-01A-01R-0436-07 |
|
|
247 |
TCGA-23-1117-01 1 TCGA-23-1117-01 1013 1 days High NA OV-like c1 NA NA NA NA mutation cluster 8 TCGA-23-1117 NA NA days 1013 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Left TCGA-23-1117-F25699 TCGA-23-1117 TCGA-23-1117-01A Stage IIIC -15690 NA 1013 0 NA NA 418 NA NA NA 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.7 NA YES G3 Recurrence NA NA NA NA TCGA-23-1117.abc636a1-677d-49e5-9259-5b5b828a575e.pdf 1117 NA WITH TUMOR NO Complete Remission/Response Other Method YES NA Primary Tumor 01 0.4 NA NA 23 1-10 mm Ovary YES A DECEASED 1998 NA NA NA 7cf2b05a-4475-44db-af64-1889f8073941 NA NA NA TCGA-23-1117-01A-02D-0432-05 TCGA-23-1117-01A-02W-0488-09 NA TCGA-23-1117-01A-02W-0488-09 NA TCGA-23-1117-01A-02D-0428-01 TCGA-23-1117-01 NA NA TCGA-23-1117-01A-02D-0428-01 NA NA NA NA TCGA-23-1117-01 NA NA TCGA-23-1117-01A-02W-0488-09 TCGA-23-1117-01A-02R-0436-07 |
|
|
248 |
TCGA-23-1118-01 0 TCGA-23-1118-01 2616 0 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-23-1118 NA NA days 2616 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 45 Left TCGA-23-1118-F25708 TCGA-23-1118 NA Stage IIIC -16471 NA NA 0 2616 NA NA NA NA NA 2009-2-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 NA NA NA NA NA NA 1118 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 23 >20 mm Ovary YES NA LIVING 2001 NA TCGA-23-1118-01 NA cbd86cfc-faa7-40dd-a544-3c0dba5849aa NA TCGA-23-1118-01 NA TCGA-23-1118-01A-01D-0432-05 TCGA-23-1118-01A-01W-0488-09 NA TCGA-23-1118-01A-01W-0488-09 NA TCGA-23-1118-01A-01D-0428-01 TCGA-23-1118-01 NA NA TCGA-23-1118-01A-01D-0428-01 NA NA NA NA TCGA-23-1118-01 NA NA TCGA-23-1118-01A-01W-0488-09 TCGA-23-1118-01A-01R-0436-07 |
|
|
249 |
TCGA-23-1119-01 0 TCGA-23-1119-01 3953 0 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 4 NA TCGA-23-1119 NA NA days 3953 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Left TCGA-23-1119-F25711 TCGA-23-1119 TCGA-23-1119-01A Stage IIIC -23686 NA NA 0 3953 NA 3378 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 0.8 NA YES G3 Recurrence NA NA NA NA TCGA-23-1119.86389912-6945-49e6-9255-e7a41fde197a.pdf 1119 NA TUMOR FREE YES Complete Remission/Response Other Method NO NA Primary Tumor 01 0.6 NA NA 23 1-10 mm Ovary YES A LIVING 1997 NA TCGA-23-1119-01 TCGA-23-1119-01A-02W-0484-10 14dd1630-da1d-47ca-bae2-457903a26761 NA TCGA-23-1119-01 TCGA-23-1119-01A-02W-0484-10 TCGA-23-1119-01A-02D-0432-05 NA NA NA NA TCGA-23-1119-01A-02D-0428-01 TCGA-23-1119-01 NA NA TCGA-23-1119-01A-02D-0428-01 NA NA NA NA TCGA-23-1119-01 NA NA NA TCGA-23-1119-01A-02R-0436-07 |
|
|
250 |
TCGA-23-1120-01 0 TCGA-23-1120-01 130 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 3 mutation cluster 2 TCGA-23-1120 NA NA days 130 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Right TCGA-23-1120-F25715 TCGA-23-1120 TCGA-23-1120-01A Stage IIIC -22148 NA NA 0 130 NA NA NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.8 NA NO G3 NA NA NA NA NA TCGA-23-1120.e12ef7d5-6fa8-46fa-bedc-da6ddbbecc37.pdf 1120 NA NA YES Complete Remission/Response NA NO NA Primary Tumor 01 0.6 NA NA 23 1-10 mm Ovary NO A LIVING 2008 TCGA-23-1120-01 TCGA-23-1120-01 TCGA-23-1120-01A-02W-0484-10 0486be96-3c9f-41a7-9115-295646258378 NA TCGA-23-1120-01 TCGA-23-1120-01A-02W-0484-10 TCGA-23-1120-01A-02D-0432-05 NA NA NA 9b64998e-eed9-428b-97ac-4de398caaf81 TCGA-23-1120-01A-02D-0428-01 TCGA-23-1120-01 NA NA TCGA-23-1120-01A-02D-0428-01 9b64998e-eed9-428b-97ac-4de398caaf81 NA 9b64998e-eed9-428b-97ac-4de398caaf81 NA TCGA-23-1120-01 TCGA-23-1120-01 9b64998e-eed9-428b-97ac-4de398caaf81 TCGA-23-1120-01A-02W-0484-10 TCGA-23-1120-01A-02R-0436-07 |
|
|
251 |
TCGA-23-1121-01 0 TCGA-23-1121-01 194 0 days High NA Cluster 5 OV-like c4 NA miRNA cluster 1 cluster 5 NA TCGA-23-1121 NA NA days 194 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Left TCGA-23-1121-F25719 TCGA-23-1121 TCGA-23-1121-01A Stage IIIC -18983 NA NA 0 194 NA NA NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.2 NA YES G3 NA NA NA NA NA TCGA-23-1121.ed14039c-9ecf-4e01-9a1c-7a227847b8a3.pdf 1121 NA NA YES NA NA NO NA Primary Tumor 01 0.6 NA NA 23 >20 mm Ovary NA A LIVING 2008 NA TCGA-23-1121-01 NA e3fca11d-248c-4852-ad4b-09867693fd39 NA TCGA-23-1121-01 NA TCGA-23-1121-01A-01D-0432-05 NA TCGA-23-1121-01A-11-1562-20 NA NA TCGA-23-1121-01A-01D-0428-01 TCGA-23-1121-01 97eb2839-fc59-4c0a-a075-b5fd802799c6 NA TCGA-23-1121-01A-01D-0428-01 NA NA NA NA TCGA-23-1121-01 NA NA NA TCGA-23-1121-01A-01R-0436-07 |
|
|
252 |
TCGA-23-1122-01 1 TCGA-23-1122-01 1189 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-23-1122 NA NA days 1189 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 53 Left TCGA-23-1122-F25724 TCGA-23-1122 TCGA-23-1122-01A Stage IIIC -19537 NA 1189 0 NA NA 447 NA NA NA 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.1 NA NO G3 Recurrence NA NA NA NA TCGA-23-1122.9507d553-b1c7-4b71-90c1-064fd8ef15ba.pdf 1122 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 23 1-10 mm Ovary NA A DECEASED 1998 TCGA-23-1122-01 TCGA-23-1122-01 NA c619e051-c770-4ed9-957b-b27ec8784864 NA TCGA-23-1122-01 NA TCGA-23-1122-01A-01D-0432-05 NA TCGA-23-1122-01A-11-1562-20 NA 54b75801-ad36-49a1-b0c2-edc0053b897e TCGA-23-1122-01A-01D-0428-01 TCGA-23-1122-01 2877f544-7459-4a43-9e89-a014008f6a58 NA TCGA-23-1122-01A-01D-0428-01 54b75801-ad36-49a1-b0c2-edc0053b897e NA 54b75801-ad36-49a1-b0c2-edc0053b897e TCGA-23-1122-01A-01W-0486-08 TCGA-23-1122-01 TCGA-23-1122-01 54b75801-ad36-49a1-b0c2-edc0053b897e TCGA-23-1122-01A-01W-0486-08 TCGA-23-1122-01A-01R-0436-07 |
|
|
253 |
TCGA-23-1123-01 1 TCGA-23-1123-01 1018 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-23-1123 NA NA days 1018 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Left TCGA-23-1123-F25733 TCGA-23-1123 TCGA-23-1123-01A Stage IIIC -21552 NA 1018 0 NA NA NA NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 0.8 NA YES G3 NA NA NA NA NA TCGA-23-1123.28f9189b-24eb-4540-8551-4eaacc296c20.pdf 1123 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.6 NA NA 23 11-20 mm Ovary NA A DECEASED 1998 TCGA-23-1123-01 TCGA-23-1123-01 NA c7657407-5f4d-441a-a943-90315de8c660 NA TCGA-23-1123-01 NA TCGA-23-1123-01A-01D-0432-05 TCGA-23-1123-01A-01W-0488-09 TCGA-23-1123-01A-11-1562-20 TCGA-23-1123-01A-01W-0488-09 71543abc-9f15-48d9-994d-e7b963a4d8f3 TCGA-23-1123-01A-01D-0428-01 TCGA-23-1123-01 184da43f-2906-495a-a714-031b30a78cdb NA TCGA-23-1123-01A-01D-0428-01 71543abc-9f15-48d9-994d-e7b963a4d8f3 NA 71543abc-9f15-48d9-994d-e7b963a4d8f3 NA TCGA-23-1123-01 TCGA-23-1123-01 71543abc-9f15-48d9-994d-e7b963a4d8f3 TCGA-23-1123-01A-01W-0488-09 TCGA-23-1123-01A-01R-0436-07 |
|
|
254 |
TCGA-23-1124-01 1 TCGA-23-1124-01 1768 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-23-1124 NA NA days 1768 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 62 Left TCGA-23-1124-F25739 TCGA-23-1124 NA Stage IIIC -23005 NA 1768 0 NA NA 641 NA NA NA 2009-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 Recurrence NA NA NA NA NA 1124 NA WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 NA NA NA 23 No Macroscopic disease Ovary YES NA DECEASED 1999 NA TCGA-23-1124-01 NA e707d0a2-6e26-48dc-9020-ae36b666321a NA TCGA-23-1124-01 NA TCGA-23-1124-01A-01D-0432-05 TCGA-23-1124-01A-01W-0488-09 TCGA-23-1124-01A-11-1562-20 TCGA-23-1124-01A-01W-0488-09 NA TCGA-23-1124-01A-01D-0428-01 TCGA-23-1124-01 fe87e0a2-b27c-402c-81d8-ec0d24e7ce81 NA TCGA-23-1124-01A-01D-0428-01 NA NA NA NA TCGA-23-1124-01 NA NA TCGA-23-1124-01A-01W-0488-09 TCGA-23-1124-01A-01R-0436-07 |
|
|
255 |
TCGA-23-1809-01 0 TCGA-23-1809-01 16 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-23-1809 NA NA days 16 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Right TCGA-23-1809-F25753 TCGA-23-1809 TCGA-23-1809-01A Stage IIC -23111 NA NA 0 16 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 0.9 NA NO G3 NA NA NA NA NA TCGA-23-1809.f69b3aba-61df-4fd8-94d7-9bb80692464c.pdf 1809 NA NA YES NA NA NO NA Primary Tumor 01 0.4 NA NA 23 1-10 mm Ovary NO A LIVING 2009 TCGA-23-1809-01 TCGA-23-1809-01 NA 2bf22a99-e464-4889-9c1c-0208d5df2f36 NA TCGA-23-1809-01 NA TCGA-23-1809-01A-01D-0563-05 NA TCGA-23-1809-01A-21-1559-20 TCGA-23-1809-01A-01W-0633-09 ac764277-4d48-489a-8625-f27541b11258 TCGA-23-1809-01A-01D-0559-01 TCGA-23-1809-01 2341af5b-d30e-4ae0-9384-119f66a797ed NA TCGA-23-1809-01A-01D-0559-01 ac764277-4d48-489a-8625-f27541b11258 NA ac764277-4d48-489a-8625-f27541b11258 NA TCGA-23-1809-01 TCGA-23-1809-01 ac764277-4d48-489a-8625-f27541b11258 NA TCGA-23-1809-01A-01R-0566-07 |
|
|
256 |
TCGA-23-2072-01 1 TCGA-23-2072-01 759 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-23-2072 NA NA days 759 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Right TCGA-23-2072-F25757 TCGA-23-2072 TCGA-23-2072-01A Stage IV -21523 NA 759 0 NA NA 476 NA NA NA 2009-11-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-23-2072.b0475cc1-edd5-451c-8f26-ec3594811f2e.pdf 2072 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.2 NA NA 23 >20 mm Ovary NA A DECEASED 2000 NA TCGA-23-2072-01 NA 5ba9bc54-191b-4a8b-8571-24a780a2e7d5 NA TCGA-23-2072-01 NA TCGA-23-2072-01A-01D-0667-05 NA NA NA NA TCGA-23-2072-01A-01D-0663-01 TCGA-23-2072-01 NA NA TCGA-23-2072-01A-01D-0663-01 NA NA NA TCGA-23-2072-01A-01W-0722-08 TCGA-23-2072-01 NA NA TCGA-23-2072-01A-01W-0722-08 TCGA-23-2072-01A-01R-0670-07 |
|
|
257 |
TCGA-23-2077-01 0 TCGA-23-2077-01 3525 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 8 TCGA-23-2077 NA NA days 3525 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Left TCGA-23-2077-F25763 TCGA-23-2077 TCGA-23-2077-01A Stage IIIC -16552 NA NA 0 3525 NA 1232 NA NA NA 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.1 NA NO G3 Recurrence NA NA NA NA TCGA-23-2077.55589297-f28e-422c-beee-6cb19a2350be.pdf 2077 NA TUMOR FREE YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 23 No Macroscopic disease Ovary YES A LIVING 1999 TCGA-23-2077-01 TCGA-23-2077-01 NA 2db607b0-cd7f-4686-9f85-a119b089ed7f NA TCGA-23-2077-01 NA TCGA-23-2077-01A-01D-0667-05 NA TCGA-23-2077-01A-21-1560-20 NA 16c61c5a-a9b3-4022-9b79-d593e3519794 TCGA-23-2077-01A-01D-0663-01 TCGA-23-2077-01 3848ccad-5f29-40f6-8407-05e548a3b8e5 NA TCGA-23-2077-01A-01D-0663-01 16c61c5a-a9b3-4022-9b79-d593e3519794 NA 16c61c5a-a9b3-4022-9b79-d593e3519794 TCGA-23-2077-01A-01W-0722-08 TCGA-23-2077-01 TCGA-23-2077-01 16c61c5a-a9b3-4022-9b79-d593e3519794 TCGA-23-2077-01A-01W-0722-08 TCGA-23-2077-01A-01R-0670-07 |
|
|
258 |
TCGA-23-2078-01 0 TCGA-23-2078-01 2661 0 days Squamous C9-OV OV-like c1 KIRC-like c1 NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-23-2078 NA NA days 2661 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 66 Bilateral TCGA-23-2078-F25771 TCGA-23-2078 TCGA-23-2078-01A Stage IIIC -24223 NA NA 0 2661 NA NA NA NA NA 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 0.9 NA YES G3 NA NA NA NA NA TCGA-23-2078.19ed5fbe-17e1-43f3-bfa0-32f474a00be8.pdf 2078 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 23 No Macroscopic disease Ovary YES A LIVING 2001 TCGA-23-2078-01 TCGA-23-2078-01 NA ec2fe757-24f2-4ffc-bf20-f6d6632eb775 NA TCGA-23-2078-01 NA TCGA-23-2078-01A-01D-0667-05 NA TCGA-23-2078-01A-21-1560-20 NA 9f35075d-4d81-44f2-a672-12028d6231be TCGA-23-2078-01A-01D-0663-01 TCGA-23-2078-01 5ea02416-3cd8-443c-8336-4ad367757f38 NA TCGA-23-2078-01A-01D-0663-01 9f35075d-4d81-44f2-a672-12028d6231be NA 9f35075d-4d81-44f2-a672-12028d6231be TCGA-23-2078-01A-01W-0722-08 TCGA-23-2078-01 TCGA-23-2078-01 9f35075d-4d81-44f2-a672-12028d6231be TCGA-23-2078-01A-01W-0722-08 TCGA-23-2078-01A-01R-0670-07 |
|
|
259 |
TCGA-23-2079-01 0 TCGA-23-2079-01 2788 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation c1uster 9 TCGA-23-2079 NA NA days 2788 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 46 Bilateral TCGA-23-2079-F25775 TCGA-23-2079 TCGA-23-2079-01A Stage IIIC -17122 NA NA 0 2788 NA 283 NA NA NA 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-23-2079.66ace408-fc31-463b-a218-94fdef0afaaf.pdf 2079 NA TUMOR FREE YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 23 No Macroscopic disease Ovary YES A LIVING 2001 NA TCGA-23-2079-01 NA 6bbbfad0-800f-4537-99f2-6d5f1e5bdab0 NA TCGA-23-2079-01 NA TCGA-23-2079-01A-01D-0667-05 NA TCGA-23-2079-01A-21-1560-20 NA NA TCGA-23-2079-01A-01D-0663-01 TCGA-23-2079-01 527e6a80-10fe-4b9d-9169-63ea62681e4a NA TCGA-23-2079-01A-01D-0663-01 NA NA NA TCGA-23-2079-01A-01W-0722-08 TCGA-23-2079-01 NA NA TCGA-23-2079-01A-01W-0722-08 TCGA-23-2079-01A-01R-0670-07 |
|
|
260 |
TCGA-23-2081-01 1 TCGA-23-2081-01 2342 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-23-2081 NA NA days 2342 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-23-2081-F25781 TCGA-23-2081 TCGA-23-2081-01A Stage IV -18162 NA 2342 0 NA 250 NA NA NA NA 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.8 NA YES G3 Locoregional Disease YES NA NA NA TCGA-23-2081.05dc597f-052a-461e-a67c-27dac0d10972.pdf 2081 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.5 NA NA 23 1-10 mm Ovary NA A DECEASED 2000 TCGA-23-2081-01 TCGA-23-2081-01 NA c5bdab9f-b9fc-4f96-bc7b-b5a65ec3cf68 NA TCGA-23-2081-01 NA TCGA-23-2081-01A-01D-0667-05 NA TCGA-23-2081-01A-21-1560-20 NA 4c8dd391-5a1c-490e-a7d7-fde372c3ec47 TCGA-23-2081-01A-01D-0663-01 TCGA-23-2081-01 330a8af7-1a12-46a0-8ede-ca4e244de117 NA TCGA-23-2081-01A-01D-0663-01 4c8dd391-5a1c-490e-a7d7-fde372c3ec47 NA 4c8dd391-5a1c-490e-a7d7-fde372c3ec47 TCGA-23-2081-01A-01W-0722-08 TCGA-23-2081-01 TCGA-23-2081-01 4c8dd391-5a1c-490e-a7d7-fde372c3ec47 TCGA-23-2081-01A-01W-0722-08 TCGA-23-2081-01A-01R-0670-07 |
|
|
261 |
TCGA-23-2084-01 1 TCGA-23-2084-01 1516 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 NA TCGA-23-2084 NA NA days 1516 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Right TCGA-23-2084-F25795 TCGA-23-2084 TCGA-23-2084-01A Stage IV -16493 NA 1516 0 NA NA 619 NA NA NA 2009-11-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.4 NA YES G3 Recurrence NA NA NA NA TCGA-23-2084.00fd3d04-b48e-434e-8d25-0f0949e796cc.pdf 2084 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 23 No Macroscopic disease Ovary YES A DECEASED 2000 TCGA-23-2084-01 TCGA-23-2084-01 NA 6c08e99a-bd74-4e72-8d22-4295edfe6225 NA TCGA-23-2084-01 NA TCGA-23-2084-01A-02D-0667-05 NA NA NA 858a382c-49dc-4990-8c0f-017fedd9a6db TCGA-23-2084-01A-02D-0663-01 TCGA-23-2084-01 NA NA TCGA-23-2084-01A-02D-0663-01 858a382c-49dc-4990-8c0f-017fedd9a6db NA 858a382c-49dc-4990-8c0f-017fedd9a6db NA TCGA-23-2084-01 TCGA-23-2084-01 858a382c-49dc-4990-8c0f-017fedd9a6db NA TCGA-23-2084-01A-02R-0670-07 |
|
|
262 |
TCGA-23-2641-01 0 TCGA-23-2641-01 84 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-23-2641 NA NA days 84 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 85 Left TCGA-23-2641-F25810 TCGA-23-2641 TCGA-23-2641-01A Stage IIIC -31232 NA NA 0 84 NA NA NA NA NA 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.8 NA YES G3 NA NA NA NA NA TCGA-23-2641.0b8f79ba-dbf1-4978-9661-bb0b0dcc8768.pdf 2641 NA NA YES NA NA NO NA Primary Tumor 01 0.6 NA NA 23 1-10 mm Ovary NA A LIVING 2009 NA NA NA c7559a8a-552e-44e1-97dd-d3a333a5e283 NA NA NA TCGA-23-2641-01A-01D-1047-05 NA TCGA-23-2641-01A-21-20 TCGA-23-2641-01A-01D-1526-09 NA TCGA-23-2641-01A-01D-1043-01 TCGA-23-2641-01 42dc7e58-4deb-4a79-8b08-67295835b807 NA TCGA-23-2641-01A-01D-1043-01 NA NA NA NA TCGA-23-2641-01 NA NA NA TCGA-23-2641-01A-01R-1050-07 |
|
|
263 |
TCGA-23-2643-01 0 TCGA-23-2643-01 143 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-23-2643 NA NA days 143 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 74 Right TCGA-23-2643-F25812 TCGA-23-2643 TCGA-23-2643-01A Stage IIIC -27093 NA NA 0 143 NA NA NA NA NA 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.2 NA NA G3 NA NA NA NA NA TCGA-23-2643.8481bd3e-147d-4a67-acdd-08fea5be431a.pdf 2643 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 23 1-10 mm Ovary NA A LIVING 2009 NA NA NA 02d0fc82-4de5-4543-88e1-b069652b6c4b NA NA NA TCGA-23-2643-01A-01D-1047-05 NA TCGA-23-2643-01A-21-20 TCGA-23-2643-01A-01D-1526-09 NA TCGA-23-2643-01A-01D-1043-01 TCGA-23-2643-01 061c8e23-337c-49f7-84bb-9289b1e71595 NA TCGA-23-2643-01A-01D-1043-01 NA NA NA NA TCGA-23-2643-01 NA NA NA TCGA-23-2643-01A-01R-1050-07 |
|
|
264 |
TCGA-23-2645-01 0 TCGA-23-2645-01 137 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-23-2645 NA NA days 137 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 54 Right TCGA-23-2645-F25818 TCGA-23-2645 TCGA-23-2645-01A Stage IIIC -19758 NA NA 0 137 NA NA NA NA NA 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA YES G3 NA NA NA NA NA TCGA-23-2645.e1651bbc-ed16-4e45-b6f8-283459d72568.pdf 2645 NA NA YES NA NA NO NA Primary Tumor 01 0.5 NA NA 23 No Macroscopic disease Ovary NA A LIVING 2009 NA NA NA f6880438-40e9-4c78-ac4b-fbdf71637a68 NA NA NA TCGA-23-2645-01A-01D-1047-05 NA TCGA-23-2645-01A-21-20 TCGA-23-2645-01A-01W-1091-09 NA TCGA-23-2645-01A-01D-1043-01 TCGA-23-2645-01 7326a637-b5db-47d8-a114-030db3a91417 NA TCGA-23-2645-01A-01D-1043-01 NA NA NA NA TCGA-23-2645-01 NA NA NA TCGA-23-2645-01A-01R-1050-07 |
|
|
265 |
TCGA-23-2647-01 0 TCGA-23-2647-01 135 0 days NA NA OV-like c1 OV-like c4 NA NA NA NA TCGA-23-2647 NA NA days 135 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Bilateral TCGA-23-2647-F25820 TCGA-23-2647 NA Stage IIIC -18205 NA NA 0 135 NA NA NA NA NA 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 NA NA NA NA NA NA 2647 NA NA YES NA NA NO NA Primary Tumor 01 NA NA NA 23 1-10 mm Ovary YES NA LIVING 2009 NA NA NA f50b14e1-8106-4823-9bbd-68cf5f17189b NA NA NA TCGA-23-2647-01A-01D-1047-05 NA TCGA-23-2647-01A-21-20 TCGA-23-2647-01A-01D-1526-09 NA NA TCGA-23-2647-01 eeaa45e2-a17d-475c-b9a9-fbec7fa7ecd1 NA NA NA NA NA NA NA NA NA NA TCGA-23-2647-01A-01R-1050-07 |
|
|
266 |
TCGA-23-2649-01 0 TCGA-23-2649-01 116 0 days NA NA OV-like c1 OV-like c4 NA NA NA NA TCGA-23-2649 NA NA days 116 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Left TCGA-23-2649-F25822 TCGA-23-2649 TCGA-23-2649-01A Stage IIIC -22210 NA NA 0 116 NA NA NA NA NA 2009-12-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.3 NA YES G3 NA NA NA NA NA TCGA-23-2649.7a0bd8e4-1c7b-4bbc-bddc-e06902fc4db5.pdf 2649 NA NA YES NA NA NO NA Primary Tumor 01 0.3 NA NA 23 1-10 mm Ovary YES A LIVING 2009 NA NA NA 408178f3-62ee-4c5d-a160-355deedc69c8 NA NA NA TCGA-23-2649-01A-01D-1047-05 NA TCGA-23-2649-01A-21-20 TCGA-23-2649-01A-01D-1526-09 NA NA TCGA-23-2649-01 2d3ae942-c1d4-4e80-a0e1-4b7fbc15952a NA NA NA NA NA NA NA NA NA NA TCGA-23-2649-01A-01R-1050-07 |
|
|
267 |
TCGA-24-0966-01 0 TCGA-24-0966-01 232 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 2 mutation cluster 2 TCGA-24-0966 NA NA days 232 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Bilateral TCGA-24-0966-F25875 TCGA-24-0966 TCGA-24-0966-01A Stage IIIC -28529 NA NA 0 232 NA NA NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.3 NA YES G3 NA NA NA NA NA TCGA-24-0966.99D5CA9E-3E3F-4037-96B9-9D4A34C614B3.pdf 0966 NA WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.7 NA NA 24 >20 mm Ovary NA A LIVING 2008 NA TCGA-24-0966-01 NA 5f1ed5e0-4a91-404f-a3b9-e855ff3ac303 NA TCGA-24-0966-01 NA TCGA-24-0966-01A-01D-0402-05 TCGA-24-0966-01A-01W-0977-09 TCGA-24-0966-01A-21-1562-20 TCGA-24-0966-01A-01W-0977-09 NA TCGA-24-0966-01A-01D-0399-01 TCGA-24-0966-01 02ebd198-faca-4fb3-ba5a-531389b4fffa NA TCGA-24-0966-01A-01D-0399-01 NA NA NA NA TCGA-24-0966-01 NA NA TCGA-24-0966-01A-01W-0977-09 TCGA-24-0966-01A-01R-0406-07 |
|
|
268 |
TCGA-24-0968-01 NA TCGA-24-0968-01 NA NA days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-0968 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Left TCGA-24-0968-F25880 TCGA-24-0968 NA Stage IIIC -21664 NA NA 0 598 NA NA NA NA NA 2009-3-10 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA YES G3 NA NA NA NA NA NA 0968 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 NA NA NA 24 1-10 mm Ovary NA NA DECEASED 2005 NA TCGA-24-0968-01 TCGA-24-0968-01A-01W-0484-10 e6f5bb0e-aab8-4243-b233-e07b2e5811f4 NA TCGA-24-0968-01 TCGA-24-0968-01A-01W-0484-10 TCGA-24-0968-01A-01D-0432-05 NA NA NA NA TCGA-24-0968-01A-01D-0428-01 TCGA-24-0968-01 NA NA TCGA-24-0968-01A-01D-0428-01 NA NA NA NA TCGA-24-0968-01 NA NA TCGA-24-0968-01A-01W-0484-10 TCGA-24-0968-01A-01R-0436-07 |
|
|
269 |
TCGA-24-0970-01 1 TCGA-24-0970-01 354 1 days High C9-OV Low purity c2 OV-like c4 NA miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-24-0970 NA NA days 354 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Bilateral TCGA-24-0970-F25870 TCGA-24-0970 TCGA-24-0970-01B Stage IIIC -23276 NA 354 0 354 NA 280 NA NA NA 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 0.8 NO NA 2 NA YES G3 Recurrence NA NA NA NA TCGA-24-0970.50AB91D8-AEC6-46B6-95C1-8F008EE0ED8F.pdf 0970 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.8 NA NA 24 >20 mm Ovary NA B DECEASED 2005 NA TCGA-24-0970-01 NA ec3d35b4-27f6-4dd6-a6f2-596eed1a6547 NA TCGA-24-0970-01 NA TCGA-24-0970-01B-01D-0432-05 NA TCGA-24-0970-01B-11-1562-20 NA NA TCGA-24-0970-01B-01D-0428-01 TCGA-24-0970-01 02d6074d-90c9-472f-a355-c799e2c96f4a NA TCGA-24-0970-01B-01D-0428-01 NA NA NA TCGA-24-0970-01B-01W-0486-08 TCGA-24-0970-01 NA NA TCGA-24-0970-01B-01W-0486-08 TCGA-24-0970-01B-01R-0436-07 |
|
|
270 |
TCGA-24-0975-01 1 TCGA-24-0975-01 663 1 days High C9-OV Low purity c2 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-24-0975 NA NA days 663 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-24-0975-F25861 TCGA-24-0975 TCGA-24-0975-01A Stage IIIC -21417 NA 663 0 663 NA NA NA NA NA 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-24-0975.8AA65DCA-E057-486F-AEFA-D8A3485416EC.pdf 0975 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 0.7 NA NA 24 1-10 mm Ovary NA A DECEASED 2004 TCGA-24-0975-01 TCGA-24-0975-01 NA 9f531d00-af98-4a8e-9614-74c063fa2f15 NA TCGA-24-0975-01 NA TCGA-24-0975-01B-02D-0432-05 NA NA NA a16723c4-d5b1-40a0-9890-570351738879 TCGA-24-0975-01B-02D-0428-01 TCGA-24-0975-01 NA NA TCGA-24-0975-01B-02D-0428-01 a16723c4-d5b1-40a0-9890-570351738879 NA a16723c4-d5b1-40a0-9890-570351738879 TCGA-24-0975-01B-02W-0486-08 TCGA-24-0975-01 TCGA-24-0975-01 a16723c4-d5b1-40a0-9890-570351738879 TCGA-24-0975-01B-02W-0486-08 TCGA-24-0975-01A-02R-0436-07 |
|
|
271 |
TCGA-24-0979-01 1 TCGA-24-0979-01 1264 1 days High C9-OV Low purity c2 OV-like c4 NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-24-0979 NA NA days 1264 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 53 Bilateral TCGA-24-0979-F25891 TCGA-24-0979 TCGA-24-0979-01A Stage IV -19595 NA 1264 0 1264 NA 428 NA NA NA 2009-5-11 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO NA 0.8 NA NA G3 Recurrence NA NA NA NA TCGA-24-0979.3385E5B4-EBD4-4317-8805-EE6EA47A2E4A.pdf 0979 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 >20 mm Ovary NA A DECEASED 2003 NA TCGA-24-0979-01 NA 3a1401ac-2bfc-4baa-9018-bb71de5cfb51 NA TCGA-24-0979-01 NA TCGA-24-0979-01A-01D-0432-05 NA TCGA-24-0979-01A-21-20 NA NA TCGA-24-0979-01A-01D-0428-01 TCGA-24-0979-01 1c5c8013-17c7-4be1-888c-ab0da1e3afdd NA TCGA-24-0979-01A-01D-0428-01 NA NA NA TCGA-24-0979-01A-01W-0486-08 TCGA-24-0979-01 NA NA TCGA-24-0979-01A-01W-0486-08 TCGA-24-0979-01A-01R-0436-07 |
|
|
272 |
TCGA-24-0980-01 1 TCGA-24-0980-01 233 1 days Squamous C9-OV OV-like c1 OV-like c4 NA NA NA mutation cluster 5 TCGA-24-0980 NA NA days 233 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-24-0980-F25896 TCGA-24-0980 NA Stage IIIC -19579 NA 233 0 233 NA 145 NA NA NA 2009-2-24 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA YES G3 Recurrence NA NA NA NA NA 0980 NA WITH TUMOR YES Progressive Disease Other Method NO NA Primary Tumor 01 NA NA NA 24 >20 mm Ovary NA NA DECEASED 2003 NA NA NA eed170f8-eef5-4e58-8dda-64324bf900e2 NA NA NA TCGA-24-0980-01A-01D-0402-05 TCGA-24-0980-01A-01W-0421-09 TCGA-24-0980-01A-21-20 TCGA-24-0980-01A-01W-0421-09 NA TCGA-24-0980-01A-01D-0399-01 TCGA-24-0980-01 e09cff37-f92b-48f7-a2d6-e72b68d0a8b4 NA TCGA-24-0980-01A-01D-0399-01 NA NA NA NA TCGA-24-0980-01 NA NA TCGA-24-0980-01A-01W-0421-09 TCGA-24-0980-01A-01R-0406-07 |
|
|
273 |
TCGA-24-0981-01 NA TCGA-24-0981-01 NA NA days NA NA NA NA NA NA NA NA TCGA-24-0981 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-24-0981-01A-01D-0432-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-24-0981-01A-01R-0436-07 |
|
|
274 |
TCGA-24-0982-01 1 TCGA-24-0982-01 679 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-0982 NA NA days 679 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 77 Bilateral TCGA-24-0982-F25900 TCGA-24-0982 NA Stage IIIC -28201 NA 679 0 679 NA 153 NA NA NA 2009-3-10 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 0982 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 24 1-10 mm Ovary NA NA DECEASED 2003 NA TCGA-24-0982-01 NA fc2dbc4a-dd8a-4174-a186-15ceaaaac881 NA TCGA-24-0982-01 NA TCGA-24-0982-01A-01D-0432-05 TCGA-24-0982-01A-01W-0488-09 TCGA-24-0982-01A-21-20 TCGA-24-0982-01A-01W-0488-09 NA TCGA-24-0982-01A-01D-0428-01 TCGA-24-0982-01 d712585f-3d02-4e1a-a11a-4ffac7295711 NA TCGA-24-0982-01A-01D-0428-01 NA NA NA NA TCGA-24-0982-01 NA NA TCGA-24-0982-01A-01W-0488-09 TCGA-24-0982-01A-01R-0436-07 |
|
|
275 |
TCGA-24-1103-01 1 TCGA-24-1103-01 1646 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1103 NA NA days 1646 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-24-1103-F25824 TCGA-24-1103 TCGA-24-1103-01A Stage IIIC -18583 NA 1646 0 1646 NA 678 NA NA NA 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-1103.B9628222-5530-4A82-9F13-2773173A0C95.pdf 1103 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 24 1-10 mm Ovary NA A DECEASED 2001 TCGA-24-1103-01 TCGA-24-1103-01 NA 77d9fb44-1cbe-41aa-8abe-e66fa774a33e NA TCGA-24-1103-01 NA TCGA-24-1103-01A-01D-0432-05 TCGA-24-1103-01A-01W-0488-09 TCGA-24-1103-01A-11-1562-20 TCGA-24-1103-01A-01W-0488-09 202abe19-20e0-4ea9-8653-bf5145da351c TCGA-24-1103-01A-01D-0428-01 TCGA-24-1103-01 6f0a19c3-b3d6-44da-8962-79cd723f0fab NA TCGA-24-1103-01A-01D-0428-01 202abe19-20e0-4ea9-8653-bf5145da351c NA 202abe19-20e0-4ea9-8653-bf5145da351c NA TCGA-24-1103-01 TCGA-24-1103-01 202abe19-20e0-4ea9-8653-bf5145da351c TCGA-24-1103-01A-01W-0488-09 TCGA-24-1103-01A-01R-0436-07 |
|
|
276 |
TCGA-24-1104-01 1 TCGA-24-1104-01 1933 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-24-1104 NA NA days 1933 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 56 Left TCGA-24-1104-F25834 TCGA-24-1104 TCGA-24-1104-01A Stage IV -20527 NA 1933 0 1933 NA 959 NA NA NA 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-1104.4991D5F7-0259-430F-AFF7-1307DF563E41.pdf 1104 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.7 NA NA 24 >20 mm Ovary NA A DECEASED 2001 NA TCGA-24-1104-01 NA 14fde2bb-46b6-410f-89c6-f32a6f084668 NA TCGA-24-1104-01 NA TCGA-24-1104-01A-01D-0432-05 TCGA-24-1104-01A-01W-0488-09 TCGA-24-1104-01A-21-1562-20 TCGA-24-1104-01A-01W-0488-09 NA TCGA-24-1104-01A-01D-0428-01 TCGA-24-1104-01 14177a50-0360-47ce-b24b-3468b4a2b75f NA TCGA-24-1104-01A-01D-0428-01 NA NA NA NA TCGA-24-1104-01 NA NA TCGA-24-1104-01A-01W-0488-09 TCGA-24-1104-01A-01R-0436-07 |
|
|
277 |
TCGA-24-1105-01 1 TCGA-24-1105-01 1442 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1105 NA NA days 1442 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 36 Bilateral TCGA-24-1105-F25844 TCGA-24-1105 TCGA-24-1105-01A Stage IIIC -13187 NA 1442 0 1442 NA 470 NA NA NA 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 1.4 NA NA G3 Recurrence NA NA NA NA TCGA-24-1105.DE593AFC-BC21-4183-94A6-B8BA9931B70F.pdf 1105 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.8 NA NA 24 1-10 mm Ovary NA A DECEASED 2001 NA TCGA-24-1105-01 TCGA-24-1105-01A-01W-0484-10 9840b4a9-5f2f-4263-905f-e395092e2cea NA TCGA-24-1105-01 TCGA-24-1105-01A-01W-0484-10 TCGA-24-1105-01A-01D-0432-05 NA TCGA-24-1105-01A-21-1562-20 NA NA TCGA-24-1105-01A-01D-0428-01 TCGA-24-1105-01 ea5d304a-364c-4633-860b-f2e7be2ca00e NA TCGA-24-1105-01A-01D-0428-01 NA NA NA NA TCGA-24-1105-01 NA NA TCGA-24-1105-01A-01W-0484-10 TCGA-24-1105-01A-01R-0436-07 |
|
|
278 |
TCGA-24-1413-01 0 TCGA-24-1413-01 192 0 days BRCA-LUAD+ C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1413 NA NA days 192 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-24-1413-F25910 TCGA-24-1413 TCGA-24-1413-01A Stage IIIC -18846 NA NA 0 192 NA NA NA NA NA 2009-3-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.1 NA YES G3 NA NA NA NA NA TCGA-24-1413.2ca18d08-e930-4244-a0d5-316dfbca0fb4.pdf 1413 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A LIVING 2008 TCGA-24-1413-01 TCGA-24-1413-01 NA 78f0e50d-6dc9-4c74-8674-3cb6800ea7a6 NA TCGA-24-1413-01 NA TCGA-24-1413-01A-01D-0460-05 TCGA-24-1413-01A-01W-0494-09 NA TCGA-24-1413-01A-01W-0494-09 545867ef-1299-410d-bbbf-d6c189344b0f TCGA-24-1413-01A-01D-0452-01 TCGA-24-1413-01 NA NA TCGA-24-1413-01A-01D-0452-01 545867ef-1299-410d-bbbf-d6c189344b0f NA 545867ef-1299-410d-bbbf-d6c189344b0f NA TCGA-24-1413-01 TCGA-24-1413-01 545867ef-1299-410d-bbbf-d6c189344b0f TCGA-24-1413-01A-01W-0494-09 TCGA-24-1413-01A-01R-0456-07 |
|
|
279 |
TCGA-24-1416-01 0 TCGA-24-1416-01 194 0 days High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 3 TCGA-24-1416 NA NA days 194 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 34 Bilateral TCGA-24-1416-F25914 TCGA-24-1416 TCGA-24-1416-01A Stage IV -12772 NA NA 0 194 NA NA NA NA NA 2009-4-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-24-1416.c5a7b8b5-65b5-47d0-84dc-882024042a6f.pdf 1416 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A LIVING 2008 TCGA-24-1416-01 TCGA-24-1416-01 NA f46fbaaf-21ba-40c3-9e27-db0febe3b250 NA TCGA-24-1416-01 NA TCGA-24-1416-01A-01D-0475-05 TCGA-24-1416-01A-01W-0549-09 TCGA-24-1416-01A-21-20 TCGA-24-1416-01A-01W-0549-09 67fcea16-d5bc-4edd-b66d-bfc5d56d976d TCGA-24-1416-01A-01D-0472-01 TCGA-24-1416-01 0eda7c90-97fe-4184-b8ad-73e7820c3b7e NA TCGA-24-1416-01A-01D-0472-01 67fcea16-d5bc-4edd-b66d-bfc5d56d976d NA 67fcea16-d5bc-4edd-b66d-bfc5d56d976d NA TCGA-24-1416-01 TCGA-24-1416-01 67fcea16-d5bc-4edd-b66d-bfc5d56d976d TCGA-24-1416-01A-01W-0549-09 TCGA-24-1416-01A-01R-0479-07 |
|
|
280 |
TCGA-24-1417-01 0 TCGA-24-1417-01 238 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1417 NA NA days 238 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 54 Left TCGA-24-1417-F25920 TCGA-24-1417 TCGA-24-1417-01A Stage IV -19775 NA NA 0 238 NA NA NA NA NA 2009-4-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.3 NA NA G3 NA NA NA NA NA TCGA-24-1417.4058a172-a0f6-4c91-9c79-aab63525340f.pdf 1417 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Ovary NA A LIVING 2008 TCGA-24-1417-01 TCGA-24-1417-01 NA 68f0717d-5edc-43f0-bbde-606574f02b4f NA TCGA-24-1417-01 NA TCGA-24-1417-01A-01D-0475-05 TCGA-24-1417-01A-01W-0549-09 TCGA-24-1417-01A-21-20 TCGA-24-1417-01A-01W-0549-09 e76a7745-3193-4650-9a7a-c96329690be3 TCGA-24-1417-01A-01D-0472-01 TCGA-24-1417-01 4e9ef1e1-1dd3-4027-8a72-11dcbce7e12a NA TCGA-24-1417-01A-01D-0472-01 e76a7745-3193-4650-9a7a-c96329690be3 NA e76a7745-3193-4650-9a7a-c96329690be3 NA TCGA-24-1417-01 TCGA-24-1417-01 e76a7745-3193-4650-9a7a-c96329690be3 TCGA-24-1417-01A-01W-0549-09 TCGA-24-1417-01A-01R-0479-07 |
|
|
281 |
TCGA-24-1418-01 0 TCGA-24-1418-01 243 0 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1418 NA NA days 243 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 68 Bilateral TCGA-24-1418-F25924 TCGA-24-1418 TCGA-24-1418-01A Stage IIIC -24842 NA NA 0 243 NA NA 0 NA NA 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 1.2 NO NA 1.2 NA NA G3 NA NA NA NA NA TCGA-24-1418.14fdb291-ba79-4852-9242-02dc191ca8c5.pdf 1418 Other TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 >20 mm Ovary NA A LIVING 2008 TCGA-24-1418-01 TCGA-24-1418-01 NA 8302128a-2f41-42d9-8ebc-ceedb67f2919 NA TCGA-24-1418-01 NA TCGA-24-1418-01A-01D-0475-05 TCGA-24-1418-01A-01W-0549-09 NA TCGA-24-1418-01A-01W-0549-09 4e701e9f-9127-4d61-8a72-7e440b969fbe TCGA-24-1418-01A-01D-0472-01 TCGA-24-1418-01 NA NA TCGA-24-1418-01A-01D-0472-01 4e701e9f-9127-4d61-8a72-7e440b969fbe NA 4e701e9f-9127-4d61-8a72-7e440b969fbe NA TCGA-24-1418-01 TCGA-24-1418-01 4e701e9f-9127-4d61-8a72-7e440b969fbe TCGA-24-1418-01A-01W-0549-09 TCGA-24-1418-01A-01R-0479-07 |
|
|
282 |
TCGA-24-1419-01 0 TCGA-24-1419-01 239 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1419 NA NA days 239 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Bilateral TCGA-24-1419-F25929 TCGA-24-1419 TCGA-24-1419-01A Stage IIIC -22659 NA NA 0 239 NA NA NA NA NA 2009-4-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.8 NA NA G3 NA NA NA NA NA TCGA-24-1419.0a8c75aa-8031-4f1d-9dba-9029b009d677.pdf 1419 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 11-20 mm Ovary NA A LIVING 2008 TCGA-24-1419-01 TCGA-24-1419-01 NA 8edd134e-95e4-47d2-9a2a-b68b0ca427ea NA TCGA-24-1419-01 NA TCGA-24-1419-01A-01D-0475-05 NA TCGA-24-1419-01A-21-20 NA 7bf43d51-2714-419e-a52f-863ca54c90e5 TCGA-24-1419-01A-01D-0472-01 TCGA-24-1419-01 e55a0b2e-1cba-4732-a04d-2dc2eb49cdcc NA TCGA-24-1419-01A-01D-0472-01 7bf43d51-2714-419e-a52f-863ca54c90e5 NA 7bf43d51-2714-419e-a52f-863ca54c90e5 TCGA-24-1419-01A-01W-0545-08 TCGA-24-1419-01 TCGA-24-1419-01 7bf43d51-2714-419e-a52f-863ca54c90e5 TCGA-24-1419-01A-01W-0545-08 TCGA-24-1419-01A-01R-0479-07 |
|
|
283 |
TCGA-24-1422-01 1 TCGA-24-1422-01 23 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1422 NA NA days 23 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 82 Bilateral TCGA-24-1422-F25934 TCGA-24-1422 TCGA-24-1422-01A Stage IIIC -30234 NA 23 0 23 NA NA NA NA NA 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.8 NA NA G3 NA NA NA NA NA TCGA-24-1422.8bcb6cf4-84ea-41a1-9113-061a7523c19f.pdf 1422 NA NA NO NA NA NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 2008 NA TCGA-24-1422-01 NA 48e00661-f995-42b5-9400-3391914a90d9 NA TCGA-24-1422-01 NA TCGA-24-1422-01A-01D-0475-05 NA TCGA-24-1422-01A-21-1562-20 NA NA TCGA-24-1422-01A-01D-0472-01 TCGA-24-1422-01 52fbe264-2840-4bae-86a9-17f09ebe5053 NA TCGA-24-1422-01A-01D-0472-01 NA NA NA TCGA-24-1422-01A-01W-0545-08 TCGA-24-1422-01 NA NA TCGA-24-1422-01A-01W-0545-08 TCGA-24-1422-01A-01R-0479-07 |
|
|
284 |
TCGA-24-1423-01 0 TCGA-24-1423-01 190 0 days BRCA-LUAD+ C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1423 NA NA days 190 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 61 Bilateral TCGA-24-1423-F25936 TCGA-24-1423 TCGA-24-1423-01A Stage IIIC -22281 NA NA 0 190 NA NA NA NA NA 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.8 NA YES G3 NA NA NA NA NA TCGA-24-1423.47331163-68e9-44fd-8b80-b9f70058957f.pdf 1423 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.6 NA NA 24 1-10 mm Ovary NA A LIVING 2008 TCGA-24-1423-01 TCGA-24-1423-01 NA 670fe1e4-f612-4797-a926-41cd2da84843 NA TCGA-24-1423-01 NA TCGA-24-1423-01A-01D-0475-05 NA TCGA-24-1423-01A-21-1562-20 NA b493df11-1929-4e35-ac44-49057cdbd86b TCGA-24-1423-01A-01D-0472-01 TCGA-24-1423-01 5a0afbd0-e504-46d6-b268-2b04d7f8be98 NA TCGA-24-1423-01A-01D-0472-01 b493df11-1929-4e35-ac44-49057cdbd86b NA b493df11-1929-4e35-ac44-49057cdbd86b TCGA-24-1423-01A-01W-0545-08 TCGA-24-1423-01 TCGA-24-1423-01 b493df11-1929-4e35-ac44-49057cdbd86b TCGA-24-1423-01A-01W-0545-08 TCGA-24-1423-01A-01R-0479-07 |
|
|
285 |
TCGA-24-1424-01 0 TCGA-24-1424-01 183 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-1424 NA NA days 183 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 67 Bilateral TCGA-24-1424-F25941 TCGA-24-1424 NA Stage IIIC -24545 NA NA 0 183 NA NA NA NA NA 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 1424 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 24 1-10 mm Ovary NA NA LIVING 2008 TCGA-24-1424-01 TCGA-24-1424-01 NA fdda2c0b-816d-4e49-83e8-2e40d4444f0c NA TCGA-24-1424-01 NA TCGA-24-1424-01A-01D-0475-05 TCGA-24-1424-01A-01W-0549-09 TCGA-24-1424-01A-21-1562-20 TCGA-24-1424-01A-01W-0549-09 d3fbcdaa-11af-4233-9700-57c6e1628c4b TCGA-24-1424-01A-01D-0472-01 TCGA-24-1424-01 b64c050d-b09e-4fbb-a906-b5d5e3904149 NA TCGA-24-1424-01A-01D-0472-01 d3fbcdaa-11af-4233-9700-57c6e1628c4b NA d3fbcdaa-11af-4233-9700-57c6e1628c4b NA TCGA-24-1424-01 TCGA-24-1424-01 d3fbcdaa-11af-4233-9700-57c6e1628c4b TCGA-24-1424-01A-01W-0549-09 TCGA-24-1424-01A-01R-0479-07 |
|
|
286 |
TCGA-24-1425-01 0 TCGA-24-1425-01 181 0 days Squamous NA OV-like c1 NA NA miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-24-1425 NA NA days 181 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 45 Bilateral TCGA-24-1425-F25946 TCGA-24-1425 NA Stage IIIC -16764 NA NA 0 181 NA NA 0 NA NA 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 1425 Other TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 24 1-10 mm Ovary NA NA LIVING 2008 TCGA-24-1425-01 TCGA-24-1425-01 NA f112ed71-765e-48bc-a5ab-196f42740078 NA TCGA-24-1425-01 NA TCGA-24-1425-01A-02D-0501-05 TCGA-24-1425-01A-02W-0553-09 NA TCGA-24-1425-01A-02W-0553-09 f580e84b-b405-43dc-9dae-4588cedf435f TCGA-24-1425-01A-02D-0497-01 TCGA-24-1425-01 NA NA TCGA-24-1425-01A-02D-0497-01 f580e84b-b405-43dc-9dae-4588cedf435f NA f580e84b-b405-43dc-9dae-4588cedf435f NA TCGA-24-1425-01 TCGA-24-1425-01 f580e84b-b405-43dc-9dae-4588cedf435f TCGA-24-1425-01A-02W-0553-09 TCGA-24-1425-01A-02R-0504-07 |
|
|
287 |
TCGA-24-1426-01 0 TCGA-24-1426-01 163 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-24-1426 NA NA days 163 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 43 Bilateral TCGA-24-1426-F25951 TCGA-24-1426 TCGA-24-1426-01A Stage IIIC -15949 NA NA 0 163 NA NA NA NA NA 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1.2 NA YES G3 NA NA NA NA NA TCGA-24-1426.72914511-b2f7-484f-a7ab-3f4f1868f2cb.pdf 1426 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Ovary NA A LIVING 2008 NA TCGA-24-1426-01 NA 8395c4e0-d327-472d-a7e6-3af3e2cbb0be NA TCGA-24-1426-01 NA TCGA-24-1426-01A-01D-0475-05 TCGA-24-1426-01A-01W-0549-09 NA TCGA-24-1426-01A-01W-0549-09 NA TCGA-24-1426-01A-01D-0472-01 TCGA-24-1426-01 NA NA TCGA-24-1426-01A-01D-0472-01 NA NA NA NA TCGA-24-1426-01 NA NA TCGA-24-1426-01A-01W-0549-09 TCGA-24-1426-01A-01R-0479-07 |
|
|
288 |
TCGA-24-1427-01 0 TCGA-24-1427-01 147 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-24-1427 NA NA days 147 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Bilateral TCGA-24-1427-F25956 TCGA-24-1427 TCGA-24-1427-01A Stage IIIC -21423 NA NA 0 147 NA NA NA NA NA 2009-4-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.7 NA YES G3 NA NA NA NA NA TCGA-24-1427.af63c4e2-2f77-4311-bfe2-ee45cfd200bb.pdf 1427 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 0.7 NA NA 24 >20 mm Ovary NA A LIVING 2008 TCGA-24-1427-01 TCGA-24-1427-01 NA 5beadb09-fe3f-44aa-8c20-fdf66e0a68ca NA TCGA-24-1427-01 NA TCGA-24-1427-01A-01D-0475-05 TCGA-24-1427-01A-01W-0549-09 TCGA-24-1427-01A-21-1562-20 TCGA-24-1427-01A-01W-0549-09 5a505632-422c-4083-b867-82a7a503b314 TCGA-24-1427-01A-01D-0472-01 TCGA-24-1427-01 87a8658e-3143-4074-9988-b0fed3d25f8b NA TCGA-24-1427-01A-01D-0472-01 5a505632-422c-4083-b867-82a7a503b314 NA 5a505632-422c-4083-b867-82a7a503b314 NA TCGA-24-1427-01 TCGA-24-1427-01 5a505632-422c-4083-b867-82a7a503b314 TCGA-24-1427-01A-01W-0549-09 TCGA-24-1427-01A-01R-0479-07 |
|
|
289 |
TCGA-24-1428-01 0 TCGA-24-1428-01 529 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-24-1428 NA NA days 529 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Left TCGA-24-1428-F25960 TCGA-24-1428 TCGA-24-1428-01A Stage IIIC -18306 NA NA 0 529 NA 448 NA NA NA 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-1428.9fcdd584-25e6-4a5a-ae15-f2956de32822.pdf 1428 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A LIVING 2008 TCGA-24-1428-01 TCGA-24-1428-01 NA c9eb8b63-8b8a-47eb-8fb1-11b089bf4a00 NA TCGA-24-1428-01 NA TCGA-24-1428-01A-01D-0475-05 TCGA-24-1428-01A-01W-0549-09 TCGA-24-1428-01A-21-1562-20 TCGA-24-1428-01A-01W-0549-09 30b9b778-1422-4842-ae99-658b8b1d7605 TCGA-24-1428-01A-01D-0472-01 TCGA-24-1428-01 66bafc53-dafe-493e-8ede-22866b714a76 NA TCGA-24-1428-01A-01D-0472-01 30b9b778-1422-4842-ae99-658b8b1d7605 NA 30b9b778-1422-4842-ae99-658b8b1d7605 NA TCGA-24-1428-01 TCGA-24-1428-01 30b9b778-1422-4842-ae99-658b8b1d7605 TCGA-24-1428-01A-01W-0549-09 TCGA-24-1428-01A-01R-0479-07 |
|
|
290 |
TCGA-24-1430-01 1 TCGA-24-1430-01 863 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-24-1430 NA NA days 863 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Bilateral TCGA-24-1430-F25966 TCGA-24-1430 TCGA-24-1430-01A Stage IIIC -24939 NA 863 0 863 NA 449 1 NA NA 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.7 NO NA 2 NA NA G3 Recurrence NA NA NA NA TCGA-24-1430.d0f95ced-e33f-4796-a6a4-3030f8e21761.pdf 1430 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.8 NA NA 24 >20 mm Ovary NA A DECEASED 2000 TCGA-24-1430-01 TCGA-24-1430-01 NA 0bad8ba4-8a10-49d9-a2f6-5e833fb9f2da NA TCGA-24-1430-01 NA TCGA-24-1430-01A-01D-0475-05 NA TCGA-24-1430-01A-21-1562-20 NA 4c19d12e-0160-4d01-b621-65335156488b TCGA-24-1430-01A-01D-0472-01 TCGA-24-1430-01 7dbdc93e-9d1d-48fe-92eb-9615eac2adb6 NA TCGA-24-1430-01A-01D-0472-01 4c19d12e-0160-4d01-b621-65335156488b NA 4c19d12e-0160-4d01-b621-65335156488b NA TCGA-24-1430-01 TCGA-24-1430-01 4c19d12e-0160-4d01-b621-65335156488b NA TCGA-24-1430-01A-01R-0479-07 |
|
|
291 |
TCGA-24-1431-01 1 TCGA-24-1431-01 567 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-24-1431 NA NA days 567 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Bilateral TCGA-24-1431-F25977 TCGA-24-1431 NA Stage IIIC -24758 NA 567 0 583 NA 199 NA NA NA 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 Recurrence NA NA NA NA NA 1431 NA WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 NA NA NA 24 1-10 mm Ovary NA NA DECEASED 1999 NA TCGA-24-1431-01 NA e5aed4a1-b8f1-44bd-957c-94acfca519a7 NA TCGA-24-1431-01 NA TCGA-24-1431-01A-01D-0475-05 NA TCGA-24-1431-01A-21-1562-20 NA NA TCGA-24-1431-01A-01D-0472-01 TCGA-24-1431-01 a2ff2d82-073d-4ea0-b407-5a68de79f622 NA TCGA-24-1431-01A-01D-0472-01 NA NA NA TCGA-24-1431-01A-01D-0472-08 TCGA-24-1431-01 NA NA TCGA-24-1431-01A-01D-0472-08 TCGA-24-1431-01A-01R-0479-07 |
|
|
292 |
TCGA-24-1434-01 1 TCGA-24-1434-01 568 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1434 NA NA days 568 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-24-1434-F25984 TCGA-24-1434 TCGA-24-1434-01A Stage IIIC -21810 NA 568 0 568 NA 337 NA NA NA 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 1.5 NA YES G3 Recurrence NA NA NA NA TCGA-24-1434.0a5fd2a4-560b-4769-ba4e-868854471961.pdf 1434 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 24 1-10 mm Ovary NA A DECEASED 1999 TCGA-24-1434-01 TCGA-24-1434-01 NA a6c7ca3f-b07b-46d5-a1ba-f1c88a358229 NA TCGA-24-1434-01 NA TCGA-24-1434-01A-01D-0475-05 NA TCGA-24-1434-01A-21-1562-20 NA 368f21cd-dd07-440d-89f5-5874e37fe63b TCGA-24-1434-01A-01D-0472-01 TCGA-24-1434-01 0106e887-2791-4c17-9260-07bd927e5d9b NA TCGA-24-1434-01A-01D-0472-01 368f21cd-dd07-440d-89f5-5874e37fe63b NA 368f21cd-dd07-440d-89f5-5874e37fe63b TCGA-24-1434-01A-01W-0545-08 TCGA-24-1434-01 TCGA-24-1434-01 368f21cd-dd07-440d-89f5-5874e37fe63b TCGA-24-1434-01A-01W-0545-08 TCGA-24-1434-01A-01R-0479-07 |
|
|
293 |
TCGA-24-1435-01 1 TCGA-24-1435-01 1324 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 2 TCGA-24-1435 NA NA days 1324 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-24-1435-F25993 TCGA-24-1435 TCGA-24-1435-01A Stage IIIC -21107 NA 1324 0 1324 NA 505 NA NA NA 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.5 NA NO G3 Recurrence NA NA NA NA TCGA-24-1435.d1574b6c-6cc1-45bc-86d0-97585d8a5c93.pdf 1435 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 1999 TCGA-24-1435-01 TCGA-24-1435-01 NA ac8a9858-933c-4d44-ae0c-e8b964344d0c NA TCGA-24-1435-01 NA TCGA-24-1435-01A-01D-0475-05 TCGA-24-1435-01A-01W-0549-09 TCGA-24-1435-01A-21-1562-20 TCGA-24-1435-01A-01W-0549-09 c20ba763-e310-448a-9c85-0b4f680e6196 TCGA-24-1435-01A-01D-0472-01 TCGA-24-1435-01 591cd2fa-3920-42e9-a1ed-d76898930e6f NA TCGA-24-1435-01A-01D-0472-01 c20ba763-e310-448a-9c85-0b4f680e6196 NA c20ba763-e310-448a-9c85-0b4f680e6196 NA TCGA-24-1435-01 TCGA-24-1435-01 c20ba763-e310-448a-9c85-0b4f680e6196 TCGA-24-1435-01A-01W-0549-09 TCGA-24-1435-01A-01R-0479-07 |
|
|
294 |
TCGA-24-1436-01 1 TCGA-24-1436-01 260 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1436 NA NA days 260 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Right TCGA-24-1436-F26004 TCGA-24-1436 TCGA-24-1436-01A Stage IIIC -20881 NA 260 0 260 NA NA NA NA NA 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.5 NA YES G3 NA NA NA NA NA TCGA-24-1436.621d3f29-b555-4767-83dd-a6989af0be12.pdf 1436 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Ovary NA A DECEASED 1999 TCGA-24-1436-01 TCGA-24-1436-01 NA 432c75c7-ece9-49a3-8f6e-ceb61c30ca10 NA TCGA-24-1436-01 NA TCGA-24-1436-01A-01D-0475-05 TCGA-24-1436-01A-01W-0549-09 TCGA-24-1436-01A-21-1563-20 TCGA-24-1436-01A-01W-0549-09 45ff767a-721a-4d89-b5e9-0c6e7eba476d TCGA-24-1436-01A-01D-0472-01 TCGA-24-1436-01 d6aaae43-70fd-461e-b240-8ba220221828 NA TCGA-24-1436-01A-01D-0472-01 45ff767a-721a-4d89-b5e9-0c6e7eba476d NA 45ff767a-721a-4d89-b5e9-0c6e7eba476d NA TCGA-24-1436-01 TCGA-24-1436-01 45ff767a-721a-4d89-b5e9-0c6e7eba476d TCGA-24-1436-01A-01W-0549-09 TCGA-24-1436-01A-01R-0479-07 |
|
|
295 |
TCGA-24-1463-01 1 TCGA-24-1463-01 2218 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 2 mutation cluster 2 TCGA-24-1463 NA NA days 2218 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Bilateral TCGA-24-1463-F26009 TCGA-24-1463 TCGA-24-1463-01A Stage IIIC -25734 NA 2218 0 2218 NA 971 NA NA NA 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 2 NA NA G3 Recurrence NA NA NA NA TCGA-24-1463.864CB084-569A-47F0-A83D-F3FA649A6B00.pdf 1463 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 >20 mm Ovary NA A DECEASED 2000 TCGA-24-1463-01 TCGA-24-1463-01 NA 28787351-5cbd-4d64-910c-e306e7f65d8e NA TCGA-24-1463-01 NA TCGA-24-1463-01A-01D-0475-05 TCGA-24-1463-01A-01W-0549-09 TCGA-24-1463-01A-21-1562-20 TCGA-24-1463-01A-01W-0549-09 939d41b7-9ccb-4cf6-be16-f2792aece5eb TCGA-24-1463-01A-01D-0472-01 TCGA-24-1463-01 62f0c11f-4f42-45f6-9916-f4470a096431 NA TCGA-24-1463-01A-01D-0472-01 939d41b7-9ccb-4cf6-be16-f2792aece5eb NA 939d41b7-9ccb-4cf6-be16-f2792aece5eb NA TCGA-24-1463-01 TCGA-24-1463-01 939d41b7-9ccb-4cf6-be16-f2792aece5eb TCGA-24-1463-01A-01W-0549-09 TCGA-24-1463-01A-01R-0479-07 |
|
|
296 |
TCGA-24-1464-01 1 TCGA-24-1464-01 379 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1464 NA NA days 379 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 70 Left TCGA-24-1464-F26022 TCGA-24-1464 TCGA-24-1464-01A Stage IIIC -25874 NA 379 0 379 NA 323 1 NA NA 2009-3-23 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.5 NA YES G3 Recurrence NA NA NA NA TCGA-24-1464.242047B0-E0E3-4BA3-A0DF-95887392602E.pdf 1464 Post-Adjuvant Therapy WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 0.7 NA NA 24 >20 mm Ovary NA A DECEASED 1998 NA TCGA-24-1464-01 NA 2ed4bcf3-8abb-454c-a19d-54101ccf222f NA TCGA-24-1464-01 NA TCGA-24-1464-01A-01D-0475-05 TCGA-24-1464-01A-01W-0549-09 TCGA-24-1464-01A-21-1562-20 TCGA-24-1464-01A-01W-0549-09 NA TCGA-24-1464-01A-01D-0472-01 TCGA-24-1464-01 eef306a8-dd2b-4d8e-90c2-cb05094fd5f2 NA TCGA-24-1464-01A-01D-0472-01 NA NA NA NA TCGA-24-1464-01 NA NA TCGA-24-1464-01A-01W-0549-09 TCGA-24-1464-01A-01R-0479-07 |
|
|
297 |
TCGA-24-1466-01 1 TCGA-24-1466-01 1373 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-24-1466 NA NA days 1373 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-24-1466-F26028 TCGA-24-1466 TCGA-24-1466-01A Stage IIIC -27307 NA 1373 0 1373 NA 491 NA NA NA 2009-4-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.7 NA NA G3 Recurrence NA NA NA NA TCGA-24-1466.BA86880B-184B-4CB7-8BBF-100D5CBD76C0.pdf 1466 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1998 NA TCGA-24-1466-01 NA 2f2c0eed-dd98-42f0-af6e-7c2290a12f37 NA TCGA-24-1466-01 NA TCGA-24-1466-01A-01D-0475-05 NA TCGA-24-1466-01A-21-1562-20 NA NA TCGA-24-1466-01A-01D-0472-01 TCGA-24-1466-01 b5bd0882-705b-4f50-a748-8dc096d39717 NA TCGA-24-1466-01A-01D-0472-01 NA NA NA TCGA-24-1466-01A-01W-0545-08 TCGA-24-1466-01 NA NA TCGA-24-1466-01A-01W-0545-08 TCGA-24-1466-01A-01R-0479-07 |
|
|
298 |
TCGA-24-1467-01 1 TCGA-24-1467-01 3224 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-24-1467 NA NA days 3224 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Right TCGA-24-1467-F26039 TCGA-24-1467 TCGA-24-1467-01A Stage IIIC -18652 NA 3224 0 3224 NA 1253 NA NA NA 2009-4-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.3 NA YES G3 Recurrence NA NA NA NA TCGA-24-1467.6949EFBE-C2EA-4767-B194-2343254F2752.pdf 1467 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 0.7 NA NA 24 1-10 mm Ovary NA A DECEASED 1998 TCGA-24-1467-01 TCGA-24-1467-01 NA f521b01e-14ea-4350-ad50-ce4dfa9594b6 NA TCGA-24-1467-01 NA TCGA-24-1467-01A-01D-0475-05 NA TCGA-24-1467-01A-21-1562-20 NA 22902cdb-69f7-4bfc-a5c3-a56229ee501d TCGA-24-1467-01A-01D-0472-01 TCGA-24-1467-01 efc7b16f-9e40-480e-b0ba-0a92cc54c0b9 NA TCGA-24-1467-01A-01D-0472-01 22902cdb-69f7-4bfc-a5c3-a56229ee501d NA 22902cdb-69f7-4bfc-a5c3-a56229ee501d NA TCGA-24-1467-01 TCGA-24-1467-01 22902cdb-69f7-4bfc-a5c3-a56229ee501d NA TCGA-24-1467-01A-01R-0479-07 |
|
|
299 |
TCGA-24-1469-01 0 TCGA-24-1469-01 277 0 days High C9-OV OV-like c1 BRCA basal-like c6 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-24-1469 NA NA days 277 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 71 Right TCGA-24-1469-F26060 TCGA-24-1469 TCGA-24-1469-01A Stage IIIC -25937 NA NA 0 277 NA NA NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-24-1469.8f0b80d0-cf56-477c-898b-bb92934f64d4.pdf 1469 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Ovary NA A LIVING 2008 TCGA-24-1469-01 TCGA-24-1469-01 NA 1a83a75d-e788-407c-afae-326d9a553604 NA TCGA-24-1469-01 NA TCGA-24-1469-01A-01D-0501-05 TCGA-24-1469-01A-01W-0553-09 TCGA-24-1469-01A-21-1562-20 TCGA-24-1469-01A-01W-0553-09 7b6fe6e3-145b-46e6-884e-fcec23514674 TCGA-24-1469-01A-01D-0497-01 TCGA-24-1469-01 6f95df6b-dcdc-4727-8cf5-76b30b6ae455 NA TCGA-24-1469-01A-01D-0497-01 7b6fe6e3-145b-46e6-884e-fcec23514674 NA 7b6fe6e3-145b-46e6-884e-fcec23514674 NA TCGA-24-1469-01 TCGA-24-1469-01 7b6fe6e3-145b-46e6-884e-fcec23514674 TCGA-24-1469-01A-01W-0553-09 TCGA-24-1469-01A-01R-0504-07 |
|
|
300 |
TCGA-24-1470-01 0 TCGA-24-1470-01 105 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1470 NA NA days 105 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 54 Bilateral TCGA-24-1470-F26064 TCGA-24-1470 NA Stage IIIB -20007 NA NA 0 105 NA NA 1 NA NA 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 1470 Other TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 24 1-10 mm Ovary NA NA LIVING 2009 NA TCGA-24-1470-01 NA a10cd463-df96-48b7-a4cc-21268bce6eb0 NA TCGA-24-1470-01 NA TCGA-24-1470-01A-01D-0501-05 TCGA-24-1470-01A-01W-0553-09 TCGA-24-1470-01A-21-1562-20 TCGA-24-1470-01A-01W-0553-09 NA TCGA-24-1470-01A-01D-0497-01 TCGA-24-1470-01 c9231718-6532-4ff2-b83f-4050d75b82fe NA TCGA-24-1470-01A-01D-0497-01 NA NA NA NA TCGA-24-1470-01 NA NA TCGA-24-1470-01A-01W-0553-09 TCGA-24-1470-01A-01R-0504-07 |
|
|
301 |
TCGA-24-1471-01 0 TCGA-24-1471-01 36 0 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 mutation cluster 13 TCGA-24-1471 NA NA days 36 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Left TCGA-24-1471-F26069 TCGA-24-1471 TCGA-24-1471-01A Stage IIIC -22081 NA NA 0 36 NA NA NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA YES G3 NA NA NA NA NA TCGA-24-1471.d20b8ed1-c74e-4ee8-9ae2-5512429810bc.pdf 1471 NA NA YES NA NA NO NA Primary Tumor 01 0.5 NA NA 24 >20 mm Ovary NA A LIVING 2009 NA TCGA-24-1471-01 NA 2434de17-87b9-44f4-85b9-e07932d062ae NA TCGA-24-1471-01 NA TCGA-24-1471-01A-01D-0501-05 NA TCGA-24-1471-01A-21-1562-20 NA NA TCGA-24-1471-01A-01D-0497-01 TCGA-24-1471-01 f9ddc125-66a3-4277-ac22-1b3b2acced36 NA TCGA-24-1471-01A-01D-0497-01 NA NA NA TCGA-24-1471-01A-01W-0551-08 TCGA-24-1471-01 NA NA TCGA-24-1471-01A-01W-0551-08 TCGA-24-1471-01A-01R-0504-07 |
|
|
302 |
TCGA-24-1474-01 1 TCGA-24-1474-01 676 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1474 NA NA days 676 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Left TCGA-24-1474-F26073 TCGA-24-1474 TCGA-24-1474-01A Stage IIIC -20902 NA 676 0 676 NA 332 NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-24-1474.c4d49a95-0478-4399-a5eb-224ca6d16cd7.pdf 1474 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.7 NA NA 24 1-10 mm Ovary NA A DECEASED 2000 TCGA-24-1474-01 TCGA-24-1474-01 NA c6e04760-3285-42ad-b307-cb00ffbe2e9e NA TCGA-24-1474-01 NA TCGA-24-1474-01A-01D-0501-05 NA TCGA-24-1474-01A-21-1562-20 NA 4da3ccd5-53e1-46f5-874d-e5d131dbfc52 TCGA-24-1474-01A-01D-0497-01 TCGA-24-1474-01 e5f26e9b-2fc8-4514-a028-cd97c5390b0a NA TCGA-24-1474-01A-01D-0497-01 4da3ccd5-53e1-46f5-874d-e5d131dbfc52 NA 4da3ccd5-53e1-46f5-874d-e5d131dbfc52 TCGA-24-1474-01A-01W-0551-08 TCGA-24-1474-01 TCGA-24-1474-01 4da3ccd5-53e1-46f5-874d-e5d131dbfc52 TCGA-24-1474-01A-01W-0551-08 TCGA-24-1474-01A-01R-0504-07 |
|
|
303 |
TCGA-24-1544-01 1 TCGA-24-1544-01 820 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation c1uster 9 TCGA-24-1544 NA NA days 820 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-24-1544-F26080 TCGA-24-1544 TCGA-24-1544-01A Stage IIIC -26141 NA 820 0 820 NA 643 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.4 NA NA G3 Progression of Disease NA NA NA NA TCGA-24-1544.2fd78a14-cc3f-4920-9c50-6051579b6ad4.pdf 1544 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 2000 TCGA-24-1544-01 TCGA-24-1544-01 TCGA-24-1544-01A-01W-0615-10 d403d7b8-d8d8-47ba-9821-a314704866bb NA TCGA-24-1544-01 TCGA-24-1544-01A-01W-0615-10 TCGA-24-1544-01A-01D-0536-05 NA TCGA-24-1544-01A-21-1558-20 NA 83333a5a-de0b-4d72-b886-e5488c619827 TCGA-24-1544-01A-01D-0533-01 TCGA-24-1544-01 9653a9c6-37fa-4e38-9c7e-c48ae95933ec NA TCGA-24-1544-01A-01D-0533-01 83333a5a-de0b-4d72-b886-e5488c619827 NA 83333a5a-de0b-4d72-b886-e5488c619827 NA TCGA-24-1544-01 TCGA-24-1544-01 83333a5a-de0b-4d72-b886-e5488c619827 TCGA-24-1544-01A-01W-0615-10 TCGA-24-1544-01A-01R-0540-07 |
|
|
304 |
TCGA-24-1545-01 1 TCGA-24-1545-01 1746 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1545 NA NA days 1746 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 69 Bilateral TCGA-24-1545-F26088 TCGA-24-1545 TCGA-24-1545-01A Stage IIIC -25460 NA 1746 0 1746 NA 861 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.8 NA NA G3 Recurrence NA NA NA NA TCGA-24-1545.0D1CB67F-57E1-4234-AA1A-5EF0E6EC3975.pdf 1545 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 >20 mm Ovary NA A DECEASED 1997 TCGA-24-1545-01 TCGA-24-1545-01 TCGA-24-1545-01A-01W-0615-10 3ed80032-69ae-4f21-8e60-8f177787e9f0 NA TCGA-24-1545-01 TCGA-24-1545-01A-01W-0615-10 TCGA-24-1545-01A-01D-0536-05 NA TCGA-24-1545-01A-21-1558-20 NA e2fcba09-755d-425d-ab4d-cede8ef86e48 TCGA-24-1545-01A-01D-0533-01 TCGA-24-1545-01 f3a3c3dc-4069-4c53-9017-c6dc610240e4 NA TCGA-24-1545-01A-01D-0533-01 e2fcba09-755d-425d-ab4d-cede8ef86e48 NA e2fcba09-755d-425d-ab4d-cede8ef86e48 NA TCGA-24-1545-01 TCGA-24-1545-01 e2fcba09-755d-425d-ab4d-cede8ef86e48 TCGA-24-1545-01A-01W-0615-10 TCGA-24-1545-01A-01R-0540-07 |
|
|
305 |
TCGA-24-1546-01 1 TCGA-24-1546-01 1955 1 days High NA Low purity c2 OV-like c4 NA miRNA cluster 3 cluster 6 NA TCGA-24-1546 NA NA days 1955 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 46 Bilateral TCGA-24-1546-F26097 TCGA-24-1546 TCGA-24-1546-01A Stage IIIC -17130 NA 1955 0 1955 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-24-1546.d6eec9a6-7bfd-40e2-891e-0a3cd7759ace.pdf 1546 NA NA YES NA NA NA NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 TCGA-24-1546-01 TCGA-24-1546-01 TCGA-24-1546-01A-01W-0615-10 67d70140-fcb4-4b5b-9821-498cbd5d53c2 NA TCGA-24-1546-01 TCGA-24-1546-01A-01W-0615-10 TCGA-24-1546-01A-01D-0536-05 NA TCGA-24-1546-01A-21-1563-20 NA 9984be2d-c37f-44cd-9eb8-61b65efcf8cb TCGA-24-1546-01A-01D-0533-01 TCGA-24-1546-01 9cdbc7ad-cffd-4f34-b805-47e7c57d9978 NA TCGA-24-1546-01A-01D-0533-01 9984be2d-c37f-44cd-9eb8-61b65efcf8cb NA 9984be2d-c37f-44cd-9eb8-61b65efcf8cb NA TCGA-24-1546-01 TCGA-24-1546-01 9984be2d-c37f-44cd-9eb8-61b65efcf8cb NA TCGA-24-1546-01A-01R-0540-07 |
|
|
306 |
TCGA-24-1548-01 1 TCGA-24-1548-01 493 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-1548 NA NA days 493 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-24-1548-F26101 TCGA-24-1548 TCGA-24-1548-01A Stage IIIC -20945 NA 493 0 493 NA 207 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-24-1548.d7b9bc71-e243-478f-a116-7e9371b87327.pdf 1548 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 TCGA-24-1548-01 TCGA-24-1548-01 TCGA-24-1548-01A-01W-0615-10 45cc6ed6-17ea-4291-8654-2b5b30c5a5e1 NA TCGA-24-1548-01 TCGA-24-1548-01A-01W-0615-10 TCGA-24-1548-01A-01D-0536-05 NA TCGA-24-1548-01A-21-1558-20 NA 77b1c06b-46ef-4c8c-8a82-37f83e3c48cf TCGA-24-1548-01A-01D-0533-01 TCGA-24-1548-01 adc1690a-194c-44ea-8344-7bac461ab669 NA TCGA-24-1548-01A-01D-0533-01 77b1c06b-46ef-4c8c-8a82-37f83e3c48cf NA 77b1c06b-46ef-4c8c-8a82-37f83e3c48cf NA TCGA-24-1548-01 TCGA-24-1548-01 77b1c06b-46ef-4c8c-8a82-37f83e3c48cf TCGA-24-1548-01A-01W-0615-10 TCGA-24-1548-01A-01R-0540-07 |
|
|
307 |
TCGA-24-1549-01 1 TCGA-24-1549-01 1721 1 days Squamous C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1549 NA NA days 1721 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-24-1549-F26113 TCGA-24-1549 NA Stage IIIB -21432 NA 1721 0 1721 NA 1042 NA NA NA 2009-5-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1549 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 24 NA Ovary NA NA DECEASED 1997 TCGA-24-1549-01 TCGA-24-1549-01 NA f0c19024-16a9-4bc1-af8a-5f55326a22d4 NA TCGA-24-1549-01 NA TCGA-24-1549-01A-01D-0501-05 TCGA-24-1549-01A-01W-0553-09 TCGA-24-1549-01A-21-1558-20 TCGA-24-1549-01A-01W-0553-09 f8ead0c8-9072-4a1d-9e07-f724a0d74a0f TCGA-24-1549-01A-01D-0497-01 TCGA-24-1549-01 b18db100-89ea-409a-841a-e90e9e9b65b2 NA TCGA-24-1549-01A-01D-0497-01 f8ead0c8-9072-4a1d-9e07-f724a0d74a0f NA f8ead0c8-9072-4a1d-9e07-f724a0d74a0f NA TCGA-24-1549-01 TCGA-24-1549-01 f8ead0c8-9072-4a1d-9e07-f724a0d74a0f TCGA-24-1549-01A-01W-0553-09 TCGA-24-1549-01A-01R-0504-07 |
|
|
308 |
TCGA-24-1550-01 1 TCGA-24-1550-01 1249 1 days High C9-OV OV-like c1 BRCA basal-like c6 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-24-1550 NA NA days 1249 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Left TCGA-24-1550-F26130 TCGA-24-1550 TCGA-24-1550-01A Stage IIIC -18049 NA 1249 0 1249 NA 892 1 NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-1550.7ebd8d19-0a81-4623-8127-f225ad650d46.pdf 1550 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.7 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 TCGA-24-1550-01 TCGA-24-1550-01 NA d5e13008-a81c-4dc5-b621-6d11b492883b NA TCGA-24-1550-01 NA TCGA-24-1550-01A-01D-0501-05 NA TCGA-24-1550-01A-21-1558-20 NA 648cb96f-df1c-48c1-bb15-c37a2784a9db TCGA-24-1550-01A-01D-0497-01 TCGA-24-1550-01 907ac822-b65b-45f3-87ea-fc78f06bab60 NA TCGA-24-1550-01A-01D-0497-01 648cb96f-df1c-48c1-bb15-c37a2784a9db NA 648cb96f-df1c-48c1-bb15-c37a2784a9db NA TCGA-24-1550-01 TCGA-24-1550-01 648cb96f-df1c-48c1-bb15-c37a2784a9db NA TCGA-24-1550-01A-01R-0504-07 |
|
|
309 |
TCGA-24-1551-01 1 TCGA-24-1551-01 1579 1 days Squamous C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1551 NA NA days 1579 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-24-1551-F26139 TCGA-24-1551 TCGA-24-1551-01A Stage IIIC -19661 NA 1579 0 1579 NA 764 1 NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-24-1551.474ac527-45a2-4258-bec4-0a48a3b80742.pdf 1551 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 TCGA-24-1551-01 TCGA-24-1551-01 NA 6e9136b5-6f84-4b3d-9586-257b42d3d8e2 NA TCGA-24-1551-01 NA TCGA-24-1551-01A-01D-0501-05 NA TCGA-24-1551-01A-21-1558-20 NA 0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8 TCGA-24-1551-01A-01D-0497-01 TCGA-24-1551-01 48b26794-efa4-4e9a-b3c0-5a5391b17b03 NA TCGA-24-1551-01A-01D-0497-01 0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8 NA 0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8 TCGA-24-1551-01A-01W-0551-08 TCGA-24-1551-01 TCGA-24-1551-01 0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8 TCGA-24-1551-01A-01W-0551-08 TCGA-24-1551-01A-01R-0504-07 |
|
|
310 |
TCGA-24-1552-01 1 TCGA-24-1552-01 1259 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1552 NA NA days 1259 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 77 Left TCGA-24-1552-F26148 TCGA-24-1552 TCGA-24-1552-01A Stage IIIC -28129 NA 1259 0 1259 NA 403 0 NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 0.9 NA YES G3 Recurrence NA NA NA NA TCGA-24-1552.FF7B6D0B-D13B-473E-A924-C63CB0B46511.pdf 1552 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.8 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 TCGA-24-1552-01 TCGA-24-1552-01 NA 62b27771-c8c0-41f8-852f-07b188f7b8e3 NA TCGA-24-1552-01 NA TCGA-24-1552-01A-01D-0501-05 NA TCGA-24-1552-01A-21-1558-20 NA 990bcb1f-7269-4020-8ea5-8ba338b390b8 TCGA-24-1552-01A-01D-0497-01 TCGA-24-1552-01 ce833a2e-7c81-4720-baa7-49cf52f4f0bd NA TCGA-24-1552-01A-01D-0497-01 990bcb1f-7269-4020-8ea5-8ba338b390b8 NA 990bcb1f-7269-4020-8ea5-8ba338b390b8 TCGA-24-1552-01A-01W-0551-08 TCGA-24-1552-01 TCGA-24-1552-01 990bcb1f-7269-4020-8ea5-8ba338b390b8 TCGA-24-1552-01A-01W-0551-08 TCGA-24-1552-01A-01R-0504-07 |
|
|
311 |
TCGA-24-1553-01 1 TCGA-24-1553-01 1767 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1553 NA NA days 1767 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-24-1553-F26157 TCGA-24-1553 TCGA-24-1553-01A Stage IIIB -19393 NA 1767 0 1767 NA 553 NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.3 NA NA G3 Recurrence NA NA NA NA TCGA-24-1553.5abe7782-ca53-4add-9a9a-01955859420b.pdf 1553 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 TCGA-24-1553-01 TCGA-24-1553-01 TCGA-24-1553-01A-01W-0552-10 6007eb37-11b8-4127-b498-f3ada326b0e1 NA TCGA-24-1553-01 TCGA-24-1553-01A-01W-0552-10 TCGA-24-1553-01A-01D-0501-05 NA TCGA-24-1553-01A-21-1558-20 NA 7c607e77-a353-4995-855b-36ccaaf3bde6 TCGA-24-1553-01A-01D-0497-01 TCGA-24-1553-01 64c63ba8-750c-4ac7-a0e9-57044507a0a4 NA TCGA-24-1553-01A-01D-0497-01 7c607e77-a353-4995-855b-36ccaaf3bde6 NA 7c607e77-a353-4995-855b-36ccaaf3bde6 NA TCGA-24-1553-01 TCGA-24-1553-01 7c607e77-a353-4995-855b-36ccaaf3bde6 TCGA-24-1553-01A-01W-0552-10 TCGA-24-1553-01A-01R-0504-07 |
|
|
312 |
TCGA-24-1555-01 1 TCGA-24-1555-01 2692 1 days Squamous C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-24-1555 NA NA days 2692 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-24-1555-F26171 TCGA-24-1555 TCGA-24-1555-01A Stage IIIC -18404 NA 2692 0 2692 NA 1577 0 NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-24-1555.b7b2f370-207a-4849-b7a0-528789363a02.pdf 1555 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 NA Ovary NA A DECEASED 1997 TCGA-24-1555-01 TCGA-24-1555-01 TCGA-24-1555-01A-01W-0552-10 b3e00fd1-65a1-4254-ac59-1d56b879c253 NA TCGA-24-1555-01 TCGA-24-1555-01A-01W-0552-10 TCGA-24-1555-01A-01D-0501-05 NA TCGA-24-1555-01A-21-1558-20 NA 0ec7ea28-7bd4-45c3-b03c-d855014fa4f4 TCGA-24-1555-01A-01D-0497-01 TCGA-24-1555-01 10cb1259-03bf-4d9e-946e-bea05e4f23bd NA TCGA-24-1555-01A-01D-0497-01 0ec7ea28-7bd4-45c3-b03c-d855014fa4f4 NA 0ec7ea28-7bd4-45c3-b03c-d855014fa4f4 NA TCGA-24-1555-01 TCGA-24-1555-01 0ec7ea28-7bd4-45c3-b03c-d855014fa4f4 TCGA-24-1555-01A-01W-0552-10 TCGA-24-1555-01A-01R-0504-07 |
|
|
313 |
TCGA-24-1556-01 1 TCGA-24-1556-01 2148 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1556 NA NA days 2148 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 50 Left TCGA-24-1556-F26184 TCGA-24-1556 TCGA-24-1556-01A Stage IIB -18517 NA 2148 0 2148 NA 539 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.9 NA NA G3 Recurrence NA NA NA NA TCGA-24-1556.75c91323-45a7-4629-b014-f7eda2f1075e.pdf 1556 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 24 1-10 mm Ovary NA A DECEASED 2000 TCGA-24-1556-01 TCGA-24-1556-01 TCGA-24-1556-01A-01W-0615-10 3602ad67-bdfb-48a8-8a58-8019bee04630 NA TCGA-24-1556-01 TCGA-24-1556-01A-01W-0615-10 TCGA-24-1556-01A-01D-0536-05 NA TCGA-24-1556-01A-21-1558-20 NA 31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd TCGA-24-1556-01A-01D-0533-01 TCGA-24-1556-01 7c4dcb9c-346b-4b52-9b64-f835ebc85dba NA TCGA-24-1556-01A-01D-0533-01 31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd NA 31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd NA TCGA-24-1556-01 TCGA-24-1556-01 31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd TCGA-24-1556-01A-01W-0615-10 TCGA-24-1556-01A-01R-0540-07 |
|
|
314 |
TCGA-24-1557-01 1 TCGA-24-1557-01 1213 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 mutation cluster 5 TCGA-24-1557 NA NA days 1213 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-24-1557-F26194 TCGA-24-1557 NA Stage IIIC -17943 NA 1213 0 1213 NA 447 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Progression of Disease NA NA NA NA NA 1557 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 24 >20 mm Ovary NA NA DECEASED 2000 TCGA-24-1557-01 TCGA-24-1557-01 TCGA-24-1557-01A-01W-0615-10 e9f05aba-2e25-44c7-b49f-9300cb5c61e1 NA TCGA-24-1557-01 TCGA-24-1557-01A-01W-0615-10 TCGA-24-1557-01A-01D-0536-05 NA TCGA-24-1557-01A-21-1558-20 NA bca48aa6-25bc-49e4-8bb5-edf38362b4a8 TCGA-24-1557-01A-01D-0533-01 TCGA-24-1557-01 d534bbdd-5827-426e-ad74-9346b06716f5 NA TCGA-24-1557-01A-01D-0533-01 bca48aa6-25bc-49e4-8bb5-edf38362b4a8 NA bca48aa6-25bc-49e4-8bb5-edf38362b4a8 NA TCGA-24-1557-01 TCGA-24-1557-01 bca48aa6-25bc-49e4-8bb5-edf38362b4a8 TCGA-24-1557-01A-01W-0615-10 TCGA-24-1557-01A-01R-0540-07 |
|
|
315 |
TCGA-24-1558-01 1 TCGA-24-1558-01 594 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 2 TCGA-24-1558 NA NA days 594 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 73 Bilateral TCGA-24-1558-F26212 TCGA-24-1558 TCGA-24-1558-01A Stage IIIC -27004 NA 594 0 594 NA 273 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.9 NA NA G3 Recurrence NA NA NA NA TCGA-24-1558.62143e5f-4452-47ca-a67c-cd87036424b1.pdf 1558 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.9 NA NA 24 1-10 mm Ovary NA A DECEASED 2000 TCGA-24-1558-01 TCGA-24-1558-01 TCGA-24-1558-01A-01W-0615-10 beca71a6-9c32-4f27-9419-32d96cafed27 NA TCGA-24-1558-01 TCGA-24-1558-01A-01W-0615-10 TCGA-24-1558-01A-01D-0536-05 NA TCGA-24-1558-01A-21-1558-20 NA 1b8d5b5e-f671-419a-844a-6640fe5a896d TCGA-24-1558-01A-01D-0533-01 TCGA-24-1558-01 b37713e8-e63a-4dba-b7fb-aebc5914676d NA TCGA-24-1558-01A-01D-0533-01 1b8d5b5e-f671-419a-844a-6640fe5a896d NA 1b8d5b5e-f671-419a-844a-6640fe5a896d NA TCGA-24-1558-01 TCGA-24-1558-01 1b8d5b5e-f671-419a-844a-6640fe5a896d TCGA-24-1558-01A-01W-0615-10 TCGA-24-1558-01A-01R-0540-07 |
|
|
316 |
TCGA-24-1560-01 1 TCGA-24-1560-01 1341 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1560 NA NA days 1341 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Left TCGA-24-1560-F26221 TCGA-24-1560 TCGA-24-1560-01A Stage IIIC -18671 NA 1341 0 1341 NA 143 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA NA G4 Recurrence NA NA NA NA TCGA-24-1560.464e1a20-b2d1-49c4-8da5-11b8c0f96b4e.pdf 1560 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 1999 TCGA-24-1560-01 TCGA-24-1560-01 TCGA-24-1560-01A-01W-0615-10 5b6e5bbe-fe20-4613-b55c-2e544ea51a2b NA TCGA-24-1560-01 TCGA-24-1560-01A-01W-0615-10 TCGA-24-1560-01A-01D-0536-05 NA TCGA-24-1560-01A-21-1558-20 NA a7ea40ed-6cfb-42b7-92b7-64d6ba988414 TCGA-24-1560-01A-01D-0533-01 TCGA-24-1560-01 15295f32-7794-43cb-a943-03a38d4b6016 NA TCGA-24-1560-01A-01D-0533-01 a7ea40ed-6cfb-42b7-92b7-64d6ba988414 NA a7ea40ed-6cfb-42b7-92b7-64d6ba988414 NA TCGA-24-1560-01 TCGA-24-1560-01 a7ea40ed-6cfb-42b7-92b7-64d6ba988414 TCGA-24-1560-01A-01W-0615-10 TCGA-24-1560-01A-01R-0540-07 |
|
|
317 |
TCGA-24-1562-01 1 TCGA-24-1562-01 1384 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-1562 NA NA days 1384 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Bilateral TCGA-24-1562-F26237 TCGA-24-1562 TCGA-24-1562-01A Stage IIIC -24747 NA 1384 0 1384 NA 229 0 NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-24-1562.0ce36daf-9512-4860-a5a3-b2ff7f487c5a.pdf 1562 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 1999 TCGA-24-1562-01 TCGA-24-1562-01 NA f36d78a7-5e27-4a7a-8055-a7ca51b8c371 NA TCGA-24-1562-01 NA TCGA-24-1562-01A-01D-0501-05 TCGA-24-1562-01A-01W-0553-09 TCGA-24-1562-01A-21-1558-20 TCGA-24-1562-01A-01W-0553-09 eb8cb3b3-d1b1-4d2d-b048-7394931040bd TCGA-24-1562-01A-01D-0497-01 TCGA-24-1562-01 9082bc34-1aa2-4e77-bb64-22778ee28635 NA TCGA-24-1562-01A-01D-0497-01 eb8cb3b3-d1b1-4d2d-b048-7394931040bd NA eb8cb3b3-d1b1-4d2d-b048-7394931040bd NA TCGA-24-1562-01 TCGA-24-1562-01 eb8cb3b3-d1b1-4d2d-b048-7394931040bd TCGA-24-1562-01A-01W-0553-09 TCGA-24-1562-01A-01R-0504-07 |
|
|
318 |
TCGA-24-1563-01 1 TCGA-24-1563-01 1451 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1563 NA NA days 1451 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 Left TCGA-24-1563-F26248 TCGA-24-1563 TCGA-24-1563-01A Stage IIIC -24274 NA 1451 0 1451 NA 396 NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.1 NA NA G3 Recurrence NA NA NA NA TCGA-24-1563.6fdeb714-439d-49d7-aae0-99166a3e8eba.pdf 1563 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1999 TCGA-24-1563-01 TCGA-24-1563-01 NA 70951f22-8982-42be-bf1e-15f24b415708 NA TCGA-24-1563-01 NA TCGA-24-1563-01A-01D-0501-05 TCGA-24-1563-01A-01W-0553-09 TCGA-24-1563-01A-21-1558-20 TCGA-24-1563-01A-01W-0553-09 a9c4a08c-1db7-49eb-8685-b5ca442c3e7a TCGA-24-1563-01A-01D-0497-01 TCGA-24-1563-01 e52eaae7-ae99-43fe-a752-89045be81447 NA TCGA-24-1563-01A-01D-0497-01 a9c4a08c-1db7-49eb-8685-b5ca442c3e7a NA a9c4a08c-1db7-49eb-8685-b5ca442c3e7a NA TCGA-24-1563-01 TCGA-24-1563-01 a9c4a08c-1db7-49eb-8685-b5ca442c3e7a TCGA-24-1563-01A-01W-0553-09 TCGA-24-1563-01A-01R-0504-07 |
|
|
319 |
TCGA-24-1564-01 1 TCGA-24-1564-01 787 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1564 NA NA days 787 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 67 Bilateral TCGA-24-1564-F26260 TCGA-24-1564 TCGA-24-1564-01A Stage IIIC -24668 NA 787 0 787 NA 221 NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.4 NA NA G3 Recurrence NA NA NA NA TCGA-24-1564.fa1c8286-2e55-4137-93ae-c19d470ce2e4.pdf 1564 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 TCGA-24-1564-01 TCGA-24-1564-01 NA 3b4f61f1-616b-4995-bcb6-6eb2e11be681 NA TCGA-24-1564-01 NA TCGA-24-1564-01A-01D-0501-05 NA TCGA-24-1564-01A-21-1558-20 NA 03b8480f-d19e-43e4-8a09-f9230c525c1e TCGA-24-1564-01A-01D-0497-01 TCGA-24-1564-01 b6e7fde5-418d-4848-a99e-6fc8c943bd7b NA TCGA-24-1564-01A-01D-0497-01 03b8480f-d19e-43e4-8a09-f9230c525c1e NA 03b8480f-d19e-43e4-8a09-f9230c525c1e TCGA-24-1564-01A-01W-0551-08 TCGA-24-1564-01 TCGA-24-1564-01 03b8480f-d19e-43e4-8a09-f9230c525c1e TCGA-24-1564-01A-01W-0551-08 TCGA-24-1564-01A-01R-0504-07 |
|
|
320 |
TCGA-24-1565-01 1 TCGA-24-1565-01 312 1 days Iq C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 mutation c1uster 9 TCGA-24-1565 NA NA days 312 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-24-1565-F26274 TCGA-24-1565 TCGA-24-1565-01A Stage IIIC -27048 NA 312 0 312 NA 145 NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.8 NA YES G3 Recurrence NA NA NA NA TCGA-24-1565.f424905e-3dc2-4e37-b6c4-8a77c7ce817b.pdf 1565 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 NA TCGA-24-1565-01 NA 8c0e5f5a-fd1e-40de-9746-1b22572df7b8 NA TCGA-24-1565-01 NA TCGA-24-1565-01A-01D-0501-05 NA TCGA-24-1565-01A-21-1558-20 NA NA TCGA-24-1565-01A-01D-0497-01 TCGA-24-1565-01 bd856415-5235-4086-a72f-9d0a65b8867b NA TCGA-24-1565-01A-01D-0497-01 NA NA NA TCGA-24-1565-01A-01W-0551-08 TCGA-24-1565-01 NA NA TCGA-24-1565-01A-01W-0551-08 TCGA-24-1565-01A-01R-0504-07 |
|
|
321 |
TCGA-24-1567-01 1 TCGA-24-1567-01 524 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1567 NA NA days 524 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-24-1567-F26279 TCGA-24-1567 TCGA-24-1567-01A Stage IIIB -19843 NA 524 0 524 NA 319 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.3 NO NA 1.1 NA NA G3 Recurrence NA NA NA NA TCGA-24-1567.90910bbc-49e1-495b-9b06-11056ff401df.pdf 1567 NA WITH TUMOR YES NA Molecular Markers NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Ovary NA A DECEASED 1999 TCGA-24-1567-01 TCGA-24-1567-01 TCGA-24-1567-01A-01W-0615-10 b39f67ca-abb2-4f96-a0c4-79ea6cbe523e NA TCGA-24-1567-01 TCGA-24-1567-01A-01W-0615-10 TCGA-24-1567-01A-01D-0536-05 NA TCGA-24-1567-01A-21-1558-20 NA 97c0b20f-ee65-42b2-af2d-92dcf48b2cd5 TCGA-24-1567-01A-01D-0533-01 TCGA-24-1567-01 e4b66de6-faab-41b2-af46-ad0f9f81bed7 NA TCGA-24-1567-01A-01D-0533-01 97c0b20f-ee65-42b2-af2d-92dcf48b2cd5 NA 97c0b20f-ee65-42b2-af2d-92dcf48b2cd5 NA TCGA-24-1567-01 TCGA-24-1567-01 97c0b20f-ee65-42b2-af2d-92dcf48b2cd5 TCGA-24-1567-01A-01W-0615-10 TCGA-24-1567-01A-01R-0540-07 |
|
|
322 |
TCGA-24-1603-01 1 TCGA-24-1603-01 2742 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1603 NA NA days 2742 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-24-1603-F26284 TCGA-24-1603 TCGA-24-1603-01A Stage IIIB -19681 NA 2742 0 2742 NA 992 NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-24-1603.b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9.pdf 1603 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.7 NA NA 24 NA Ovary NA A DECEASED 1996 TCGA-24-1603-01 TCGA-24-1603-01 NA 74a46153-942a-42e8-b6a0-ac066c006e5d NA TCGA-24-1603-01 NA TCGA-24-1603-01A-01D-0501-05 NA TCGA-24-1603-01A-21-1558-20 NA f4187f4f-9c52-4065-818b-c884183a5a70 TCGA-24-1603-01A-01D-0497-01 TCGA-24-1603-01 eecacbb1-98ef-4194-957d-5a49f9548657 NA TCGA-24-1603-01A-01D-0497-01 f4187f4f-9c52-4065-818b-c884183a5a70 NA f4187f4f-9c52-4065-818b-c884183a5a70 TCGA-24-1603-01A-01W-0551-08 TCGA-24-1603-01 TCGA-24-1603-01 f4187f4f-9c52-4065-818b-c884183a5a70 TCGA-24-1603-01A-01W-0551-08 TCGA-24-1603-01A-01R-0504-07 |
|
|
323 |
TCGA-24-1604-01 1 TCGA-24-1604-01 2688 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-1604 NA NA days 2688 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 66 Bilateral TCGA-24-1604-F26299 TCGA-24-1604 TCGA-24-1604-01A Stage IIIC -24471 NA 2688 0 2688 NA NA NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 1.4 NA NA G3 NA NA NA NA NA TCGA-24-1604.de978a3d-92f9-4bd8-98f4-f8a3ec09b362.pdf 1604 NA WITH TUMOR YES Complete Remission/Response NA NO NA Primary Tumor 01 0.6 NA NA 24 NA Ovary NA A DECEASED 1996 TCGA-24-1604-01 TCGA-24-1604-01 TCGA-24-1604-01A-01W-0552-10 08109bba-5c11-4400-a968-c858329cbedf NA TCGA-24-1604-01 TCGA-24-1604-01A-01W-0552-10 TCGA-24-1604-01A-01D-0501-05 NA TCGA-24-1604-01A-21-1558-20 NA a658045c-93a6-4aac-abbb-1cd6093b7735 TCGA-24-1604-01A-01D-0497-01 TCGA-24-1604-01 2350016d-f638-4c02-a24b-76f1df75cb69 NA TCGA-24-1604-01A-01D-0497-01 a658045c-93a6-4aac-abbb-1cd6093b7735 NA a658045c-93a6-4aac-abbb-1cd6093b7735 NA TCGA-24-1604-01 TCGA-24-1604-01 a658045c-93a6-4aac-abbb-1cd6093b7735 TCGA-24-1604-01A-01W-0552-10 TCGA-24-1604-01A-01R-0504-07 |
|
|
324 |
TCGA-24-1614-01 1 TCGA-24-1614-01 1470 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-24-1614 NA NA days 1470 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Right TCGA-24-1614-F26306 TCGA-24-1614 TCGA-24-1614-01A Stage IIIC -20993 NA 1470 0 1470 NA 644 NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO 100 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-24-1614.4e371c15-c0d1-454a-997d-dfbe98b02f7e.pdf 1614 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Ovary NA A DECEASED 2001 NA TCGA-24-1614-01 TCGA-24-1614-01A-01W-0552-10 a85349ef-886c-4d39-8c23-ff13b920059a NA TCGA-24-1614-01 TCGA-24-1614-01A-01W-0552-10 TCGA-24-1614-01A-01D-0501-05 NA TCGA-24-1614-01A-21-1558-20 NA NA TCGA-24-1614-01A-01D-0497-01 TCGA-24-1614-01 6ceece0c-56d0-41e6-93e9-12e2a4fdb4c4 NA TCGA-24-1614-01A-01D-0497-01 NA NA NA NA TCGA-24-1614-01 NA NA TCGA-24-1614-01A-01W-0552-10 TCGA-24-1614-01A-01R-0504-07 |
|
|
325 |
TCGA-24-1616-01 1 TCGA-24-1616-01 1163 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-24-1616 NA NA days 1163 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-24-1616-F26315 TCGA-24-1616 TCGA-24-1616-01A Stage IIIC -20785 NA 1163 0 1163 NA 405 NA NA NA 2009-5-13 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.9 NA NA G3 Recurrence NA NA NA NA TCGA-24-1616.d8c764d9-0fe8-488e-8aa1-da73a8c10b01.pdf 1616 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 2001 TCGA-24-1616-01 TCGA-24-1616-01 NA e40e646a-09da-49ad-bcca-1e56df395a36 NA TCGA-24-1616-01 NA TCGA-24-1616-01A-01D-0501-05 TCGA-24-1616-01A-01W-0553-09 TCGA-24-1616-01A-21-1558-20 TCGA-24-1616-01A-01W-0553-09 c334b353-0652-49fb-8cd6-5bcf8485e5d0 TCGA-24-1616-01A-01D-0497-01 TCGA-24-1616-01 3e449bae-1749-47d9-adc1-6e70b0c829dc NA TCGA-24-1616-01A-01D-0497-01 c334b353-0652-49fb-8cd6-5bcf8485e5d0 NA c334b353-0652-49fb-8cd6-5bcf8485e5d0 NA TCGA-24-1616-01 TCGA-24-1616-01 c334b353-0652-49fb-8cd6-5bcf8485e5d0 TCGA-24-1616-01A-01W-0553-09 TCGA-24-1616-01A-01R-0504-07 |
|
|
326 |
TCGA-24-1842-01 0 TCGA-24-1842-01 253 0 days High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-24-1842 NA NA days 253 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Bilateral TCGA-24-1842-F26325 TCGA-24-1842 TCGA-24-1842-01A Stage IIIC -18227 NA NA 0 253 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.5 NA YES G3 NA NA NA NA NA TCGA-24-1842.3465aae7-0664-44e5-a27f-c02fd73526a1.pdf 1842 Other TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.7 NA NA 24 1-10 mm Ovary NA A LIVING 2009 TCGA-24-1842-01 TCGA-24-1842-01 NA af43832d-2996-4a7f-8e5c-6bd2ec938cfe NA TCGA-24-1842-01 NA TCGA-24-1842-01A-01D-0581-05 NA TCGA-24-1842-01A-21-1559-20 TCGA-24-1842-01A-01W-0639-09 6cb78602-e09f-4dbc-b3e5-684ebe77bddc TCGA-24-1842-01A-01D-0577-01 TCGA-24-1842-01 5dcf27b7-8966-4c46-a0f6-5a1450f60d1d NA TCGA-24-1842-01A-01D-0577-01 6cb78602-e09f-4dbc-b3e5-684ebe77bddc NA 6cb78602-e09f-4dbc-b3e5-684ebe77bddc NA TCGA-24-1842-01 TCGA-24-1842-01 6cb78602-e09f-4dbc-b3e5-684ebe77bddc NA TCGA-24-1842-01A-01R-0584-07 |
|
|
327 |
TCGA-24-1843-01 0 TCGA-24-1843-01 106 0 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-24-1843 NA NA days 106 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 66 Right TCGA-24-1843-F26330 TCGA-24-1843 TCGA-24-1843-01A Stage IIIC -24469 NA NA 0 106 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.4 NA YES G3 NA NA NA NA NA TCGA-24-1843.d2625c77-0f03-42ea-b5ea-df45769f0fbb.pdf 1843 NA NA YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A LIVING 2009 TCGA-24-1843-01 TCGA-24-1843-01 NA 51ac296a-c599-47db-9a67-5aacf572efab NA TCGA-24-1843-01 NA TCGA-24-1843-01A-01D-0581-05 NA NA TCGA-24-1843-01A-01W-0639-09 c50cf5af-3375-4748-9894-1f9521f746da TCGA-24-1843-01A-01D-0577-01 TCGA-24-1843-01 NA NA TCGA-24-1843-01A-01D-0577-01 c50cf5af-3375-4748-9894-1f9521f746da NA c50cf5af-3375-4748-9894-1f9521f746da NA TCGA-24-1843-01 TCGA-24-1843-01 c50cf5af-3375-4748-9894-1f9521f746da NA TCGA-24-1843-01A-01R-0584-07 |
|
|
328 |
TCGA-24-1844-01 0 TCGA-24-1844-01 113 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-24-1844 NA NA days 113 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 64 Bilateral TCGA-24-1844-F26335 TCGA-24-1844 TCGA-24-1844-01A Stage IIIC -23542 NA NA 0 113 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA NA G3 NA NA NA NA NA TCGA-24-1844.5fd30c3c-9734-40dd-b81e-ae3f364c8fa8.pdf 1844 NA NA YES NA NA NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A LIVING 2009 TCGA-24-1844-01 TCGA-24-1844-01 NA 5f13ef2d-8e72-4552-8ace-f089597b1131 NA TCGA-24-1844-01 NA TCGA-24-1844-01A-01D-0581-05 NA TCGA-24-1844-01A-21-1559-20 TCGA-24-1844-01A-01W-0639-09 53a60e9f-3541-4fe7-a7ea-87ee888c0446 TCGA-24-1844-01A-01D-0577-01 TCGA-24-1844-01 d95c8065-b35e-47b0-899a-305b14ed2a56 NA TCGA-24-1844-01A-01D-0577-01 53a60e9f-3541-4fe7-a7ea-87ee888c0446 NA 53a60e9f-3541-4fe7-a7ea-87ee888c0446 NA TCGA-24-1844-01 TCGA-24-1844-01 53a60e9f-3541-4fe7-a7ea-87ee888c0446 NA TCGA-24-1844-01A-01R-0584-07 |
|
|
329 |
TCGA-24-1845-01 0 TCGA-24-1845-01 116 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 2 NA TCGA-24-1845 NA NA days 116 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 42 Bilateral TCGA-24-1845-F26340 TCGA-24-1845 TCGA-24-1845-01A Stage IIIC -15599 NA NA 0 116 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.8 NA NA G3 NA NA NA NA NA TCGA-24-1845.1fda446a-e0d2-422a-a023-57ec5bfae62b.pdf 1845 NA NA YES NA NA NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A LIVING 2009 NA TCGA-24-1845-01 NA 24d1e3ea-44ad-4bb9-8aa7-cd448b8bec21 NA TCGA-24-1845-01 NA TCGA-24-1845-01A-01D-0581-05 NA TCGA-24-1845-01A-21-1559-20 TCGA-24-1845-01A-01W-0639-09 NA TCGA-24-1845-01A-01D-0577-01 TCGA-24-1845-01 cd017460-81cb-4e71-b352-42612cae745e NA TCGA-24-1845-01A-01D-0577-01 NA NA NA NA TCGA-24-1845-01 NA NA NA TCGA-24-1845-01A-01R-0584-07 |
|
|
330 |
TCGA-24-1846-01 0 TCGA-24-1846-01 133 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-24-1846 NA NA days 133 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 45 Bilateral TCGA-24-1846-F26346 TCGA-24-1846 TCGA-24-1846-01A Stage IIIC -16534 NA NA 0 133 NA NA 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.1 NA YES G3 NA NA NA NA NA TCGA-24-1846.fb12e5b3-1529-4873-90fd-7ba0a78dd9f4.pdf 1846 Other NA YES NA NA NO NA Primary Tumor 01 0.6 NA NA 24 1-10 mm Ovary NA A LIVING 2009 TCGA-24-1846-01 TCGA-24-1846-01 NA 50b9dcb5-0fb8-4be7-97ce-5cd477d6c351 NA TCGA-24-1846-01 NA TCGA-24-1846-01A-01D-0581-05 NA TCGA-24-1846-01A-21-1559-20 TCGA-24-1846-01A-01W-0639-09 4b073708-9525-4340-90dc-ede08ee24977 TCGA-24-1846-01A-01D-0577-01 TCGA-24-1846-01 15134c0c-7253-481e-83e3-7d1c57bc521d NA TCGA-24-1846-01A-01D-0577-01 4b073708-9525-4340-90dc-ede08ee24977 NA 4b073708-9525-4340-90dc-ede08ee24977 NA TCGA-24-1846-01 TCGA-24-1846-01 4b073708-9525-4340-90dc-ede08ee24977 NA TCGA-24-1846-01A-01R-0584-07 |
|
|
331 |
TCGA-24-1847-01 0 TCGA-24-1847-01 343 0 days High NA OV-like c1 NA OV-like c16 miRNA cluster 3 cluster 6 NA TCGA-24-1847 NA NA days 343 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 45 Bilateral TCGA-24-1847-F26350 TCGA-24-1847 TCGA-24-1847-01A Stage IV -16529 NA NA 0 343 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy NA 0.9 NO NA 1 NA YES G3 NA NA NA NA NA TCGA-24-1847.20d96d45-40d3-44ad-a9e8-fdc7e545ed5d.pdf 1847 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Ovary NA A LIVING 2009 TCGA-24-1847-01 TCGA-24-1847-01 NA 74b939d6-c502-4edf-a412-df6dc9484eb6 NA TCGA-24-1847-01 NA TCGA-24-1847-01A-01D-0563-05 NA NA TCGA-24-1847-01A-01W-0633-09 83354694-078e-411e-89d2-029649708528 TCGA-24-1847-01A-01D-0559-01 TCGA-24-1847-01 NA NA TCGA-24-1847-01A-01D-0559-01 83354694-078e-411e-89d2-029649708528 NA 83354694-078e-411e-89d2-029649708528 NA TCGA-24-1847-01 TCGA-24-1847-01 83354694-078e-411e-89d2-029649708528 NA TCGA-24-1847-01A-01R-0566-07 |
|
|
332 |
TCGA-24-1849-01 0 TCGA-24-1849-01 176 0 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 NA TCGA-24-1849 NA NA days 176 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 80 Bilateral TCGA-24-1849-F26355 TCGA-24-1849 TCGA-24-1849-01A Stage IIIC -29555 NA NA 0 176 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.4 NO NA 1.8 NA YES G3 NA NA NA NA NA TCGA-24-1849.a2181913-086c-42a2-99fd-057b17025deb.pdf 1849 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A LIVING 2009 TCGA-24-1849-01 TCGA-24-1849-01 NA 36592a9b-a440-4741-95bc-51e700d14b52 NA TCGA-24-1849-01 NA TCGA-24-1849-01A-01D-0581-05 NA TCGA-24-1849-01A-21-1562-20 TCGA-24-1849-01A-01W-0639-09 58f3764a-4651-4c26-a667-74aef5c5679c TCGA-24-1849-01A-01D-0577-01 TCGA-24-1849-01 66dc2c60-9fa1-4fb7-8bd4-76da1e11229a NA TCGA-24-1849-01A-01D-0577-01 58f3764a-4651-4c26-a667-74aef5c5679c NA 58f3764a-4651-4c26-a667-74aef5c5679c NA TCGA-24-1849-01 TCGA-24-1849-01 58f3764a-4651-4c26-a667-74aef5c5679c NA TCGA-24-1849-01A-01R-0584-07 |
|
|
333 |
TCGA-24-1850-01 0 TCGA-24-1850-01 168 0 days High C9-OV UCEC Serous c4 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-24-1850 NA NA days 168 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 72 Bilateral TCGA-24-1850-F26359 TCGA-24-1850 TCGA-24-1850-01A Stage IIIC -26369 NA NA 0 168 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 2 NA YES G3 NA NA NA NA NA TCGA-24-1850.a8c2f09f-6971-48e1-b890-f1d63611cdbd.pdf 1850 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A LIVING 2009 TCGA-24-1850-01 TCGA-24-1850-01 NA 717a05a3-2930-4f69-a497-d884d493edaa NA TCGA-24-1850-01 NA TCGA-24-1850-01A-01D-0581-05 NA TCGA-24-1850-01A-21-1559-20 TCGA-24-1850-01A-01W-0639-09 9d88c064-c348-4f3f-a1f1-5884e0b66d9e TCGA-24-1850-01A-01D-0577-01 TCGA-24-1850-01 eacc0479-97ed-45f6-a4cb-9cca12252bd2 NA TCGA-24-1850-01A-01D-0577-01 9d88c064-c348-4f3f-a1f1-5884e0b66d9e NA 9d88c064-c348-4f3f-a1f1-5884e0b66d9e NA TCGA-24-1850-01 TCGA-24-1850-01 9d88c064-c348-4f3f-a1f1-5884e0b66d9e NA TCGA-24-1850-01A-01R-0584-07 |
|
|
334 |
TCGA-24-1852-01 1 TCGA-24-1852-01 2201 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-24-1852 NA NA days 2201 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-24-1852-F26363 TCGA-24-1852 TCGA-24-1852-01A Stage IIIC -20390 NA 2201 0 2201 NA 1009 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8461/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.4 NA NA G3 Recurrence NA NA NA NA TCGA-24-1852.FC6FD336-EB96-40CD-91FB-9371A305EF76.pdf 1852 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 NA NA NA 8bc4b5b7-b987-475b-90f7-28c8bd19a0fa NA NA NA TCGA-24-1852-01A-01D-0807-05 NA TCGA-24-1852-01A-21-1559-20 NA NA TCGA-24-1852-01A-01D-0803-01 TCGA-24-1852-01 6800890d-adf7-4831-8a21-68fc3b583fe6,b2810bf7-eaed-4955-b0da-e6ea3c65a9a7 NA TCGA-24-1852-01A-01D-0803-01 NA NA NA NA TCGA-24-1852-01 NA NA NA TCGA-24-1852-01A-01R-0810-07 |
|
|
335 |
TCGA-24-1852-02 1 TCGA-24-1852-02 2201 1 days NA NA OV-like c1 NA NA NA NA NA TCGA-24-1852 NA NA days 2201 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-24-1852-F26363 TCGA-24-1852 TCGA-24-1852-02A Stage IIIC -20390 NA 2201 0 2201 NA 1009 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8461/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-24-1852.FC644609-4B3F-41A5-9164-BC024C95DAB0.pdf 1852 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Recurrent Tumor 02 0.3 NA NA 24 1-10 mm Ovary NA A DECEASED 1997 NA NA NA 7c459b65-7eca-4081-83f0-ff67f0410a9b NA NA NA TCGA-24-1852-02A-01D-0807-05 NA NA NA NA NA NA 8e296930-ef86-4ff6-ac5c-11ef322d0dc2 NA NA NA NA NA NA NA NA NA NA TCGA-24-1852-02A-01R-0810-07 |
|
|
336 |
TCGA-24-1920-01 0 TCGA-24-1920-01 298 0 days High NA OV-like c1 BRCA basal-like c6 NA miRNA cluster 1 cluster 3 NA TCGA-24-1920 NA NA days 298 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 74 Right TCGA-24-1920-F26373 TCGA-24-1920 TCGA-24-1920-01A Stage IIIC -27042 NA NA 0 298 NA NA 0 NA NA 2010-2-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 2 NA NA G3 NA NA NA NA NA TCGA-24-1920.292d7fe5-e949-458b-b7da-cc55009b1c06.pdf 1920 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A LIVING 2009 NA TCGA-24-1920-01 NA 678cbaa5-cd2a-4cf5-a7e5-34b3db7281cc NA TCGA-24-1920-01 NA TCGA-24-1920-01A-01D-0652-05 NA TCGA-24-1920-01A-21-1559-20 NA NA TCGA-24-1920-01A-01D-0648-01 TCGA-24-1920-01 300fb12e-d372-4a03-ae7f-95d0cef8027a NA TCGA-24-1920-01A-01D-0648-01 NA NA NA NA TCGA-24-1920-01 NA NA NA TCGA-24-1920-01A-01R-0655-07 |
|
|
337 |
TCGA-24-1923-01 1 TCGA-24-1923-01 690 1 days Squamous NA Low purity c2 OV-like c4 NA miRNA cluster 3 cluster 6 NA TCGA-24-1923 NA NA days 690 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-24-1923-F26379 TCGA-24-1923 TCGA-24-1923-01A Stage IIIC -18628 NA 690 0 690 NA 343 NA NA NA 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 0.6 NO NA 1.3 NA YES G3 Recurrence NA NA NA NA TCGA-24-1923.6ae8158a-e236-4cc0-88d2-50756216f0e7.pdf 1923 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 24 1-10 mm Ovary NA A DECEASED 2001 NA TCGA-24-1923-01 NA fde22a7e-62c4-4c20-ac40-ac1b873edf9a NA TCGA-24-1923-01 NA TCGA-24-1923-01A-01D-0652-05 NA TCGA-24-1923-01A-21-1559-20 NA NA TCGA-24-1923-01A-01D-0648-01 TCGA-24-1923-01 9c88c21f-4bb9-41cc-b942-9c6e73a46511 NA TCGA-24-1923-01A-01D-0648-01 NA NA NA NA TCGA-24-1923-01 NA NA NA TCGA-24-1923-01A-01R-0655-07 |
|
|
338 |
TCGA-24-1924-01 1 TCGA-24-1924-01 919 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-24-1924 NA NA days 919 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-24-1924-F26386 TCGA-24-1924 TCGA-24-1924-01A Stage IIIC -23801 NA 919 0 919 NA 320 NA NA NA 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-24-1924.4199b57a-81f5-4d5f-9f4c-1e514dcd26dc.pdf 1924 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 2001 TCGA-24-1924-01 TCGA-24-1924-01 NA 16cd57f0-1334-447e-828e-989c2339c282 NA TCGA-24-1924-01 NA TCGA-24-1924-01A-01D-0652-05 NA TCGA-24-1924-01A-21-1559-20 NA 2592f314-cc0a-4d00-bdcf-6376afd32bb7 TCGA-24-1924-01A-01D-0648-01 TCGA-24-1924-01 d4067ae4-665b-4539-938c-e86a08523d3f NA TCGA-24-1924-01A-01D-0648-01 2592f314-cc0a-4d00-bdcf-6376afd32bb7 NA 2592f314-cc0a-4d00-bdcf-6376afd32bb7 NA TCGA-24-1924-01 TCGA-24-1924-01 2592f314-cc0a-4d00-bdcf-6376afd32bb7 NA TCGA-24-1924-01A-01R-0655-07 |
|
|
339 |
TCGA-24-1927-01 1 TCGA-24-1927-01 500 1 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-24-1927 NA NA days 500 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-24-1927-F26396 TCGA-24-1927 NA Stage IIIC -21719 NA 500 0 500 NA 290 NA NA NA 2010-3-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1927 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 24 1-10 mm Ovary NA NA DECEASED 1999 NA NA NA NA NA NA NA TCGA-24-1927-01A-01D-0652-05 NA TCGA-24-1927-01A-21-1559-20 NA NA TCGA-24-1927-01A-01D-0648-01 TCGA-24-1927-01 f9b9b275-8678-4ff8-95fe-dd804f20713d NA TCGA-24-1927-01A-01D-0648-01 NA NA NA NA TCGA-24-1927-01 NA NA NA TCGA-24-1927-01A-01R-0655-07 |
|
|
340 |
TCGA-24-1928-01 1 TCGA-24-1928-01 336 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 2 NA TCGA-24-1928 NA NA days 336 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 77 Bilateral TCGA-24-1928-F26403 TCGA-24-1928 TCGA-24-1928-01A Stage IIIC -28126 NA 336 0 336 NA 70 NA NA NA 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.5 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-1928.dc4407fb-d15b-44d5-9c3b-129cca67d8f1.pdf 1928 NA WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 0.3 NA NA 24 11-20 mm Ovary NA A DECEASED 1998 TCGA-24-1928-01 TCGA-24-1928-01 NA 681d19fb-e521-4105-8d76-275624c1d3b0 NA TCGA-24-1928-01 NA TCGA-24-1928-01A-01D-0652-05 NA NA NA 433d642a-06fe-454f-a2bf-3e0afb3dd23b TCGA-24-1928-01A-01D-0648-01 TCGA-24-1928-01 NA NA TCGA-24-1928-01A-01D-0648-01 433d642a-06fe-454f-a2bf-3e0afb3dd23b NA 433d642a-06fe-454f-a2bf-3e0afb3dd23b NA TCGA-24-1928-01 TCGA-24-1928-01 433d642a-06fe-454f-a2bf-3e0afb3dd23b NA TCGA-24-1928-01A-01R-0655-07 |
|
|
341 |
TCGA-24-1930-01 1 TCGA-24-1930-01 2467 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-24-1930 NA NA days 2467 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 53 Bilateral TCGA-24-1930-F26410 TCGA-24-1930 TCGA-24-1930-01A Stage IIIC -19387 NA 2467 0 2467 NA 544 0 NA NA 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO 100 1 NA NA G3 Recurrence NA NA NA NA TCGA-24-1930.746ac85a-ea6d-4d60-859f-69bf580a707c.pdf 1930 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 24 1-10 mm Ovary NA A DECEASED 1998 TCGA-24-1930-01 TCGA-24-1930-01 NA 3412c513-36c6-459c-9f66-3dd15d0d8e72 NA TCGA-24-1930-01 NA TCGA-24-1930-01A-01D-0652-05 NA TCGA-24-1930-01A-21-1559-20 NA d85ca8ac-9458-4f3a-b2ef-db4df852f75e TCGA-24-1930-01A-01D-0648-01 TCGA-24-1930-01 bf3c2d8b-6072-4f59-8f19-128cfff7314e NA TCGA-24-1930-01A-01D-0648-01 d85ca8ac-9458-4f3a-b2ef-db4df852f75e NA d85ca8ac-9458-4f3a-b2ef-db4df852f75e NA TCGA-24-1930-01 TCGA-24-1930-01 d85ca8ac-9458-4f3a-b2ef-db4df852f75e NA TCGA-24-1930-01A-01R-0655-07 |
|
|
342 |
TCGA-24-2019-01 0 TCGA-24-2019-01 148 0 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-24-2019 NA NA days 148 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 46 Bilateral TCGA-24-2019-F26429 TCGA-24-2019 TCGA-24-2019-01A Stage IIIC -17009 NA NA 0 148 NA NA 1 NA NA 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-24-2019.15a77e5d-acfb-4013-81de-ef9d2f6398d1.pdf 2019 Other NA YES NA NA NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Ovary NA A LIVING 2009 TCGA-24-2019-01 TCGA-24-2019-01 NA 437a6ae6-ad96-446e-ad48-d2d8f608e915 NA TCGA-24-2019-01 NA TCGA-24-2019-01A-02D-0667-05 NA NA NA 52908652-f29a-4517-8ff6-6f4cd31c691b TCGA-24-2019-01A-02D-0663-01 TCGA-24-2019-01 NA NA TCGA-24-2019-01A-02D-0663-01 52908652-f29a-4517-8ff6-6f4cd31c691b NA 52908652-f29a-4517-8ff6-6f4cd31c691b TCGA-24-2019-01A-02W-0722-08 TCGA-24-2019-01 TCGA-24-2019-01 52908652-f29a-4517-8ff6-6f4cd31c691b TCGA-24-2019-01A-02W-0722-08 TCGA-24-2019-01A-02R-0670-07 |
|
|
343 |
TCGA-24-2020-01 1 TCGA-24-2020-01 4624 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-24-2020 NA NA days 4624 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Bilateral TCGA-24-2020-F26431 TCGA-24-2020 TCGA-24-2020-01A Stage IIIC -24682 NA 4624 0 4624 NA 723 NA NA NA 2010-3-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.1 NA NA G3 Recurrence NA NA NA NA TCGA-24-2020.4f529d42-acb0-4c02-bd0f-d4a650655df8.pdf 2020 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1994 TCGA-24-2020-01 TCGA-24-2020-01 NA dfccfa2b-c85a-4ef7-815f-75d1042b5c6d NA TCGA-24-2020-01 NA TCGA-24-2020-01A-01D-0652-05 NA TCGA-24-2020-01A-21-1560-20 NA 19765b4f-458e-4f02-bf96-01498d80ac83 TCGA-24-2020-01A-01D-0648-01 TCGA-24-2020-01 809ac07d-5244-462e-a41e-531eeb193296 NA TCGA-24-2020-01A-01D-0648-01 19765b4f-458e-4f02-bf96-01498d80ac83 NA 19765b4f-458e-4f02-bf96-01498d80ac83 NA TCGA-24-2020-01 TCGA-24-2020-01 19765b4f-458e-4f02-bf96-01498d80ac83 NA TCGA-24-2020-01A-01R-0655-07 |
|
|
344 |
TCGA-24-2023-01 1 TCGA-24-2023-01 1364 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-24-2023 NA NA days 1364 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-24-2023-F26442 TCGA-24-2023 TCGA-24-2023-01A Stage IIIA -19901 NA 1364 0 1364 NA 1069 NA NA NA 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-24-2023.2a255fa6-65cd-4fb7-9d08-1b6aadd6682b.pdf 2023 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 1994 TCGA-24-2023-01 TCGA-24-2023-01 NA feeee3cc-2213-4b46-b985-4575d7dcbf23 NA TCGA-24-2023-01 NA TCGA-24-2023-01A-01D-0652-05 NA TCGA-24-2023-01A-21-1560-20 NA 11fd4bb1-0f8d-4830-a7f0-83897a5df11d TCGA-24-2023-01A-01D-0648-01 TCGA-24-2023-01 53cd60af-85e4-468e-a6f8-f21be9631a23 NA TCGA-24-2023-01A-01D-0648-01 11fd4bb1-0f8d-4830-a7f0-83897a5df11d NA 11fd4bb1-0f8d-4830-a7f0-83897a5df11d NA TCGA-24-2023-01 TCGA-24-2023-01 11fd4bb1-0f8d-4830-a7f0-83897a5df11d NA TCGA-24-2023-01A-01R-0655-07 |
|
|
345 |
TCGA-24-2024-01 1 TCGA-24-2024-01 1769 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-2024 NA NA days 1769 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 72 Bilateral TCGA-24-2024-F26450 TCGA-24-2024 TCGA-24-2024-01A Stage IIIC -26476 NA 1769 0 1769 NA 421 NA NA NA 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA NA G3 Recurrence NA NA NA NA TCGA-24-2024.4189cfa0-00c3-42fb-91b9-d2f4b4887061.pdf 2024 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 1994 TCGA-24-2024-01 TCGA-24-2024-01 NA 3f66920b-c10b-4768-a706-c8a6cef1c149 NA TCGA-24-2024-01 NA TCGA-24-2024-01A-02D-0667-05 NA TCGA-24-2024-01A-03-1563-20 NA bdd5afb1-a251-4541-bbbe-0fcd1126a3ce TCGA-24-2024-01A-02D-0663-01 TCGA-24-2024-01 c3771a58-897b-4427-8dbb-70214f74dc03 NA TCGA-24-2024-01A-02D-0663-01 bdd5afb1-a251-4541-bbbe-0fcd1126a3ce NA bdd5afb1-a251-4541-bbbe-0fcd1126a3ce TCGA-24-2024-01A-02W-0722-08 TCGA-24-2024-01 TCGA-24-2024-01 bdd5afb1-a251-4541-bbbe-0fcd1126a3ce TCGA-24-2024-01A-02W-0722-08 TCGA-24-2024-01A-02R-0670-07 |
|
|
346 |
TCGA-24-2026-01 1 TCGA-24-2026-01 1059 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-24-2026 NA NA days 1059 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 79 Bilateral TCGA-24-2026-F26456 TCGA-24-2026 NA Stage IIIC -29050 NA 1059 0 1059 NA NA NA NA NA 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 NA NA NA NA NA NA 2026 NA NA YES NA NA NO NA Primary Tumor 01 NA NA NA 24 >20 mm Ovary NA NA DECEASED 1995 TCGA-24-2026-01 TCGA-24-2026-01 NA ccb2b163-3da6-4594-b55b-c63221fc8ad5 NA TCGA-24-2026-01 NA TCGA-24-2026-01A-01D-0652-05 NA TCGA-24-2026-01A-21-1560-20 NA ce0fd762-e18f-4cca-a4c4-c064dca62e60 TCGA-24-2026-01A-01D-0648-01 TCGA-24-2026-01 f68086f7-8d41-4631-9346-849088f1f577 NA TCGA-24-2026-01A-01D-0648-01 ce0fd762-e18f-4cca-a4c4-c064dca62e60 NA ce0fd762-e18f-4cca-a4c4-c064dca62e60 NA TCGA-24-2026-01 TCGA-24-2026-01 ce0fd762-e18f-4cca-a4c4-c064dca62e60 NA TCGA-24-2026-01A-01R-0655-07 |
|
|
347 |
TCGA-24-2027-01 1 TCGA-24-2027-01 3337 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-24-2027 NA NA days 3337 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-24-2027-F26460 TCGA-24-2027 TCGA-24-2027-01A Stage IV -18835 NA 3337 0 3337 NA 617 0 NA NA 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.6 NA NA G3 Recurrence NA NA NA NA TCGA-24-2027.8a4d0373-9d57-4cf7-ac78-d8b558d43df6.pdf 2027 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 24 >20 mm Ovary NA A DECEASED 1995 TCGA-24-2027-01 TCGA-24-2027-01 NA e9c0e81a-4be2-4ab2-a0fe-33ea200f4047 NA TCGA-24-2027-01 NA TCGA-24-2027-01A-01D-0652-05 NA TCGA-24-2027-01A-21-1560-20 NA fc1f34ba-12e1-46d8-85ef-15b9486b37c2 TCGA-24-2027-01A-01D-0648-01 TCGA-24-2027-01 55afc19d-b001-47f3-9d3d-9bc9a8681031 NA TCGA-24-2027-01A-01D-0648-01 fc1f34ba-12e1-46d8-85ef-15b9486b37c2 NA fc1f34ba-12e1-46d8-85ef-15b9486b37c2 NA TCGA-24-2027-01 TCGA-24-2027-01 fc1f34ba-12e1-46d8-85ef-15b9486b37c2 NA TCGA-24-2027-01A-01R-0655-07 |
|
|
348 |
TCGA-24-2029-01 1 TCGA-24-2029-01 439 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 2 NA TCGA-24-2029 NA NA days 439 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 75 Bilateral TCGA-24-2029-F26476 TCGA-24-2029 NA Stage IIIC -27527 NA 439 0 439 NA 372 NA NA NA 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 2029 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 24 >20 mm Ovary NA NA DECEASED 1995 NA TCGA-24-2029-01 NA fc252b6a-222d-4529-a609-012e71c0b436 NA TCGA-24-2029-01 NA TCGA-24-2029-01A-01D-0652-05 NA TCGA-24-2029-01A-21-1560-20 NA NA TCGA-24-2029-01A-01D-0648-01 TCGA-24-2029-01 c10a5aef-aa73-4f20-acef-a5bd42e29fca NA TCGA-24-2029-01A-01D-0648-01 NA NA NA NA TCGA-24-2029-01 NA NA NA TCGA-24-2029-01A-01R-0655-07 |
|
|
349 |
TCGA-24-2030-01 1 TCGA-24-2030-01 1701 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 mutation cluster 13 TCGA-24-2030 NA NA days 1701 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 87 Left TCGA-24-2030-F26480 TCGA-24-2030 TCGA-24-2030-01A Stage IIIC -31900 NA 1701 0 1641 NA 646 NA NA NA 2010-2-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-2030.bb1b63ab-1e13-4401-ab6a-0325da96b17f.pdf 2030 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 24 >20 mm Ovary NA A DECEASED 1995 NA TCGA-24-2030-01 NA 07894e29-8a70-415e-a10d-389d652f11a5 NA TCGA-24-2030-01 NA TCGA-24-2030-01A-01D-0667-05 NA TCGA-24-2030-01A-21-1560-20 NA NA TCGA-24-2030-01A-01D-0663-01 TCGA-24-2030-01 827506c7-c89c-4301-971d-b42ace20769e NA TCGA-24-2030-01A-01D-0663-01 NA NA NA TCGA-24-2030-01A-01W-0722-08 TCGA-24-2030-01 NA NA TCGA-24-2030-01A-01W-0722-08 TCGA-24-2030-01A-01R-0670-07 |
|
|
350 |
TCGA-24-2033-01 1 TCGA-24-2033-01 562 1 days High C9-OV OV-like c1 UCEC-like c5 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-24-2033 NA NA days 562 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 87 Bilateral TCGA-24-2033-F26490 TCGA-24-2033 NA Stage IIIC -31977 NA 562 0 562 NA 351 NA NA NA 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 2033 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 NA NA NA 24 >20 mm Ovary NA NA DECEASED 1995 TCGA-24-2033-01 TCGA-24-2033-01 NA a735c975-e05c-4389-a39d-80c25462dfe6 NA TCGA-24-2033-01 NA TCGA-24-2033-01A-01D-0667-05 NA TCGA-24-2033-01A-21-1560-20 NA b03b75e2-d1d0-4fd7-b66e-891f7b0acb76 TCGA-24-2033-01A-01D-0663-01 TCGA-24-2033-01 d671c1b8-d45e-4d50-bf32-458677874c49 NA TCGA-24-2033-01A-01D-0663-01 b03b75e2-d1d0-4fd7-b66e-891f7b0acb76 NA b03b75e2-d1d0-4fd7-b66e-891f7b0acb76 NA TCGA-24-2033-01 TCGA-24-2033-01 b03b75e2-d1d0-4fd7-b66e-891f7b0acb76 NA TCGA-24-2033-01A-01R-0670-07 |
|
|
351 |
TCGA-24-2035-01 1 TCGA-24-2035-01 857 1 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-24-2035 NA NA days 857 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Left TCGA-24-2035-F26496 TCGA-24-2035 NA Stage IIIC -23855 NA 857 0 857 NA 287 0 NA NA 2010-3-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 2035 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 24 1-10 mm Ovary NA NA DECEASED 1996 TCGA-24-2035-01 TCGA-24-2035-01 NA ede49e4b-e555-4d20-99cb-e98ea98ddec2 NA TCGA-24-2035-01 NA TCGA-24-2035-01A-01D-0667-05 NA NA NA e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0 TCGA-24-2035-01A-01D-0663-01 TCGA-24-2035-01 NA NA TCGA-24-2035-01A-01D-0663-01 e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0 NA e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0 TCGA-24-2035-01A-01W-0722-08 TCGA-24-2035-01 TCGA-24-2035-01 e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0 TCGA-24-2035-01A-01W-0722-08 TCGA-24-2035-01A-01R-0670-07 |
|
|
352 |
TCGA-24-2036-01 1 TCGA-24-2036-01 1947 1 days BRCA-LUAD+ C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-24-2036 NA NA days 1947 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 50 NA TCGA-24-2036-F26505 TCGA-24-2036 TCGA-24-2036-01A Stage IIIA -18582 NA 1947 0 1947 NA 914 0 NA NA 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.1 NA NA G3 Recurrence NA NA NA NA TCGA-24-2036.3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e.pdf 2036 Other WITH TUMOR YES Complete Remission/Response Physical Examination NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1996 TCGA-24-2036-01 NA NA b7b09d06-e228-4549-b19a-99561867345b NA NA NA TCGA-24-2036-01A-01D-0667-05 NA TCGA-24-2036-01A-21-1560-20 NA 788ade22-382b-49ca-b2b1-447a2072d0ea TCGA-24-2036-01A-01D-0663-01 TCGA-24-2036-01 bcde7ed3-4bc7-41c7-99af-f132bda4a6ef NA TCGA-24-2036-01A-01D-0663-01 788ade22-382b-49ca-b2b1-447a2072d0ea NA 788ade22-382b-49ca-b2b1-447a2072d0ea NA TCGA-24-2036-01 TCGA-24-2036-01 788ade22-382b-49ca-b2b1-447a2072d0ea NA TCGA-24-2036-01A-01R-0670-07 |
|
|
353 |
TCGA-24-2038-01 1 TCGA-24-2038-01 1354 1 days Iq C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 12 TCGA-24-2038 NA NA days 1354 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Right TCGA-24-2038-F26518 TCGA-24-2038 TCGA-24-2038-01A Stage IIIA -24957 NA 1354 0 1354 NA 1169 NA NA NA 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NA GB Recurrence NA NA NA NA TCGA-24-2038.82958234-9de0-429f-8e63-3e8891f1df81.pdf 2038 NA WITH TUMOR NO Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 2000 TCGA-24-2038-01 TCGA-24-2038-01 NA 05783372-9fc0-426a-a1ea-203af160b5b6 NA TCGA-24-2038-01 NA TCGA-24-2038-01A-01D-0667-05 NA TCGA-24-2038-01A-21-1560-20 NA 372a8471-dff3-44c0-9393-94ad511a7374 TCGA-24-2038-01A-01D-0663-01 TCGA-24-2038-01 b9526a72-d01f-46bc-896d-4798319abebf NA TCGA-24-2038-01A-01D-0663-01 372a8471-dff3-44c0-9393-94ad511a7374 NA 372a8471-dff3-44c0-9393-94ad511a7374 TCGA-24-2038-01A-01W-0722-08 TCGA-24-2038-01 TCGA-24-2038-01 372a8471-dff3-44c0-9393-94ad511a7374 TCGA-24-2038-01A-01W-0722-08 TCGA-24-2038-01A-01R-0670-07 |
|
|
354 |
TCGA-24-2254-01 1 TCGA-24-2254-01 1736 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 2 TCGA-24-2254 NA NA days 1736 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 Bilateral TCGA-24-2254-F26523 TCGA-24-2254 TCGA-24-2254-01A Stage IIIC -24407 NA 1736 0 1736 NA 606 0 NA NA 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-24-2254.3788629f-17da-4075-af61-cf124bdfb48e.pdf 2254 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 2003 TCGA-24-2254-01 TCGA-24-2254-01 NA b8cac420-a963-4be2-9ecf-dd92700477e1 NA TCGA-24-2254-01 NA TCGA-24-2254-01A-01D-0667-05 NA TCGA-24-2254-01A-21-1560-20 NA e496319b-df71-44a0-bfa6-90f50ae54654 TCGA-24-2254-01A-01D-0663-01 TCGA-24-2254-01 9525da91-59ae-487e-b9cb-925f263dfcb6 NA TCGA-24-2254-01A-01D-0663-01 e496319b-df71-44a0-bfa6-90f50ae54654 NA e496319b-df71-44a0-bfa6-90f50ae54654 TCGA-24-2254-01A-01W-0722-08 TCGA-24-2254-01 TCGA-24-2254-01 e496319b-df71-44a0-bfa6-90f50ae54654 TCGA-24-2254-01A-01W-0722-08 TCGA-24-2254-01A-01R-0670-07 |
|
|
355 |
TCGA-24-2260-01 1 TCGA-24-2260-01 1100 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-2260 NA NA days 1100 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-24-2260-F26532 TCGA-24-2260 TCGA-24-2260-01A Stage IIIB -27112 NA 1100 0 1100 NA 667 NA NA NA 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 1 NO NA 1.7 NA NA G3 Recurrence NA NA NA NA TCGA-24-2260.920817f6-bd04-4e9a-8f41-ba28be22cbc8.pdf 2260 NA WITH TUMOR YES Complete Remission/Response Physical Examination NO NA Primary Tumor 01 0.5 NA NA 24 1-10 mm Ovary NA A DECEASED 1992 NA TCGA-24-2260-01 NA 0bfc4955-78bd-4883-b7b0-a262b6c1594f NA TCGA-24-2260-01 NA TCGA-24-2260-01A-01D-0667-05 NA TCGA-24-2260-01A-21-1560-20 NA NA TCGA-24-2260-01A-01D-0663-01 TCGA-24-2260-01 34ce0e32-d482-45e5-8663-edf50b16309a NA TCGA-24-2260-01A-01D-0663-01 NA NA NA TCGA-24-2260-01A-01W-0722-08 TCGA-24-2260-01 NA NA TCGA-24-2260-01A-01W-0722-08 TCGA-24-2260-01A-01R-0670-07 |
|
|
356 |
TCGA-24-2261-01 1 TCGA-24-2261-01 24 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-24-2261 NA NA days 24 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 76 Left TCGA-24-2261-F26540 TCGA-24-2261 TCGA-24-2261-01A Stage IIIC -27897 NA 24 0 24 NA NA NA NA NA 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.4 NO NA 1.7 NA YES G3 NA NA NA NA NA TCGA-24-2261.6145afd6-e7d7-47bc-a659-ac84c3434e86.pdf 2261 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.4 NA NA 24 11-20 mm Ovary NA A DECEASED 1992 TCGA-24-2261-01 TCGA-24-2261-01 NA 8c41ba6a-3315-4903-9cd5-ac3f82576008 NA TCGA-24-2261-01 NA TCGA-24-2261-01A-01D-0667-05 NA TCGA-24-2261-01A-21-1560-20 NA 75e9506a-d007-4fb2-8bdd-7e7780653a63 TCGA-24-2261-01A-01D-0663-01 TCGA-24-2261-01 cbbb0190-5bfe-4a4f-aabe-63d68021b388 NA TCGA-24-2261-01A-01D-0663-01 75e9506a-d007-4fb2-8bdd-7e7780653a63 NA 75e9506a-d007-4fb2-8bdd-7e7780653a63 TCGA-24-2261-01A-01W-0722-08 TCGA-24-2261-01 TCGA-24-2261-01 75e9506a-d007-4fb2-8bdd-7e7780653a63 TCGA-24-2261-01A-01W-0722-08 TCGA-24-2261-01A-01R-0670-07 |
|
|
357 |
TCGA-24-2262-01 1 TCGA-24-2262-01 11 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-2262 NA NA days 11 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Right TCGA-24-2262-F26542 TCGA-24-2262 TCGA-24-2262-01A Stage IIIC -20861 NA 11 0 11 NA NA NA NA NA 2010-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-24-2262.d58b58ac-365c-43d0-a893-0becfb6e9fff.pdf 2262 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A DECEASED 1992 TCGA-24-2262-01 TCGA-24-2262-01 NA 8462f214-6bf7-4018-b40b-f9a3f3847542 NA TCGA-24-2262-01 NA TCGA-24-2262-01A-01D-0708-05 NA TCGA-24-2262-01A-21-1560-20 NA efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe TCGA-24-2262-01A-01D-0704-01 TCGA-24-2262-01 5d31db74-24ef-4322-9880-5189dee10ccb NA TCGA-24-2262-01A-01D-0704-01 efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe NA efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe TCGA-24-2262-01A-01W-0799-08 TCGA-24-2262-01 TCGA-24-2262-01 efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe TCGA-24-2262-01A-01W-0799-08 TCGA-24-2262-01A-01R-0711-07 |
|
|
358 |
TCGA-24-2267-01 1 TCGA-24-2267-01 1446 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-2267 NA NA days 1446 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-24-2267-F26544 TCGA-24-2267 TCGA-24-2267-01A Stage IIB -21293 NA 1446 0 1446 NA 512 NA NA NA 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 1.5 NA YES G3 Recurrence NA NA NA NA TCGA-24-2267.24844312-f32c-4366-945e-96d9a923f82a.pdf 2267 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 24 No Macroscopic disease Ovary NA A DECEASED 1993 TCGA-24-2267-01 TCGA-24-2267-01 NA 7d6e82dd-4715-42df-8325-444be465aa24 NA TCGA-24-2267-01 NA TCGA-24-2267-01A-01D-0708-05 NA TCGA-24-2267-01A-21-1560-20 NA 9ebb3535-6536-49fc-a88b-473235972378 TCGA-24-2267-01A-01D-0704-01 TCGA-24-2267-01 25f1b635-6318-41d5-a0c8-37e8d263dddd NA TCGA-24-2267-01A-01D-0704-01 9ebb3535-6536-49fc-a88b-473235972378 NA 9ebb3535-6536-49fc-a88b-473235972378 TCGA-24-2267-01A-01W-0799-08 TCGA-24-2267-01 TCGA-24-2267-01 9ebb3535-6536-49fc-a88b-473235972378 TCGA-24-2267-01A-01W-0799-08 TCGA-24-2267-01A-01R-0711-07 |
|
|
359 |
TCGA-24-2271-01 1 TCGA-24-2271-01 962 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-2271 NA NA days 962 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-24-2271-F26557 TCGA-24-2271 TCGA-24-2271-01A Stage IIIC -20399 NA 962 0 962 NA 827 NA NA NA 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.6 NA YES G3 Recurrence NA NA NA NA TCGA-24-2271.87d64a93-9b08-48a5-a26e-1cc4b5ac8bde.pdf 2271 NA WITH TUMOR YES NA Physical Examination NO NA Primary Tumor 01 0.5 NA NA 24 >20 mm Ovary YES A DECEASED 1999 TCGA-24-2271-01 TCGA-24-2271-01 NA 3f1bd8a1-5a33-4c68-9d62-a65289c677dd NA TCGA-24-2271-01 NA TCGA-24-2271-01A-01D-0708-05 NA TCGA-24-2271-01A-21-1560-20 NA f3581696-e1db-4d0f-9ce7-5fb0f5c08906 TCGA-24-2271-01A-01D-0704-01 TCGA-24-2271-01 9651ae11-92cc-4085-b9f5-b141eff0fb99 NA TCGA-24-2271-01A-01D-0704-01 f3581696-e1db-4d0f-9ce7-5fb0f5c08906 NA f3581696-e1db-4d0f-9ce7-5fb0f5c08906 TCGA-24-2271-01A-01W-0799-08 TCGA-24-2271-01 TCGA-24-2271-01 f3581696-e1db-4d0f-9ce7-5fb0f5c08906 TCGA-24-2271-01A-01W-0799-08 TCGA-24-2271-01A-01R-0711-07 |
|
|
360 |
TCGA-24-2280-01 0 TCGA-24-2280-01 2143 0 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-24-2280 NA NA days 2143 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Bilateral TCGA-24-2280-F26561 TCGA-24-2280 TCGA-24-2280-01A Stage IIIC -27356 NA NA 0 2143 NA 535 0 NA NA 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-2280.deb1a0d1-92a0-4c10-b491-a6a1ca5e3192.pdf 2280 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 1-10 mm Ovary NA A LIVING 2004 NA TCGA-24-2280-01 NA 964fcf21-982e-474f-ab2d-cfcb0bbd0e15 NA TCGA-24-2280-01 NA TCGA-24-2280-01A-01D-0708-05 NA NA NA NA TCGA-24-2280-01A-01D-0704-01 TCGA-24-2280-01 NA NA TCGA-24-2280-01A-01D-0704-01 NA NA NA TCGA-24-2280-01A-01W-0799-08 TCGA-24-2280-01 NA NA TCGA-24-2280-01A-01W-0799-08 TCGA-24-2280-01A-01R-0711-07 |
|
|
361 |
TCGA-24-2281-01 0 TCGA-24-2281-01 1357 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-24-2281 NA NA days 1357 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 68 Bilateral TCGA-24-2281-F26570 TCGA-24-2281 TCGA-24-2281-01A Stage IIA -25019 NA NA 0 1357 NA NA 0 NA NA 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.5 NA YES G3 NA NA NA NA NA TCGA-24-2281.363dc00f-480d-4a3f-8950-80a6bc0b7dd8.pdf 2281 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.2 NA NA 24 1-10 mm Ovary NA A LIVING 2006 TCGA-24-2281-01 TCGA-24-2281-01 NA 0ca4dc50-aee3-49e2-b327-b86ddfce658f NA TCGA-24-2281-01 NA TCGA-24-2281-01A-01D-0708-05 NA TCGA-24-2281-01A-21-1560-20 NA 44948279-405d-42f6-ad29-465150ee6d85 TCGA-24-2281-01A-01D-0704-01 TCGA-24-2281-01 e83257be-084b-405a-8098-b10055d1ad85 NA TCGA-24-2281-01A-01D-0704-01 44948279-405d-42f6-ad29-465150ee6d85 NA 44948279-405d-42f6-ad29-465150ee6d85 TCGA-24-2281-01A-01W-0799-08 TCGA-24-2281-01 TCGA-24-2281-01 44948279-405d-42f6-ad29-465150ee6d85 TCGA-24-2281-01A-01W-0799-08 TCGA-24-2281-01A-01R-0711-07 |
|
|
362 |
TCGA-24-2288-01 1 TCGA-24-2288-01 25 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 8 TCGA-24-2288 NA NA days 25 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 70 Bilateral TCGA-24-2288-F26574 TCGA-24-2288 TCGA-24-2288-01A Stage IIIC -25831 NA 25 0 25 NA NA NA NA NA 2010-2-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.2 NA YES G3 NA NA NA NA NA TCGA-24-2288.a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45.pdf 2288 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.5 NA NA 24 >20 mm Ovary NA A DECEASED 1999 TCGA-24-2288-01 TCGA-24-2288-01 NA bea203c5-e349-4941-aa28-d3b9372ad7a2 NA TCGA-24-2288-01 NA TCGA-24-2288-01A-01D-0708-05 NA TCGA-24-2288-01A-21-1560-20 NA dbc2cfac-df65-4750-af39-37760bad1057 TCGA-24-2288-01A-01D-0704-01 TCGA-24-2288-01 7c143023-df5b-42cb-958b-962d6f607e92 NA TCGA-24-2288-01A-01D-0704-01 dbc2cfac-df65-4750-af39-37760bad1057 NA dbc2cfac-df65-4750-af39-37760bad1057 TCGA-24-2288-01A-01W-0799-08 TCGA-24-2288-01 TCGA-24-2288-01 dbc2cfac-df65-4750-af39-37760bad1057 TCGA-24-2288-01A-01W-0799-08 TCGA-24-2288-01A-01R-0711-07 |
|
|
363 |
TCGA-24-2289-01 1 TCGA-24-2289-01 2049 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 5 mutation cluster 8 TCGA-24-2289 NA NA days 2049 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Bilateral TCGA-24-2289-F26578 TCGA-24-2289 TCGA-24-2289-01A Stage IV -25191 NA 2049 0 2049 NA 568 NA NA NA 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-2289.3c9bb67a-702f-4e9b-bd0f-c0ef8a5d237d.pdf 2289 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 0.4 NA NA 24 >20 mm Ovary NA A DECEASED 1997 TCGA-24-2289-01 TCGA-24-2289-01 NA 9ef0fcf7-e7c3-4c19-ab2b-185392963182 NA TCGA-24-2289-01 NA TCGA-24-2289-01A-01D-0708-05 NA TCGA-24-2289-01A-21-1560-20 NA bdc4400c-c552-450b-a806-2ae10f61cca8 TCGA-24-2289-01A-01D-0704-01 TCGA-24-2289-01 992227e4-86a6-4703-ac81-cae8ea4a5dac NA TCGA-24-2289-01A-01D-0704-01 bdc4400c-c552-450b-a806-2ae10f61cca8 NA bdc4400c-c552-450b-a806-2ae10f61cca8 TCGA-24-2289-01A-01W-0799-08 TCGA-24-2289-01 TCGA-24-2289-01 bdc4400c-c552-450b-a806-2ae10f61cca8 TCGA-24-2289-01A-01W-0799-08 TCGA-24-2289-01A-01R-0711-07 |
|
|
364 |
TCGA-24-2290-01 1 TCGA-24-2290-01 1102 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-24-2290 NA NA days 1102 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 NA TCGA-24-2290-F26583 TCGA-24-2290 TCGA-24-2290-01A Stage IIIC -20530 NA 1102 0 1102 NA 324 0 NA NA 2010-2-19 FEMALE Serous Cystadenocarcinoma No C48.1 8441/3 C48.1 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-24-2290.71036f77-0d99-427a-883c-75624453890d.pdf 2290 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 24 1-10 mm Omentum NA A DECEASED 1997 TCGA-24-2290-01 TCGA-24-2290-01 NA ad9e04b7-2000-411e-81bd-d1d22381d5c8 NA TCGA-24-2290-01 NA TCGA-24-2290-01A-01D-0708-05 NA TCGA-24-2290-01A-21-1560-20 NA a3173b33-aa16-48a2-b733-0345aad49755 TCGA-24-2290-01A-01D-0704-01 TCGA-24-2290-01 7ede9f43-4fe6-4cd4-a1fe-b6a0677b40d9 NA TCGA-24-2290-01A-01D-0704-01 a3173b33-aa16-48a2-b733-0345aad49755 NA a3173b33-aa16-48a2-b733-0345aad49755 TCGA-24-2290-01A-01W-0799-08 TCGA-24-2290-01 TCGA-24-2290-01 a3173b33-aa16-48a2-b733-0345aad49755 TCGA-24-2290-01A-01W-0799-08 TCGA-24-2290-01A-01R-0711-07 |
|
|
365 |
TCGA-24-2293-01 1 TCGA-24-2293-01 506 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 5 mutation c1uster 9 TCGA-24-2293 NA NA days 506 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 47 Right TCGA-24-2293-F26598 TCGA-24-2293 TCGA-24-2293-01A NA -17235 NA 506 0 506 NA NA NA NA NA 2010-2-26 FEMALE Serous Cystadenocarcinoma No C48.1 8441/3 C48.1 YES Tumor resection NA 1.1 NO NA 1.3 NA NA G3 NA NA NA NA NA TCGA-24-2293.caf7dd79-d1f9-4061-8b50-aa8e5a4f18b7.pdf 2293 NA NA YES Partial Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 >20 mm Omentum NA A DECEASED 1995 TCGA-24-2293-01 TCGA-24-2293-01 NA 87480009-8495-4826-9d10-dbe6dc6281f1 NA TCGA-24-2293-01 NA TCGA-24-2293-01A-01D-0708-05 NA TCGA-24-2293-01A-21-1560-20 NA d554a1f1-3e8a-4b8c-a458-36e6550905dd TCGA-24-2293-01A-01D-0704-01 TCGA-24-2293-01 a40fdeac-ebb6-4f9f-9f90-837deef5095e NA TCGA-24-2293-01A-01D-0704-01 d554a1f1-3e8a-4b8c-a458-36e6550905dd NA d554a1f1-3e8a-4b8c-a458-36e6550905dd TCGA-24-2293-01A-01W-0799-08 TCGA-24-2293-01 TCGA-24-2293-01 d554a1f1-3e8a-4b8c-a458-36e6550905dd TCGA-24-2293-01A-01W-0799-08 TCGA-24-2293-01A-01R-0711-07 |
|
|
366 |
TCGA-24-2295-01 1 TCGA-24-2295-01 1007 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-24-2295 NA NA days 1007 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 69 Right TCGA-24-2295-F26605 TCGA-24-2295 TCGA-24-2295-01A Stage IIIC -25416 NA 1007 0 1007 NA 281 NA NA NA 2010-4-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.1 NA YES G3 Recurrence NA NA NA NA TCGA-24-2295.44d946e9-12ae-437b-9211-1be42b4d6439.pdf 2295 NA WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 0.4 NA NA 24 >20 mm Ovary NA A DECEASED 1995 NA NA NA 8a525a38-29e3-457d-a665-e05297e6b07a NA NA NA TCGA-24-2295-01A-01D-0708-05 NA TCGA-24-2295-01A-21-1560-20 NA NA TCGA-24-2295-01A-01D-0704-01 TCGA-24-2295-01 eb245ed7-60fc-47eb-9d75-4704c337b943 NA TCGA-24-2295-01A-01D-0704-01 NA NA NA NA TCGA-24-2295-01 NA NA NA TCGA-24-2295-01A-01R-0711-07 |
|
|
367 |
TCGA-24-2297-01 1 TCGA-24-2297-01 1699 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-24-2297 NA NA days 1699 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 56 Bilateral TCGA-24-2297-F26612 TCGA-24-2297 TCGA-24-2297-01A Stage IIIC -20487 NA 1699 0 1699 NA NA NA NA NA 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NA G3 NA NA NA NA NA TCGA-24-2297.12b02227-4050-4d02-bdb8-939d348a4c19.pdf 2297 NA NA YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 24 >20 mm Ovary NA A DECEASED 1993 TCGA-24-2297-01 TCGA-24-2297-01 NA 971a0b51-b807-436b-ac4c-ef9cc2e2038d NA TCGA-24-2297-01 NA TCGA-24-2297-01A-01D-0708-05 NA TCGA-24-2297-01A-21-1560-20 NA 2b0089bc-b493-4179-bf5c-e58550e1ee5b TCGA-24-2297-01A-01D-0704-01 TCGA-24-2297-01 f700e3e2-462f-4889-82fa-ac614983d642 NA TCGA-24-2297-01A-01D-0704-01 2b0089bc-b493-4179-bf5c-e58550e1ee5b NA 2b0089bc-b493-4179-bf5c-e58550e1ee5b NA TCGA-24-2297-01 TCGA-24-2297-01 2b0089bc-b493-4179-bf5c-e58550e1ee5b NA TCGA-24-2297-01A-01R-0711-07 |
|
|
368 |
TCGA-24-2298-01 1 TCGA-24-2298-01 1620 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-24-2298 NA NA days 1620 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-24-2298-F26616 TCGA-24-2298 TCGA-24-2298-01A Stage IIIC -20453 NA 1620 0 1620 NA 469 NA NA NA 2010-3-16 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-24-2298.fe9d7bf4-a278-4842-b911-018d0127ef20.pdf 2298 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 24 >20 mm Ovary NA A DECEASED 1993 TCGA-24-2298-01 TCGA-24-2298-01 NA 9c71ce7f-4e80-46bc-b66c-c893614dd207 NA TCGA-24-2298-01 NA TCGA-24-2298-01A-01D-0708-05 NA TCGA-24-2298-01A-21-1560-20 NA 7b39cb0a-7152-4037-9989-57545a1df980 TCGA-24-2298-01A-01D-0704-01 TCGA-24-2298-01 a99356d2-7d94-4274-9720-3defe513159a NA TCGA-24-2298-01A-01D-0704-01 7b39cb0a-7152-4037-9989-57545a1df980 NA 7b39cb0a-7152-4037-9989-57545a1df980 TCGA-24-2298-01A-01W-0799-08 TCGA-24-2298-01 TCGA-24-2298-01 7b39cb0a-7152-4037-9989-57545a1df980 TCGA-24-2298-01A-01W-0799-08 TCGA-24-2298-01A-01R-0711-07 |
|
|
369 |
TCGA-25-1312-01 1 TCGA-25-1312-01 31 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-25-1312 NA NA days 31 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 69 Left TCGA-25-1312-F26626 TCGA-25-1312 TCGA-25-1312-01A Stage IV -25537 NA 31 0 31 NA NA NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2.5 NO NA 3 NA NA G3 NA NA NA NA NA TCGA-25-1312.9AD5ADDB-713E-4FF7-97F1-123FA771AC5B.pdf 1312 NA NA NA NA NA NO NA Primary Tumor 01 1 NA NA 25 1-10 mm Ovary NA A DECEASED 2001 TCGA-25-1312-01 TCGA-25-1312-01 NA c31a0d45-5e8c-4fcb-b773-1bd3744b5eea NA TCGA-25-1312-01 NA TCGA-25-1312-01A-01D-0460-05 NA TCGA-25-1312-01A-11-1562-20 NA 0d7561dc-7069-41df-ba49-8fcd4df52efb TCGA-25-1312-01A-01D-0452-01 TCGA-25-1312-01 43e59c4e-4bf0-45d0-9c02-1d1c43eeef9b NA TCGA-25-1312-01A-01D-0452-01 0d7561dc-7069-41df-ba49-8fcd4df52efb NA 0d7561dc-7069-41df-ba49-8fcd4df52efb NA TCGA-25-1312-01 TCGA-25-1312-01 0d7561dc-7069-41df-ba49-8fcd4df52efb NA TCGA-25-1312-01A-01R-0456-07 |
|
|
370 |
TCGA-25-1313-01 1 TCGA-25-1313-01 820 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 13 TCGA-25-1313 NA NA days 820 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 62 Bilateral TCGA-25-1313-F26628 TCGA-25-1313 TCGA-25-1313-01A Stage IV -22982 NA 820 0 820 NA 394 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 2 NA NA G3 Recurrence NA NA NA NA TCGA-25-1313.3F5AAE21-3694-4AC2-8A18-4970090A08F4.pdf 1313 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NA NA Primary Tumor 01 1.5 NA NA 25 1-10 mm Ovary NA A DECEASED 2000 TCGA-25-1313-01 TCGA-25-1313-01 NA 5e71901f-ac21-4d6d-8705-ab20c65ec0f0 NA TCGA-25-1313-01 NA TCGA-25-1313-01A-01D-0460-05 NA TCGA-25-1313-01A-21-1562-20 NA ab99683f-6116-463d-8bf6-5782809d4729 TCGA-25-1313-01A-01D-0452-01 TCGA-25-1313-01 291a8a6a-23e2-42c9-a260-8696b9795cf2 NA TCGA-25-1313-01A-01D-0452-01 ab99683f-6116-463d-8bf6-5782809d4729 NA ab99683f-6116-463d-8bf6-5782809d4729 TCGA-25-1313-01A-01W-0492-08 TCGA-25-1313-01 TCGA-25-1313-01 ab99683f-6116-463d-8bf6-5782809d4729 TCGA-25-1313-01A-01W-0492-08 TCGA-25-1313-01A-01R-0456-07 |
|
|
371 |
TCGA-25-1314-01 1 TCGA-25-1314-01 1004 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-25-1314 NA NA days 1004 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 42 Bilateral TCGA-25-1314-F26633 TCGA-25-1314 NA Stage IV -15462 NA 1004 0 974 NA 274 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Progression of Disease NA NA NA NA NA 1314 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 NA NA NA 25 1-10 mm Ovary NA NA DECEASED 2000 TCGA-25-1314-01 TCGA-25-1314-01 NA da862d11-c970-44ee-af78-1179902f9310 NA TCGA-25-1314-01 NA TCGA-25-1314-01A-01D-0460-05 NA TCGA-25-1314-01A-21-1562-20 NA b571f7cf-e9b8-493f-822b-a489f114420b TCGA-25-1314-01A-01D-0452-01 TCGA-25-1314-01 b17945ba-39d6-400d-8e3e-e81123595c51 NA TCGA-25-1314-01A-01D-0452-01 b571f7cf-e9b8-493f-822b-a489f114420b NA b571f7cf-e9b8-493f-822b-a489f114420b NA TCGA-25-1314-01 TCGA-25-1314-01 b571f7cf-e9b8-493f-822b-a489f114420b NA TCGA-25-1314-01A-01R-0456-07 |
|
|
372 |
TCGA-25-1315-01 1 TCGA-25-1315-01 1583 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-25-1315 NA NA days 1583 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-25-1315-F26639 TCGA-25-1315 TCGA-25-1315-01A Stage IIIC -18263 NA 1583 0 1553 NA 153 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2 NO NA 3.5 NA NA G3 Progression of Disease NA NA NA NA TCGA-25-1315.486E22A0-A224-4471-BA52-9F52E021B131.pdf 1315 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 0.9 NA NA 25 1-10 mm Ovary NA A DECEASED 2000 TCGA-25-1315-01 TCGA-25-1315-01 NA 6f8cdfc3-aada-43e2-a9ce-9d8d437b9442 NA TCGA-25-1315-01 NA TCGA-25-1315-01A-01D-0460-05 TCGA-25-1315-01A-01W-0494-09 TCGA-25-1315-01A-21-1562-20 TCGA-25-1315-01A-01W-0494-09 b6908d33-80c8-4fc0-bd1d-829ec3161527 TCGA-25-1315-01A-01D-0452-01 TCGA-25-1315-01 1ecf4db0-2d32-4ad5-a14a-ce5065f7fb01 NA TCGA-25-1315-01A-01D-0452-01 b6908d33-80c8-4fc0-bd1d-829ec3161527 NA b6908d33-80c8-4fc0-bd1d-829ec3161527 NA TCGA-25-1315-01 TCGA-25-1315-01 b6908d33-80c8-4fc0-bd1d-829ec3161527 TCGA-25-1315-01A-01W-0494-09 TCGA-25-1315-01A-01R-0456-07 |
|
|
373 |
TCGA-25-1316-01 1 TCGA-25-1316-01 1279 1 days BRCA-LUAD+ C9-OV OV-like c1 UCEC-like c5 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 12 TCGA-25-1316 NA NA days 1279 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Right TCGA-25-1316-F26646 TCGA-25-1316 TCGA-25-1316-01A Stage IIIC -20331 NA 1279 0 1126 NA 276 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2.5 NO NA 3 NA NA G3 Progression of Disease NA NA NA NA TCGA-25-1316.B766CB7E-C4EC-489C-AEF0-BE28132D5BA5.pdf 1316 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 1.5 NA NA 25 1-10 mm Ovary NA A DECEASED 2000 TCGA-25-1316-01 TCGA-25-1316-01 NA 5c167e3e-7757-4a02-b218-81c2ba107bfa NA TCGA-25-1316-01 NA TCGA-25-1316-01A-01D-0460-05 TCGA-25-1316-01A-01W-0494-09 TCGA-25-1316-01A-21-20 TCGA-25-1316-01A-01W-0494-09 6cb5e275-1284-482b-a4e9-933acf9aad44 TCGA-25-1316-01A-01D-0452-01 TCGA-25-1316-01 4d3e28c0-7510-4c0e-a4c2-d2af7bcb82b4 NA TCGA-25-1316-01A-01D-0452-01 6cb5e275-1284-482b-a4e9-933acf9aad44 NA 6cb5e275-1284-482b-a4e9-933acf9aad44 NA TCGA-25-1316-01 TCGA-25-1316-01 6cb5e275-1284-482b-a4e9-933acf9aad44 TCGA-25-1316-01A-01W-0494-09 TCGA-25-1316-01A-01R-0456-07 |
|
|
374 |
TCGA-25-1317-01 1 TCGA-25-1317-01 61 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-25-1317 NA NA days 61 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 66 Bilateral TCGA-25-1317-F26651 TCGA-25-1317 TCGA-25-1317-01A Stage IIIC -24199 NA 61 0 NA NA NA NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.4 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-25-1317.5DC53520-0991-42B6-B10D-0D62C3F92BAD.pdf 1317 NA NA YES NA NA NO NA Primary Tumor 01 0.5 NA NA 25 NA Ovary NA A DECEASED 2000 TCGA-25-1317-01 TCGA-25-1317-01 TCGA-25-1317-01A-01W-0490-10 5b49f5cc-28fd-4b1e-ae8e-6391f99ccb46 NA TCGA-25-1317-01 TCGA-25-1317-01A-01W-0490-10 TCGA-25-1317-01A-01D-0460-05 NA NA NA 423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf TCGA-25-1317-01A-01D-0452-01 TCGA-25-1317-01 NA NA TCGA-25-1317-01A-01D-0452-01 423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf NA 423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf NA TCGA-25-1317-01 TCGA-25-1317-01 423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf TCGA-25-1317-01A-01W-0490-10 TCGA-25-1317-01A-01R-0456-07 |
|
|
375 |
TCGA-25-1318-01 1 TCGA-25-1318-01 1064 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1318 NA NA days 1064 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-25-1318-F26655 TCGA-25-1318 TCGA-25-1318-01A Stage IIIC -19755 NA 1064 0 1064 NA 185 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2 NO NA 4.5 NA NA G3 Recurrence NA NA NA NA TCGA-25-1318.D9B9F69A-265C-42F4-BCD2-4B136A7FE935.pdf 1318 NA WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 0.8 NA NA 25 1-10 mm Ovary NA A DECEASED 2000 TCGA-25-1318-01 TCGA-25-1318-01 TCGA-25-1318-01A-01W-0490-10 f912d9b2-2f49-4c3f-aed0-3edc0065d54b NA TCGA-25-1318-01 TCGA-25-1318-01A-01W-0490-10 TCGA-25-1318-01A-01D-0460-05 NA TCGA-25-1318-01A-21-1562-20 NA 4d3e0164-1346-4e8e-b478-29bd8b1f1ce5 TCGA-25-1318-01A-01D-0452-01 TCGA-25-1318-01 2f954b2b-ab8d-4f81-8717-e85d500987ee NA TCGA-25-1318-01A-01D-0452-01 4d3e0164-1346-4e8e-b478-29bd8b1f1ce5 NA 4d3e0164-1346-4e8e-b478-29bd8b1f1ce5 NA TCGA-25-1318-01 TCGA-25-1318-01 4d3e0164-1346-4e8e-b478-29bd8b1f1ce5 TCGA-25-1318-01A-01W-0490-10 TCGA-25-1318-01A-01R-0456-07 |
|
|
376 |
TCGA-25-1319-01 1 TCGA-25-1319-01 1977 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1319 NA NA days 1977 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 73 Bilateral TCGA-25-1319-F26660 TCGA-25-1319 TCGA-25-1319-01A Stage IIIC -26786 NA 1977 0 1977 NA 730 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2.5 NO NA 3 NA NA G3 Recurrence NA NA NA NA TCGA-25-1319.62BFD64E-1C60-49A8-BAD0-B173DD22C951.pdf 1319 NA NA YES NA NA NO NA Primary Tumor 01 1 NA NA 25 11-20 mm Ovary NA A DECEASED 2000 TCGA-25-1319-01 TCGA-25-1319-01 NA 7f028062-e863-4f7d-8ec6-8e91da60fc74 NA TCGA-25-1319-01 NA TCGA-25-1319-01A-01D-0460-05 NA TCGA-25-1319-01A-21-1562-20 NA 8f0f34fb-bbef-4a17-8324-4ebda56f9e0e TCGA-25-1319-01A-01D-0452-01 TCGA-25-1319-01 09ef1041-497f-409f-9892-b5a1631a647f NA TCGA-25-1319-01A-01D-0452-01 8f0f34fb-bbef-4a17-8324-4ebda56f9e0e NA 8f0f34fb-bbef-4a17-8324-4ebda56f9e0e TCGA-25-1319-01A-01W-0492-08 TCGA-25-1319-01 TCGA-25-1319-01 8f0f34fb-bbef-4a17-8324-4ebda56f9e0e TCGA-25-1319-01A-01W-0492-08 TCGA-25-1319-01A-01R-0456-07 |
|
|
377 |
TCGA-25-1320-01 1 TCGA-25-1320-01 1155 1 days High C9-OV OV-like c1 BRCA basal-like c6 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-25-1320 NA NA days 1155 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-25-1320-F26664 TCGA-25-1320 TCGA-25-1320-01A Stage IIIC -24018 NA 1155 0 1124 NA 424 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 3 NO NA 3.4 NA NA G3 Recurrence NA NA NA NA TCGA-25-1320.AF68EF8D-A31D-453B-8083-CF6B9EE4E838.pdf 1320 NA WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 1 NA NA 25 1-10 mm Ovary NA A DECEASED 2001 TCGA-25-1320-01 TCGA-25-1320-01 NA 7a1cfa3d-a19e-42b1-91b5-485891ff2d34 NA TCGA-25-1320-01 NA TCGA-25-1320-01A-01D-0460-05 NA TCGA-25-1320-01A-21-1562-20 NA 52697815-ede2-4ce3-a6d0-2680f6b9bb73 TCGA-25-1320-01A-01D-0452-01 TCGA-25-1320-01 d1b3fd86-d1f2-4621-980a-19f3d9ee76f4 NA TCGA-25-1320-01A-01D-0452-01 52697815-ede2-4ce3-a6d0-2680f6b9bb73 NA 52697815-ede2-4ce3-a6d0-2680f6b9bb73 TCGA-25-1320-01A-01W-0492-08 TCGA-25-1320-01 TCGA-25-1320-01 52697815-ede2-4ce3-a6d0-2680f6b9bb73 TCGA-25-1320-01A-01W-0492-08 TCGA-25-1320-01A-01R-0456-07 |
|
|
378 |
TCGA-25-1321-01 1 TCGA-25-1321-01 1033 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-25-1321 NA NA days 1033 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-25-1321-F26670 TCGA-25-1321 TCGA-25-1321-01A Stage IIIC -23987 NA 1033 0 1033 NA 454 0 NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.6 NO NA 3 NA NA G3 Recurrence NA NA NA NA TCGA-25-1321.5D309784-AED1-4946-817D-37AC8969315C.pdf 1321 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.8 NA NA 25 No Macroscopic disease Ovary NA A DECEASED 2001 TCGA-25-1321-01 TCGA-25-1321-01 NA 8f9bea4f-6738-429b-8ebb-8ae8cf65d294 NA TCGA-25-1321-01 NA TCGA-25-1321-01A-01D-0460-05 NA TCGA-25-1321-01A-21-1562-20 NA 74ad9d3e-97a9-419d-8842-3fb37d3f099a TCGA-25-1321-01A-01D-0452-01 TCGA-25-1321-01 9790631d-f673-415e-8644-5419b2b956b2 NA TCGA-25-1321-01A-01D-0452-01 74ad9d3e-97a9-419d-8842-3fb37d3f099a NA 74ad9d3e-97a9-419d-8842-3fb37d3f099a TCGA-25-1321-01A-01W-0492-08 TCGA-25-1321-01 TCGA-25-1321-01 74ad9d3e-97a9-419d-8842-3fb37d3f099a TCGA-25-1321-01A-01W-0492-08 TCGA-25-1321-01A-01R-0456-07 |
|
|
379 |
TCGA-25-1322-01 1 TCGA-25-1322-01 91 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1322 NA NA days 91 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Bilateral TCGA-25-1322-F26676 TCGA-25-1322 TCGA-25-1322-01A Stage IV -22646 NA 91 0 91 NA NA NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.8 NO NA 2.6 NA NA G3 NA NA NA NA NA TCGA-25-1322.6EAF4358-51F9-4999-A219-39178418CC9C.pdf 1322 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.8 NA NA 25 >20 mm Ovary NA A DECEASED 2001 TCGA-25-1322-01 TCGA-25-1322-01 NA 34a7dcf3-fc87-4334-8ee0-77166a5398fa NA TCGA-25-1322-01 NA TCGA-25-1322-01A-01D-0460-05 TCGA-25-1322-01A-01W-0494-09 TCGA-25-1322-01A-21-20 TCGA-25-1322-01A-01W-0494-09 bce04e1e-a90c-4e81-bd16-415cccc9d7e2 TCGA-25-1322-01A-01D-0452-01 TCGA-25-1322-01 90cba3ae-e75e-4a1e-bc31-293ac260cf96 NA TCGA-25-1322-01A-01D-0452-01 bce04e1e-a90c-4e81-bd16-415cccc9d7e2 NA bce04e1e-a90c-4e81-bd16-415cccc9d7e2 NA TCGA-25-1322-01 TCGA-25-1322-01 bce04e1e-a90c-4e81-bd16-415cccc9d7e2 TCGA-25-1322-01A-01W-0494-09 TCGA-25-1322-01A-01R-0456-07 |
|
|
380 |
TCGA-25-1323-01 1 TCGA-25-1323-01 395 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 1 NA TCGA-25-1323 NA NA days 395 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 72 Bilateral TCGA-25-1323-F26680 TCGA-25-1323 TCGA-25-1323-01A Stage IIIC -26602 NA 395 0 365 NA 365 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2 NO NA 2.5 NA NA G3 Progression of Disease NA NA NA NA TCGA-25-1323.AFE55BB2-F0FC-4B39-A61A-2287B62354AD.pdf 1323 NA WITH TUMOR YES Complete Remission/Response Physical Examination NO NA Primary Tumor 01 0.6 NA NA 25 1-10 mm Ovary NA A DECEASED 2001 TCGA-25-1323-01 TCGA-25-1323-01 NA 61b1bbe5-434f-4d88-aadb-a42344b0e0fb NA TCGA-25-1323-01 NA TCGA-25-1323-01A-01D-0460-05 NA TCGA-25-1323-01A-21-1562-20 NA cd401b89-ae05-4775-94b0-6800f88652b0 TCGA-25-1323-01A-01D-0452-01 TCGA-25-1323-01 e89ce7f4-4c3f-4c48-a222-506d3806ad33 NA TCGA-25-1323-01A-01D-0452-01 cd401b89-ae05-4775-94b0-6800f88652b0 NA cd401b89-ae05-4775-94b0-6800f88652b0 NA TCGA-25-1323-01 TCGA-25-1323-01 cd401b89-ae05-4775-94b0-6800f88652b0 NA TCGA-25-1323-01A-01R-0456-07 |
|
|
381 |
TCGA-25-1324-01 1 TCGA-25-1324-01 1035 1 days NA NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 11 TCGA-25-1324 NA NA days 1035 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 74 Bilateral TCGA-25-1324-F26685 TCGA-25-1324 TCGA-25-1324-01A Stage IIIC -27090 NA 1035 0 1035 NA NA NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-25-1324.53AE406F-E6E6-4137-A7B3-01DAFAEDE783.pdf 1324 NA NA YES NA NA NO NA Primary Tumor 01 0.8 NA NA 25 1-10 mm Ovary NA A DECEASED 2001 TCGA-25-1324-01 TCGA-25-1324-01 TCGA-25-1324-01A-01W-0490-10 dadc9a44-fbec-4109-b5e5-4a21ad28eb63 NA TCGA-25-1324-01 TCGA-25-1324-01A-01W-0490-10 TCGA-25-1324-01A-01D-0460-05 NA NA NA 790c6d79-9f7d-4e9a-89db-43b26fe16816 NA TCGA-25-1324-01 NA NA NA 790c6d79-9f7d-4e9a-89db-43b26fe16816 NA 790c6d79-9f7d-4e9a-89db-43b26fe16816 NA NA NA 790c6d79-9f7d-4e9a-89db-43b26fe16816 TCGA-25-1324-01A-01W-0490-10 TCGA-25-1324-01A-01R-0456-07 |
|
|
382 |
TCGA-25-1325-01 1 TCGA-25-1325-01 976 1 days NA NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 NA TCGA-25-1325 NA NA days 976 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 77 Left TCGA-25-1325-F26689 TCGA-25-1325 TCGA-25-1325-01A Stage IV -28183 NA 976 0 976 NA NA NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.4 NO NA 5 NA NA G3 NA NA NA NA NA TCGA-25-1325.E9315413-584C-4F29-B05D-657DB9A0B4F5.pdf 1325 NA NA NA NA NA NO NA Primary Tumor 01 1.3 NA NA 25 >20 mm Ovary NA A DECEASED 2002 NA TCGA-25-1325-01 TCGA-25-1325-01A-01W-0490-10 7d8ca51a-3995-47a6-89ad-63ffd81e32a0 NA TCGA-25-1325-01 TCGA-25-1325-01A-01W-0490-10 TCGA-25-1325-01A-01D-0460-05 NA TCGA-25-1325-01A-21-1562-20 NA NA NA TCGA-25-1325-01 8896ef4e-3809-4ed8-befa-a014b7b81da1 NA NA NA NA NA NA NA NA NA NA TCGA-25-1325-01A-01R-0456-07 |
|
|
383 |
TCGA-25-1326-01 1 TCGA-25-1326-01 1249 1 days NA C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1326 NA NA days 1249 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-25-1326-F26691 TCGA-25-1326 TCGA-25-1326-01A Stage IIIC -22339 NA 1249 0 945 NA 396 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2.5 NO NA 3 NA NA G3 Recurrence NA NA NA NA TCGA-25-1326.B17E5B27-48DB-4E64-A1C3-CAE4921C14DF.pdf 1326 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 1.2 NA NA 25 1-10 mm Ovary NA A DECEASED 2002 TCGA-25-1326-01 TCGA-25-1326-01 NA f01d69dc-1d50-4afb-83de-8124b93685a9 NA TCGA-25-1326-01 NA TCGA-25-1326-01A-01D-0460-05 NA TCGA-25-1326-01A-21-1562-20 NA b29bd766-95b1-46fa-a070-d2206cd5722a NA TCGA-25-1326-01 6e7bb043-ec9a-4648-9acd-14526dca800e NA NA b29bd766-95b1-46fa-a070-d2206cd5722a NA b29bd766-95b1-46fa-a070-d2206cd5722a TCGA-25-1326-01A-01W-0492-08 NA NA b29bd766-95b1-46fa-a070-d2206cd5722a TCGA-25-1326-01A-01W-0492-08 TCGA-25-1326-01A-01R-0456-07 |
|
|
384 |
TCGA-25-1328-01 1 TCGA-25-1328-01 2009 1 days NA C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-25-1328 NA NA days 2009 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 38 Bilateral TCGA-25-1328-F26698 TCGA-25-1328 TCGA-25-1328-01A Stage IIIC -13911 NA 2009 0 1979 NA 244 NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.8 NO NA 2.8 NA NA G3 Recurrence NA NA NA NA TCGA-25-1328.A2DA7EB3-8E42-4E86-9352-99673F51AEFF.pdf 1328 NA WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 1 NA NA 25 1-10 mm Ovary NA A DECEASED 2001 TCGA-25-1328-01 TCGA-25-1328-01 NA 73b10e0b-cb82-49ec-8bdd-07d79bc2b8d6 NA TCGA-25-1328-01 NA TCGA-25-1328-01A-01D-0460-05 NA TCGA-25-1328-01A-21-1562-20 NA 9ba8d6bf-1541-4127-bc60-73091d2d81c7 NA TCGA-25-1328-01 d064cdc4-ad95-4e85-b9b0-6871d9c2698d NA NA 9ba8d6bf-1541-4127-bc60-73091d2d81c7 NA 9ba8d6bf-1541-4127-bc60-73091d2d81c7 TCGA-25-1328-01A-01W-0492-08 NA NA 9ba8d6bf-1541-4127-bc60-73091d2d81c7 TCGA-25-1328-01A-01W-0492-08 TCGA-25-1328-01A-01R-0456-07 |
|
|
385 |
TCGA-25-1329-01 1 TCGA-25-1329-01 457 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1329 NA NA days 457 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 76 Bilateral TCGA-25-1329-F26705 TCGA-25-1329 TCGA-25-1329-01A Stage IIIC -28093 NA 457 0 90 NA NA NA NA NA 2009-3-27 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2.6 NO NA 3 NA NA G3 NA NA NA NA NA TCGA-25-1329.857409C6-75EC-4935-85BC-6D5F66AF4DB3.pdf 1329 NA NA YES NA NA NA NA Primary Tumor 01 0.6 NA NA 25 11-20 mm Ovary NA A DECEASED 2002 TCGA-25-1329-01 TCGA-25-1329-01 NA 3bd2e158-9743-44cd-a5c3-0ba7179b8660 NA TCGA-25-1329-01 NA TCGA-25-1329-01A-01D-0460-05 NA TCGA-25-1329-01A-21-1562-20 NA 5cf09ce6-44b1-4f0e-89ac-3ea302d684d8 TCGA-25-1329-01A-01D-0452-01 TCGA-25-1329-01 299168d0-39ac-4d64-9345-88fe0f6746ee NA TCGA-25-1329-01A-01D-0452-01 5cf09ce6-44b1-4f0e-89ac-3ea302d684d8 NA 5cf09ce6-44b1-4f0e-89ac-3ea302d684d8 TCGA-25-1329-01A-01W-0492-08 TCGA-25-1329-01 TCGA-25-1329-01 5cf09ce6-44b1-4f0e-89ac-3ea302d684d8 TCGA-25-1329-01A-01W-0492-08 TCGA-25-1329-01A-01R-0456-07 |
|
|
386 |
TCGA-25-1623-01 1 TCGA-25-1623-01 565 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-25-1623 NA NA days 565 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-25-1623-F26707 TCGA-25-1623 TCGA-25-1623-01A Stage IV -26060 NA 565 0 565 NA 342 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.8 NA NA G3 Recurrence NA NA NA NA TCGA-25-1623.A57CB221-076A-4EE5-8C77-D1E33070597C.pdf 1623 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 25 No Macroscopic disease Ovary NA A DECEASED 2006 TCGA-25-1623-01 TCGA-25-1623-01 TCGA-25-1623-01A-01W-0615-10 47640c72-6c10-4956-8a89-0c5f0b12cc49 NA TCGA-25-1623-01 TCGA-25-1623-01A-01W-0615-10 TCGA-25-1623-01A-01D-0536-05 NA TCGA-25-1623-01A-21-1558-20 NA 3e4f0ca7-8428-47df-80a3-3bc9153aedfa TCGA-25-1623-01A-01D-0533-01 TCGA-25-1623-01 ef62a625-cf2c-45d1-aa59-9d44e16a37fa NA TCGA-25-1623-01A-01D-0533-01 3e4f0ca7-8428-47df-80a3-3bc9153aedfa NA 3e4f0ca7-8428-47df-80a3-3bc9153aedfa NA TCGA-25-1623-01 TCGA-25-1623-01 3e4f0ca7-8428-47df-80a3-3bc9153aedfa TCGA-25-1623-01A-01W-0615-10 TCGA-25-1623-01A-01R-0540-07 |
|
|
387 |
TCGA-25-1625-01 1 TCGA-25-1625-01 840 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-1625 NA NA days 840 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 Bilateral TCGA-25-1625-F26712 TCGA-25-1625 TCGA-25-1625-01A Stage IIIC -24298 NA 840 0 548 NA 526 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-25-1625.BDE314E3-1E2C-440E-8561-A260C1D0933A.pdf 1625 NA WITH TUMOR YES Stable Disease Imaging Study NO NA Primary Tumor 01 0.3 NA NA 25 1-10 mm Ovary NA A DECEASED 2006 TCGA-25-1625-01 TCGA-25-1625-01 TCGA-25-1625-01A-01W-0615-10 b176a30a-0977-46e6-b577-a421ca9bb340 NA TCGA-25-1625-01 TCGA-25-1625-01A-01W-0615-10 TCGA-25-1625-01A-01D-0536-05 NA TCGA-25-1625-01A-21-1558-20 NA 921fab94-5522-4c08-8e02-13fb6ea2d388 TCGA-25-1625-01A-01D-0533-01 TCGA-25-1625-01 ffb78d5c-46f5-4f3a-8572-55df5db80a1d NA TCGA-25-1625-01A-01D-0533-01 921fab94-5522-4c08-8e02-13fb6ea2d388 NA 921fab94-5522-4c08-8e02-13fb6ea2d388 NA TCGA-25-1625-01 TCGA-25-1625-01 921fab94-5522-4c08-8e02-13fb6ea2d388 TCGA-25-1625-01A-01W-0615-10 TCGA-25-1625-01A-01R-0540-07 |
|
|
388 |
TCGA-25-1626-01 1 TCGA-25-1626-01 518 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-25-1626 NA NA days 518 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Right TCGA-25-1626-F26716 TCGA-25-1626 TCGA-25-1626-01A Stage IIIC -23932 NA 518 0 481 NA 318 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.4 NA NA G3 Recurrence NA NA NA NA TCGA-25-1626.4B54A1C9-6F08-435B-B85F-736D4278EA82.pdf 1626 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 25 >20 mm Ovary NA A DECEASED 2006 TCGA-25-1626-01 TCGA-25-1626-01 TCGA-25-1626-01A-01W-0615-10 a1ed5a8a-8ac2-4d94-96e0-92bb4dcc8af6 NA TCGA-25-1626-01 TCGA-25-1626-01A-01W-0615-10 TCGA-25-1626-01A-01D-0536-05 NA TCGA-25-1626-01A-21-1558-20 NA daaba89d-acd3-4670-a618-89e5973b03f4 TCGA-25-1626-01A-01D-0533-01 TCGA-25-1626-01 7a9090de-0e14-4fc3-a2d7-c42629b3afd7 NA TCGA-25-1626-01A-01D-0533-01 daaba89d-acd3-4670-a618-89e5973b03f4 NA daaba89d-acd3-4670-a618-89e5973b03f4 NA TCGA-25-1626-01 TCGA-25-1626-01 daaba89d-acd3-4670-a618-89e5973b03f4 TCGA-25-1626-01A-01W-0615-10 TCGA-25-1626-01A-01R-0540-07 |
|
|
389 |
TCGA-25-1627-01 1 TCGA-25-1627-01 394 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-25-1627 NA NA days 394 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 Bilateral TCGA-25-1627-F26722 TCGA-25-1627 TCGA-25-1627-01A Stage IIIC -26784 NA 394 0 11 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-25-1627.FB36B0F9-6519-4CF5-9A74-F7015FD405FF.pdf 1627 NA NA YES NA NA NO NA Primary Tumor 01 0.3 NA NA 25 1-10 mm Ovary NA A DECEASED 2003 TCGA-25-1627-01 TCGA-25-1627-01 TCGA-25-1627-01A-01W-0615-10 d1eafd5b-5036-44dd-b902-92951e9d31c5 NA TCGA-25-1627-01 TCGA-25-1627-01A-01W-0615-10 TCGA-25-1627-01A-01D-0536-05 NA TCGA-25-1627-01A-21-1558-20 NA 0fc68715-c7fc-4481-a5bf-68a281f5ec64 TCGA-25-1627-01A-01D-0533-01 TCGA-25-1627-01 a2210172-a1e0-4bbf-a38a-363571251f90 NA TCGA-25-1627-01A-01D-0533-01 0fc68715-c7fc-4481-a5bf-68a281f5ec64 NA 0fc68715-c7fc-4481-a5bf-68a281f5ec64 NA TCGA-25-1627-01 TCGA-25-1627-01 0fc68715-c7fc-4481-a5bf-68a281f5ec64 TCGA-25-1627-01A-01W-0615-10 TCGA-25-1627-01A-01R-0540-07 |
|
|
390 |
TCGA-25-1628-01 1 TCGA-25-1628-01 627 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1628 NA NA days 627 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 NA TCGA-25-1628-F26724 TCGA-25-1628 TCGA-25-1628-01A Stage IIIC -24488 NA 627 0 627 NA 287 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 2 NA NA G3 Recurrence NA NA NA NA TCGA-25-1628.790D6E48-15D0-45F9-B6DD-182787298EBA.pdf 1628 NA WITH TUMOR YES Stable Disease Imaging Study NO NA Primary Tumor 01 0.4 NA NA 25 1-10 mm Ovary NA A DECEASED 2002 TCGA-25-1628-01 TCGA-25-1628-01 TCGA-25-1628-01A-01W-0615-10 7db7c522-1983-4b98-b630-2ddbd5d4aefa NA TCGA-25-1628-01 TCGA-25-1628-01A-01W-0615-10 TCGA-25-1628-01A-01D-0536-05 NA TCGA-25-1628-01A-21-1558-20 NA a3083fd8-f5d0-486b-bf3d-31ae094b1cbf TCGA-25-1628-01A-01D-0533-01 TCGA-25-1628-01 f7ac6f1b-7ee1-4536-84ae-48d20a61df99 NA TCGA-25-1628-01A-01D-0533-01 a3083fd8-f5d0-486b-bf3d-31ae094b1cbf NA a3083fd8-f5d0-486b-bf3d-31ae094b1cbf NA TCGA-25-1628-01 TCGA-25-1628-01 a3083fd8-f5d0-486b-bf3d-31ae094b1cbf TCGA-25-1628-01A-01W-0615-10 TCGA-25-1628-01A-01R-0540-07 |
|
|
391 |
TCGA-25-1630-01 1 TCGA-25-1630-01 1162 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-1630 NA NA days 1162 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 Bilateral TCGA-25-1630-F26729 TCGA-25-1630 NA Stage IIIC -27006 NA 1162 0 239 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 1630 NA NA YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 25 1-10 mm Ovary NA NA DECEASED 2002 TCGA-25-1630-01 TCGA-25-1630-01 TCGA-25-1630-01A-01W-0615-10 f497f9fd-9a0e-446e-98fa-265e325e194e NA TCGA-25-1630-01 TCGA-25-1630-01A-01W-0615-10 TCGA-25-1630-01A-01D-0536-05 NA TCGA-25-1630-01A-21-1558-20 NA c5a82b6e-048d-4377-9b6c-4417ba1876fe TCGA-25-1630-01A-01D-0533-01 TCGA-25-1630-01 c0b3ff41-c34a-4f86-b029-5a761ff85b2e NA TCGA-25-1630-01A-01D-0533-01 c5a82b6e-048d-4377-9b6c-4417ba1876fe NA c5a82b6e-048d-4377-9b6c-4417ba1876fe NA TCGA-25-1630-01 TCGA-25-1630-01 c5a82b6e-048d-4377-9b6c-4417ba1876fe TCGA-25-1630-01A-01W-0615-10 TCGA-25-1630-01A-01R-0540-07 |
|
|
392 |
TCGA-25-1631-01 1 TCGA-25-1631-01 9 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-1631 NA NA days 9 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 Bilateral TCGA-25-1631-F26733 TCGA-25-1631 TCGA-25-1631-01A Stage IIIC -26687 NA 9 0 9 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2 NO NA 2 NA NA G3 NA NA NA NA NA TCGA-25-1631.1C74F61E-1131-4782-8117-20C59B86D845.pdf 1631 NA TUMOR FREE NO NA NA NO NA Primary Tumor 01 0.4 NA NA 25 1-10 mm Ovary NA A DECEASED 2002 TCGA-25-1631-01 TCGA-25-1631-01 TCGA-25-1631-01A-01W-0615-10 2fab3946-dfac-449c-971a-9312801bbe51 NA TCGA-25-1631-01 TCGA-25-1631-01A-01W-0615-10 TCGA-25-1631-01A-01D-0536-05 NA TCGA-25-1631-01A-21-1558-20 NA 29c4cab9-c19e-4416-ad88-484cc02a980f TCGA-25-1631-01A-01D-0533-01 TCGA-25-1631-01 51225525-5680-46ab-8e00-f35ed4df6470 NA TCGA-25-1631-01A-01D-0533-01 29c4cab9-c19e-4416-ad88-484cc02a980f NA 29c4cab9-c19e-4416-ad88-484cc02a980f NA TCGA-25-1631-01 TCGA-25-1631-01 29c4cab9-c19e-4416-ad88-484cc02a980f TCGA-25-1631-01A-01W-0615-10 TCGA-25-1631-01A-01R-0540-07 |
|
|
393 |
TCGA-25-1632-01 1 TCGA-25-1632-01 1799 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 8 TCGA-25-1632 NA NA days 1799 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 68 Bilateral TCGA-25-1632-F26735 TCGA-25-1632 TCGA-25-1632-01A Stage IV -24993 NA 1799 0 1732 NA 537 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.4 NA NA G3 Recurrence NA NA NA NA TCGA-25-1632.F083C2B4-20DE-440F-B6A8-2F332346CECA.pdf 1632 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 25 1-10 mm Ovary NA A DECEASED 2002 TCGA-25-1632-01 TCGA-25-1632-01 TCGA-25-1632-01A-01W-0615-10 8736b37d-cdc1-4e9e-8215-edb675c8a072 NA TCGA-25-1632-01 TCGA-25-1632-01A-01W-0615-10 TCGA-25-1632-01A-01D-0536-05 NA TCGA-25-1632-01A-21-1558-20 NA 12c78d62-6045-4f77-bd84-9ab5a38f4635 TCGA-25-1632-01A-01D-0533-01 TCGA-25-1632-01 105464b7-4efd-4ed6-a906-2dab64b49ad0 NA TCGA-25-1632-01A-01D-0533-01 12c78d62-6045-4f77-bd84-9ab5a38f4635 NA 12c78d62-6045-4f77-bd84-9ab5a38f4635 NA TCGA-25-1632-01 TCGA-25-1632-01 12c78d62-6045-4f77-bd84-9ab5a38f4635 TCGA-25-1632-01A-01W-0615-10 TCGA-25-1632-01A-01R-0540-07 |
|
|
394 |
TCGA-25-1633-01 1 TCGA-25-1633-01 1891 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-25-1633 NA NA days 1891 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Bilateral TCGA-25-1633-F26742 TCGA-25-1633 TCGA-25-1633-01A Stage IIIC -23407 NA 1891 0 1843 NA 616 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.3 NA NA G3 Recurrence NA NA NA NA TCGA-25-1633.B3B45EA2-B154-45DC-B49D-422500EA1D9C.pdf 1633 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.2 NA NA 25 1-10 mm Ovary NA A DECEASED 2002 TCGA-25-1633-01 TCGA-25-1633-01 TCGA-25-1633-01A-01W-0615-10 9f229f84-97c9-4684-8eb7-f2af666e3399 NA TCGA-25-1633-01 TCGA-25-1633-01A-01W-0615-10 TCGA-25-1633-01A-01D-0536-05 NA TCGA-25-1633-01A-21-1558-20 NA 7517c446-401d-4501-bf27-916e0835deac TCGA-25-1633-01A-01D-0533-01 TCGA-25-1633-01 a9062738-4ec8-464c-b5c9-abd82bf322bc NA TCGA-25-1633-01A-01D-0533-01 7517c446-401d-4501-bf27-916e0835deac NA 7517c446-401d-4501-bf27-916e0835deac NA TCGA-25-1633-01 TCGA-25-1633-01 7517c446-401d-4501-bf27-916e0835deac TCGA-25-1633-01A-01W-0615-10 TCGA-25-1633-01A-01R-0540-07 |
|
|
395 |
TCGA-25-1634-01 1 TCGA-25-1634-01 1091 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 1 mutation cluster 5 TCGA-25-1634 NA NA days 1091 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 75 Bilateral TCGA-25-1634-F26749 TCGA-25-1634 NA Stage IIIC -27749 NA 1091 0 1081 NA 380 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1634 NA WITH TUMOR YES Complete Remission/Response Other Method NO NA Primary Tumor 01 NA NA NA 25 No Macroscopic disease Ovary NA NA DECEASED 2002 TCGA-25-1634-01 TCGA-25-1634-01 TCGA-25-1634-01A-01W-0615-10 e3aae8d6-511b-40ce-8ade-6208c6fcdb9f NA TCGA-25-1634-01 TCGA-25-1634-01A-01W-0615-10 TCGA-25-1634-01A-01D-0536-05 NA NA NA d10f0cee-d755-43cc-8d3d-8974cea0defb TCGA-25-1634-01A-01D-0533-01 TCGA-25-1634-01 NA NA TCGA-25-1634-01A-01D-0533-01 d10f0cee-d755-43cc-8d3d-8974cea0defb NA d10f0cee-d755-43cc-8d3d-8974cea0defb NA TCGA-25-1634-01 TCGA-25-1634-01 d10f0cee-d755-43cc-8d3d-8974cea0defb TCGA-25-1634-01A-01W-0615-10 TCGA-25-1634-01A-01R-0540-07 |
|
|
396 |
TCGA-25-1635-01 1 TCGA-25-1635-01 1583 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-25-1635 NA NA days 1583 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-25-1635-F26756 TCGA-25-1635 TCGA-25-1635-01A Stage IIIC -26200 NA 1583 0 1558 NA 614 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 1.7 NA NA G3 Recurrence NA NA NA NA TCGA-25-1635.28168C52-FD75-4B43-918B-C48CC8DA9C66.pdf 1635 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 25 1-10 mm Ovary NA A DECEASED 2002 TCGA-25-1635-01 TCGA-25-1635-01 TCGA-25-1635-01A-01W-0615-10 2fc96f18-9f32-4d5f-b768-587981329254 NA TCGA-25-1635-01 TCGA-25-1635-01A-01W-0615-10 TCGA-25-1635-01A-01D-0536-05 NA TCGA-25-1635-01A-21-1558-20 NA 877d96a2-6e5c-472c-b190-59fcfd1febb4 TCGA-25-1635-01A-01D-0533-01 TCGA-25-1635-01 e22c9a04-50e5-40e2-9df0-66c86b6f3b38 NA TCGA-25-1635-01A-01D-0533-01 877d96a2-6e5c-472c-b190-59fcfd1febb4 NA 877d96a2-6e5c-472c-b190-59fcfd1febb4 NA TCGA-25-1635-01 TCGA-25-1635-01 877d96a2-6e5c-472c-b190-59fcfd1febb4 TCGA-25-1635-01A-01W-0615-10 TCGA-25-1635-01A-01R-0540-07 |
|
|
397 |
TCGA-25-1870-01 1 TCGA-25-1870-01 455 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-25-1870 NA NA days 455 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-25-1870-F26763 TCGA-25-1870 NA Stage IIIC -21550 NA 455 0 455 NA 243 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1870 NA WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 NA NA NA 25 11-20 mm Ovary NA NA DECEASED 1994 TCGA-25-1870-01 TCGA-25-1870-01 NA fc0c9f6b-6603-4200-9190-25422af07078 NA TCGA-25-1870-01 NA TCGA-25-1870-01A-01D-0652-05 NA NA NA c446d667-ea88-40fe-ad97-fd3fcceb7dd1 TCGA-25-1870-01A-01D-0648-01 TCGA-25-1870-01 NA NA TCGA-25-1870-01A-01D-0648-01 c446d667-ea88-40fe-ad97-fd3fcceb7dd1 NA c446d667-ea88-40fe-ad97-fd3fcceb7dd1 NA TCGA-25-1870-01 TCGA-25-1870-01 c446d667-ea88-40fe-ad97-fd3fcceb7dd1 NA TCGA-25-1870-01A-01R-0655-07 |
|
|
398 |
TCGA-25-1871-01 1 TCGA-25-1871-01 760 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-25-1871 NA NA days 760 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 70 Bilateral TCGA-25-1871-F26769 TCGA-25-1871 TCGA-25-1871-01A Stage IIIC -25627 NA 760 0 760 NA 230 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.7 NA NA G3 Recurrence NA NA NA NA TCGA-25-1871.737827A6-C99E-49BE-90AD-004FE8DF11F1.pdf 1871 NA WITH TUMOR YES Progressive Disease Physical Examination NO NA Primary Tumor 01 0.1 NA NA 25 11-20 mm Ovary NA A DECEASED 1993 TCGA-25-1871-01 TCGA-25-1871-01 NA 2ee780b4-d0ac-4d56-9120-fdf5e98b4249 NA TCGA-25-1871-01 NA TCGA-25-1871-01A-01D-0652-05 NA NA NA efcc36b2-e351-4875-b743-df58480bc9fb TCGA-25-1871-01A-01D-0648-01 TCGA-25-1871-01 NA NA TCGA-25-1871-01A-01D-0648-01 efcc36b2-e351-4875-b743-df58480bc9fb NA efcc36b2-e351-4875-b743-df58480bc9fb NA TCGA-25-1871-01 TCGA-25-1871-01 efcc36b2-e351-4875-b743-df58480bc9fb NA TCGA-25-1871-01A-01R-0655-07 |
|
|
399 |
TCGA-25-1877-01 1 TCGA-25-1877-01 730 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 NA TCGA-25-1877 NA NA days 730 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 81 Left TCGA-25-1877-F26774 TCGA-25-1877 TCGA-25-1877-01A Stage IIIC -29615 NA 730 0 549 NA 549 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.7 NA NA G3 Recurrence NA NA NA NA TCGA-25-1877.D98B5A1F-DF34-43E7-826F-BCB45DEC582D.pdf 1877 NA WITH TUMOR YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 25 1-10 mm Ovary NA A DECEASED 1993 NA TCGA-25-1877-01 NA 8918bbfe-a867-41ea-a137-46e704232e6d NA TCGA-25-1877-01 NA TCGA-25-1877-01A-01D-0652-05 NA NA NA NA TCGA-25-1877-01A-01D-0648-01 TCGA-25-1877-01 NA NA TCGA-25-1877-01A-01D-0648-01 NA NA NA NA TCGA-25-1877-01 NA NA NA TCGA-25-1877-01A-01R-0655-07 |
|
|
400 |
TCGA-25-1878-01 1 TCGA-25-1878-01 2587 1 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-25-1878 NA NA days 2587 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-25-1878-F26779 TCGA-25-1878 NA Stage IIIC -22035 NA 2587 0 2587 NA 971 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1878 NA WITH TUMOR YES Complete Remission/Response Molecular Markers NO NA Primary Tumor 01 NA NA NA 25 1-10 mm Ovary NA NA DECEASED 1994 NA TCGA-25-1878-01 NA f38efeef-0f8b-48f8-8ad9-caaaad82eecc NA TCGA-25-1878-01 NA TCGA-25-1878-01A-01D-0652-05 NA TCGA-25-1878-01A-21-1559-20 NA NA TCGA-25-1878-01A-01D-0648-01 TCGA-25-1878-01 c747a216-2d46-4b01-a34d-651fa616109a NA TCGA-25-1878-01A-01D-0648-01 NA NA NA NA TCGA-25-1878-01 NA NA NA TCGA-25-1878-01A-01R-0655-07 |
|
|
401 |
TCGA-25-2042-01 1 TCGA-25-2042-01 396 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 mutation c1uster 9 TCGA-25-2042 NA NA days 396 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Bilateral TCGA-25-2042-F26785 TCGA-25-2042 TCGA-25-2042-01A Stage IIIC -22127 NA 396 0 396 123 NA NA NA NA 2009-11-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.4 NA NA G3 Metastatic YES NA NA NA TCGA-25-2042.4D14A408-E3F6-47EB-A67C-0606450DB0C5.pdf 2042 NA WITH TUMOR YES Progressive Disease First Seen At Further Surgery NO NA Primary Tumor 01 0.3 NA NA 25 >20 mm Ovary NA A DECEASED 2006 TCGA-25-2042-01 TCGA-25-2042-01 NA 4873bfbf-079c-407d-9d8f-5bab18d1c3a0 NA TCGA-25-2042-01 NA TCGA-25-2042-01A-01D-0708-05 NA TCGA-25-2042-01A-21-1560-20 NA ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c TCGA-25-2042-01A-01D-0704-01 TCGA-25-2042-01 59676524-6b40-4bcc-b488-120781e23d22 NA TCGA-25-2042-01A-01D-0704-01 ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c NA ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c TCGA-25-2042-01A-01W-0799-08 TCGA-25-2042-01 TCGA-25-2042-01 ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c TCGA-25-2042-01A-01W-0799-08 TCGA-25-2042-01A-01R-0711-07 |
|
|
402 |
TCGA-25-2390-01 NA TCGA-25-2390-01 NA NA days NA NA OV-like c1 OV-like c4 NA NA NA NA TCGA-25-2390 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 80 NA NA TCGA-25-2390 TCGA-25-2390-01A NA -29257 NA NA 0 NA NA NA NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES NA NA 0.6 NO NA 1.6 NA NA NA NA NA NA NA NA TCGA-25-2390.B57A7111-209E-4FD3-8E2E-868B70BFF806.pdf 2390 NA NA NA NA NA NA NA Primary Tumor 01 0.3 NA NA 25 NA Ovary NA A NA 2003 NA NA NA NA NA NA NA TCGA-25-2390-01A-01D-0708-05 NA TCGA-25-2390-01A-21-1560-20 NA NA NA NA 29f6e462-4410-445e-8777-3402fc8488be NA NA NA NA NA NA NA NA NA NA TCGA-25-2390-01A-01R-0711-07 |
|
|
403 |
TCGA-25-2391-01 1 TCGA-25-2391-01 1492 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-2391 NA NA days 1492 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Bilateral TCGA-25-2391-F26796 TCGA-25-2391 TCGA-25-2391-01A Stage IIIC -20939 NA 1492 0 1492 NA NA NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-25-2391.32AC761D-67A0-46C5-AB01-AE9BBE7307CA.pdf 2391 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 25 >20 mm Ovary NA A DECEASED 2003 TCGA-25-2391-01 TCGA-25-2391-01 NA bf367755-354c-4d12-a8a8-7a1373b8d397 NA TCGA-25-2391-01 NA TCGA-25-2391-01A-01D-0708-05 NA TCGA-25-2391-01A-21-1560-20 NA 0ee0c708-77c4-4ac3-be13-0d08e6444003 TCGA-25-2391-01A-01D-0704-01 TCGA-25-2391-01 53220d7f-967c-4101-82ce-24495a3e2b9a NA TCGA-25-2391-01A-01D-0704-01 0ee0c708-77c4-4ac3-be13-0d08e6444003 NA 0ee0c708-77c4-4ac3-be13-0d08e6444003 TCGA-25-2391-01A-01W-0799-08 TCGA-25-2391-01 TCGA-25-2391-01 0ee0c708-77c4-4ac3-be13-0d08e6444003 TCGA-25-2391-01A-01W-0799-08 TCGA-25-2391-01A-01R-0711-07 |
|
|
404 |
TCGA-25-2392-01 1 TCGA-25-2392-01 31 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 5 mutation cluster 2 TCGA-25-2392 NA NA days 31 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 75 Bilateral TCGA-25-2392-F26801 TCGA-25-2392 TCGA-25-2392-01A Stage IV -27667 NA 31 0 31 NA NA NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-25-2392.C520D0D6-F104-492C-A4C2-844390F55570.pdf 2392 NA NA NO NA NA NO NA Primary Tumor 01 0.3 NA NA 25 11-20 mm Ovary NA A DECEASED 2003 TCGA-25-2392-01 TCGA-25-2392-01 NA 62414e51-fd9a-4ed8-bc34-c4d194fdc884 NA TCGA-25-2392-01 NA TCGA-25-2392-01A-01D-0708-05 NA NA NA 95b7a71d-8cf5-4660-ac1d-52a888cd2f20 TCGA-25-2392-01A-01D-0704-01 TCGA-25-2392-01 NA NA TCGA-25-2392-01A-01D-0704-01 95b7a71d-8cf5-4660-ac1d-52a888cd2f20 NA 95b7a71d-8cf5-4660-ac1d-52a888cd2f20 TCGA-25-2392-01A-01W-0799-08 TCGA-25-2392-01 TCGA-25-2392-01 95b7a71d-8cf5-4660-ac1d-52a888cd2f20 TCGA-25-2392-01A-01W-0799-08 TCGA-25-2392-01A-01R-0711-07 |
|
|
405 |
TCGA-25-2393-01 1 TCGA-25-2393-01 1157 1 days High C9-OV UCEC Serous c4 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-25-2393 NA NA days 1157 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 81 Left TCGA-25-2393-F26803 TCGA-25-2393 TCGA-25-2393-01A Stage IIIC -29585 NA 1157 0 1157 NA 305 NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.3 NA NA G3 Recurrence NA NA NA NA TCGA-25-2393.0B780E04-2DE3-4C56-9B93-1919F4BBE5D4.pdf 2393 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 25 11-20 mm Ovary NA A DECEASED 2003 TCGA-25-2393-01 TCGA-25-2393-01 NA 93d53663-d5fc-4a27-8844-d58f09f47c64 NA TCGA-25-2393-01 NA TCGA-25-2393-01A-01D-0708-05 NA TCGA-25-2393-01A-21-1560-20 NA 93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e TCGA-25-2393-01A-01D-0704-01 TCGA-25-2393-01 7ab7162d-0b8e-42de-80ee-70a7aa8ef6a5 NA TCGA-25-2393-01A-01D-0704-01 93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e NA 93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e TCGA-25-2393-01A-01W-0799-08 TCGA-25-2393-01 TCGA-25-2393-01 93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e TCGA-25-2393-01A-01W-0799-08 TCGA-25-2393-01A-01R-0711-07 |
|
|
406 |
TCGA-25-2396-01 1 TCGA-25-2396-01 92 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-25-2396 NA NA days 92 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 71 Bilateral TCGA-25-2396-F26808 TCGA-25-2396 TCGA-25-2396-01A Stage IIIC -26145 NA 92 0 92 NA NA NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA NA G3 NA NA NA NA NA TCGA-25-2396.5AD36576-BDCD-4DE8-9D8C-CD8BE71E4FCF.pdf 2396 NA NA NA NA NA NO NA Primary Tumor 01 1 NA NA 25 No Macroscopic disease Ovary NA A DECEASED 2004 TCGA-25-2396-01 TCGA-25-2396-01 NA 5cbceba0-c820-45dc-926d-ee4893659503 NA TCGA-25-2396-01 NA TCGA-25-2396-01A-01D-0708-05 NA TCGA-25-2396-01A-21-1560-20 NA 43352a4d-f866-4ed7-81f5-5dc478c10992 TCGA-25-2396-01A-01D-0704-01 TCGA-25-2396-01 abf3ad2e-f8d1-4a58-a48b-eaf3b553e793 NA TCGA-25-2396-01A-01D-0704-01 43352a4d-f866-4ed7-81f5-5dc478c10992 NA 43352a4d-f866-4ed7-81f5-5dc478c10992 TCGA-25-2396-01A-01W-0799-08 TCGA-25-2396-01 TCGA-25-2396-01 43352a4d-f866-4ed7-81f5-5dc478c10992 TCGA-25-2396-01A-01W-0799-08 TCGA-25-2396-01A-01R-0711-07 |
|
|
407 |
TCGA-25-2397-01 1 TCGA-25-2397-01 365 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-25-2397 NA NA days 365 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Bilateral TCGA-25-2397-F26810 TCGA-25-2397 TCGA-25-2397-01A Stage IV -21581 NA 365 0 365 NA NA NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 2.2 NA NA G3 NA NA NA NA NA TCGA-25-2397.D67C4E1F-6A68-4EE6-B143-22038C05C926.pdf 2397 NA NA NA NA NA NO NA Primary Tumor 01 0.7 NA NA 25 No Macroscopic disease Ovary NA A DECEASED 2004 TCGA-25-2397-01 TCGA-25-2397-01 NA 3faab68c-41ef-4eef-8ed1-1d5c7c5b9a8b NA TCGA-25-2397-01 NA TCGA-25-2397-01A-01D-0708-05 NA TCGA-25-2397-01A-21-1560-20 NA 7ad7080c-730b-4a5d-a8c1-f6387fbee72e TCGA-25-2397-01A-01D-0704-01 TCGA-25-2397-01 eac7612a-49d6-4b40-84b7-c68db54e56c1 NA TCGA-25-2397-01A-01D-0704-01 7ad7080c-730b-4a5d-a8c1-f6387fbee72e NA 7ad7080c-730b-4a5d-a8c1-f6387fbee72e NA TCGA-25-2397-01 TCGA-25-2397-01 7ad7080c-730b-4a5d-a8c1-f6387fbee72e NA TCGA-25-2397-01A-01R-0711-07 |
|
|
408 |
TCGA-25-2398-01 1 TCGA-25-2398-01 1369 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-2398 NA NA days 1369 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-25-2398-F26812 TCGA-25-2398 TCGA-25-2398-01A Stage IIIC -26267 NA 1369 0 1369 NA 577 NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-25-2398.CFF4E9E3-AC10-4A50-BE90-5A12822FEF42.pdf 2398 NA WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 0.5 NA NA 25 1-10 mm Ovary NA A DECEASED 2004 TCGA-25-2398-01 TCGA-25-2398-01 NA bcdd8efe-1f50-4bb6-904a-b8bdfd32dfbd NA TCGA-25-2398-01 NA TCGA-25-2398-01A-01D-0708-05 NA TCGA-25-2398-01A-21-1563-20 NA 3a080008-8266-4e2d-a143-adac14991b22 TCGA-25-2398-01A-01D-0704-01 TCGA-25-2398-01 b081cedd-6727-478d-9ebf-22ad78c34b27 NA TCGA-25-2398-01A-01D-0704-01 3a080008-8266-4e2d-a143-adac14991b22 NA 3a080008-8266-4e2d-a143-adac14991b22 TCGA-25-2398-01A-01W-0799-08 TCGA-25-2398-01 TCGA-25-2398-01 3a080008-8266-4e2d-a143-adac14991b22 TCGA-25-2398-01A-01W-0799-08 TCGA-25-2398-01A-01R-0711-07 |
|
|
409 |
TCGA-25-2399-01 1 TCGA-25-2399-01 608 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-25-2399 NA NA days 608 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 80 Bilateral TCGA-25-2399-F26818 TCGA-25-2399 TCGA-25-2399-01A Stage IIIC -29373 NA 608 0 608 NA 243 NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.6 NA NA G3 Recurrence NA NA NA NA TCGA-25-2399.38AEA3BF-A853-4719-B308-63884A6F8F13.pdf 2399 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 25 >20 mm Ovary NA A DECEASED 2004 TCGA-25-2399-01 TCGA-25-2399-01 NA a05df1ef-35d1-4fe3-a944-ab5c6b52d468 NA TCGA-25-2399-01 NA TCGA-25-2399-01A-01D-0708-05 NA TCGA-25-2399-01A-21-1560-20 NA 28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1 TCGA-25-2399-01A-01D-0704-01 TCGA-25-2399-01 27dde0e4-5be8-4045-910b-24c0535a4623 NA TCGA-25-2399-01A-01D-0704-01 28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1 NA 28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1 TCGA-25-2399-01A-01W-0799-08 TCGA-25-2399-01 TCGA-25-2399-01 28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1 TCGA-25-2399-01A-01W-0799-08 TCGA-25-2399-01A-01R-0711-07 |
|
|
410 |
TCGA-25-2400-01 1 TCGA-25-2400-01 1278 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-25-2400 NA NA days 1278 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Bilateral TCGA-25-2400-F26823 TCGA-25-2400 TCGA-25-2400-01A Stage IIIC -27789 NA 1278 0 1278 NA 577 NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.1 NA NA G3 Recurrence NA NA NA NA TCGA-25-2400.0C87DA7B-EBA1-4998-88D5-6DF2B0E6A40C.pdf 2400 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 25 No Macroscopic disease Ovary NA A DECEASED 2004 TCGA-25-2400-01 TCGA-25-2400-01 NA 1dab017a-bf35-4cec-9bef-f03b5c5b363c NA TCGA-25-2400-01 NA TCGA-25-2400-01A-01D-0708-05 NA TCGA-25-2400-01A-21-1560-20 NA 5c98c2c5-806f-4562-ad57-e152ea8388ab TCGA-25-2400-01A-01D-0704-01 TCGA-25-2400-01 ab4e5114-ba2a-4706-8be1-a359c4e5b547 NA TCGA-25-2400-01A-01D-0704-01 5c98c2c5-806f-4562-ad57-e152ea8388ab NA 5c98c2c5-806f-4562-ad57-e152ea8388ab TCGA-25-2400-01A-01W-0799-08 TCGA-25-2400-01 TCGA-25-2400-01 5c98c2c5-806f-4562-ad57-e152ea8388ab TCGA-25-2400-01A-01W-0799-08 TCGA-25-2400-01A-01R-0711-07 |
|
|
411 |
TCGA-25-2401-01 1 TCGA-25-2401-01 90 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-25-2401 NA NA days 90 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 64 Bilateral TCGA-25-2401-F26829 TCGA-25-2401 TCGA-25-2401-01A Stage IIIC -23711 NA 90 0 90 NA NA NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.8 NA NA G3 NA NA NA NA NA TCGA-25-2401.5B192072-1F11-4316-AC39-81085F7E425D.pdf 2401 NA NA NA NA NA NO NA Primary Tumor 01 0.3 NA NA 25 1-10 mm Ovary NA A DECEASED 2004 TCGA-25-2401-01 TCGA-25-2401-01 NA d34e80bb-5261-478c-9aa8-6732cc107f9f NA TCGA-25-2401-01 NA TCGA-25-2401-01A-01D-0708-05 NA TCGA-25-2401-01A-21-1560-20 NA c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c TCGA-25-2401-01A-01D-0704-01 TCGA-25-2401-01 8b55fa70-3074-4209-ab77-4634075aa0d1 NA TCGA-25-2401-01A-01D-0704-01 c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c NA c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c TCGA-25-2401-01A-01W-0799-08 TCGA-25-2401-01 TCGA-25-2401-01 c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c TCGA-25-2401-01A-01W-0799-08 TCGA-25-2401-01A-01R-0711-07 |
|
|
412 |
TCGA-25-2404-01 1 TCGA-25-2404-01 883 1 days High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-25-2404 NA NA days 883 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 38 Bilateral TCGA-25-2404-F26831 TCGA-25-2404 TCGA-25-2404-01A Stage IIIC -14184 NA 883 0 883 NA 426 NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 2 NA NA G3 Recurrence NA NA NA NA TCGA-25-2404.7B13E549-204D-47F8-93EB-D8C5C8D259FA.pdf 2404 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 25 No Macroscopic disease Ovary NA A DECEASED 2005 TCGA-25-2404-01 TCGA-25-2404-01 NA df215206-d33b-40b7-94dc-86d5a3cfbc87 NA TCGA-25-2404-01 NA TCGA-25-2404-01A-01D-0708-05 NA TCGA-25-2404-01A-21-1560-20 NA 05ab6bb9-0cb1-47f1-8dd2-92a48239e82e TCGA-25-2404-01A-01D-0704-01 TCGA-25-2404-01 2300785c-d77b-4d40-94e5-7947b18f9c24 NA TCGA-25-2404-01A-01D-0704-01 05ab6bb9-0cb1-47f1-8dd2-92a48239e82e NA 05ab6bb9-0cb1-47f1-8dd2-92a48239e82e TCGA-25-2404-01A-01W-0799-08 TCGA-25-2404-01 TCGA-25-2404-01 05ab6bb9-0cb1-47f1-8dd2-92a48239e82e TCGA-25-2404-01A-01W-0799-08 TCGA-25-2404-01A-01R-0711-07 |
|
|
413 |
TCGA-25-2408-01 1 TCGA-25-2408-01 943 1 days Iq C9-OV Low purity c2 OV-like c4 NA miRNA cluster 1 cluster 6 mutation c1uster 9 TCGA-25-2408 NA NA days 943 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NO 37 Bilateral TCGA-25-2408-F26837 TCGA-25-2408 TCGA-25-2408-01A Stage IV -13606 NA 943 0 943 NA 334 NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA NA G2 Recurrence NA NA NA NA TCGA-25-2408.2A91BE69-31C8-456E-8EBB-8AD08AAAB3A9.pdf 2408 NA WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 0.3 NA NA 25 1-10 mm Ovary NA A DECEASED 2005 NA TCGA-25-2408-01 NA a693a4be-bb91-4608-bacb-4ffa101e413a NA TCGA-25-2408-01 NA TCGA-25-2408-01A-01D-0708-05 NA TCGA-25-2408-01A-21-1562-20 NA NA TCGA-25-2408-01A-01D-0704-01 TCGA-25-2408-01 19590adb-d236-4acf-a78f-275de0e8f0e1 NA TCGA-25-2408-01A-01D-0704-01 NA NA NA TCGA-25-2408-01A-01W-0799-08 TCGA-25-2408-01 NA NA TCGA-25-2408-01A-01W-0799-08 TCGA-25-2408-01A-01R-0711-07 |
|
|
414 |
TCGA-25-2409-01 1 TCGA-25-2409-01 821 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-25-2409 NA NA days 821 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-25-2409-F26841 TCGA-25-2409 TCGA-25-2409-01A Stage IV -26267 NA 821 0 821 NA 304 NA NA NA 2010-1-5 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-25-2409.89A631C6-5000-4A96-B752-879EAA7231CB.pdf 2409 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 25 1-10 mm Ovary NA A DECEASED 2005 TCGA-25-2409-01 TCGA-25-2409-01 NA 71b8d6ab-57cb-411e-89f3-9ea82e67abff NA TCGA-25-2409-01 NA TCGA-25-2409-01A-01D-0708-05 NA TCGA-25-2409-01A-21-1560-20 NA 4e5f3a15-68fd-4be0-b368-e0bd04eaf872 TCGA-25-2409-01A-01D-0704-01 TCGA-25-2409-01 bfaa6831-b085-4b98-90a5-fef72266d642 NA TCGA-25-2409-01A-01D-0704-01 4e5f3a15-68fd-4be0-b368-e0bd04eaf872 NA 4e5f3a15-68fd-4be0-b368-e0bd04eaf872 TCGA-25-2409-01A-01W-0799-08 TCGA-25-2409-01 TCGA-25-2409-01 4e5f3a15-68fd-4be0-b368-e0bd04eaf872 TCGA-25-2409-01A-01W-0799-08 TCGA-25-2409-01A-01R-0711-07 |
|
|
415 |
TCGA-29-1688-01 1 TCGA-29-1688-01 2400 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 NA TCGA-29-1688 NA NA days 2400 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 39 Bilateral TCGA-29-1688-F27124 TCGA-29-1688 TCGA-29-1688-01A Stage IIIC -14574 NA 2400 0 2400 NA 184 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 2.5 NA NA G2 Recurrence NA NA NA NA TCGA-29-1688.cb2bd608-b9d4-497e-9058-2269dc86b5b3.pdf 1688 NA WITH TUMOR YES Stable Disease First Seen At Further Surgery NO NA Primary Tumor 01 0.5 NA NA 29 NA Ovary YES A DECEASED 1992 TCGA-29-1688-01 TCGA-29-1688-01 NA 065ec84d-9986-4b99-8c58-3d0a578cd8fb NA TCGA-29-1688-01 NA TCGA-29-1688-01A-01D-0563-05 NA TCGA-29-1688-01A-21-1558-20 TCGA-29-1688-01A-01W-0633-09 5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf TCGA-29-1688-01A-01D-0559-01 TCGA-29-1688-01 46d8cea8-b5a2-4136-bfeb-4969e3ccbd85 NA TCGA-29-1688-01A-01D-0559-01 5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf NA 5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf NA TCGA-29-1688-01 TCGA-29-1688-01 5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf NA TCGA-29-1688-01A-01R-0566-07 |
|
|
416 |
TCGA-29-1690-01 1 TCGA-29-1690-01 1448 1 days Iq C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 NA TCGA-29-1690 NA NA days 1448 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 66 Bilateral TCGA-29-1690-F27142 TCGA-29-1690 TCGA-29-1690-01A Stage IIIC -24319 NA 1448 0 1360 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.3 NO NA 1.4 NA NA G2 NA NA NA NA NA TCGA-29-1690.a44f0507-fc95-410a-a6b2-b66caacee30e.pdf 1690 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.7 NA NA 29 11-20 mm Ovary NA A DECEASED 1993 TCGA-29-1690-01 TCGA-29-1690-01 NA 21ed8b03-3122-4467-8542-a90a261e9934 NA TCGA-29-1690-01 NA TCGA-29-1690-01A-01D-0563-05 NA TCGA-29-1690-01A-21-1558-20 TCGA-29-1690-01A-01W-0633-09 d78906d7-c8f2-4bf0-86cc-2b60b067aaa6 TCGA-29-1690-01A-01D-0559-01 TCGA-29-1690-01 865fd9bb-d8c0-43d0-874c-ce6e69ce93be NA TCGA-29-1690-01A-01D-0559-01 d78906d7-c8f2-4bf0-86cc-2b60b067aaa6 NA d78906d7-c8f2-4bf0-86cc-2b60b067aaa6 NA TCGA-29-1690-01 TCGA-29-1690-01 d78906d7-c8f2-4bf0-86cc-2b60b067aaa6 NA TCGA-29-1690-01A-01R-0566-07 |
|
|
417 |
TCGA-29-1691-01 1 TCGA-29-1691-01 1470 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-29-1691 NA NA days 1470 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-29-1691-F27148 TCGA-29-1691 NA Stage IIIC -18664 NA 1470 0 1435 NA 613 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G2 Recurrence NA NA NA NA NA 1691 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 29 1-10 mm Ovary NA NA DECEASED 1995 TCGA-29-1691-01 TCGA-29-1691-01 NA cbacc51e-d8b4-4dab-8ba8-7e769d19c26a NA TCGA-29-1691-01 NA TCGA-29-1691-01A-01D-0563-05 NA TCGA-29-1691-01A-21-1558-20 TCGA-29-1691-01A-01W-0633-09 f83833b8-8cb2-44d8-8ac7-c4d2d2463053 TCGA-29-1691-01A-01D-0559-01 TCGA-29-1691-01 e634e64b-7b5c-4d33-88f9-c5c83442fdc1 NA TCGA-29-1691-01A-01D-0559-01 f83833b8-8cb2-44d8-8ac7-c4d2d2463053 NA f83833b8-8cb2-44d8-8ac7-c4d2d2463053 NA TCGA-29-1691-01 TCGA-29-1691-01 f83833b8-8cb2-44d8-8ac7-c4d2d2463053 NA TCGA-29-1691-01A-01R-0566-07 |
|
|
418 |
TCGA-29-1692-01 1 TCGA-29-1692-01 2872 1 days High NA OV-like c1 NA NA NA NA NA TCGA-29-1692 NA NA days 2872 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Right TCGA-29-1692-F27159 TCGA-29-1692 TCGA-29-1692-01B Stage IIIC -21193 NA 2872 0 2872 NA 544 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.7 NA NA G2 Recurrence NA NA NA NA TCGA-29-1692.522E504C-7F53-4E91-A684-FD7B3C54CF06.pdf 1692 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response NA NO R1 Primary Tumor 01 0.2 NA NA 29 11-20 mm Ovary NA B DECEASED 1997 NA NA NA 2ecbe10e-1afc-4a38-91ee-cb0cc670f254 NA NA NA TCGA-29-1692-01B-01D-0807-05 NA NA NA NA TCGA-29-1692-01B-01D-2069-01 TCGA-29-1692-01 NA NA TCGA-29-1692-01B-01D-2069-01 NA NA NA NA TCGA-29-1692-01 NA NA NA TCGA-29-1692-01B-01R-0810-07 |
|
|
419 |
TCGA-29-1692-02 1 TCGA-29-1692-02 2872 1 days NA NA OV-like c1 NA NA NA NA NA TCGA-29-1692 NA NA days 2872 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Right TCGA-29-1692-F27159 TCGA-29-1692 TCGA-29-1692-02A Stage IIIC -21193 NA 2872 0 2872 NA 544 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NA G2 Recurrence NA NA NA NA TCGA-29-1692.FF9EECFF-66C4-440F-91AB-42ACCEED0A3B.pdf 1692 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response NA NO R1 Recurrent Tumor 02 0.6 NA NA 29 11-20 mm Ovary NA A DECEASED 1997 NA NA NA 4001650f-30d3-46dd-8ba2-7f148afe4ba7 NA NA NA TCGA-29-1692-02A-01D-0807-05 NA NA NA NA NA NA fb710151-c817-4915-90d2-2997726ceccd NA NA NA NA NA NA NA NA NA NA TCGA-29-1692-02A-01R-0810-07 |
|
|
420 |
TCGA-29-1693-01 0 TCGA-29-1693-01 3096 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-29-1693 NA NA days 3096 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 72 Left TCGA-29-1693-F27174 TCGA-29-1693 TCGA-29-1693-01A Stage IIIC -26300 NA NA 0 3096 NA 694 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.7 NA YES G3 Recurrence NA NA NA NA TCGA-29-1693.90087244-634d-45eb-a877-ff7cc6bd2282.pdf 1693 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary YES A LIVING 2001 TCGA-29-1693-01 TCGA-29-1693-01 NA 111c7bf6-d79d-48e4-adf8-94bc0c538ab5 NA TCGA-29-1693-01 NA TCGA-29-1693-01A-01D-0563-05 NA TCGA-29-1693-01A-21-1558-20 TCGA-29-1693-01A-01W-0633-09 7e5d2390-1e04-4e46-aa48-4b0131076007 TCGA-29-1693-01A-01D-0559-01 TCGA-29-1693-01 75dd78d6-cd26-476f-927f-ddb0d4a9c66f NA TCGA-29-1693-01A-01D-0559-01 7e5d2390-1e04-4e46-aa48-4b0131076007 NA 7e5d2390-1e04-4e46-aa48-4b0131076007 NA TCGA-29-1693-01 TCGA-29-1693-01 7e5d2390-1e04-4e46-aa48-4b0131076007 NA TCGA-29-1693-01A-01R-0566-07 |
|
|
421 |
TCGA-29-1694-01 1 TCGA-29-1694-01 1187 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-29-1694 NA NA days 1187 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 45 Bilateral TCGA-29-1694-F27192 TCGA-29-1694 TCGA-29-1694-01A Stage IIIC -16523 NA 1187 0 [Discrepancy] 206 NA 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NA GX Locoregional Disease YES NA NA NA TCGA-29-1694.ccfb9f1d-1779-4fae-a34f-c46a19d4b095.pdf 1694 Other WITH TUMOR YES Stable Disease First Seen At Further Surgery NO NA Primary Tumor 01 0.3 NA NA 29 11-20 mm Ovary NA A DECEASED 2002 TCGA-29-1694-01 TCGA-29-1694-01 NA 57cead11-58b6-4d8e-ab66-b742de63ae1d NA TCGA-29-1694-01 NA TCGA-29-1694-01A-01D-0563-05 NA TCGA-29-1694-01A-21-1558-20 TCGA-29-1694-01A-01W-0633-09 e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6 TCGA-29-1694-01A-01D-0559-01 TCGA-29-1694-01 463fec61-5758-4225-b43e-b77f36ece717 NA TCGA-29-1694-01A-01D-0559-01 e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6 NA e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6 NA TCGA-29-1694-01 TCGA-29-1694-01 e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6 NA TCGA-29-1694-01A-01R-0566-07 |
|
|
422 |
TCGA-29-1695-01 1 TCGA-29-1695-01 1229 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-29-1695 NA NA days 1229 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Left TCGA-29-1695-F27204 TCGA-29-1695 TCGA-29-1695-01A Stage IIIC -22895 NA 1229 0 24 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA NA G2 NA NA NA NA NA TCGA-29-1695.136a4380-2a2a-489f-8675-886e876f17f7.pdf 1695 NA NA NA NA NA NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A DECEASED 2003 TCGA-29-1695-01 TCGA-29-1695-01 NA 43c657df-dd50-4c53-a5de-e73d3a5e1b0c NA TCGA-29-1695-01 NA TCGA-29-1695-01A-01D-0563-05 NA TCGA-29-1695-01A-21-1558-20 TCGA-29-1695-01A-01W-0633-09 33f1dda6-7601-48c6-b46d-f0ba759e4048 TCGA-29-1695-01A-01D-0559-01 TCGA-29-1695-01 997dba94-b0d4-4872-b93b-d561f71f6ba3 NA TCGA-29-1695-01A-01D-0559-01 33f1dda6-7601-48c6-b46d-f0ba759e4048 NA 33f1dda6-7601-48c6-b46d-f0ba759e4048 NA TCGA-29-1695-01 TCGA-29-1695-01 33f1dda6-7601-48c6-b46d-f0ba759e4048 NA TCGA-29-1695-01A-01R-0566-07 |
|
|
423 |
TCGA-29-1696-01 1 TCGA-29-1696-01 1032 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-29-1696 NA NA days 1032 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 43 Right TCGA-29-1696-F27206 TCGA-29-1696 TCGA-29-1696-01A Stage IIIC -15818 NA 1032 0 1025 NA 342 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 0.8 NA NO G2 Recurrence NA NA NA NA TCGA-29-1696.5e817943-3108-4838-bf8c-85c4507eb873.pdf 1696 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 29 1-10 mm Ovary NA A DECEASED 2003 TCGA-29-1696-01 TCGA-29-1696-01 NA fea497c6-293b-49aa-9d5f-021f2f89913e NA TCGA-29-1696-01 NA TCGA-29-1696-01A-01D-0563-05 NA TCGA-29-1696-01A-21-1558-20 TCGA-29-1696-01A-01W-0633-09 23c4ab1a-f8ce-47be-ab03-abfc66ea70ef TCGA-29-1696-01A-01D-0559-01 TCGA-29-1696-01 93ea52c3-dc03-4845-9493-f1ecdd9e9124 NA TCGA-29-1696-01A-01D-0559-01 23c4ab1a-f8ce-47be-ab03-abfc66ea70ef NA 23c4ab1a-f8ce-47be-ab03-abfc66ea70ef NA TCGA-29-1696-01 TCGA-29-1696-01 23c4ab1a-f8ce-47be-ab03-abfc66ea70ef NA TCGA-29-1696-01A-01R-0566-07 |
|
|
424 |
TCGA-29-1697-01 1 TCGA-29-1697-01 949 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 12 cluster 5 NA TCGA-29-1697 NA NA days 949 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 62 Bilateral TCGA-29-1697-F27216 TCGA-29-1697 TCGA-29-1697-01A Stage IIIC -22933 NA 949 0 949 NA 500 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.9 NA NA G3 Recurrence NA NA NA NA TCGA-29-1697.294ba09f-347a-4129-847d-211cdf73ca99.pdf 1697 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A DECEASED 2003 TCGA-29-1697-01 TCGA-29-1697-01 NA bd90331c-acc6-49f5-8943-065fbfb16519 NA TCGA-29-1697-01 NA TCGA-29-1697-01A-01D-0563-05 NA TCGA-29-1697-01A-21-1558-20 TCGA-29-1697-01A-01W-0633-09 75435634-4311-49d8-8e42-ae1069c1e2ef TCGA-29-1697-01A-01D-0559-01 TCGA-29-1697-01 9efe9dcc-44d7-47ae-b404-d324e821910e NA TCGA-29-1697-01A-01D-0559-01 75435634-4311-49d8-8e42-ae1069c1e2ef NA 75435634-4311-49d8-8e42-ae1069c1e2ef NA TCGA-29-1697-01 TCGA-29-1697-01 75435634-4311-49d8-8e42-ae1069c1e2ef NA TCGA-29-1697-01A-01R-0566-07 |
|
|
425 |
TCGA-29-1698-01 0 TCGA-29-1698-01 2078 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-29-1698 NA NA days 2078 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-29-1698-F27227 TCGA-29-1698 TCGA-29-1698-01A Stage IIIC -19611 NA NA 0 2078 NA 181 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.4 NA NA G3 Recurrence NA NA NA NA TCGA-29-1698.133f2df5-6c22-4653-9d2e-f3d5971502b0.pdf 1698 NA WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 0.3 NA NA 29 1-10 mm Ovary NA A LIVING 2004 TCGA-29-1698-01 TCGA-29-1698-01 NA 86e20816-f37a-4686-876b-3ef6f0be521a NA TCGA-29-1698-01 NA TCGA-29-1698-01A-01D-0563-05 NA TCGA-29-1698-01A-21-1558-20 TCGA-29-1698-01A-01W-0633-09 74970c45-4cc5-4952-9846-ce2d959437ea TCGA-29-1698-01A-01D-0559-01 TCGA-29-1698-01 a40be7ea-f682-4d3e-a749-74aec6961b88 NA TCGA-29-1698-01A-01D-0559-01 74970c45-4cc5-4952-9846-ce2d959437ea NA 74970c45-4cc5-4952-9846-ce2d959437ea NA TCGA-29-1698-01 TCGA-29-1698-01 74970c45-4cc5-4952-9846-ce2d959437ea NA TCGA-29-1698-01A-01R-0566-07 |
|
|
426 |
TCGA-29-1699-01 1 TCGA-29-1699-01 1106 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-29-1699 1106 0 days 1106 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Bilateral TCGA-29-1699-F41729 TCGA-29-1699 TCGA-29-1699-01A Stage IIIC -21130 NA 1106 0 16 NA NA 1 NA Progressive Disease 2013-8-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.5 NA YES G3 NA NA NO NA NA TCGA-29-1699.9e2cf2f9-c45c-4702-8b6f-565c59730036.pdf 1699 Preoperative NA NA NA NA NA NA Primary Tumor 01 0.6 NA NA 29 1-10 mm Ovary NA A DECEASED 2004 TCGA-29-1699-01 TCGA-29-1699-01 NA 036b4d31-1291-4092-9442-9950564a6699 NA TCGA-29-1699-01 NA TCGA-29-1699-01A-01D-0563-05 NA TCGA-29-1699-01A-21-1558-20 TCGA-29-1699-01A-01W-0633-09 6d1d8c8a-fea0-4a47-bd2a-124270561406 TCGA-29-1699-01A-01D-0559-01 TCGA-29-1699-01 21c96f53-087e-42c2-86ce-ea45cf876627 NA TCGA-29-1699-01A-01D-0559-01 6d1d8c8a-fea0-4a47-bd2a-124270561406 NA 6d1d8c8a-fea0-4a47-bd2a-124270561406 NA TCGA-29-1699-01 TCGA-29-1699-01 6d1d8c8a-fea0-4a47-bd2a-124270561406 NA TCGA-29-1699-01A-01R-0566-07 |
|
|
427 |
TCGA-29-1701-01 1 TCGA-29-1701-01 515 1 days High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-29-1701 NA NA days 515 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-29-1701-F27243 TCGA-29-1701 TCGA-29-1701-01A Stage IIIC -20737 NA 515 0 514 NA 298 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.3 NA YES G3 Recurrence NA NA NA NA TCGA-29-1701.f7568046-b77a-4654-9f94-8978bd3e22c4.pdf 1701 Post-Adjuvant Therapy WITH TUMOR NO Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.6 NA NA 29 NA Ovary YES A DECEASED 2004 TCGA-29-1701-01 TCGA-29-1701-01 NA 9ffceda1-d2ab-4689-baee-eab0b133ded9 NA TCGA-29-1701-01 NA TCGA-29-1701-01A-01D-0563-05 NA TCGA-29-1701-01A-21-1558-20 TCGA-29-1701-01A-01W-0633-09 e5e6f25b-d641-4598-8bb1-0850750ef048 TCGA-29-1701-01A-01D-0559-01 TCGA-29-1701-01 d770980a-b6ef-4e85-8ed6-a22702326573 NA TCGA-29-1701-01A-01D-0559-01 e5e6f25b-d641-4598-8bb1-0850750ef048 NA e5e6f25b-d641-4598-8bb1-0850750ef048 NA TCGA-29-1701-01 TCGA-29-1701-01 e5e6f25b-d641-4598-8bb1-0850750ef048 NA TCGA-29-1701-01A-01R-0566-07 |
|
|
428 |
TCGA-29-1702-01 1 TCGA-29-1702-01 728 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-29-1702 NA NA days 728 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 84 Right TCGA-29-1702-F27249 TCGA-29-1702 TCGA-29-1702-01A Stage IIIC -30910 NA 728 0 568 NA 286 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-29-1702.f825bb6c-afc2-48ea-9286-09c09c7e9918.pdf 1702 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 29 1-10 mm Ovary NA A DECEASED 2005 TCGA-29-1702-01 TCGA-29-1702-01 NA 3a13cc49-5376-4695-9e64-45b457b9d36b NA TCGA-29-1702-01 NA TCGA-29-1702-01A-01D-0563-05 NA TCGA-29-1702-01A-21-1558-20 TCGA-29-1702-01A-01W-0633-09 c317689f-a405-4486-9a22-ff6eadd2d5b8 TCGA-29-1702-01A-01D-0559-01 TCGA-29-1702-01 0160cfab-a19a-415e-a418-5679ae8d6779 NA TCGA-29-1702-01A-01D-0559-01 c317689f-a405-4486-9a22-ff6eadd2d5b8 NA c317689f-a405-4486-9a22-ff6eadd2d5b8 NA TCGA-29-1702-01 TCGA-29-1702-01 c317689f-a405-4486-9a22-ff6eadd2d5b8 NA TCGA-29-1702-01A-01R-0566-07 |
|
|
429 |
TCGA-29-1703-01 1 TCGA-29-1703-01 1815 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-29-1703 NA NA days 1815 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-29-1703-F27255 TCGA-29-1703 TCGA-29-1703-01A Stage IIIC -20622 NA 1815 0 1815 NA 324 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.4 NA NA G2 Recurrence NA NA NA NA TCGA-29-1703.c8397af0-67d2-4e69-993b-7349657e9953.pdf 1703 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 29 1-10 mm Ovary NA A DECEASED 2005 TCGA-29-1703-01 TCGA-29-1703-01 NA 059bf2b5-7752-44aa-935c-8b9c482e29e2 NA TCGA-29-1703-01 NA TCGA-29-1703-01A-01D-0563-05 NA TCGA-29-1703-01A-21-1558-20 TCGA-29-1703-01A-01W-0633-09 64e3f978-d213-45e2-bb52-e9b9a2032dc0 TCGA-29-1703-01A-01D-0559-01 TCGA-29-1703-01 13530c03-540d-4e0d-a760-c0f6946f0480 NA TCGA-29-1703-01A-01D-0559-01 64e3f978-d213-45e2-bb52-e9b9a2032dc0 NA 64e3f978-d213-45e2-bb52-e9b9a2032dc0 NA TCGA-29-1703-01 TCGA-29-1703-01 64e3f978-d213-45e2-bb52-e9b9a2032dc0 NA TCGA-29-1703-01A-01R-0566-07 |
|
|
430 |
TCGA-29-1704-01 0 TCGA-29-1704-01 1587 0 days High NA OV-like c1 NA NA NA NA NA TCGA-29-1704 NA NA days 1587 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Bilateral TCGA-29-1704-F27269 TCGA-29-1704 NA Stage IIIC -22511 NA NA 0 1587 NA 568 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1704 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Other Method NO R1 Primary Tumor 01 NA NA NA 29 11-20 mm Ovary NA NA LIVING 2005 NA NA NA bbc42149-d2c4-44f9-a59f-bd9397bc96e8 NA NA NA TCGA-29-1704-01B-01D-0807-05 NA NA NA NA TCGA-29-1704-01B-01D-0803-01 TCGA-29-1704-01 NA NA TCGA-29-1704-01B-01D-0803-01 NA NA NA NA TCGA-29-1704-01 NA NA NA TCGA-29-1704-01B-01R-0810-07 |
|
|
431 |
TCGA-29-1704-02 0 TCGA-29-1704-02 1587 0 days NA NA OV-like c1 NA NA NA NA NA TCGA-29-1704 NA NA days 1587 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Bilateral TCGA-29-1704-F27269 TCGA-29-1704 TCGA-29-1704-02A Stage IIIC -22511 NA NA 0 1587 NA 568 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.6 NA NA G3 Recurrence NA NA NA NA TCGA-29-1704.4C689C80-12E5-4E40-8A12-910D07C8C084.pdf 1704 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Other Method NO R1 Recurrent Tumor 02 0.2 NA NA 29 11-20 mm Ovary NA A LIVING 2005 NA NA NA NA NA NA NA TCGA-29-1704-02A-01D-0807-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
432 |
TCGA-29-1705-01 1 TCGA-29-1705-01 555 1 days BRCA-LUAD+ C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 NA TCGA-29-1705 NA NA days 555 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-29-1705-F27279 TCGA-29-1705 TCGA-29-1705-01A Stage IIIC -17530 NA 555 0 555 NA 283 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.8 NA NA G2 Recurrence NA NA NA NA TCGA-29-1705.e7a899e9-2c61-4bda-874c-0f1b456e5dfc.pdf 1705 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.7 NA NA 29 >20 mm Ovary NA A DECEASED 2005 TCGA-29-1705-01 TCGA-29-1705-01 NA 3d4c3c05-1760-43b8-9a4d-e66ebfaf9533 NA TCGA-29-1705-01 NA TCGA-29-1705-01A-01D-0563-05 NA TCGA-29-1705-01A-21-1558-20 TCGA-29-1705-01A-01W-0633-09 d1603029-2b45-4c5c-b313-8846d0ebdbdb TCGA-29-1705-01A-01D-0559-01 TCGA-29-1705-01 94faea93-a4a5-45c7-9b05-b342bec4e176,daae8ca1-a6fd-43cc-a82e-32ffe02803c7 NA TCGA-29-1705-01A-01D-0559-01 d1603029-2b45-4c5c-b313-8846d0ebdbdb NA d1603029-2b45-4c5c-b313-8846d0ebdbdb NA TCGA-29-1705-01 TCGA-29-1705-01 d1603029-2b45-4c5c-b313-8846d0ebdbdb NA TCGA-29-1705-01A-01R-0566-07 |
|
|
433 |
TCGA-29-1705-02 1 TCGA-29-1705-02 555 1 days NA C9-OV OV-like c1 NA NA miRNA cluster 3 NA NA TCGA-29-1705 NA NA days 555 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-29-1705-F27279 TCGA-29-1705 TCGA-29-1705-02A Stage IIIC -17530 NA 555 0 555 NA 283 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.3 NA NA G2 Recurrence NA NA NA NA TCGA-29-1705.EADA1E69-0CAB-4521-ABE4-035F73ABB54A.pdf 1705 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Recurrent Tumor 02 0.4 NA NA 29 >20 mm Ovary NA A DECEASED 2005 NA TCGA-29-1705-02 NA 83b8567f-7316-4c8b-877d-b5db5bf8c9da NA TCGA-29-1705-02 NA TCGA-29-1705-02A-01D-0807-05 NA NA NA NA NA NA 032aec92-5009-4a62-94cf-7dca39023322 NA NA NA NA NA NA NA NA NA NA TCGA-29-1705-02A-01R-0810-07 |
|
|
434 |
TCGA-29-1707-01 0 TCGA-29-1707-01 1277 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-29-1707 NA NA days 1277 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 41 Left TCGA-29-1707-F27288 TCGA-29-1707 TCGA-29-1707-01A Stage IIC -15017 NA NA 0 1277 NA 1201 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-29-1707.da725324-2b94-47d4-a35c-a5f2233a024f.pdf 1707 Post-Adjuvant Therapy NA YES Complete Remission/Response Other Method NO NA Primary Tumor 01 0.5 NA NA 29 No Macroscopic disease Ovary NA A LIVING 2006 NA TCGA-29-1707-01 NA 5a0fb2e7-59de-4180-9b11-456580ad1d78 NA TCGA-29-1707-01 NA TCGA-29-1707-01A-01D-0563-05 NA TCGA-29-1707-01A-21-1559-20 TCGA-29-1707-01A-01W-0633-09 NA TCGA-29-1707-01A-01D-0559-01 TCGA-29-1707-01 c7511c99-d363-45ed-9d27-cff988927e46,26e9028d-8002-4408-82e8-68bf43f27fec NA TCGA-29-1707-01A-01D-0559-01 NA NA NA NA TCGA-29-1707-01 NA NA NA TCGA-29-1707-01A-01R-0566-07 |
|
|
435 |
TCGA-29-1707-02 0 TCGA-29-1707-02 1277 0 days NA NA OV-like c1 NA NA miRNA cluster 1 NA NA TCGA-29-1707 NA NA days 1277 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 41 Left TCGA-29-1707-F27288 TCGA-29-1707 TCGA-29-1707-02A Stage IIC -15017 NA NA 0 1277 NA 1201 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-29-1707.264DFD3E-7413-4DEA-A115-14887718139D.pdf 1707 Post-Adjuvant Therapy NA YES Complete Remission/Response Other Method NO NA Recurrent Tumor 02 0.5 NA NA 29 No Macroscopic disease Ovary NA A LIVING 2006 NA TCGA-29-1707-02 NA ef4e079b-c946-4598-a7dd-575e48a4a133 NA TCGA-29-1707-02 NA TCGA-29-1707-02A-01D-0807-05 NA NA NA NA NA NA 08fc3ec8-3c83-4ffc-bd91-67e6b162790b NA NA NA NA NA NA NA NA NA NA TCGA-29-1707-02A-01R-0810-07 |
|
|
436 |
TCGA-29-1710-01 1 TCGA-29-1710-01 951 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 NA TCGA-29-1710 NA NA days 951 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-29-1710-F27294 TCGA-29-1710 TCGA-29-1710-01A Stage IIIC -19969 NA 951 0 889 NA 315 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.8 NA NA G2 Recurrence NA NA NA NA TCGA-29-1710.52a0d2ae-7467-40f0-b8f3-59812cfac52a.pdf 1710 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 29 1-10 mm Ovary NA A DECEASED 2006 TCGA-29-1710-01 TCGA-29-1710-01 NA 31aaa27c-8eaf-4030-9067-d505d9abf983 NA TCGA-29-1710-01 NA TCGA-29-1710-01A-02D-0563-05 NA NA TCGA-29-1710-01A-02W-0633-09 3bf24456-4b70-4313-a04d-19aba239108d TCGA-29-1710-01A-02D-0559-01 TCGA-29-1710-01 34b987ae-5e5a-435b-b1f3-0cf9623f1337 NA TCGA-29-1710-01A-02D-0559-01 3bf24456-4b70-4313-a04d-19aba239108d NA 3bf24456-4b70-4313-a04d-19aba239108d NA TCGA-29-1710-01 TCGA-29-1710-01 3bf24456-4b70-4313-a04d-19aba239108d NA TCGA-29-1710-01A-02R-0566-07 |
|
|
437 |
TCGA-29-1710-02 1 TCGA-29-1710-02 951 1 days NA NA OV-like c1 NA NA NA NA NA TCGA-29-1710 NA NA days 951 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-29-1710-F27294 TCGA-29-1710 TCGA-29-1710-02A Stage IIIC -19969 NA 951 0 889 NA 315 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA NA G2 Recurrence NA NA NA NA TCGA-29-1710.4FD493D6-DAA8-497E-8EB2-ED2A97034B23.pdf 1710 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Recurrent Tumor 02 0.3 NA NA 29 1-10 mm Ovary NA A DECEASED 2006 NA NA NA 4a8f0084-d5a6-4f5b-bc46-8494a2bfe6b1 NA NA NA TCGA-29-1710-02A-01D-0807-05 NA NA NA NA NA NA 8fdfe883-7ce3-46b5-a3c7-e34b59a5557c NA NA NA NA NA NA NA NA NA NA TCGA-29-1710-02A-01R-0810-07 |
|
|
438 |
TCGA-29-1711-01 0 TCGA-29-1711-01 1053 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-29-1711 NA NA days 1053 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 45 Bilateral TCGA-29-1711-F27307 TCGA-29-1711 TCGA-29-1711-01A Stage IIIC -16485 NA NA 0 1053 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.2 NA NA G2 NA NA NA NA NA TCGA-29-1711.e0e207a0-c3c2-4bfc-9d7d-d00c5c953d3d.pdf 1711 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 29 No Macroscopic disease Ovary NA A LIVING 2006 TCGA-29-1711-01 TCGA-29-1711-01 NA 299a04e7-e90f-4a24-a211-7f0bd18b3ea0 NA TCGA-29-1711-01 NA TCGA-29-1711-01A-01D-0563-05 NA TCGA-29-1711-01A-21-1559-20 TCGA-29-1711-01A-01W-0633-09 c512a6e3-8bc8-4188-b264-89b2fe02baa8 TCGA-29-1711-01A-01D-0559-01 TCGA-29-1711-01 8aedfe25-9010-4502-a25c-88ed899eeb22 NA TCGA-29-1711-01A-01D-0559-01 c512a6e3-8bc8-4188-b264-89b2fe02baa8 NA c512a6e3-8bc8-4188-b264-89b2fe02baa8 NA TCGA-29-1711-01 TCGA-29-1711-01 c512a6e3-8bc8-4188-b264-89b2fe02baa8 NA TCGA-29-1711-01A-01R-0566-07 |
|
|
439 |
TCGA-29-1761-01 1 TCGA-29-1761-01 528 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-29-1761 NA NA days 528 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 80 Bilateral TCGA-29-1761-F27312 TCGA-29-1761 TCGA-29-1761-01A Stage IIIC -29337 NA 528 0 517 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.9 NA NA G3 NA NA NA NA NA TCGA-29-1761.63defa27-e729-4514-bdd2-d887c4100854.pdf 1761 NA WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A DECEASED 1998 TCGA-29-1761-01 TCGA-29-1761-01 NA 288d1cec-45f2-448c-8bf1-ce001420d126 NA TCGA-29-1761-01 NA TCGA-29-1761-01A-01D-0563-05 NA TCGA-29-1761-01A-21-1559-20 TCGA-29-1761-01A-01W-0633-09 c4446f6f-fae9-414c-8bae-7c78bb894982 TCGA-29-1761-01A-01D-0559-01 TCGA-29-1761-01 1dfcb901-e9df-4eee-af4c-5c9c22cbe0e8 NA TCGA-29-1761-01A-01D-0559-01 c4446f6f-fae9-414c-8bae-7c78bb894982 NA c4446f6f-fae9-414c-8bae-7c78bb894982 NA TCGA-29-1761-01 TCGA-29-1761-01 c4446f6f-fae9-414c-8bae-7c78bb894982 NA TCGA-29-1761-01A-01R-0566-07 |
|
|
440 |
TCGA-29-1762-01 1 TCGA-29-1762-01 2634 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-29-1762 NA NA days 2634 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-29-1762-F27316 TCGA-29-1762 TCGA-29-1762-01A Stage IV -21879 NA 2634 0 2606 NA 1375 2 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 0.9 NA NA G2 Recurrence NA NA NA NA TCGA-29-1762.f94712a1-78da-4341-9ac9-6ea41c11610e.pdf 1762 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A DECEASED 1998 TCGA-29-1762-01 TCGA-29-1762-01 NA 49c0d36f-14fc-49f0-90a0-57cfbd8ec25b NA TCGA-29-1762-01 NA TCGA-29-1762-01A-01D-0563-05 NA TCGA-29-1762-01A-21-1559-20 TCGA-29-1762-01A-01W-0633-09 c3559ae3-3355-4f38-9c07-e557e435fcbd TCGA-29-1762-01A-01D-0559-01 TCGA-29-1762-01 a8bcbfb3-7a83-4170-8b2c-fa5447b5abce NA TCGA-29-1762-01A-01D-0559-01 c3559ae3-3355-4f38-9c07-e557e435fcbd NA c3559ae3-3355-4f38-9c07-e557e435fcbd NA TCGA-29-1762-01 TCGA-29-1762-01 c3559ae3-3355-4f38-9c07-e557e435fcbd NA TCGA-29-1762-01A-01R-0566-07 |
|
|
441 |
TCGA-29-1763-01 0 TCGA-29-1763-01 2032 0 days High NA Low purity c2 NA OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-29-1763 NA NA days 2032 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 43 Bilateral TCGA-29-1763-F27325 TCGA-29-1763 NA Stage IIC -16021 NA NA 0 2032 NA 428 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G2 Recurrence NA NA NA NA NA 1763 Other WITH TUMOR YES Complete Remission/Response Other Method NO NA Primary Tumor 01 NA NA NA 29 1-10 mm Ovary NA NA LIVING 2004 TCGA-29-1763-01 TCGA-29-1763-01 NA afc40d40-daf1-4bb5-8813-017913722541 NA TCGA-29-1763-01 NA TCGA-29-1763-01A-02D-0563-05 NA NA TCGA-29-1763-01A-02W-0633-09 af63aa43-ab5f-44c5-85cf-01d84be261a3 TCGA-29-1763-01A-02D-0559-01 TCGA-29-1763-01 NA NA TCGA-29-1763-01A-02D-0559-01 af63aa43-ab5f-44c5-85cf-01d84be261a3 NA af63aa43-ab5f-44c5-85cf-01d84be261a3 NA TCGA-29-1763-01 TCGA-29-1763-01 af63aa43-ab5f-44c5-85cf-01d84be261a3 NA TCGA-29-1763-01A-02R-0566-07 |
|
|
442 |
TCGA-29-1764-01 0 TCGA-29-1764-01 1914 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 NA TCGA-29-1764 NA NA days 1914 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-29-1764-F27338 TCGA-29-1764 TCGA-29-1764-01A Stage IIIC -18012 NA NA 0 1914 NA 792 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 0.6 NA NA G2 Recurrence NA NA NA NA TCGA-29-1764.3bae7a57-63d7-4770-a960-cd8f0749ca17.pdf 1764 Other WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A LIVING 2004 NA TCGA-29-1764-01 NA 523d9b2a-4c0b-479c-917c-2086480c8558 NA TCGA-29-1764-01 NA TCGA-29-1764-01A-01D-0563-05 NA TCGA-29-1764-01A-21-1559-20 TCGA-29-1764-01A-01W-0633-09 NA TCGA-29-1764-01A-01D-0559-01 TCGA-29-1764-01 3c3a33be-9e62-4a32-946a-15f32661e2a1 NA TCGA-29-1764-01A-01D-0559-01 NA NA NA NA TCGA-29-1764-01 NA NA NA TCGA-29-1764-01A-01R-0566-07 |
|
|
443 |
TCGA-29-1766-01 1 TCGA-29-1766-01 1199 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 NA TCGA-29-1766 NA NA days 1199 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 74 Right TCGA-29-1766-F27350 TCGA-29-1766 NA Stage IIIC -27359 NA 1199 0 1190 NA 672 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C48.2 8441/3 C48.2 YES Tumor resection NA NA NA NA NA NA NA G2 Recurrence NA NA NA NA NA 1766 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 NA NA NA 29 11-20 mm Peritoneum ovary NA NA DECEASED 2006 NA TCGA-29-1766-01 NA a7005558-9983-48f6-8252-943b8a9dd384 NA TCGA-29-1766-01 NA TCGA-29-1766-01A-01D-0563-05 NA TCGA-29-1766-01A-21-1559-20 TCGA-29-1766-01A-01W-0633-09 NA TCGA-29-1766-01A-01D-0559-01 TCGA-29-1766-01 dd8951d2-5b83-4b78-9b04-52d474639e2f NA TCGA-29-1766-01A-01D-0559-01 NA NA NA NA TCGA-29-1766-01 NA NA NA TCGA-29-1766-01A-01R-0566-07 |
|
|
444 |
TCGA-29-1768-01 1 TCGA-29-1768-01 952 1 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 NA TCGA-29-1768 NA NA days 952 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-29-1768-F27358 TCGA-29-1768 TCGA-29-1768-01A Stage IV -18396 NA 952 0 950 NA 547 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-29-1768.12d9b343-a52d-4a36-ba7b-31bfeb66da50.pdf 1768 Post-Adjuvant Therapy WITH TUMOR YES Stable Disease Imaging Study NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A DECEASED 2006 NA TCGA-29-1768-01 NA 83edce75-1b96-4e56-8042-76fc6e87f25f NA TCGA-29-1768-01 NA TCGA-29-1768-01A-01D-0563-05 NA TCGA-29-1768-01A-21-1559-20 TCGA-29-1768-01A-01W-0633-09 NA TCGA-29-1768-01A-01D-0559-01 TCGA-29-1768-01 f70a1542-3bd5-4ebe-880a-e8f7c75faaba NA TCGA-29-1768-01A-01D-0559-01 NA NA NA NA TCGA-29-1768-01 NA NA NA TCGA-29-1768-01A-01R-0566-07 |
|
|
445 |
TCGA-29-1769-01 0 TCGA-29-1769-01 699 0 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 NA TCGA-29-1769 NA NA days 699 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 40 Bilateral TCGA-29-1769-F27366 TCGA-29-1769 TCGA-29-1769-01A Stage IIIC -14754 NA NA 0 699 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.1 NA NO G3 NA NA NA NA NA TCGA-29-1769.67f144b3-c10b-4f96-a70b-6794d817170f.pdf 1769 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 29 1-10 mm Ovary NA A LIVING 2007 NA TCGA-29-1769-01 NA 8e7a34f7-d49b-46c8-8b74-374232c60b71 NA TCGA-29-1769-01 NA TCGA-29-1769-01A-01D-0581-05 NA TCGA-29-1769-01A-21-1559-20 TCGA-29-1769-01A-01W-0639-09 NA TCGA-29-1769-01A-01D-0577-01 TCGA-29-1769-01 161fd24e-ed8c-41ef-8f00-000b3554d9e8 NA TCGA-29-1769-01A-01D-0577-01 NA NA NA NA TCGA-29-1769-01 NA NA NA TCGA-29-1769-01A-01R-0584-07 |
|
|
446 |
TCGA-29-1770-01 0 TCGA-29-1770-01 741 0 days High C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 NA TCGA-29-1770 NA NA days 741 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-29-1770-F27373 TCGA-29-1770 TCGA-29-1770-01A Stage IIIC -20015 NA NA 0 741 NA 377 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.2 NA NA G2 Recurrence NA NA NA NA TCGA-29-1770.05816aac-55d2-4604-9300-e268f73338fe.pdf 1770 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.5 NA NA 29 1-10 mm Ovary NA A LIVING 2007 TCGA-29-1770-01 TCGA-29-1770-01 NA 17024b36-bf59-4753-bcb3-7ddda14f1556 NA TCGA-29-1770-01 NA TCGA-29-1770-01A-01D-0563-05 NA TCGA-29-1770-01A-21-1559-20 TCGA-29-1770-01A-01W-0633-09 5ba75bb8-6229-4d6a-80e5-9a79a548e167 TCGA-29-1770-01A-01D-0559-01 TCGA-29-1770-01 1577dc3d-937d-4fbb-b280-25f969e43f81 NA TCGA-29-1770-01A-01D-0559-01 5ba75bb8-6229-4d6a-80e5-9a79a548e167 NA 5ba75bb8-6229-4d6a-80e5-9a79a548e167 NA TCGA-29-1770-01 TCGA-29-1770-01 5ba75bb8-6229-4d6a-80e5-9a79a548e167 NA TCGA-29-1770-01A-01R-0566-07 |
|
|
447 |
TCGA-29-1770-02 0 TCGA-29-1770-02 741 0 days NA C9-OV Low purity c2 NA OV-like c16 miRNA cluster 3 NA NA TCGA-29-1770 NA NA days 741 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-29-1770-F27373 TCGA-29-1770 TCGA-29-1770-02A Stage IIIC -20015 NA NA 0 741 NA 377 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.4 NA NA G2 Recurrence NA NA NA NA TCGA-29-1770.49220236-FBFE-44AA-89BC-FC4E7CBC94FA.pdf 1770 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Recurrent Tumor 02 0.2 NA NA 29 1-10 mm Ovary NA A LIVING 2007 NA TCGA-29-1770-02 NA 4ccece6b-c6cf-4921-81e5-af3780afffbc NA TCGA-29-1770-02 NA TCGA-29-1770-02A-01D-0807-05 NA NA NA ea119111-5217-4b8a-88e0-36dc77782241 NA NA NA NA NA ea119111-5217-4b8a-88e0-36dc77782241 NA ea119111-5217-4b8a-88e0-36dc77782241 NA NA NA ea119111-5217-4b8a-88e0-36dc77782241 NA TCGA-29-1770-02A-01R-0810-07 |
|
|
448 |
TCGA-29-1771-01 0 TCGA-29-1771-01 686 0 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-29-1771 NA NA days 686 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Bilateral TCGA-29-1771-F27383 TCGA-29-1771 NA Stage IIIC -28093 NA NA 0 686 NA 595 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G2 Recurrence NA NA NA NA NA 1771 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 29 >20 mm Ovary NA NA LIVING 2007 NA TCGA-29-1771-01 NA d95ccef1-6cfa-4bda-ab09-c931f8c7a344 NA TCGA-29-1771-01 NA TCGA-29-1771-01A-01D-0563-05 NA TCGA-29-1771-01A-21-1559-20 TCGA-29-1771-01A-01W-0633-09 NA TCGA-29-1771-01A-01D-0559-01 TCGA-29-1771-01 b69387b5-4b22-4ef1-8711-d1e406c1afdc NA TCGA-29-1771-01A-01D-0559-01 NA NA NA NA TCGA-29-1771-01 NA NA NA TCGA-29-1771-01A-01R-0566-07 |
|
|
449 |
TCGA-29-1774-01 0 TCGA-29-1774-01 527 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-29-1774 NA NA days 527 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 82 Bilateral TCGA-29-1774-F27391 TCGA-29-1774 NA Stage IIIC -29991 NA NA 0 527 NA 234 2 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1774 NA WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 NA NA NA 29 >20 mm Ovary NA NA LIVING 2008 NA TCGA-29-1774-01 NA d9a5abd2-9d18-48b7-a38a-c69c134e6086 NA TCGA-29-1774-01 NA TCGA-29-1774-01A-01D-0581-05 NA TCGA-29-1774-01A-21-1559-20 TCGA-29-1774-01A-01W-0639-09 NA TCGA-29-1774-01A-01D-0577-01 TCGA-29-1774-01 eed4cd8b-16bc-419f-8474-248270a93780 NA TCGA-29-1774-01A-01D-0577-01 NA NA NA NA TCGA-29-1774-01 NA NA NA TCGA-29-1774-01A-01R-0584-07 |
|
|
450 |
TCGA-29-1775-01 0 TCGA-29-1775-01 376 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-29-1775 NA NA days 376 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-29-1775-F27398 TCGA-29-1775 TCGA-29-1775-01A Stage IIIC -18943 NA NA 0 376 NA 341 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Incisional Biopsy NA 0.7 NO NA 1.1 NA NA G2 Recurrence NA NA NA NA TCGA-29-1775.8f5dd3e0-b6c8-443e-88d9-c9d02a531f60.pdf 1775 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 0.5 NA NA 29 1-10 mm Ovary NA A LIVING 2008 NA NA NA 8ead8627-a2d2-4952-9d59-cb15c2ae2021 NA NA NA TCGA-29-1775-01A-01D-0581-05 NA TCGA-29-1775-01A-21-1559-20 TCGA-29-1775-01A-01W-0639-09 NA TCGA-29-1775-01A-01D-0577-01 TCGA-29-1775-01 8a55a793-3d3c-455f-a342-3c5cbd01f849 NA TCGA-29-1775-01A-01D-0577-01 NA NA NA NA TCGA-29-1775-01 NA NA NA TCGA-29-1775-01A-01R-0584-07 |
|
|
451 |
TCGA-29-1776-01 0 TCGA-29-1776-01 360 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 NA TCGA-29-1776 NA NA days 360 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Bilateral TCGA-29-1776-F27409 TCGA-29-1776 TCGA-29-1776-01A Stage IIIC -23016 NA NA 0 360 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.9 NA NA G3 NA NA NA NA NA TCGA-29-1776.eb6df66e-c6ee-4c63-889d-9f4b6ca170c7.pdf 1776 Post-Adjuvant Therapy WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A LIVING 2008 TCGA-29-1776-01 TCGA-29-1776-01 NA 1549eee5-f999-4053-b926-baae183792f1 NA TCGA-29-1776-01 NA TCGA-29-1776-01A-01D-0581-05 NA TCGA-29-1776-01A-21-1559-20 TCGA-29-1776-01A-01W-0639-09 50867fed-2fda-4c45-aa08-042087e7daa9 TCGA-29-1776-01A-01D-0577-01 TCGA-29-1776-01 3da0c471-ede3-480f-b692-f94939ed8ac3 NA TCGA-29-1776-01A-01D-0577-01 50867fed-2fda-4c45-aa08-042087e7daa9 NA 50867fed-2fda-4c45-aa08-042087e7daa9 NA TCGA-29-1776-01 TCGA-29-1776-01 50867fed-2fda-4c45-aa08-042087e7daa9 NA TCGA-29-1776-01A-01R-0584-07 |
|
|
452 |
TCGA-29-1777-01 0 TCGA-29-1777-01 374 0 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 NA TCGA-29-1777 NA NA days 374 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 47 Bilateral TCGA-29-1777-F27415 TCGA-29-1777 TCGA-29-1777-01A Stage IIIC -17356 NA NA 0 374 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.3 NA NA G2 NA NA NA NA NA TCGA-29-1777.bfd59906-509b-4ca3-9282-c881f9962e15.pdf 1777 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.5 NA NA 29 >20 mm Ovary NA A LIVING 2008 NA TCGA-29-1777-01 NA 79992944-6a6c-4f97-baf4-132689a69fff NA TCGA-29-1777-01 NA TCGA-29-1777-01A-01D-0581-05 NA TCGA-29-1777-01A-21-1559-20 TCGA-29-1777-01A-01W-0639-09 NA TCGA-29-1777-01A-01D-0577-01 TCGA-29-1777-01 9b5e802b-56e7-4f93-8869-2db3170006bc NA TCGA-29-1777-01A-01D-0577-01 NA NA NA NA TCGA-29-1777-01 NA NA NA TCGA-29-1777-01A-01R-0584-07 |
|
|
453 |
TCGA-29-1778-01 0 TCGA-29-1778-01 454 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-29-1778 NA NA days 454 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 77 Right TCGA-29-1778-F27420 TCGA-29-1778 TCGA-29-1778-01A Stage IIIC -28147 NA NA 0 454 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA NA G3 NA NA NA NA NA TCGA-29-1778.439a81dd-dc54-49e5-942c-4aa8d0be8701.pdf 1778 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 29 No Macroscopic disease Ovary NA A LIVING 2008 TCGA-29-1778-01 TCGA-29-1778-01 NA 0654179f-2887-47e8-b4f4-051312a4907c NA TCGA-29-1778-01 NA TCGA-29-1778-01A-01D-0581-05 NA TCGA-29-1778-01A-21-1559-20 TCGA-29-1778-01A-01W-0639-09 7ecd0f7a-d186-422b-a2e1-833dfc400e39 TCGA-29-1778-01A-01D-0577-01 TCGA-29-1778-01 9a724a0a-6807-4995-889b-4b80a32e280d NA TCGA-29-1778-01A-01D-0577-01 7ecd0f7a-d186-422b-a2e1-833dfc400e39 NA 7ecd0f7a-d186-422b-a2e1-833dfc400e39 NA TCGA-29-1778-01 TCGA-29-1778-01 7ecd0f7a-d186-422b-a2e1-833dfc400e39 NA TCGA-29-1778-01A-01R-0584-07 |
|
|
454 |
TCGA-29-1781-01 0 TCGA-29-1781-01 255 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 NA TCGA-29-1781 NA NA days 255 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 69 Bilateral TCGA-29-1781-F27427 TCGA-29-1781 TCGA-29-1781-01A Stage IIIC -25404 NA NA 0 255 NA NA 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NA G3 NA NA NA NA NA TCGA-29-1781.959c11fe-f170-49bc-a1fe-73b799741b93.pdf 1781 Pre-Adjuvant Therapy TUMOR FREE NO Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 29 No Macroscopic disease Ovary NA A LIVING 2009 TCGA-29-1781-01 TCGA-29-1781-01 NA b87d2ec7-4fbf-4ecd-99fd-4983eb2fb7d8 NA TCGA-29-1781-01 NA TCGA-29-1781-01A-01D-0563-05 NA TCGA-29-1781-01A-21-1559-20 TCGA-29-1781-01A-01W-0633-09 5fd66773-ed5a-438c-a7c1-d029f05798e5 TCGA-29-1781-01A-01D-0559-01 TCGA-29-1781-01 7b26743c-756e-45d0-8eaa-cffb1c11fef1 NA TCGA-29-1781-01A-01D-0559-01 5fd66773-ed5a-438c-a7c1-d029f05798e5 NA 5fd66773-ed5a-438c-a7c1-d029f05798e5 NA TCGA-29-1781-01 TCGA-29-1781-01 5fd66773-ed5a-438c-a7c1-d029f05798e5 NA TCGA-29-1781-01A-01R-0566-07 |
|
|
455 |
TCGA-29-1783-01 0 TCGA-29-1783-01 220 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-29-1783 NA NA days 220 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Right TCGA-29-1783-F27431 TCGA-29-1783 TCGA-29-1783-01A Stage IIIC -21284 NA NA 0 220 NA NA 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NA G3 NA NA NA NA NA TCGA-29-1783.6ebf4763-bb2a-4ef5-ab22-23460980df1c.pdf 1783 Post-Adjuvant Therapy TUMOR FREE YES NA NA NO NA Primary Tumor 01 0.4 NA NA 29 1-10 mm Ovary NA A LIVING 2009 TCGA-29-1783-01 TCGA-29-1783-01 NA 2981b53e-f39a-4c5e-9254-dd1a6bf6c4e6 NA TCGA-29-1783-01 NA TCGA-29-1783-01A-01D-0563-05 NA TCGA-29-1783-01A-21-1559-20 TCGA-29-1783-01A-01W-0633-09 dad3688e-fdd7-4c85-a1df-cf0e1cc0a235 TCGA-29-1783-01A-01D-0559-01 TCGA-29-1783-01 82dd8748-e0c5-4030-bf40-fe5d229adeae NA TCGA-29-1783-01A-01D-0559-01 dad3688e-fdd7-4c85-a1df-cf0e1cc0a235 NA dad3688e-fdd7-4c85-a1df-cf0e1cc0a235 NA TCGA-29-1783-01 TCGA-29-1783-01 dad3688e-fdd7-4c85-a1df-cf0e1cc0a235 NA TCGA-29-1783-01A-01R-0566-07 |
|
|
456 |
TCGA-29-1784-01 0 TCGA-29-1784-01 163 0 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-29-1784 NA NA days 163 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Right TCGA-29-1784-F27436 TCGA-29-1784 TCGA-29-1784-01A Stage IIIC -20210 NA NA 0 163 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA YES G3 NA NA NA NA NA TCGA-29-1784.e4614e5d-eb1f-4ac7-a17f-105936745e80.pdf 1784 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 29 No Macroscopic disease Ovary NA A LIVING 2009 TCGA-29-1784-01 TCGA-29-1784-01 NA 3720cc8a-5b9c-44cb-ba9d-5540f1ece950 NA TCGA-29-1784-01 NA TCGA-29-1784-01A-02D-0563-05 NA NA TCGA-29-1784-01A-02W-0633-09 c72e442b-36f5-4ea6-a893-505b5ccd8c4f TCGA-29-1784-01A-02D-0559-01 TCGA-29-1784-01 NA NA TCGA-29-1784-01A-02D-0559-01 c72e442b-36f5-4ea6-a893-505b5ccd8c4f NA c72e442b-36f5-4ea6-a893-505b5ccd8c4f NA TCGA-29-1784-01 TCGA-29-1784-01 c72e442b-36f5-4ea6-a893-505b5ccd8c4f NA TCGA-29-1784-01A-02R-0566-07 |
|
|
457 |
TCGA-29-1785-01 1 TCGA-29-1785-01 1104 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-29-1785 NA NA days 1104 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Right TCGA-29-1785-F27442 TCGA-29-1785 TCGA-29-1785-01A Stage IIIC -20417 NA 1104 0 1053 NA 473 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.2 NA YES G3 Recurrence NA NA NA NA TCGA-29-1785.b520ed75-17dd-420f-b444-4436bb03f40f.pdf 1785 Post-Adjuvant Therapy NA YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A DECEASED 2006 TCGA-29-1785-01 TCGA-29-1785-01 NA 89db2b71-04a7-42f7-8480-a8ba3f118bcc NA TCGA-29-1785-01 NA TCGA-29-1785-01A-01D-0563-05 NA TCGA-29-1785-01A-21-1559-20 TCGA-29-1785-01A-01W-0633-09 dcff1416-56fd-4d8e-a472-a40a00ef3066 TCGA-29-1785-01A-01D-0559-01 TCGA-29-1785-01 c7002a87-0a3e-4ffb-b976-b1d7f768dd30 NA TCGA-29-1785-01A-01D-0559-01 dcff1416-56fd-4d8e-a472-a40a00ef3066 NA dcff1416-56fd-4d8e-a472-a40a00ef3066 NA TCGA-29-1785-01 TCGA-29-1785-01 dcff1416-56fd-4d8e-a472-a40a00ef3066 NA TCGA-29-1785-01A-01R-0566-07 |
|
|
458 |
TCGA-29-2414-01 1 TCGA-29-2414-01 2621 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 NA TCGA-29-2414 NA NA days 2621 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 75 Left TCGA-29-2414-F27451 TCGA-29-2414 TCGA-29-2414-01A Stage IIIC -27417 NA 2621 0 2621 NA 552 NA NA NA 2010-2-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1 NA NA G2 Recurrence NA NA NA NA TCGA-29-2414.1A4882EA-818E-4A23-8584-2881D0DE8406.pdf 2414 NA WITH TUMOR YES Complete Remission/Response Other Method NO R1 Primary Tumor 01 0.5 NA NA 29 11-20 mm Ovary NO A DECEASED 1998 TCGA-29-2414-01 TCGA-29-2414-01 NA 9d580db8-ad4f-4ecb-affd-e9ae032e8ebb NA TCGA-29-2414-01 NA TCGA-29-2414-01A-02D-0708-05 NA NA NA ecbadb01-01ec-4d9f-877c-75709d6f5914 TCGA-29-2414-01A-02D-2069-01 TCGA-29-2414-01 2433c714-344b-4fa6-91a4-2cab830a4485 NA TCGA-29-2414-01A-02D-2069-01 ecbadb01-01ec-4d9f-877c-75709d6f5914 NA ecbadb01-01ec-4d9f-877c-75709d6f5914 NA TCGA-29-2414-01 TCGA-29-2414-01 ecbadb01-01ec-4d9f-877c-75709d6f5914 NA TCGA-29-2414-01A-02R-0711-07 |
|
|
459 |
TCGA-29-2414-02 1 TCGA-29-2414-02 2621 1 days NA NA OV-like c1 NA OV-like c16 miRNA cluster 1 NA NA TCGA-29-2414 NA NA days 2621 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 75 Left TCGA-29-2414-F27451 TCGA-29-2414 TCGA-29-2414-02A Stage IIIC -27417 NA 2621 0 2621 NA 552 NA NA NA 2010-2-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1 NA NA G2 Recurrence NA NA NA NA TCGA-29-2414.1A4882EA-818E-4A23-8584-2881D0DE8406.pdf 2414 NA WITH TUMOR YES Complete Remission/Response Other Method NO R1 Recurrent Tumor 02 0.3 NA NA 29 11-20 mm Ovary NO A DECEASED 1998 NA TCGA-29-2414-02 NA 4e488bb5-78b0-4a28-b276-109b203230d4 NA TCGA-29-2414-02 NA TCGA-29-2414-02A-01D-0807-05 NA NA NA 1558c0c4-6bd2-482d-9c4e-2430a402dacc NA NA 754eb22a-d0a5-4ea9-9fee-685e6d2cad7f NA NA 1558c0c4-6bd2-482d-9c4e-2430a402dacc NA 1558c0c4-6bd2-482d-9c4e-2430a402dacc NA NA NA 1558c0c4-6bd2-482d-9c4e-2430a402dacc NA TCGA-29-2414-02A-01R-0810-07 |
|
|
460 |
TCGA-29-2425-01 0 TCGA-29-2425-01 1977 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-29-2425 NA NA days 1977 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 NA TCGA-29-2425-F27462 TCGA-29-2425 TCGA-29-2425-01A Stage IIIC -22089 NA NA 0 1977 NA 1577 0 NA NA 2010-2-9 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1 NA NO G2 Progression of Disease NA NA NA NA TCGA-29-2425.ec04e6ae-ae66-4fc2-b77b-485f77ce39bc.pdf 2425 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.5 NA NA 29 >20 mm Ovary NA A LIVING 2004 TCGA-29-2425-01 TCGA-29-2425-01 NA 572ffa30-3fd6-49b7-a250-f8505555bde9 NA TCGA-29-2425-01 NA TCGA-29-2425-01A-01D-0708-05 NA TCGA-29-2425-01A-21-1560-20 NA 3ce6b8c4-7020-447a-8eb8-5370eef05344 TCGA-29-2425-01A-01D-0704-01 TCGA-29-2425-01 8d87815d-6b5a-4713-9f0b-0ca8609996f2 NA TCGA-29-2425-01A-01D-0704-01 3ce6b8c4-7020-447a-8eb8-5370eef05344 NA 3ce6b8c4-7020-447a-8eb8-5370eef05344 NA TCGA-29-2425-01 TCGA-29-2425-01 3ce6b8c4-7020-447a-8eb8-5370eef05344 NA TCGA-29-2425-01A-01R-0711-07 |
|
|
461 |
TCGA-29-2427-01 0 TCGA-29-2427-01 1900 0 days BRCA-LUAD+ C9-OV Low purity c2 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-29-2427 NA NA days 1900 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Left TCGA-29-2427-F27470 TCGA-29-2427 TCGA-29-2427-01A Stage IIIC -21940 NA NA 0 1900 NA 1582 0 NA NA 2010-2-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-29-2427.b53536ca-770c-4482-b2f7-4284d804db2e.pdf 2427 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.5 NA NA 29 >20 mm Ovary NA A LIVING 2004 TCGA-29-2427-01 TCGA-29-2427-01 NA 68e99d72-4df2-4d2d-9e24-b8fc81942a46 NA TCGA-29-2427-01 NA TCGA-29-2427-01A-01D-0708-05 NA TCGA-29-2427-01A-21-1560-20 NA f1579d6e-6efd-47b5-b2b4-a97e1480ce0a TCGA-29-2427-01A-01D-0704-01 TCGA-29-2427-01 596d6d8e-d15c-442b-bcd4-ed2dec59aef2 NA TCGA-29-2427-01A-01D-0704-01 f1579d6e-6efd-47b5-b2b4-a97e1480ce0a NA f1579d6e-6efd-47b5-b2b4-a97e1480ce0a TCGA-29-2427-01A-01W-0799-08 TCGA-29-2427-01 TCGA-29-2427-01 f1579d6e-6efd-47b5-b2b4-a97e1480ce0a TCGA-29-2427-01A-01W-0799-08 TCGA-29-2427-01A-01R-0711-07 |
|
|
462 |
TCGA-29-2428-01 0 TCGA-29-2428-01 1372 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-29-2428 NA NA days 1372 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Left TCGA-29-2428-F27478 TCGA-29-2428 TCGA-29-2428-01A Stage IIIC -21392 NA NA 0 1372 NA NA 0 NA NA 2010-2-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.7 NA YES G3 NA NA NA NA NA TCGA-29-2428.45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb.pdf 2428 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO R1 Primary Tumor 01 0.4 NA NA 29 >20 mm Ovary NA A LIVING 2005 TCGA-29-2428-01 TCGA-29-2428-01 NA b7c8f2a5-de96-4a38-bfa4-2a6c1b8ea1e2 NA TCGA-29-2428-01 NA TCGA-29-2428-01A-01D-0708-05 NA TCGA-29-2428-01A-21-1560-20 NA 9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b TCGA-29-2428-01A-01D-0704-01 TCGA-29-2428-01 364ced0b-2737-4f70-a7bb-a5a9171e4ef8 NA TCGA-29-2428-01A-01D-0704-01 9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b NA 9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b NA TCGA-29-2428-01 TCGA-29-2428-01 9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b NA TCGA-29-2428-01A-01R-0711-07 |
|
|
463 |
TCGA-29-2429-01 1 TCGA-29-2429-01 421 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-29-2429 421 0 days 421 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 79 Right TCGA-29-2429-F44633 TCGA-29-2429 TCGA-29-2429-01A Stage IIIC -29156 NA 421 0 NA NA NA NA NA NA 2013-8-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.1 YES NA G3 NA NA NO NA NA TCGA-29-2429.09804c6e-b6f3-482f-a23e-a4efa84f2ab7.pdf 2429 NA WITH TUMOR NA NA NA NA R1 Primary Tumor 01 0.3 NA NA 29 >20 mm Ovary NA A DECEASED 2005 NA NA NA 1142b276-1e85-4021-8fa7-85e562b6c747 NA NA NA TCGA-29-2429-01A-01D-1047-05 NA TCGA-29-2429-01A-21-1560-20 TCGA-29-2429-01A-01D-1526-09 NA TCGA-29-2429-01A-01D-1043-01 TCGA-29-2429-01 3ba731e2-2840-44c0-aa48-541f8f9e4d29 NA TCGA-29-2429-01A-01D-1043-01 NA NA NA NA TCGA-29-2429-01 NA NA NA TCGA-29-2429-01A-01R-1050-07 |
|
|
464 |
TCGA-29-2431-01 0 TCGA-29-2431-01 1285 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-29-2431 NA NA days 1285 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-29-2431-F27485 TCGA-29-2431 TCGA-29-2431-01A Stage IIIC -21833 NA NA 0 1285 NA 960 0 NA NA 2010-6-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.5 NA NA G2 Recurrence NA NA NA NA TCGA-29-2431.cbd3ddd8-b431-4852-b4db-b4be535115d6.pdf 2431 Post-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO R0 Primary Tumor 01 0.3 NA NA 29 1-10 mm Ovary NA A LIVING 2006 NA NA NA 88be95fd-3aa9-4279-91ff-e705db3e187c NA NA NA TCGA-29-2431-01A-01D-1047-05 NA TCGA-29-2431-01A-21-1560-20 TCGA-29-2431-01A-01D-1526-09 NA TCGA-29-2431-01A-01D-1043-01 TCGA-29-2431-01 f02341bc-10e3-4bbf-98c8-0604616796ea NA TCGA-29-2431-01A-01D-1043-01 NA NA NA NA TCGA-29-2431-01 NA NA NA TCGA-29-2431-01A-01R-1050-07 |
|
|
465 |
TCGA-29-2432-01 1 TCGA-29-2432-01 653 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-29-2432 NA NA days 653 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-29-2432-F27492 TCGA-29-2432 TCGA-29-2432-01A Stage IIIC -22605 NA 653 0 360 NA 174 NA NA NA 2010-6-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.3 NA NA G3 Recurrence NA NA NA NA TCGA-29-2432.9de0ca7f-0603-46a9-9c69-7e2196cbfb6f.pdf 2432 NA WITH TUMOR YES Progressive Disease NA NO R1 Primary Tumor 01 0.5 NA NA 29 11-20 mm Ovary NA A DECEASED 2008 NA NA NA 6fcda1cc-9224-452c-8fda-369e73f2f05e NA NA NA TCGA-29-2432-01A-01D-1047-05 NA TCGA-29-2432-01A-21-1560-20 TCGA-29-2432-01A-01D-1526-09 NA TCGA-29-2432-01A-01D-1043-01 TCGA-29-2432-01 a835eb6a-c37b-49de-bea5-9f9251f817a5 NA TCGA-29-2432-01A-01D-1043-01 NA NA NA NA TCGA-29-2432-01 NA NA NA TCGA-29-2432-01A-01R-1050-07 |
|
|
466 |
TCGA-29-2434-01 0 TCGA-29-2434-01 349 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-29-2434 NA NA days 349 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Left TCGA-29-2434-F27505 TCGA-29-2434 TCGA-29-2434-01A Stage IIIC -18997 NA NA 0 349 NA NA NA NA NA 2010-6-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-29-2434.0891ac31-d9ed-4cb3-82ae-8499fb4c29ea.pdf 2434 NA TUMOR FREE YES Complete Remission/Response NA NO R0 Primary Tumor 01 0.4 NA NA 29 No Macroscopic disease Ovary NA A LIVING 2009 NA NA NA 7b45cfcd-a37c-4f92-b35f-e75ac6b1d000 NA NA NA TCGA-29-2434-01A-01D-1047-05 NA TCGA-29-2434-01A-21-1560-20 TCGA-29-2434-01A-01D-1526-09 NA TCGA-29-2434-01A-01D-1043-01 TCGA-29-2434-01 9eb175cd-3311-4f57-a37a-7a2463bc58fb NA TCGA-29-2434-01A-01D-1043-01 NA NA NA NA TCGA-29-2434-01 NA NA NA TCGA-29-2434-01A-01R-1050-07 |
|
|
467 |
TCGA-29-2435-01 0 TCGA-29-2435-01 34 0 days NA NA NA OV-like c4 NA NA NA NA TCGA-29-2435 NA NA days 34 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Left TCGA-29-2435-F27510 TCGA-29-2435 TCGA-29-2435-01A Stage IV -28779 NA NA 0 34 NA NA NA NA NA 2010-6-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.5 NA NA G3 NA NA NA NA NA TCGA-29-2435.6EF128AE-31B6-483A-B0DD-9626CEEC278E.pdf 2435 NA NA YES NA NA NA R1 Primary Tumor 01 0.3 NA NA 29 11-20 mm Ovary NA A LIVING 2009 NA NA NA NA NA NA NA NA NA TCGA-29-2435-01A-21-1560-20 NA NA NA NA 84e1540d-c756-414e-92c9-3e0d5f45cd48 NA NA NA NA NA NA NA NA NA NA NA |
|
|
468 |
TCGA-29-2436-01 0 TCGA-29-2436-01 297 0 days COAD-READ NA Low purity c2 OV-like c4 NA NA NA NA TCGA-29-2436 NA NA days 297 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 36 Bilateral TCGA-29-2436-F27514 TCGA-29-2436 TCGA-29-2436-01A Stage IIIC -13346 NA NA 0 297 NA NA NA NA NA 2010-6-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.3 NA NA G2 NA NA NA NA NA TCGA-29-2436.0caa891b-3d47-44c1-bc75-0468afc11495.pdf 2436 NA TUMOR FREE YES Complete Remission/Response NA NO R0 Primary Tumor 01 0.4 NA NA 29 1-10 mm Ovary YES A LIVING 2009 NA NA NA e467e3e0-9311-48ff-8da8-f3b9118011e7 NA NA NA TCGA-29-2436-01A-01D-1047-05 NA TCGA-29-2436-01A-21-1560-20 TCGA-29-2436-01A-01D-1526-09 NA TCGA-29-2436-01A-01D-1043-01 TCGA-29-2436-01 851a2dc8-da35-4a80-bcd1-1ed74ee459c7 NA TCGA-29-2436-01A-01D-1043-01 NA NA NA NA TCGA-29-2436-01 NA NA NA TCGA-29-2436-01A-01R-1050-07 |
|
|
469 |
TCGA-29-A5NZ-01 0 TCGA-29-A5NZ-01 984 0 days NA NA NA NA NA NA NA NA TCGA-29-A5NZ 879 1 days 984 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 NA TCGA-29-A5NZ-F59530 TCGA-29-A5NZ TCGA-29-A5NZ-01A Stage IIIC -24161 515 1088 0 984 NA 879 NA Additional New Tumor Event NA 2014-5-14 FEMALE Serous Cystadenocarcinoma No C48.1 8460/3 C48.1 YES NA 1040 NA NO NA NA NO NA G3 Progression of Disease NA YES true No TCGA-29-A5NZ.B7F69EE0-E844-434B-A76B-390590C85864.pdf A5NZ NA WITH TUMOR YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 29 NA Omentum NA A LIVING 2011 TCGA-29-A5NZ-01 TCGA-29-A5NZ-01 NA NA TCGA-29-A5NZ-01A-11D-A409-05 TCGA-29-A5NZ-01 NA NA NA NA NA ea715147-2b94-4bed-9531-ba91c13630fe TCGA-29-A5NZ-01A-11D-A402-01 NA 8E54518A-2DD5-448F-AFA2-C23D91E0290D TCGA-29-A5NZ-01A-11R-A406-31 TCGA-29-A5NZ-01A-11D-A402-01 ea715147-2b94-4bed-9531-ba91c13630fe TCGA-29-A5NZ-01A-11R-A406-31 ea715147-2b94-4bed-9531-ba91c13630fe NA NA TCGA-29-A5NZ-01 ea715147-2b94-4bed-9531-ba91c13630fe NA NA |
|
|
470 |
TCGA-30-1714-01 1 TCGA-30-1714-01 1158 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 NA TCGA-30-1714 NA NA days 1158 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 68 Bilateral TCGA-30-1714-F27518 TCGA-30-1714 TCGA-30-1714-01A Stage IV -25032 NA 1158 0 1158 NA 241 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.6 NA YES G3 Recurrence NA NA NA NA TCGA-30-1714.7bec7160-e40c-4b47-b0d6-93652c5e27f2.pdf 1714 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 30 1-10 mm Ovary NO A DECEASED 2001 NA TCGA-30-1714-01 NA 9b91d688-3f05-43a9-8900-57027113b885 NA TCGA-30-1714-01 NA TCGA-30-1714-01A-02D-0563-05 NA NA TCGA-30-1714-01A-02W-0633-09 NA TCGA-30-1714-01A-02D-0559-01 TCGA-30-1714-01 NA NA TCGA-30-1714-01A-02D-0559-01 NA NA NA NA TCGA-30-1714-01 NA NA NA TCGA-30-1714-01A-02R-0566-07 |
|
|
471 |
TCGA-30-1718-01 1 TCGA-30-1718-01 1579 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 NA TCGA-30-1718 NA NA days 1579 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 44 Bilateral TCGA-30-1718-F27534 TCGA-30-1718 TCGA-30-1718-01A Stage IIIC -16400 NA 1579 0 1579 NA 896 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.3 NA NO G3 Recurrence NA NA NA NA TCGA-30-1718.078da76a-b9f5-40d0-9a57-04c306ade36a.pdf 1718 NA WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 0.4 NA NA 30 1-10 mm Ovary NO A DECEASED 2002 TCGA-30-1718-01 TCGA-30-1718-01 NA f9ba9bc4-5591-4a79-b8ad-fee2f83ea724 NA TCGA-30-1718-01 NA TCGA-30-1718-01A-01D-0563-05 NA TCGA-30-1718-01A-21-1559-20 TCGA-30-1718-01A-01W-0633-09 5abce979-686d-40c4-acd7-ef9cc5acf26f TCGA-30-1718-01A-01D-0559-01 TCGA-30-1718-01 bd7cf7cb-3d3f-44ff-a0ad-f559a3d26370 NA TCGA-30-1718-01A-01D-0559-01 5abce979-686d-40c4-acd7-ef9cc5acf26f NA 5abce979-686d-40c4-acd7-ef9cc5acf26f NA TCGA-30-1718-01 TCGA-30-1718-01 5abce979-686d-40c4-acd7-ef9cc5acf26f NA TCGA-30-1718-01A-01R-0566-07 |
|
|
472 |
TCGA-30-1853-01 1 TCGA-30-1853-01 1103 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-30-1853 NA NA days 1103 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-30-1853-F27542 TCGA-30-1853 TCGA-30-1853-01A Stage IIIC -21404 NA 1103 0 1103 NA 634 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-30-1853.ded9ba4c-8d3d-450b-a345-772a3e3ae288.pdf 1853 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 30 1-10 mm Ovary NA A DECEASED 2000 NA TCGA-30-1853-01 NA 549e923d-4430-4b66-8378-af96f66646b7 NA TCGA-30-1853-01 NA TCGA-30-1853-01A-02D-0652-05 NA NA NA NA TCGA-30-1853-01A-02D-0648-01 TCGA-30-1853-01 NA NA TCGA-30-1853-01A-02D-0648-01 NA NA NA TCGA-30-1853-01A-02W-0699-08 TCGA-30-1853-01 NA NA TCGA-30-1853-01A-02W-0699-08 TCGA-30-1853-01A-02R-0655-07 |
|
|
473 |
TCGA-30-1855-01 1 TCGA-30-1855-01 75 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-30-1855 NA NA days 75 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 61 NA TCGA-30-1855-F27550 TCGA-30-1855 TCGA-30-1855-01A Stage IIIC -22394 NA 75 0 75 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NO G3 NA NA NA NA NA TCGA-30-1855.cba111de-b005-4460-b4d1-d8b24126d1d3.pdf 1855 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.4 NA NA 30 1-10 mm Ovary NO A DECEASED 2001 TCGA-30-1855-01 TCGA-30-1855-01 NA b47399a9-31a2-4721-8da0-63bf21c6fcae NA TCGA-30-1855-01 NA TCGA-30-1855-01A-01D-0581-05 NA TCGA-30-1855-01A-21-1559-20 TCGA-30-1855-01A-01W-0639-09 732d0664-c343-4a63-9dc3-40985e540a59 TCGA-30-1855-01A-01D-0577-01 TCGA-30-1855-01 6b1438ab-2904-4d21-865d-f14c76777f62 NA TCGA-30-1855-01A-01D-0577-01 732d0664-c343-4a63-9dc3-40985e540a59 NA 732d0664-c343-4a63-9dc3-40985e540a59 NA TCGA-30-1855-01 TCGA-30-1855-01 732d0664-c343-4a63-9dc3-40985e540a59 NA TCGA-30-1855-01A-01R-0584-07 |
|
|
474 |
TCGA-30-1856-01 1 TCGA-30-1856-01 477 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 NA TCGA-30-1856 NA NA days 477 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-30-1856-F27552 TCGA-30-1856 TCGA-30-1856-01A Stage IIIC -20626 NA 477 0 477 NA 220 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-30-1856.281005d7-4231-467c-9c6c-43f536fcebe1.pdf 1856 NA WITH TUMOR YES Partial Remission/Response First Seen At Further Surgery NO NA Primary Tumor 01 0.4 NA NA 30 1-10 mm Ovary NO A DECEASED 2001 NA TCGA-30-1856-01 NA 73874ff9-38f8-4a31-9ac1-923793b88b91 NA TCGA-30-1856-01 NA TCGA-30-1856-01A-01D-0581-05 NA TCGA-30-1856-01A-21-1559-20 TCGA-30-1856-01A-01W-0639-09 NA TCGA-30-1856-01A-01D-0577-01 TCGA-30-1856-01 60d477e5-467d-4be3-b495-ed511519e4fa NA TCGA-30-1856-01A-01D-0577-01 NA NA NA NA TCGA-30-1856-01 NA NA NA TCGA-30-1856-01A-01R-0584-07 |
|
|
475 |
TCGA-30-1857-01 1 TCGA-30-1857-01 8 1 days Squamous NA OV-like c1 NA NA miRNA cluster 3 cluster 6 NA TCGA-30-1857 NA NA days 8 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 64 Right TCGA-30-1857-F27564 TCGA-30-1857 TCGA-30-1857-01A Stage IV -23689 NA 8 0 8 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.8 NA NA G3 NA NA NA NA NA TCGA-30-1857.e3d84909-0149-4691-a398-1a6b272dde60.pdf 1857 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.4 NA NA 30 NA Ovary NA A DECEASED 2001 TCGA-30-1857-01 TCGA-30-1857-01 NA bffff720-6d86-4661-9ae9-85605520064f NA TCGA-30-1857-01 NA TCGA-30-1857-01A-02D-0581-05 NA NA TCGA-30-1857-01A-02W-0639-09 7fc46368-c523-4936-84e3-bb3f77db7c48 TCGA-30-1857-01A-02D-0577-01 TCGA-30-1857-01 NA TCGA-30-1857-01A-02R-1569-13 TCGA-30-1857-01A-02D-0577-01 7fc46368-c523-4936-84e3-bb3f77db7c48 TCGA-30-1857-01A-02R-1569-13 7fc46368-c523-4936-84e3-bb3f77db7c48 NA TCGA-30-1857-01 TCGA-30-1857-01 7fc46368-c523-4936-84e3-bb3f77db7c48 NA TCGA-30-1857-01A-02R-0584-07 |
|
|
476 |
TCGA-30-1859-01 1 TCGA-30-1859-01 1463 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 NA TCGA-30-1859 NA NA days 1463 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-30-1859-F27566 TCGA-30-1859 TCGA-30-1859-01A NA -20498 NA 1463 0 1463 210 NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.3 NO NA 1 NA NA G3 Locoregional Disease YES NA NA NA TCGA-30-1859.6c4d66bc-361f-465f-b18a-7bb1a0fc7752.pdf 1859 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 30 1-10 mm Ovary NA A DECEASED 2002 NA TCGA-30-1859-01 NA 4618e0b6-9a8d-4843-a67f-a0b0de96b4ec NA TCGA-30-1859-01 NA TCGA-30-1859-01A-01D-0652-05 NA TCGA-30-1859-01A-21-1559-20 NA NA TCGA-30-1859-01A-01D-0648-01 TCGA-30-1859-01 063c9971-7f3f-45f5-8f42-11b3eca461fa NA TCGA-30-1859-01A-01D-0648-01 NA NA NA NA TCGA-30-1859-01 NA NA NA TCGA-30-1859-01A-01R-0655-07 |
|
|
477 |
TCGA-30-1860-01 1 TCGA-30-1860-01 1366 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 NA TCGA-30-1860 NA NA days 1366 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 58 Bilateral TCGA-30-1860-F27580 TCGA-30-1860 TCGA-30-1860-01A Stage IIIC -21406 NA 1366 0 1366 NA 397 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.5 NA NO G3 Recurrence NA NA NA NA TCGA-30-1860.d5b8e59f-1ae5-4e22-b933-48e48a364788.pdf 1860 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 30 >20 mm Ovary NO A DECEASED 2002 TCGA-30-1860-01 TCGA-30-1860-01 NA 713acb94-3fd4-444d-ae04-e79c1ee73b3a NA TCGA-30-1860-01 NA TCGA-30-1860-01A-01D-0652-05 NA TCGA-30-1860-01A-21-1559-20 NA 1b8eed7b-173e-4e38-80a4-a3a0aea469a1 TCGA-30-1860-01A-01D-0648-01 TCGA-30-1860-01 5c4486d9-1d91-4f42-83fd-85526c4f0836 NA TCGA-30-1860-01A-01D-0648-01 1b8eed7b-173e-4e38-80a4-a3a0aea469a1 NA 1b8eed7b-173e-4e38-80a4-a3a0aea469a1 NA TCGA-30-1860-01 TCGA-30-1860-01 1b8eed7b-173e-4e38-80a4-a3a0aea469a1 NA TCGA-30-1860-01A-01R-0655-07 |
|
|
478 |
TCGA-30-1861-01 1 TCGA-30-1861-01 1058 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 NA TCGA-30-1861 NA NA days 1058 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 74 Bilateral NA TCGA-30-1861 TCGA-30-1861-01A Stage IIIC -27103 NA 1058 0 1058 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.8 NA NA G3 NA NA NA NA NA TCGA-30-1861.446be880-d1d8-4b63-b4d5-5aa0468ccafe.pdf 1861 NA NA NA NA NA NA NA Primary Tumor 01 0.4 NA NA 30 1-10 mm Ovary NA A DECEASED 2002 TCGA-30-1861-01 TCGA-30-1861-01 NA 617ac2af-9b70-4c2b-b659-02436e604267 NA TCGA-30-1861-01 NA TCGA-30-1861-01A-01D-0652-05 NA TCGA-30-1861-01A-21-1559-20 NA 32a58029-c8aa-4647-a932-bbf57e82fc48 TCGA-30-1861-01A-01D-0648-01 TCGA-30-1861-01 7e253248-d889-4b00-a098-55cfcb18758b NA TCGA-30-1861-01A-01D-0648-01 32a58029-c8aa-4647-a932-bbf57e82fc48 NA 32a58029-c8aa-4647-a932-bbf57e82fc48 NA TCGA-30-1861-01 TCGA-30-1861-01 32a58029-c8aa-4647-a932-bbf57e82fc48 NA TCGA-30-1861-01A-01R-0655-07 |
|
|
479 |
TCGA-30-1862-01 1 TCGA-30-1862-01 186 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-30-1862 NA NA days 186 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 65 NA TCGA-30-1862-F27593 TCGA-30-1862 NA Stage IV -23895 NA 186 0 186 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NO G2 NA NA NA NA NA NA 1862 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 NA NA NA 30 >20 mm Ovary NA NA DECEASED 2003 TCGA-30-1862-01 TCGA-30-1862-01 NA b1c27950-57b3-4a9e-96f6-5c7232951f1c NA TCGA-30-1862-01 NA TCGA-30-1862-01A-02D-0652-05 NA NA NA ab0701bc-0bc5-4008-a75b-5f665ef9c14a TCGA-30-1862-01A-02D-0648-01 TCGA-30-1862-01 NA NA TCGA-30-1862-01A-02D-0648-01 ab0701bc-0bc5-4008-a75b-5f665ef9c14a NA ab0701bc-0bc5-4008-a75b-5f665ef9c14a NA TCGA-30-1862-01 TCGA-30-1862-01 ab0701bc-0bc5-4008-a75b-5f665ef9c14a TCGA-30-1862-01A-02W-0699-08 TCGA-30-1862-01A-02R-0655-07 |
|
|
480 |
TCGA-30-1866-01 1 TCGA-30-1866-01 1114 1 days High NA OV-like c1 NA NA miRNA cluster 2 cluster 1 NA TCGA-30-1866 NA NA days 1114 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-30-1866-F27595 TCGA-30-1866 NA Stage IV -22562 NA 1114 0 1114 NA 285 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G2 Recurrence NA NA NA NA NA 1866 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 30 1-10 mm Ovary NA NA DECEASED 2003 NA TCGA-30-1866-01 NA a334b0fd-05cc-4aa3-bbff-4439e2807085 NA TCGA-30-1866-01 NA TCGA-30-1866-01A-02D-0652-05 NA NA NA NA TCGA-30-1866-01A-02D-0648-01 TCGA-30-1866-01 NA NA TCGA-30-1866-01A-02D-0648-01 NA NA NA NA TCGA-30-1866-01 NA NA NA TCGA-30-1866-01A-02R-0655-07 |
|
|
481 |
TCGA-30-1867-01 1 TCGA-30-1867-01 37 1 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 6 NA TCGA-30-1867 NA NA days 37 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 46 NA TCGA-30-1867-F27605 TCGA-30-1867 TCGA-30-1867-01A Stage IV -17159 NA 37 0 37 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.3 NO NA 0.3 NA NA GX NA NA NA NA NA TCGA-30-1867.420a6b8c-33b8-4b1e-8bba-e299c20611c7.pdf 1867 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.3 NA NA 30 NA Ovary NA A DECEASED 2004 NA TCGA-30-1867-01 NA 105890a2-5198-4ecf-af7f-6538542dc162 NA TCGA-30-1867-01 NA TCGA-30-1867-01A-01D-0652-05 NA NA NA NA TCGA-30-1867-01A-01D-0648-01 TCGA-30-1867-01 NA NA TCGA-30-1867-01A-01D-0648-01 NA NA NA NA TCGA-30-1867-01 NA NA NA TCGA-30-1867-01A-01R-0655-07 |
|
|
482 |
TCGA-30-1869-01 1 TCGA-30-1869-01 1563 1 days NA NA OV-like c1 OV-like c4 NA NA NA NA TCGA-30-1869 NA NA days 1563 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 50 Bilateral TCGA-30-1869-F27607 TCGA-30-1869 TCGA-30-1869-01A Stage IV -18398 NA 1563 0 1563 NA 767 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NO NA NA NA NO G3 Recurrence NA NA NA NA TCGA-30-1869.8d42d1a4-dff9-47a9-b95b-2eb27747308c.pdf 1869 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 30 1-10 mm Ovary NA A DECEASED 2004 NA NA NA NA NA NA NA TCGA-30-1869-01A-01D-0652-05 NA TCGA-30-1869-01A-21-1559-20 NA NA NA NA 014cbeef-19c7-4ac9-b9a0-5f95e07c5d45 NA NA NA NA NA NA NA NA NA NA NA |
|
|
483 |
TCGA-30-1880-01 1 TCGA-30-1880-01 1751 1 days Squamous NA Low purity c2 NA NA miRNA cluster 1 cluster 3 NA TCGA-30-1880 NA NA days 1751 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Bilateral TCGA-30-1880-F27620 TCGA-30-1880 TCGA-30-1880-01A Stage IIIC -20525 NA 1751 0 1751 NA 348 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-30-1880.D23622FE-9648-422D-AE92-B21F9B6E5A51.pdf 1880 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.2 NA NA 30 No Macroscopic disease Ovary NA A DECEASED 2001 NA TCGA-30-1880-01 NA 2d39ca81-8c8c-43ab-b065-38627152d132 NA TCGA-30-1880-01 NA TCGA-30-1880-01A-01D-0652-05 NA NA NA NA TCGA-30-1880-01A-01D-0648-01 TCGA-30-1880-01 NA NA TCGA-30-1880-01A-01D-0648-01 NA NA NA NA TCGA-30-1880-01 NA NA NA TCGA-30-1880-01A-01R-0655-07 |
|
|
484 |
TCGA-30-1887-01 1 TCGA-30-1887-01 738 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 NA TCGA-30-1887 NA NA days 738 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 67 Bilateral TCGA-30-1887-F27633 TCGA-30-1887 TCGA-30-1887-01A Stage IIIC -24495 NA 738 0 738 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA YES G2 NA NA NA NA NA TCGA-30-1887.a074363f-dd94-4193-b583-70885400ff2f.pdf 1887 NA WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 30 1-10 mm Ovary YES A DECEASED 2005 NA TCGA-30-1887-01 NA 1065d480-5815-40a4-93c6-faa8712a1e94 NA TCGA-30-1887-01 NA TCGA-30-1887-01A-01D-0652-05 NA TCGA-30-1887-01A-21-1559-20 NA NA TCGA-30-1887-01A-01D-0648-01 TCGA-30-1887-01 e26411ea-dc83-4441-a0f4-84fd52798fdd NA TCGA-30-1887-01A-01D-0648-01 NA NA NA NA TCGA-30-1887-01 NA NA NA TCGA-30-1887-01A-01R-0655-07 |
|
|
485 |
TCGA-30-1891-01 1 TCGA-30-1891-01 914 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-30-1891 NA NA days 914 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-30-1891-F27640 TCGA-30-1891 TCGA-30-1891-01A Stage IIIC -22344 NA 914 0 914 NA 181 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.8 NO NA 1.2 NA NO G2 Recurrence NA NA NA NA TCGA-30-1891.F2E0C289-3ED3-4876-8BFA-A447AB1DBB2B.pdf 1891 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 30 1-10 mm Ovary NO A DECEASED 2004 TCGA-30-1891-01 TCGA-30-1891-01 NA d97a0c15-2c1d-4af3-9e62-ff67cbf7b700 NA TCGA-30-1891-01 NA TCGA-30-1891-01A-01D-0652-05 NA TCGA-30-1891-01A-21-1559-20 NA 690d1437-2a05-4263-8fa7-8f4481893b83 TCGA-30-1891-01A-01D-0648-01 TCGA-30-1891-01 7f8386ef-cf19-4207-86ae-13029c49d944 NA TCGA-30-1891-01A-01D-0648-01 690d1437-2a05-4263-8fa7-8f4481893b83 NA 690d1437-2a05-4263-8fa7-8f4481893b83 NA TCGA-30-1891-01 TCGA-30-1891-01 690d1437-2a05-4263-8fa7-8f4481893b83 TCGA-30-1891-01A-01W-0699-08 TCGA-30-1891-01A-01R-0655-07 |
|
|
486 |
TCGA-30-1892-01 1 TCGA-30-1892-01 1484 1 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 3 cluster 6 NA TCGA-30-1892 NA NA days 1484 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 Left TCGA-30-1892-F27654 TCGA-30-1892 TCGA-30-1892-01A Stage IIIC -19256 NA 1484 0 1484 NA 253 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-30-1892.fb7c966c-9b16-4781-9c01-2db480c88d63.pdf 1892 NA WITH TUMOR YES Complete Remission/Response Physical Examination NO NA Primary Tumor 01 0.3 NA NA 30 1-10 mm Ovary NA A DECEASED 2004 NA TCGA-30-1892-01 NA e969eb72-cef5-4c16-b1fd-8a97324ce3e4 NA TCGA-30-1892-01 NA TCGA-30-1892-01A-01D-0652-05 NA TCGA-30-1892-01A-21-1559-20 NA NA TCGA-30-1892-01A-01D-0648-01 TCGA-30-1892-01 3c68d944-a329-44c2-8697-2f8c50a8b38c NA TCGA-30-1892-01A-01D-0648-01 NA NA NA NA TCGA-30-1892-01 NA NA NA TCGA-30-1892-01A-01R-0655-07 |
|
|
487 |
TCGA-31-1944-01 0 TCGA-31-1944-01 1386 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-31-1944 NA NA days 1386 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-31-1944-F27668 TCGA-31-1944 TCGA-31-1944-01A Stage IIIC -17207 NA NA 0 1386 NA 678 NA NA NA 2009-10-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-31-1944.bd7361f7-07c1-4be8-92c6-4f0a3dea99b2.pdf 1944 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 31 No Macroscopic disease Ovary YES A LIVING 2005 TCGA-31-1944-01 TCGA-31-1944-01 NA b9b5c6a5-cbc8-4645-9ce1-131c26e36683 NA TCGA-31-1944-01 NA TCGA-31-1944-01A-01D-0652-05 NA TCGA-31-1944-01A-21-1559-20 NA c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2 TCGA-31-1944-01A-01D-0648-01 TCGA-31-1944-01 332735d2-c077-400a-b011-1f0984b07339 NA TCGA-31-1944-01A-01D-0648-01 c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2 NA c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2 NA TCGA-31-1944-01 TCGA-31-1944-01 c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2 NA TCGA-31-1944-01A-01R-0655-07 |
|
|
488 |
TCGA-31-1946-01 0 TCGA-31-1946-01 918 0 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 NA TCGA-31-1946 NA NA days 918 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 30 Bilateral TCGA-31-1946-F27679 TCGA-31-1946 TCGA-31-1946-01A Stage IIIC -11146 NA NA 0 918 NA 664 NA NA NA 2009-10-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-31-1946.5ef31a8f-38e7-486b-8efc-99cd8c1ec06d.pdf 1946 NA WITH TUMOR YES NA Physical Examination NO NA Primary Tumor 01 0.3 NA NA 31 No Macroscopic disease Ovary YES A LIVING 2006 TCGA-31-1946-01 TCGA-31-1946-01 NA fb4cc131-9ac0-4615-b8c1-802273c4c6cf NA TCGA-31-1946-01 NA TCGA-31-1946-01A-01D-0652-05 NA TCGA-31-1946-01A-21-1559-20 NA 05abb2f5-07c3-42da-92d9-0b4560fb6f09 TCGA-31-1946-01A-01D-0648-01 TCGA-31-1946-01 fb44d557-9e0a-40d5-83c3-3b9431e72d9d NA TCGA-31-1946-01A-01D-0648-01 05abb2f5-07c3-42da-92d9-0b4560fb6f09 NA 05abb2f5-07c3-42da-92d9-0b4560fb6f09 NA TCGA-31-1946-01 TCGA-31-1946-01 05abb2f5-07c3-42da-92d9-0b4560fb6f09 NA TCGA-31-1946-01A-01R-0655-07 |
|
|
489 |
TCGA-31-1950-01 0 TCGA-31-1950-01 571 0 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-31-1950 NA NA days 571 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Bilateral TCGA-31-1950-F27688 TCGA-31-1950 TCGA-31-1950-01A Stage IIIC -28100 NA NA 0 571 NA 349 1 NA NA 2009-10-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.2 NA NO G2 Recurrence NA NA NA NA TCGA-31-1950.4ed80cbd-e56d-4d09-b8ac-2b6535346b73.pdf 1950 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.2 NA NA 31 1-10 mm Ovary NO A LIVING 2007 NA TCGA-31-1950-01 NA 72689370-cb7a-4e3b-8964-2dcde6633902 NA TCGA-31-1950-01 NA TCGA-31-1950-01A-01D-0652-05 NA TCGA-31-1950-01A-21-1559-20 NA a32eba80-dbe9-464e-8102-5f77a3c7e177 TCGA-31-1950-01A-01D-0648-01 TCGA-31-1950-01 6f927c4d-19b8-4bc9-92eb-da2402ed6e31 NA TCGA-31-1950-01A-01D-0648-01 a32eba80-dbe9-464e-8102-5f77a3c7e177 NA a32eba80-dbe9-464e-8102-5f77a3c7e177 TCGA-31-1950-01A-01W-0699-08 TCGA-31-1950-01 NA a32eba80-dbe9-464e-8102-5f77a3c7e177 TCGA-31-1950-01A-01W-0699-08 TCGA-31-1950-01A-01R-0655-07 |
|
|
490 |
TCGA-31-1951-01 0 TCGA-31-1951-01 684 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 NA TCGA-31-1951 NA NA days 684 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Left TCGA-31-1951-F27692 TCGA-31-1951 TCGA-31-1951-01A Stage IIIC -21352 NA NA 0 684 NA 659 NA NA NA 2010-1-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.7 NA YES G3 Recurrence NA NA NA NA TCGA-31-1951.b10efe75-1420-47d2-9c5b-202b09099357.pdf 1951 NA WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 0.3 NA NA 31 No Macroscopic disease Ovary YES A LIVING 2007 TCGA-31-1951-01 TCGA-31-1951-01 NA c9806ee2-6323-4078-bfc0-6fc773a7f66e NA TCGA-31-1951-01 NA TCGA-31-1951-01A-01D-0652-05 NA TCGA-31-1951-01A-21-1559-20 NA 197ea6b5-5716-4e5c-9c7f-92ed4521682a TCGA-31-1951-01A-01D-0648-01 TCGA-31-1951-01 a6bb52ad-58cf-4ee0-ae89-9615811f4de6 NA TCGA-31-1951-01A-01D-0648-01 197ea6b5-5716-4e5c-9c7f-92ed4521682a NA 197ea6b5-5716-4e5c-9c7f-92ed4521682a NA TCGA-31-1951-01 TCGA-31-1951-01 197ea6b5-5716-4e5c-9c7f-92ed4521682a NA TCGA-31-1951-01A-01R-0655-07 |
|
|
491 |
TCGA-31-1953-01 0 TCGA-31-1953-01 204 0 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-31-1953 NA NA days 204 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 Bilateral TCGA-31-1953-F27698 TCGA-31-1953 TCGA-31-1953-01A Stage IIIC -19064 NA NA 0 204 NA 70 1 NA NA 2009-10-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-31-1953.c824400d-b062-4a04-b805-f717426d688e.pdf 1953 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 0.1 NA NA 31 NA Ovary NO A LIVING 2008 TCGA-31-1953-01 TCGA-31-1953-01 NA b3f75e69-3519-46eb-821c-773c2506d7fd NA TCGA-31-1953-01 NA TCGA-31-1953-01A-01D-0652-05 NA NA NA 7b31fc47-0299-4449-aa5b-622ba549371f TCGA-31-1953-01A-01D-0648-01 TCGA-31-1953-01 NA NA TCGA-31-1953-01A-01D-0648-01 7b31fc47-0299-4449-aa5b-622ba549371f NA 7b31fc47-0299-4449-aa5b-622ba549371f NA TCGA-31-1953-01 TCGA-31-1953-01 7b31fc47-0299-4449-aa5b-622ba549371f TCGA-31-1953-01A-01W-0699-08 TCGA-31-1953-01A-01R-0655-07 |
|
|
492 |
TCGA-31-1955-01 0 TCGA-31-1955-01 1293 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-31-1955 NA NA days 1293 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 43 Bilateral TCGA-31-1955-F27704 TCGA-31-1955 TCGA-31-1955-01A Stage IIIC -15926 NA NA 0 1293 NA 918 NA NA NA 2009-10-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.4 NA NO G3 Recurrence NA NA NA NA TCGA-31-1955.16f5a24e-2c57-42fe-bd79-ef174d44b8b1.pdf 1955 NA WITH TUMOR YES NA Physical Examination YES NA Primary Tumor 01 0.4 NA NA 31 No Macroscopic disease Ovary YES A LIVING 2005 NA NA NA NA NA NA NA TCGA-31-1955-01A-01D-0652-05 NA TCGA-31-1955-01A-21-1559-20 NA NA TCGA-31-1955-01A-01D-0648-01 TCGA-31-1955-01 47461ed4-1491-4f27-bd9c-cbd1ee184f5a NA TCGA-31-1955-01A-01D-0648-01 NA NA NA NA TCGA-31-1955-01 NA NA NA TCGA-31-1955-01A-01R-0655-07 |
|
|
493 |
TCGA-31-1956-01 0 TCGA-31-1956-01 1342 0 days Squamous NA OV-like c1 NA OV-like c16 miRNA cluster 3 cluster 6 NA TCGA-31-1956 NA NA days 1342 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Left TCGA-31-1956-F27711 TCGA-31-1956 TCGA-31-1956-01A Stage IIIB -22100 NA NA 0 1342 119 NA NA NA NA 2009-10-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.3 NA YES G3 Locoregional Disease YES NA NA NA TCGA-31-1956.3646c24b-c4b7-400b-bc93-7ef485c6892c.pdf 1956 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.2 NA NA 31 NA Ovary NO A LIVING 2005 TCGA-31-1956-01 TCGA-31-1956-01 NA c6dcadc5-be05-4d61-b82a-bc5111fb2634 NA TCGA-31-1956-01 NA TCGA-31-1956-01A-01D-0652-05 NA NA NA 24cfcfd9-ce30-4e24-9470-60265efd6721 TCGA-31-1956-01A-01D-0648-01 TCGA-31-1956-01 NA NA TCGA-31-1956-01A-01D-0648-01 24cfcfd9-ce30-4e24-9470-60265efd6721 NA 24cfcfd9-ce30-4e24-9470-60265efd6721 NA TCGA-31-1956-01 TCGA-31-1956-01 24cfcfd9-ce30-4e24-9470-60265efd6721 NA TCGA-31-1956-01A-01R-0655-07 |
|
|
494 |
TCGA-31-1959-01 0 TCGA-31-1959-01 67 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-31-1959 NA NA days 67 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Bilateral TCGA-31-1959-F27715 TCGA-31-1959 TCGA-31-1959-01A Stage IV -18247 NA NA 0 67 NA NA NA NA NA 2009-10-20 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy NA 0.7 NO NA 1.1 NA YES G2 NA NA NA NA NA TCGA-31-1959.c78c6998-1f86-4dd2-bf41-78f12d43c33a.pdf 1959 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.2 NA NA 31 NA Ovary YES A LIVING 2009 TCGA-31-1959-01 TCGA-31-1959-01 NA 427e1629-b22d-4421-b6f5-ffbd672fd164 NA TCGA-31-1959-01 NA TCGA-31-1959-01A-01D-0652-05 NA NA NA 25b1eb9f-7b97-4da2-96a9-a4a3aaaca192 TCGA-31-1959-01A-01D-0648-01 TCGA-31-1959-01 NA NA TCGA-31-1959-01A-01D-0648-01 25b1eb9f-7b97-4da2-96a9-a4a3aaaca192 NA 25b1eb9f-7b97-4da2-96a9-a4a3aaaca192 NA TCGA-31-1959-01 TCGA-31-1959-01 25b1eb9f-7b97-4da2-96a9-a4a3aaaca192 TCGA-31-1959-01A-01W-0699-08 TCGA-31-1959-01A-01R-0655-07 |
|
|
495 |
TCGA-36-1568-01 0 TCGA-36-1568-01 875 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-36-1568 NA NA days 875 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 52 Bilateral TCGA-36-1568-F27850 TCGA-36-1568 TCGA-36-1568-01A Stage IIIC -19311 NA NA 0 875 NA 548 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.6 NA NO G3 Recurrence NA NA NA NA TCGA-36-1568.dad4bbdc-0156-48c2-a975-27ccfb9152a3.pdf 1568 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 36 NA Ovary NA A LIVING 2007 TCGA-36-1568-01 TCGA-36-1568-01 TCGA-36-1568-01A-01W-0615-10 cde7f1d6-c4c9-4fc3-a6cf-696addee91d6 NA TCGA-36-1568-01 TCGA-36-1568-01A-01W-0615-10 TCGA-36-1568-01A-01D-0536-05 NA TCGA-36-1568-01A-21-1558-20 NA 4e539c62-454a-4b1c-bde1-6951ee12d109 TCGA-36-1568-01A-01D-0533-01 TCGA-36-1568-01 b9598717-cdb9-49e1-a8d5-49ec5189cb31 NA TCGA-36-1568-01A-01D-0533-01 4e539c62-454a-4b1c-bde1-6951ee12d109 NA 4e539c62-454a-4b1c-bde1-6951ee12d109 NA TCGA-36-1568-01 TCGA-36-1568-01 4e539c62-454a-4b1c-bde1-6951ee12d109 TCGA-36-1568-01A-01W-0615-10 TCGA-36-1568-01A-01R-0540-07 |
|
|
496 |
TCGA-36-1569-01 0 TCGA-36-1569-01 885 0 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-36-1569 NA NA days 885 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Bilateral TCGA-36-1569-F27855 TCGA-36-1569 TCGA-36-1569-01A Stage IIIC -19151 NA NA 0 885 NA NA 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.9 NO NA 1.6 NA YES G3 NA NA NA NA NA TCGA-36-1569.52192360-2ACE-401C-9642-B3D6F677362D.pdf 1569 Preoperative NA YES Partial Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 36 1-10 mm Ovary NA A LIVING 2007 TCGA-36-1569-01 TCGA-36-1569-01 TCGA-36-1569-01A-01W-0615-10 3ae2deaa-bc6d-4b38-b9ea-56e91c83b53a NA TCGA-36-1569-01 TCGA-36-1569-01A-01W-0615-10 TCGA-36-1569-01A-01D-0536-05 NA TCGA-36-1569-01A-21-1558-20 NA bb12d2f5-1865-435a-8edf-f9ee7689e0a4 TCGA-36-1569-01A-01D-0533-01 TCGA-36-1569-01 44783ce8-15cb-45b3-9a4f-e45925356334 NA TCGA-36-1569-01A-01D-0533-01 bb12d2f5-1865-435a-8edf-f9ee7689e0a4 NA bb12d2f5-1865-435a-8edf-f9ee7689e0a4 NA TCGA-36-1569-01 TCGA-36-1569-01 bb12d2f5-1865-435a-8edf-f9ee7689e0a4 TCGA-36-1569-01A-01W-0615-10 TCGA-36-1569-01A-01R-0540-07 |
|
|
497 |
TCGA-36-1570-01 0 TCGA-36-1570-01 655 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-36-1570 NA NA days 655 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 49 Bilateral TCGA-36-1570-F27857 TCGA-36-1570 TCGA-36-1570-01A Stage IIIC -17956 NA NA 0 655 NA 375 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.3 NA YES G3 Recurrence NA NA NA NA TCGA-36-1570.f83833f4-a820-4fb9-a040-c238084976c3.pdf 1570 Preoperative WITH TUMOR YES Partial Remission/Response Physical Examination NO NA Primary Tumor 01 0.7 NA NA 36 >20 mm Ovary YES A LIVING 2007 TCGA-36-1570-01 TCGA-36-1570-01 TCGA-36-1570-01A-01W-0615-10 2893bba4-3d68-4a21-97d6-51342437a657 NA TCGA-36-1570-01 TCGA-36-1570-01A-01W-0615-10 TCGA-36-1570-01A-01D-0536-05 NA TCGA-36-1570-01A-21-1558-20 NA cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7 TCGA-36-1570-01A-01D-0533-01 TCGA-36-1570-01 0bd6d1dc-2f53-479b-bbaa-ef70250341a2 NA TCGA-36-1570-01A-01D-0533-01 cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7 NA cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7 NA TCGA-36-1570-01 TCGA-36-1570-01 cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7 TCGA-36-1570-01A-01W-0615-10 TCGA-36-1570-01A-01R-0540-07 |
|
|
498 |
TCGA-36-1571-01 1 TCGA-36-1571-01 695 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-36-1571 NA NA days 695 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-36-1571-F27862 TCGA-36-1571 TCGA-36-1571-01A Stage IIIB -19608 NA 695 0 695 NA 375 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.3 NA NO G3 Recurrence NA NA NA NA TCGA-36-1571.cee6fb75-8fcc-4347-824e-b00b96e6e481.pdf 1571 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.9 NA NA 36 No Macroscopic disease Ovary NO A DECEASED 2007 TCGA-36-1571-01 TCGA-36-1571-01 TCGA-36-1571-01A-01W-0615-10 62f86b95-1bfe-4123-8f09-311c9c826de0 NA TCGA-36-1571-01 TCGA-36-1571-01A-01W-0615-10 TCGA-36-1571-01A-01D-0536-05 NA TCGA-36-1571-01A-21-1558-20 NA 55c68aef-938c-4f68-a74d-f408673fff9c TCGA-36-1571-01A-01D-0533-01 TCGA-36-1571-01 8add1736-9ac5-4d0e-9969-7ea6ffaf635c NA TCGA-36-1571-01A-01D-0533-01 55c68aef-938c-4f68-a74d-f408673fff9c NA 55c68aef-938c-4f68-a74d-f408673fff9c NA TCGA-36-1571-01 TCGA-36-1571-01 55c68aef-938c-4f68-a74d-f408673fff9c TCGA-36-1571-01A-01W-0615-10 TCGA-36-1571-01A-01R-0540-07 |
|
|
499 |
TCGA-36-1574-01 0 TCGA-36-1574-01 686 0 days Squamous C9-OV Low purity c2 NA OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 5 TCGA-36-1574 NA NA days 686 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 48 Bilateral TCGA-36-1574-F27868 TCGA-36-1574 NA Stage IIIC -17847 NA NA 0 686 NA 648 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1574 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 36 >20 mm Ovary NA NA LIVING 2007 TCGA-36-1574-01 TCGA-36-1574-01 TCGA-36-1574-01A-01W-0615-10 d83bcf90-4a10-4318-ac80-4ae41ea88894 NA TCGA-36-1574-01 TCGA-36-1574-01A-01W-0615-10 TCGA-36-1574-01A-01D-0536-05 NA NA NA ff781a4f-7281-4195-880f-3df099a401cc TCGA-36-1574-01A-01D-0533-01 TCGA-36-1574-01 NA NA TCGA-36-1574-01A-01D-0533-01 ff781a4f-7281-4195-880f-3df099a401cc NA ff781a4f-7281-4195-880f-3df099a401cc NA TCGA-36-1574-01 TCGA-36-1574-01 ff781a4f-7281-4195-880f-3df099a401cc TCGA-36-1574-01A-01W-0615-10 TCGA-36-1574-01A-01R-0540-07 |
|
|
500 |
TCGA-36-1575-01 0 TCGA-36-1575-01 260 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-36-1575 NA NA days 260 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 83 NA TCGA-36-1575-F27872 TCGA-36-1575 NA Stage IIIB -30592 NA NA 0 260 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NO G3 NA NA NA NA NA NA 1575 NA TUMOR FREE YES NA NA NO NA Primary Tumor 01 NA NA NA 36 No Macroscopic disease Ovary NO NA LIVING 2006 TCGA-36-1575-01 TCGA-36-1575-01 TCGA-36-1575-01A-01W-0615-10 fb275fb0-6793-4401-99a0-5d3bdf2a7ac0 NA TCGA-36-1575-01 TCGA-36-1575-01A-01W-0615-10 TCGA-36-1575-01A-01D-0536-05 NA TCGA-36-1575-01A-21-1558-20 NA a28ef775-c78b-416f-afeb-89ba265440f0 TCGA-36-1575-01A-01D-0533-01 TCGA-36-1575-01 ba2a2d99-a0a6-4d8d-a207-d1a82501f18d NA TCGA-36-1575-01A-01D-0533-01 a28ef775-c78b-416f-afeb-89ba265440f0 NA a28ef775-c78b-416f-afeb-89ba265440f0 NA TCGA-36-1575-01 TCGA-36-1575-01 a28ef775-c78b-416f-afeb-89ba265440f0 TCGA-36-1575-01A-01W-0615-10 TCGA-36-1575-01A-01R-0540-07 |
|
|
501 |
TCGA-36-1576-01 0 TCGA-36-1576-01 915 0 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-36-1576 NA NA days 915 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 NA TCGA-36-1576-F27874 TCGA-36-1576 TCGA-36-1576-01A Stage IIIC -27778 NA NA 0 915 NA 817 2 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 2.6 NA YES G3 Recurrence NA NA NA NA TCGA-36-1576.2eb0b46a-ecd3-43b4-bfc2-e1c5e6101d1f.pdf 1576 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 36 >20 mm Ovary YES A LIVING 2006 TCGA-36-1576-01 TCGA-36-1576-01 TCGA-36-1576-01A-01W-0615-10 15528051-b343-4e7d-9433-b9fc052e7d77 NA TCGA-36-1576-01 TCGA-36-1576-01A-01W-0615-10 TCGA-36-1576-01A-01D-0536-05 NA TCGA-36-1576-01A-21-1558-20 NA 55b6bd7c-e77d-4019-93e9-b5410e4807b2 TCGA-36-1576-01A-01D-0533-01 TCGA-36-1576-01 e1158086-b305-4b38-8ebe-43bd33c73952 NA TCGA-36-1576-01A-01D-0533-01 55b6bd7c-e77d-4019-93e9-b5410e4807b2 NA 55b6bd7c-e77d-4019-93e9-b5410e4807b2 NA TCGA-36-1576-01 TCGA-36-1576-01 55b6bd7c-e77d-4019-93e9-b5410e4807b2 TCGA-36-1576-01A-01W-0615-10 TCGA-36-1576-01A-01R-0540-07 |
|
|
502 |
TCGA-36-1577-01 0 TCGA-36-1577-01 783 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-36-1577 NA NA days 783 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 43 Bilateral TCGA-36-1577-F27878 TCGA-36-1577 TCGA-36-1577-01A Stage IIC -15804 NA NA 0 783 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO NA 1.7 NA NA G2 NA NA NA NA NA TCGA-36-1577.0c55b26c-ccf8-4223-9f5e-157bbdf6e5dc.pdf 1577 NA TUMOR FREE YES Complete Remission/Response NA YES NA Primary Tumor 01 0.6 NA NA 36 No Macroscopic disease Ovary NA A LIVING 2007 TCGA-36-1577-01 TCGA-36-1577-01 TCGA-36-1577-01A-01W-0615-10 ea44120c-4ba1-426a-a989-11ce1ca54e15 NA TCGA-36-1577-01 TCGA-36-1577-01A-01W-0615-10 TCGA-36-1577-01A-01D-0536-05 NA TCGA-36-1577-01A-21-1558-20 NA 9ec93bbd-5c62-4974-984f-f86301f0d27e TCGA-36-1577-01A-01D-0533-01 TCGA-36-1577-01 ec733c30-ab8b-454e-88f9-8ee34bcf0416 NA TCGA-36-1577-01A-01D-0533-01 9ec93bbd-5c62-4974-984f-f86301f0d27e NA 9ec93bbd-5c62-4974-984f-f86301f0d27e NA TCGA-36-1577-01 TCGA-36-1577-01 9ec93bbd-5c62-4974-984f-f86301f0d27e TCGA-36-1577-01A-01W-0615-10 TCGA-36-1577-01A-01R-0540-07 |
|
|
503 |
TCGA-36-1578-01 0 TCGA-36-1578-01 847 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-36-1578 NA NA days 847 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 NA TCGA-36-1578-F27884 TCGA-36-1578 TCGA-36-1578-01A Stage IV -23329 NA NA 0 847 NA 310 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO NA 0.6 NA NA G3 Recurrence NA NA NA NA TCGA-36-1578.6BD44F43-7D75-4DF3-891D-7E08291F020C.pdf 1578 Preoperative WITH TUMOR YES NA Imaging Study NO NA Primary Tumor 01 0.5 NA NA 36 >20 mm Ovary NO A LIVING 2007 TCGA-36-1578-01 TCGA-36-1578-01 TCGA-36-1578-01A-01W-0615-10 644de2b8-bb23-4161-b6dc-dbb926d573f0 NA TCGA-36-1578-01 TCGA-36-1578-01A-01W-0615-10 TCGA-36-1578-01A-01D-0536-05 NA TCGA-36-1578-01A-21-1558-20 NA 7ecb58fe-e2fe-4dc8-996b-2b959da43566 TCGA-36-1578-01A-01D-0533-01 TCGA-36-1578-01 cb41005f-cf76-417e-9ce8-8b5d3047609c NA TCGA-36-1578-01A-01D-0533-01 7ecb58fe-e2fe-4dc8-996b-2b959da43566 NA 7ecb58fe-e2fe-4dc8-996b-2b959da43566 NA TCGA-36-1578-01 TCGA-36-1578-01 7ecb58fe-e2fe-4dc8-996b-2b959da43566 TCGA-36-1578-01A-01W-0615-10 TCGA-36-1578-01A-01R-0540-07 |
|
|
504 |
TCGA-36-1580-01 1 TCGA-36-1580-01 737 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-36-1580 NA NA days 737 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 82 NA TCGA-36-1580-F27889 TCGA-36-1580 TCGA-36-1580-01A Stage IIIC -29992 NA 737 0 737 NA 440 1 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1 NO NA 2 NA NA G3 Recurrence NA NA NA NA TCGA-36-1580.a647e4da-8579-4848-b545-bc857db85d98.pdf 1580 Preoperative WITH TUMOR YES NA Physical Examination NO NA Primary Tumor 01 0.4 NA NA 36 >20 mm Ovary NA A DECEASED 2007 TCGA-36-1580-01 TCGA-36-1580-01 TCGA-36-1580-01A-01W-0615-10 2b7461a0-84ad-4a91-b136-395c33f059fc NA TCGA-36-1580-01 TCGA-36-1580-01A-01W-0615-10 TCGA-36-1580-01A-01D-0536-05 NA TCGA-36-1580-01A-21-1558-20 NA 6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3 TCGA-36-1580-01A-01D-0533-01 TCGA-36-1580-01 1d325272-4508-4a42-97ba-9e59edf59993 NA TCGA-36-1580-01A-01D-0533-01 6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3 NA 6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3 NA TCGA-36-1580-01 TCGA-36-1580-01 6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3 TCGA-36-1580-01A-01W-0615-10 TCGA-36-1580-01A-01R-0540-07 |
|
|
505 |
TCGA-36-1581-01 0 TCGA-36-1581-01 751 0 days High C1-LUAD-enriched Cluster 5 BRCA basal-like c6 OV-like c16 miRNA cluster 2 cluster 6 NA TCGA-36-1581 NA NA days 751 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Left TCGA-36-1581-F27893 TCGA-36-1581 NA Stage IIC -23272 NA NA 0 751 NA 702 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 1581 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 NA NA NA 36 No Macroscopic disease Ovary NA NA LIVING 2007 TCGA-36-1581-01 TCGA-36-1581-01 NA ba4c8ab9-f8ee-48ab-a513-ab43f71b8723 NA TCGA-36-1581-01 NA TCGA-36-1581-01A-01D-0536-05 NA TCGA-36-1581-01A-03-1563-20 NA d84c76a9-dbee-4720-8639-91382101b27a TCGA-36-1581-01A-01D-0533-01 TCGA-36-1581-01 c3ce568b-8558-45db-97b4-23882e482cbf NA TCGA-36-1581-01A-01D-0533-01 d84c76a9-dbee-4720-8639-91382101b27a NA d84c76a9-dbee-4720-8639-91382101b27a NA TCGA-36-1581-01 TCGA-36-1581-01 d84c76a9-dbee-4720-8639-91382101b27a NA TCGA-36-1581-01A-01R-0540-07 |
|
|
506 |
TCGA-36-2529-01 0 TCGA-36-2529-01 1066 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2529 NA NA days 1066 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-36-2529-F27897 TCGA-36-2529 NA Stage IIIC -26092 NA NA 0 1066 NA 567 0 NA NA 2010-8-17 FEMALE Serous Cystadenocarcinoma No C48.2 8441/3 C48.2 YES Tumor resection NA NA NA NA NA NA NA G3 Recurrence NA NA NA NA NA 2529 Pre-Adjuvant Therapy WITH TUMOR YES Complete Remission/Response Physical Examination NO R1 Primary Tumor 01 NA NA NA 36 >20 mm Peritoneum ovary NA NA LIVING 2007 NA NA NA d63b58d4-56b8-4879-b103-74cb3f92c242 NA NA NA TCGA-36-2529-01A-01D-1047-05 NA TCGA-36-2529-01A-21-1560-20 NA NA TCGA-36-2529-01A-01D-1043-01 TCGA-36-2529-01 a954f069-3088-49e6-839f-d823017cfa40 NA TCGA-36-2529-01A-01D-1043-01 NA NA NA NA TCGA-36-2529-01 NA NA NA TCGA-36-2529-01A-01R-1050-07 |
|
|
507 |
TCGA-36-2530-01 0 TCGA-36-2530-01 1004 0 days Squamous NA NA OV-like c4 NA NA NA NA TCGA-36-2530 NA NA days 1004 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 38 Bilateral TCGA-36-2530-F27906 TCGA-36-2530 NA Stage IIIC -13885 NA NA 0 1004 NA 630 NA NA NA 2010-8-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NO G3 Recurrence NA NA NA NA NA 2530 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 NA NA NA 36 11-20 mm Ovary NA NA LIVING 2007 NA NA NA f4fa786b-3eaf-45ab-9d3e-4cf7ec61de3c NA NA NA NA NA TCGA-36-2530-01A-21-1560-20 TCGA-36-2530-01A-01D-1526-09 NA TCGA-36-2530-01A-01D-1043-01 TCGA-36-2530-01 ae583504-181e-4199-a79c-8fd11d3c99af NA TCGA-36-2530-01A-01D-1043-01 NA NA NA NA TCGA-36-2530-01 NA NA NA TCGA-36-2530-01A-01R-1050-07 |
|
|
508 |
TCGA-36-2532-01 0 TCGA-36-2532-01 897 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2532 NA NA days 897 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 61 Bilateral TCGA-36-2532-F27913 TCGA-36-2532 TCGA-36-2532-01A Stage IIIC -22333 NA NA 0 897 NA NA NA NA NA 2010-8-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy NA 0.9 NO NA 2.7 NA YES G3 NA NA NA NA NA TCGA-36-2532.d99b756c-2a3c-48cd-844e-ce61f811c3a0.pdf 2532 NA WITH TUMOR YES NA NA NO R0 Primary Tumor 01 0.7 NA NA 36 No Macroscopic disease Ovary YES A LIVING 2007 NA NA NA 0830b9f6-0220-4c58-9c8b-58478ac2f49e NA NA NA TCGA-36-2532-01A-01D-1047-05 NA TCGA-36-2532-01A-21-1560-20 TCGA-36-2532-01A-01D-1526-09 NA TCGA-36-2532-01A-01D-1043-01 TCGA-36-2532-01 0ee5a901-a30a-493d-895a-6e674967a5eb NA TCGA-36-2532-01A-01D-1043-01 NA NA NA NA TCGA-36-2532-01 NA NA NA TCGA-36-2532-01A-01R-1050-07 |
|
|
509 |
TCGA-36-2533-01 NA TCGA-36-2533-01 NA NA days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2533 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Right NA TCGA-36-2533 TCGA-36-2533-01A Stage IIIC -20187 NA NA 0 0 NA NA NA NA NA 2010-9-14 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1 NA YES G3 NA NA NA NA NA TCGA-36-2533.ebe9dfc0-28ac-4d22-a18b-b910aa2814e0.pdf 2533 NA NA NA NA NA NA NA Primary Tumor 01 0.4 NA NA 36 NA Ovary NA A NA 2007 NA NA NA 06bf48f2-1c9a-42eb-bf68-505501a4c354 NA NA NA TCGA-36-2533-01A-01D-1047-05 NA TCGA-36-2533-01A-21-1560-20 TCGA-36-2533-01A-01D-1526-09 NA TCGA-36-2533-01A-01D-1043-01 TCGA-36-2533-01 6b83e35e-5d42-43db-a0cc-a5979af12af3 NA TCGA-36-2533-01A-01D-1043-01 NA NA NA NA TCGA-36-2533-01 NA NA NA TCGA-36-2533-01A-01R-1050-07 |
|
|
510 |
TCGA-36-2534-01 0 TCGA-36-2534-01 907 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2534 NA NA days 907 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 72 Right TCGA-36-2534-F27918 TCGA-36-2534 TCGA-36-2534-01A Stage IIIC -26621 NA NA 0 907 NA 383 1 NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.5 NA NA G3 Progression of Disease NA NA NA NA TCGA-36-2534.b62a4922-ad09-4422-8cb2-bea80a0fe533.pdf 2534 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 0.5 NA NA 36 >20 mm Ovary NA A LIVING 2007 NA NA NA 39d1a308-db4f-4161-ad51-7cb9ccb4d059 NA NA NA TCGA-36-2534-01A-01D-1047-05 NA TCGA-36-2534-01A-21-1560-20 TCGA-36-2534-01A-01D-1526-09 NA TCGA-36-2534-01A-01D-1043-01 TCGA-36-2534-01 d32b063f-7dc4-4081-8ba5-301ea0f98089 NA TCGA-36-2534-01A-01D-1043-01 NA NA NA NA TCGA-36-2534-01 NA NA NA TCGA-36-2534-01A-01R-1050-07 |
|
|
511 |
TCGA-36-2537-01 0 TCGA-36-2537-01 788 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2537 NA NA days 788 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 39 Bilateral TCGA-36-2537-F27923 TCGA-36-2537 TCGA-36-2537-01A Stage IIIC -14595 NA NA 0 788 NA 431 2 NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.8 NO NA 1.2 NA NA G3 Progression of Disease NA NA NA NA TCGA-36-2537.9b122691-9140-439e-9ef6-16701081b905.pdf 2537 Pre-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 0.8 NA NA 36 >20 mm Ovary NA A LIVING 2008 NA NA NA 74f16c9d-4f75-4307-a243-35a387eb20db NA NA NA TCGA-36-2537-01A-01D-1047-05 NA TCGA-36-2537-01A-21-1560-20 TCGA-36-2537-01A-01D-1526-09 NA TCGA-36-2537-01A-01D-1043-01 TCGA-36-2537-01 dab8df2a-7a8a-4735-9548-ebac64341b3a NA TCGA-36-2537-01A-01D-1043-01 NA NA NA NA TCGA-36-2537-01 NA NA NA TCGA-36-2537-01A-01R-1050-07 |
|
|
512 |
TCGA-36-2538-01 0 TCGA-36-2538-01 763 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2538 NA NA days 763 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 37 Right TCGA-36-2538-F27930 TCGA-36-2538 TCGA-36-2538-01A Stage IIIB -13681 NA NA 0 763 NA 523 NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.7 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-36-2538.e78dd67e-58f2-4b75-b3a5-1ca9ee6e01e5.pdf 2538 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.3 NA NA 36 11-20 mm Ovary NO A LIVING 2008 NA NA NA 8e5e1961-d950-4ae8-9f07-1c5a10c82ad4 NA NA NA TCGA-36-2538-01A-01D-1047-05 NA TCGA-36-2538-01A-21-20 TCGA-36-2538-01A-01D-1526-09 NA TCGA-36-2538-01A-01D-1043-01 TCGA-36-2538-01 da67724e-5273-48f5-8545-56c9a944c0a8 NA TCGA-36-2538-01A-01D-1043-01 NA NA NA NA TCGA-36-2538-01 NA NA NA TCGA-36-2538-01A-01R-1050-07 |
|
|
513 |
TCGA-36-2539-01 NA TCGA-36-2539-01 NA NA days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2539 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-36-2539-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.6 NO NA 1.3 NA NA NA NA NA NA NA NA TCGA-36-2539.c388f1d4-53dd-4e8b-bc68-ded38c816530.pdf NA NA NA NA NA NA NA NA Primary Tumor 01 0.4 NA NA NA NA NA NA A NA NA NA NA NA f335ca72-d387-445f-a46c-542b608b2646 NA NA NA TCGA-36-2539-01A-01D-1047-05 NA TCGA-36-2539-01A-21-20 TCGA-36-2539-01A-01D-1526-09 NA TCGA-36-2539-01A-01D-1043-01 NA 22ebbb58-a3c5-4473-82e6-4c4e0a5995e5 NA TCGA-36-2539-01A-01D-1043-01 NA NA NA NA NA NA NA NA TCGA-36-2539-01A-01R-1050-07 |
|
|
514 |
TCGA-36-2540-01 0 TCGA-36-2540-01 724 0 days Kirc+ NA Low purity c2 OV-like c4 NA NA NA NA TCGA-36-2540 NA NA days 724 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 26 Bilateral TCGA-36-2540-F27936 TCGA-36-2540 TCGA-36-2540-01A Stage IIIC -9760 NA NA 0 724 NA 665 0 NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.3 NA YES G1 Recurrence NA NA NA NA TCGA-36-2540.d66d4750-20f9-4e75-bdb7-b48de6dbc449.pdf 2540 Preoperative WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.2 NA NA 36 >20 mm Ovary YES A LIVING 2008 NA NA NA 75cee431-5541-49ea-a935-5e3b287f367b NA NA NA TCGA-36-2540-01A-01D-1047-05 NA TCGA-36-2540-01A-21-20 TCGA-36-2540-01A-01D-1526-09 NA TCGA-36-2540-01A-01D-1043-01 TCGA-36-2540-01 72b43e39-cb64-4610-b39e-02cc4b39c541 NA TCGA-36-2540-01A-01D-1043-01 NA NA NA NA TCGA-36-2540-01 NA NA NA TCGA-36-2540-01A-01R-1050-07 |
|
|
515 |
TCGA-36-2542-01 0 TCGA-36-2542-01 657 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2542 NA NA days 657 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Bilateral TCGA-36-2542-F27942 TCGA-36-2542 NA Stage IIIB -21902 NA NA 0 657 NA NA NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G3 NA NA NA NA NA NA 2542 NA TUMOR FREE YES Complete Remission/Response NA NO R1 Primary Tumor 01 NA NA NA 36 1-10 mm Ovary NA NA LIVING 2008 NA NA NA e4d9b54f-bf90-484f-9f85-06cd87712fd7 NA NA NA TCGA-36-2542-01A-01D-1047-05 NA TCGA-36-2542-01A-21-20 TCGA-36-2542-01A-01D-1526-09 NA TCGA-36-2542-01A-01D-1043-01 TCGA-36-2542-01 e58dd1a4-afb0-40c4-a0b2-aad520bcd0c9 NA TCGA-36-2542-01A-01D-1043-01 NA NA NA NA TCGA-36-2542-01 NA NA NA TCGA-36-2542-01A-01R-1050-07 |
|
|
516 |
TCGA-36-2543-01 1 TCGA-36-2543-01 68 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2543 NA NA days 68 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 85 Bilateral TCGA-36-2543-F27946 TCGA-36-2543 TCGA-36-2543-01A Stage IIIC -31211 NA 68 0 68 NA 27 3 NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.5 NO NA 1.6 NA NA G3 Progression of Disease NA NA NA NA TCGA-36-2543.ec25ac8e-1a07-459b-a986-c78edfff88c0.pdf 2543 Other WITH TUMOR NO Progressive Disease NA NO R1 Primary Tumor 01 0.4 NA NA 36 >20 mm Ovary NA A DECEASED 2008 NA NA NA c25023f6-f376-41b0-8346-3f898a11fd1f NA NA NA TCGA-36-2543-01A-01D-1047-05 NA TCGA-36-2543-01A-21-20 TCGA-36-2543-01A-01D-1526-09 NA TCGA-36-2543-01A-01D-1043-01 TCGA-36-2543-01 2146a3b5-3eb9-47be-9143-3a5de8c4a0d5 NA TCGA-36-2543-01A-01D-1043-01 NA NA NA NA TCGA-36-2543-01 NA NA NA TCGA-36-2543-01A-01R-1050-07 |
|
|
517 |
TCGA-36-2544-01 0 TCGA-36-2544-01 638 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2544 NA NA days 638 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-36-2544-F27948 TCGA-36-2544 TCGA-36-2544-01A Stage IIIC -21384 NA NA 0 638 NA 325 NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 2.3 NA NA G3 Progression of Disease NA NA NA NA TCGA-36-2544.87f69148-d6fb-4b70-8404-c24b106b6195.pdf 2544 NA WITH TUMOR YES Partial Remission/Response Imaging Study NO R1 Primary Tumor 01 0.7 NA NA 36 >20 mm Ovary NA A LIVING 2008 NA NA NA 7f53f5f6-c900-4ebb-87d8-9e1edcbe1de5 NA NA NA TCGA-36-2544-01A-01D-1047-05 NA TCGA-36-2544-01A-21-20 TCGA-36-2544-01A-01D-1526-09 NA TCGA-36-2544-01A-01D-1043-01 TCGA-36-2544-01 5ef7b46e-b379-4137-a5ab-91c9d6de74a3 NA TCGA-36-2544-01A-01D-1043-01 NA NA NA NA TCGA-36-2544-01 NA NA NA TCGA-36-2544-01A-01R-1050-07 |
|
|
518 |
TCGA-36-2545-01 0 TCGA-36-2545-01 557 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2545 NA NA days 557 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 42 Bilateral TCGA-36-2545-F27954 TCGA-36-2545 TCGA-36-2545-01A Stage IIIA -15444 NA NA 0 557 NA NA NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 2 NA NA G3 NA NA NA NA NA TCGA-36-2545.e8e6f050-7372-41f3-b198-72ddb241fb08.pdf 2545 NA TUMOR FREE YES NA NA NO R0 Primary Tumor 01 0.8 NA NA 36 No Macroscopic disease Ovary NA A LIVING 2008 NA NA NA 625f1165-c70d-4a7f-be3b-ff55aca5ca12 NA NA NA TCGA-36-2545-01A-01D-1047-05 NA TCGA-36-2545-01A-21-20 TCGA-36-2545-01A-01D-1526-09 NA TCGA-36-2545-01A-01D-1043-01 TCGA-36-2545-01 ecfb4f91-8c7a-465b-86f0-054855f71fe5 NA TCGA-36-2545-01A-01D-1043-01 NA NA NA NA TCGA-36-2545-01 NA NA NA TCGA-36-2545-01A-01R-1050-07 |
|
|
519 |
TCGA-36-2547-01 0 TCGA-36-2547-01 624 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2547 NA NA days 624 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 64 Left TCGA-36-2547-F27958 TCGA-36-2547 TCGA-36-2547-01A Stage IIIC -23706 NA NA 0 624 NA NA NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.7 NA NA G3 NA NA NA NA NA TCGA-36-2547.f615f400-96c3-42f3-bee9-c273b1a16b63.pdf 2547 NA NA YES NA NA NO R0 Primary Tumor 01 0.7 NA NA 36 No Macroscopic disease Ovary NA A LIVING 2008 NA NA NA 40ca7354-e907-4a61-853e-c1d66651f9a3 NA NA NA TCGA-36-2547-01A-01D-1047-05 NA TCGA-36-2547-01A-21-20 TCGA-36-2547-01A-01D-1526-09 NA TCGA-36-2547-01A-01D-1043-01 TCGA-36-2547-01 48b9af43-88a1-46c9-b6c7-ec1d1ac9e5f9 NA TCGA-36-2547-01A-01D-1043-01 NA NA NA NA TCGA-36-2547-01 NA NA NA TCGA-36-2547-01A-01R-1050-07 |
|
|
520 |
TCGA-36-2548-01 0 TCGA-36-2548-01 431 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2548 NA NA days 431 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Right TCGA-36-2548-F27962 TCGA-36-2548 TCGA-36-2548-01A Stage IIIC -20897 NA NA 0 431 NA 395 NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Other method, specify: NA 0.7 NO NA 1.3 NA NA G3 Recurrence NA NA NA NA TCGA-36-2548.68bf291c-3320-46f9-8e5f-7de81f0c6964.pdf 2548 NA WITH TUMOR YES NA Imaging Study NO R1 Primary Tumor 01 0.7 NA NA 36 >20 mm Ovary NA A LIVING 2008 NA NA NA abe78829-2661-4c6e-ba83-03e06963d9aa NA NA NA TCGA-36-2548-01A-01D-1047-05 NA TCGA-36-2548-01A-21-20 TCGA-36-2548-01A-01D-1526-09 NA TCGA-36-2548-01A-01D-1043-01 TCGA-36-2548-01 4794aace-89fb-4e9e-b117-3234ef1fc792 NA TCGA-36-2548-01A-01D-1043-01 NA NA NA NA TCGA-36-2548-01 NA NA NA TCGA-36-2548-01A-01R-1050-07 |
|
|
521 |
TCGA-36-2549-01 0 TCGA-36-2549-01 184 0 days BRCA-LUAD+ NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2549 NA NA days 184 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 54 Bilateral TCGA-36-2549-F27966 TCGA-36-2549 TCGA-36-2549-01A Stage IIC -20076 NA NA 0 184 NA NA NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.4 NA NA G3 NA NA NA NA NA TCGA-36-2549.42b18428-81f6-48d0-8a5f-fd08926128b1.pdf 2549 NA TUMOR FREE YES NA NA NO R0 Primary Tumor 01 0.6 NA NA 36 No Macroscopic disease Ovary NA A LIVING 2008 NA NA NA 3dac49f4-f485-4050-93d1-cbc22eef91d9 NA NA NA TCGA-36-2549-01A-01D-1047-05 NA TCGA-36-2549-01A-21-20 NA NA TCGA-36-2549-01A-01D-1043-01 TCGA-36-2549-01 0b81fd60-103b-484a-a954-839f7941bf98 NA TCGA-36-2549-01A-01D-1043-01 NA NA NA NA TCGA-36-2549-01 NA NA NA TCGA-36-2549-01A-01R-1050-07 |
|
|
522 |
TCGA-36-2551-01 0 TCGA-36-2551-01 492 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2551 NA NA days 492 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-36-2551-F27970 TCGA-36-2551 TCGA-36-2551-01A Stage IIIC -21045 NA NA 0 492 NA 338 NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.7 NO NA 1 NA NO G3 Recurrence NA NA NA NA TCGA-36-2551.c3e022a3-b58d-437b-a990-691730e9daf1.pdf 2551 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO R1 Primary Tumor 01 0.3 NA NA 36 >20 mm Ovary NA A LIVING 2009 NA NA NA 543cc9e3-5fb6-4229-aedb-a55273230b98 NA NA NA TCGA-36-2551-01A-01D-1047-05 NA TCGA-36-2551-01A-21-20 TCGA-36-2551-01A-01D-1526-09 NA TCGA-36-2551-01A-01D-1043-01 TCGA-36-2551-01 ceb02af7-9228-4bfa-812b-f1d88482c383 NA TCGA-36-2551-01A-01D-1043-01 NA NA NA NA TCGA-36-2551-01 NA NA NA TCGA-36-2551-01A-01R-1050-07 |
|
|
523 |
TCGA-36-2552-01 0 TCGA-36-2552-01 349 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-36-2552 NA NA days 349 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 64 Bilateral TCGA-36-2552-F27976 TCGA-36-2552 TCGA-36-2552-01A Stage IIC -23379 NA NA 0 349 NA NA NA NA NA 2010-8-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.3 NA NA G3 NA NA NA NA NA TCGA-36-2552.9504a356-0742-44f1-a218-62b769e64a33.pdf 2552 NA TUMOR FREE YES NA NA NO R0 Primary Tumor 01 0.8 NA NA 36 No Macroscopic disease Ovary NA A LIVING 2009 NA NA NA 4f0b1c4b-e033-4679-a32a-9bf80ff6d42d NA NA NA TCGA-36-2552-01A-01D-1047-05 NA TCGA-36-2552-01A-21-20 TCGA-36-2552-01A-01D-1526-09 NA TCGA-36-2552-01A-01D-1043-01 TCGA-36-2552-01 984b6351-1d3e-4ef1-99c4-d99895a3a49b NA TCGA-36-2552-01A-01D-1043-01 NA NA NA NA TCGA-36-2552-01 NA NA NA TCGA-36-2552-01A-01R-1050-07 |
|
|
524 |
TCGA-3P-A9WA-01 0 TCGA-3P-A9WA-01 420 0 days NA NA NA NA NA NA NA NA TCGA-3P-A9WA 420 0 days 420 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Left TCGA-3P-A9WA-F67273 TCGA-3P-A9WA TCGA-3P-A9WA-01A Stage IIB -20211 126 NA 0 420 NA NA NA Scheduled Follow-up Submission Complete Remission/Response 2014-11-4 FEMALE Serous Cystadenocarcinoma No C56.9 8440/3 C56.9 YES Other method, specify: 660 NA NO 100 NA NO NA G3 NA NA NO false Yes, History of Synchronous/Bilateral Malignancy TCGA-3P-A9WA.4B2E4D3D-128A-49DD-AE0B-ACFC78615B16.pdf A9WA Pre-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO RX Primary Tumor 01 NA YES NO 3P NA Ovary NA A LIVING 2013 TCGA-3P-A9WA-01 TCGA-3P-A9WA-01 NA NA TCGA-3P-A9WA-01A-11D-A409-05 TCGA-3P-A9WA-01 NA NA NA NA NA 94e91d8c-244a-48cf-af09-9412659e6759 TCGA-3P-A9WA-01A-11D-A402-01 NA 7C867DDB-C776-4764-8E77-F2CE4D474116 TCGA-3P-A9WA-01A-11R-A406-31 TCGA-3P-A9WA-01A-11D-A402-01 94e91d8c-244a-48cf-af09-9412659e6759 TCGA-3P-A9WA-01A-11R-A406-31 94e91d8c-244a-48cf-af09-9412659e6759 NA NA TCGA-3P-A9WA-01 94e91d8c-244a-48cf-af09-9412659e6759 NA NA |
|
|
525 |
TCGA-42-2582-01 1 TCGA-42-2582-01 1447 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-42-2582 1179 1 days 1447 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 49 Bilateral TCGA-42-2582-F34657 TCGA-42-2582 TCGA-42-2582-01A Stage IIIC -17961 NA 1447 0 435 NA 1179 1 Additional New Tumor Event Progressive Disease 2013-3-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.8 NO NA 1.3 NO YES G3 Progression of Disease NA YES NA NA TCGA-42-2582.04201F3C-F4FF-4F85-8C14-F1D754DAFDD6.pdf 2582 NA WITH TUMOR YES Stable Disease Imaging Study NO R0 Primary Tumor 01 0.2 NA NA 42 No Macroscopic disease Ovary NA A DECEASED 2009 NA NA NA 7f63006e-7016-483d-9a09-7d535a342d3a NA NA NA TCGA-42-2582-01A-01D-1047-05 NA TCGA-42-2582-01A-21-20 TCGA-42-2582-01A-01D-1526-09 NA TCGA-42-2582-01A-01D-1043-01 TCGA-42-2582-01 61f8ad02-1fe9-48ca-b317-c573aba61c08 NA TCGA-42-2582-01A-01D-1043-01 NA NA NA NA TCGA-42-2582-01 NA NA NA TCGA-42-2582-01A-01R-1231-07 |
|
|
526 |
TCGA-42-2587-01 0 TCGA-42-2587-01 722 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-42-2587 NA NA days 722 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 75 Bilateral TCGA-42-2587-F28795 TCGA-42-2587 TCGA-42-2587-01A Stage IIIC -27510 NA NA 0 722 NA NA NA NA NA 2011-8-19 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.4 NA YES G3 NA NA NA NA NA TCGA-42-2587.dc4896ef-1797-4796-8869-e9f5d19456d2.pdf 2587 NA TUMOR FREE YES Complete Remission/Response NA NO R1 Primary Tumor 01 0.6 NA NA 42 >20 mm Ovary YES A LIVING 2009 NA NA NA e8013ca8-18e0-42ee-aa94-b7171902da03 NA NA NA TCGA-42-2587-01A-01D-1047-05 NA TCGA-42-2587-01A-21-1563-20 TCGA-42-2587-01A-01D-1526-09 NA TCGA-42-2587-01A-01D-1043-01 TCGA-42-2587-01 934207be-d750-48bc-a51a-c6740d415d56 NA TCGA-42-2587-01A-01D-1043-01 NA NA NA NA TCGA-42-2587-01 NA NA NA TCGA-42-2587-01A-01R-1050-07 |
|
|
527 |
TCGA-42-2588-01 1 TCGA-42-2588-01 880 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-42-2588 NA NA days 880 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Bilateral TCGA-42-2588-F28821 TCGA-42-2588 NA Stage IV -22377 NA 880 0 287 NA 267 2 NA NA 2012-1-26 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA YES G3 Progression of Disease NA NA NA NA NA 2588 Preoperative WITH TUMOR YES Progressive Disease NA NO R2 Primary Tumor 01 NA NA NA 42 >20 mm Ovary NA NA DECEASED 2009 NA NA NA fd52301b-6882-4868-95e8-501ec794f7a8 NA NA NA TCGA-42-2588-01A-01D-1047-05 NA TCGA-42-2588-01A-21-20 TCGA-42-2588-01A-01D-1526-09 NA TCGA-42-2588-01A-01D-1043-01 TCGA-42-2588-01 ba162045-6055-466e-bf4d-ff04006919db NA TCGA-42-2588-01A-01D-1043-01 NA NA NA NA TCGA-42-2588-01 NA NA NA TCGA-42-2588-01A-01R-1050-07 |
|
|
528 |
TCGA-42-2589-01 0 TCGA-42-2589-01 1278 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-42-2589 1274 1 days 1278 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 54 Bilateral TCGA-42-2589-F41366 TCGA-42-2589 TCGA-42-2589-01A Stage IIIC -19852 NA NA 0 1278 NA 1274 NA Additional New Tumor Event Progressive Disease 2013-3-15 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Fine needle aspiration biopsy NA 1 NO NA 1 NO YES G3 NA NA YES NA NA TCGA-42-2589.07cceb21-4aca-4343-965e-81960a40cff2.pdf 2589 NA WITH TUMOR YES Complete Remission/Response NA NO R0 Primary Tumor 01 0.5 NA NA 42 1-10 mm Ovary NA A LIVING 2009 NA NA NA 9add86b7-a9d7-41ea-8536-41a204c97ae1 NA NA NA TCGA-42-2589-01A-01D-1047-05 NA TCGA-42-2589-01A-21-20 TCGA-42-2589-01A-01D-1526-09 NA TCGA-42-2589-01A-01D-1043-01 TCGA-42-2589-01 77d0cab8-5a58-4fed-ac41-68dff4f946cd NA TCGA-42-2589-01A-01D-1043-01 NA NA NA NA TCGA-42-2589-01 NA NA NA TCGA-42-2589-01A-01R-1050-07 |
|
|
529 |
TCGA-42-2590-01 1 TCGA-42-2590-01 317 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-42-2590 NA NA days 317 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 57 Bilateral TCGA-42-2590-F28809 TCGA-42-2590 TCGA-42-2590-01A Stage IV -20965 NA 317 0 227 NA 226 1 NA NA 2011-5-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO NA 2.2 NA NA G2 Progression of Disease NA NA NA NA TCGA-42-2590.9c7c0209-b1d6-4174-b57e-e8bcd3e5d766.pdf 2590 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease Imaging Study NO R1 Primary Tumor 01 0.4 NA NA 42 >20 mm Ovary NA A DECEASED 2009 NA NA NA 919946b9-3135-45fd-9fdd-b2d40c8bc3ba NA NA NA TCGA-42-2590-01A-01D-1047-05 NA TCGA-42-2590-01A-21-20 TCGA-42-2590-01A-01D-1526-09 NA TCGA-42-2590-01A-01D-1043-01 TCGA-42-2590-01 043ea617-6eec-43ae-a45c-b5cffacc7695 NA TCGA-42-2590-01A-01D-1043-01 NA NA NA NA TCGA-42-2590-01 NA NA NA TCGA-42-2590-01A-01R-1050-07 |
|
|
530 |
TCGA-42-2591-01 0 TCGA-42-2591-01 1240 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-42-2591 1240 0 days 1240 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-42-2591-F41420 TCGA-42-2591 TCGA-42-2591-01A Stage IIIC -18654 NA NA 0 1240 NA NA NA Scheduled Follow-up Submission Complete Remission/Response 2013-3-18 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.5 NO YES GX NA NA NO NA NA TCGA-42-2591.f4c9e6c0-c6bf-4793-a5de-c85c347b4097.pdf 2591 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.6 NA NA 42 No Macroscopic disease Ovary NA A LIVING 2009 NA NA NA 5c6e2798-32a6-4fb9-b246-c6267f7dfc51 NA NA NA TCGA-42-2591-01A-01D-1047-05 NA TCGA-42-2591-01A-21-20 TCGA-42-2591-01A-01D-1526-09 NA TCGA-42-2591-01A-01D-1043-01 TCGA-42-2591-01 0a1bb74b-fa00-4320-b966-ea146e76c9fa NA TCGA-42-2591-01A-01D-1043-01 NA NA NA NA TCGA-42-2591-01 NA NA NA TCGA-42-2591-01A-01R-1050-07 |
|
|
531 |
TCGA-42-2593-01 1 TCGA-42-2593-01 45 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-42-2593 45 0 days 45 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 67 Bilateral TCGA-42-2593-F39341 TCGA-42-2593 TCGA-42-2593-01A Stage IIIC -24823 NA 45 0 NA NA NA 4 Scheduled Follow-up Submission NA 2013-1-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.9 NO YES G3 NA NA NO NA NA TCGA-42-2593.302c2898-9b19-494b-86a5-f0ff3cab7163.pdf 2593 Other WITH TUMOR NO NA NA NO R2 Primary Tumor 01 0.4 YES NO 42 >20 mm Ovary YES A DECEASED 2009 NA NA NA f5e8a865-c4eb-4043-9a8f-7979d3fe6532 NA NA NA TCGA-42-2593-01A-01D-1047-05 NA TCGA-42-2593-01A-21-20 NA NA TCGA-42-2593-01A-01D-1043-01 NA 8ae9695c-082b-4011-b078-f55aa285fa11 NA TCGA-42-2593-01A-01D-1043-01 NA NA NA NA NA NA NA NA TCGA-42-2593-01A-01R-1050-07 |
|
|
532 |
TCGA-57-1582-01 1 TCGA-57-1582-01 731 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-57-1582 NA NA days 731 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 50 Left TCGA-57-1582-F28059 TCGA-57-1582 TCGA-57-1582-01A Stage IIIC NA NA 731 0 731 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 2 NA YES G3 NA NA NA NA NA TCGA-57-1582.0ed35510-c6ad-416b-8b57-e97005471dc1.pdf 1582 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.6 NA NA 57 1-10 mm Ovary YES A DECEASED 2006 TCGA-57-1582-01 TCGA-57-1582-01 TCGA-57-1582-01A-01W-0615-10 18e8fac4-913e-4c0f-bb6e-3d19b58518cc NA TCGA-57-1582-01 TCGA-57-1582-01A-01W-0615-10 TCGA-57-1582-01A-01D-0536-05 NA NA NA cb7a4405-b9a5-4e1a-825f-c3ee205c8a90 TCGA-57-1582-01A-01D-0533-01 TCGA-57-1582-01 NA NA TCGA-57-1582-01A-01D-0533-01 cb7a4405-b9a5-4e1a-825f-c3ee205c8a90 NA cb7a4405-b9a5-4e1a-825f-c3ee205c8a90 NA TCGA-57-1582-01 TCGA-57-1582-01 cb7a4405-b9a5-4e1a-825f-c3ee205c8a90 TCGA-57-1582-01A-01W-0615-10 TCGA-57-1582-01A-01R-0540-07 |
|
|
533 |
TCGA-57-1583-01 1 TCGA-57-1583-01 346 1 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-57-1583 NA NA days 346 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Left TCGA-57-1583-F28068 TCGA-57-1583 TCGA-57-1583-01A Stage IIIC -21167 NA 346 0 346 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.4 NA NO G3 NA NA NA NA NA TCGA-57-1583.b899b485-621f-46df-8bda-97b0fbe10b6d.pdf 1583 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.4 NA NA 57 No Macroscopic disease Ovary NO A DECEASED 2006 TCGA-57-1583-01 TCGA-57-1583-01 TCGA-57-1583-01A-01W-0615-10 bb6bfbc9-0379-4f74-8720-186fa0a165b9 NA TCGA-57-1583-01 TCGA-57-1583-01A-01W-0615-10 TCGA-57-1583-01A-01D-0536-05 NA NA NA 3a37e320-0301-4f2b-bf09-f102c12502b1 TCGA-57-1583-01A-01D-0533-01 TCGA-57-1583-01 NA NA TCGA-57-1583-01A-01D-0533-01 3a37e320-0301-4f2b-bf09-f102c12502b1 NA 3a37e320-0301-4f2b-bf09-f102c12502b1 NA TCGA-57-1583-01 TCGA-57-1583-01 3a37e320-0301-4f2b-bf09-f102c12502b1 TCGA-57-1583-01A-01W-0615-10 TCGA-57-1583-01A-01R-0540-07 |
|
|
534 |
TCGA-57-1584-01 0 TCGA-57-1584-01 643 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 3 cluster 6 mutation cluster 3 TCGA-57-1584 NA NA days 643 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-57-1584-F28072 TCGA-57-1584 NA Stage IIIC -17263 NA NA 0 643 NA 530 0 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 Recurrence NA NA NA NA NA 1584 Pre-Adjuvant Therapy WITH TUMOR NO NA Imaging Study NO NA Primary Tumor 01 NA NA NA 57 1-10 mm Ovary YES NA LIVING 2007 TCGA-57-1584-01 TCGA-57-1584-01 TCGA-57-1584-01A-01W-0615-10 e10d4b1f-cba8-4e34-af2e-331949b18dba NA TCGA-57-1584-01 TCGA-57-1584-01A-01W-0615-10 TCGA-57-1584-01A-01D-0536-05 NA NA NA e92b95df-bacb-4083-b2de-78e540ec0e68 TCGA-57-1584-01A-01D-0533-01 TCGA-57-1584-01 NA NA TCGA-57-1584-01A-01D-0533-01 e92b95df-bacb-4083-b2de-78e540ec0e68 NA e92b95df-bacb-4083-b2de-78e540ec0e68 NA TCGA-57-1584-01 TCGA-57-1584-01 e92b95df-bacb-4083-b2de-78e540ec0e68 TCGA-57-1584-01A-01W-0615-10 TCGA-57-1584-01A-01R-0540-07 |
|
|
535 |
TCGA-57-1585-01 1 TCGA-57-1585-01 53 1 days Squamous NA OV-like c1 NA NA miRNA cluster 3 cluster 6 NA TCGA-57-1585 NA NA days 53 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Bilateral TCGA-57-1585-F28076 TCGA-57-1585 TCGA-57-1585-01A Stage IIIC -20862 NA 53 0 53 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 0.8 NA YES G3 NA NA NA NA NA TCGA-57-1585.2c748aca-e5b2-4418-9820-1343293d379f.pdf 1585 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.3 NA NA 57 11-20 mm Ovary YES A DECEASED 2007 TCGA-57-1585-01 TCGA-57-1585-01 NA 9485c5c9-3fa8-48a3-bb75-a152f1547ae3 NA TCGA-57-1585-01 NA TCGA-57-1585-01A-01D-0536-05 NA NA NA 06df1324-bc1b-4bc3-bb01-4ef55a5aeef5 TCGA-57-1585-01A-01D-0533-01 TCGA-57-1585-01 NA NA TCGA-57-1585-01A-01D-0533-01 06df1324-bc1b-4bc3-bb01-4ef55a5aeef5 NA 06df1324-bc1b-4bc3-bb01-4ef55a5aeef5 NA TCGA-57-1585-01 TCGA-57-1585-01 06df1324-bc1b-4bc3-bb01-4ef55a5aeef5 NA TCGA-57-1585-01A-01R-0540-07 |
|
|
536 |
TCGA-57-1586-01 0 TCGA-57-1586-01 679 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-57-1586 NA NA days 679 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 66 Bilateral TCGA-57-1586-F28080 TCGA-57-1586 NA Stage IIIC -24304 NA NA 0 679 NA 259 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 Recurrence NA NA NA NA NA 1586 NA WITH TUMOR YES NA Molecular Markers NO NA Primary Tumor 01 NA NA NA 57 11-20 mm Ovary YES NA LIVING 2007 NA TCGA-57-1586-01 NA ec771953-9297-4d7d-aa29-531499b3e2eb NA TCGA-57-1586-01 NA TCGA-57-1586-01A-02D-0563-05 NA TCGA-57-1586-01A-03-1563-20 TCGA-57-1586-01A-02W-0633-09 NA TCGA-57-1586-01A-02D-0559-01 TCGA-57-1586-01 a93a15b9-aef1-403b-85c4-1d5203e6d9dc NA TCGA-57-1586-01A-02D-0559-01 NA NA NA NA TCGA-57-1586-01 NA NA NA TCGA-57-1586-01A-02R-0566-07 |
|
|
537 |
TCGA-57-1992-01 0 TCGA-57-1992-01 882 0 days High NA OV-like c1 NA NA NA NA NA TCGA-57-1992 NA NA days 882 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Left TCGA-57-1992-F28090 TCGA-57-1992 TCGA-57-1992-01A Stage IC NA NA NA 0 882 NA NA NA NA NA 2009-12-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.3 NA YES G3 NA NA NA NA NA TCGA-57-1992.77c742d8-bb0b-4ea9-9f61-9606c78c438e.pdf 1992 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 57 No Macroscopic disease Ovary YES A LIVING 2006 NA NA NA 6fcb27b1-5f0d-4c30-b9a4-205f60bc880b NA NA NA TCGA-57-1992-01A-01D-0652-05 NA NA NA NA TCGA-57-1992-01A-01D-0648-01 TCGA-57-1992-01 NA NA TCGA-57-1992-01A-01D-0648-01 NA NA NA NA TCGA-57-1992-01 NA NA NA TCGA-57-1992-01A-01R-0655-07 |
|
|
538 |
TCGA-57-1993-01 0 TCGA-57-1993-01 763 0 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-57-1993 NA NA days 763 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 56 Bilateral TCGA-57-1993-F28092 TCGA-57-1993 TCGA-57-1993-01A Stage IIIC -20498 NA NA 0 763 NA NA NA NA NA 2010-1-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.5 NA YES G3 NA NA NA NA NA TCGA-57-1993.55495e3a-6052-4fb1-b8a9-10b54dcdfbea.pdf 1993 NA TUMOR FREE YES NA NA NO R0 Primary Tumor 01 0.5 NA NA 57 No Macroscopic disease Ovary YES A LIVING 2007 TCGA-57-1993-01 TCGA-57-1993-01 NA f8c91078-d156-4ee9-96c9-7ec6937c40b3 NA TCGA-57-1993-01 NA TCGA-57-1993-01A-01D-0652-05 NA NA NA 55f9061c-54e7-465c-af61-21d8bc8ecbe0 TCGA-57-1993-01A-01D-0648-01 TCGA-57-1993-01 NA NA TCGA-57-1993-01A-01D-0648-01 55f9061c-54e7-465c-af61-21d8bc8ecbe0 NA 55f9061c-54e7-465c-af61-21d8bc8ecbe0 TCGA-57-1993-01A-01W-0699-08 TCGA-57-1993-01 TCGA-57-1993-01 55f9061c-54e7-465c-af61-21d8bc8ecbe0 TCGA-57-1993-01A-01W-0699-08 TCGA-57-1993-01A-01R-0655-07 |
|
|
539 |
TCGA-57-1994-01 0 TCGA-57-1994-01 761 0 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-57-1994 NA NA days 761 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 NA TCGA-57-1994-F28096 TCGA-57-1994 TCGA-57-1994-01A NA -23062 NA NA 0 761 NA NA NA NA NA 2011-6-10 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.5 NA NA NA NA NA NA NA NA TCGA-57-1994.54c3dd01-b473-424f-987a-c5d6e972e9bb.pdf 1994 NA NA NO NA NA NO NA Primary Tumor 01 0.4 NA NA 57 NA Ovary NA A LIVING 2004 TCGA-57-1994-01 TCGA-57-1994-01 NA 24fbfb49-2a8c-40af-b607-577cc3001b2d NA TCGA-57-1994-01 NA TCGA-57-1994-01A-01D-0652-05 NA NA NA 2cf309ea-0c2e-4f28-a94b-342dc9a1aae8 TCGA-57-1994-01A-01D-0648-01 TCGA-57-1994-01 NA NA TCGA-57-1994-01A-01D-0648-01 2cf309ea-0c2e-4f28-a94b-342dc9a1aae8 NA 2cf309ea-0c2e-4f28-a94b-342dc9a1aae8 NA TCGA-57-1994-01 TCGA-57-1994-01 2cf309ea-0c2e-4f28-a94b-342dc9a1aae8 NA TCGA-57-1994-01A-01R-0655-07 |
|
|
540 |
TCGA-59-2348-01 0 TCGA-59-2348-01 5481 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-59-2348 NA NA days 5481 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 59 Bilateral TCGA-59-2348-F28098 TCGA-59-2348 TCGA-59-2348-01A Stage IIIC NA NA NA 0 5481 NA NA NA NA NA 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 2 NA NA G3 NA NA NA NA NA TCGA-59-2348.ffb300e9-cb06-4162-a751-f079fec57153.pdf 2348 NA TUMOR FREE NA Complete Remission/Response NA NA NA Primary Tumor 01 0.4 NA NA 59 NA Ovary NA A LIVING 1994 TCGA-59-2348-01 TCGA-59-2348-01 NA 139d2d19-f3e9-46fc-bd88-b57709af9ec5 NA TCGA-59-2348-01 NA TCGA-59-2348-01A-01D-0708-05 NA TCGA-59-2348-01A-21-1560-20 NA 7162d809-ff1a-4346-bb00-c8086386ec46 TCGA-59-2348-01A-01D-0704-01 TCGA-59-2348-01 c37d3098-f79e-4ce7-9ed5-884d82725dff NA TCGA-59-2348-01A-01D-0704-01 7162d809-ff1a-4346-bb00-c8086386ec46 NA 7162d809-ff1a-4346-bb00-c8086386ec46 TCGA-59-2348-01A-01W-0799-08 TCGA-59-2348-01 TCGA-59-2348-01 7162d809-ff1a-4346-bb00-c8086386ec46 TCGA-59-2348-01A-01W-0799-08 TCGA-59-2348-01A-01R-0711-07 |
|
|
541 |
TCGA-59-2349-01 1 TCGA-59-2349-01 2437 1 days Kirc+ NA Cluster 5 BRCA basal-like c6 NA NA NA NA TCGA-59-2349 NA NA days 2437 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 71 Left TCGA-59-2349-F28100 TCGA-59-2349 TCGA-59-2349-01A Stage IA NA NA 2437 0 NA NA NA NA NA NA 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.3 NA NA G3 NA NA NA NA NA TCGA-59-2349.a56064eb-651a-4a7d-b32c-5c890821e338.pdf 2349 NA NA NA Complete Remission/Response NA NA NA Primary Tumor 01 0.3 NO YES 59 No Macroscopic disease Ovary NA A DECEASED 1994 NA NA NA 7557f686-ae87-4ab8-b7df-b1f1b0850e51 NA NA NA TCGA-59-2349-01A-01D-0708-05 NA TCGA-59-2349-01A-21-1560-20 NA NA TCGA-59-2349-01A-01D-0704-01 TCGA-59-2349-01 96c57593-695a-4b64-997b-b465ed28917c NA TCGA-59-2349-01A-01D-0704-01 NA NA NA NA TCGA-59-2349-01 NA NA NA TCGA-59-2349-01A-01R-0711-07 |
|
|
542 |
TCGA-59-2350-01 1 TCGA-59-2350-01 679 1 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-59-2350 NA NA days 679 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 44 Bilateral TCGA-59-2350-F28102 TCGA-59-2350 NA Stage IV NA NA 679 0 NA NA 211 NA NA NA 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NA G3 Progression of Disease NA NA NA NA NA 2350 NA WITH TUMOR NA Partial Remission/Response NA NA NA Primary Tumor 01 NA NO YES 59 1-10 mm Ovary NA NA DECEASED 1995 TCGA-59-2350-01 TCGA-59-2350-01 NA e5b094fc-335d-4a9e-9ead-d0bda9695e33 NA TCGA-59-2350-01 NA TCGA-59-2350-01A-01D-0708-05 NA NA NA e05f2e2a-77d2-4f86-8e21-27cdd93b88b0 TCGA-59-2350-01A-01D-0704-01 TCGA-59-2350-01 NA NA TCGA-59-2350-01A-01D-0704-01 e05f2e2a-77d2-4f86-8e21-27cdd93b88b0 NA e05f2e2a-77d2-4f86-8e21-27cdd93b88b0 TCGA-59-2350-01A-01W-0799-08 TCGA-59-2350-01 TCGA-59-2350-01 e05f2e2a-77d2-4f86-8e21-27cdd93b88b0 TCGA-59-2350-01A-01W-0799-08 TCGA-59-2350-01A-01R-0711-07 |
|
|
543 |
TCGA-59-2351-01 0 TCGA-59-2351-01 3532 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 6 mutation cluster 5 TCGA-59-2351 NA NA days 3532 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 51 Bilateral TCGA-59-2351-F28104 TCGA-59-2351 TCGA-59-2351-01A Stage IIIC NA NA NA 0 3532 NA 2139 NA NA NA 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 2 NA NA G3 Progression of Disease NA NA NA NA TCGA-59-2351.6cec74e9-4ad7-4c6d-abdd-36ba1573d6ad.pdf 2351 NA TUMOR FREE NA Complete Remission/Response Imaging Study NA NA Primary Tumor 01 0.4 NO YES 59 1-10 mm Ovary NA A LIVING 1999 TCGA-59-2351-01 TCGA-59-2351-01 NA 2c72e167-d9b6-47e2-ae10-3183a6d13e7a NA TCGA-59-2351-01 NA TCGA-59-2351-01A-01D-0708-05 NA TCGA-59-2351-01A-21-1560-20 NA 7e58cfd1-07eb-44e2-a563-fa7a00b338a3 TCGA-59-2351-01A-01D-0704-01 TCGA-59-2351-01 2cdeaf4d-f2c6-44fd-872e-965ef80e505b NA TCGA-59-2351-01A-01D-0704-01 7e58cfd1-07eb-44e2-a563-fa7a00b338a3 NA 7e58cfd1-07eb-44e2-a563-fa7a00b338a3 TCGA-59-2351-01A-01W-0799-08 TCGA-59-2351-01 TCGA-59-2351-01 7e58cfd1-07eb-44e2-a563-fa7a00b338a3 TCGA-59-2351-01A-01W-0799-08 TCGA-59-2351-01A-01R-0711-07 |
|
|
544 |
TCGA-59-2352-01 1 TCGA-59-2352-01 286 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-59-2352 NA NA days 286 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Right NA TCGA-59-2352 TCGA-59-2352-01A Stage IIIC NA NA 286 0 NA NA NA NA NA NA 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.2 NO NA 2 NA NA G3 NA NA NA NA NA TCGA-59-2352.15f65643-b84c-4239-bc14-0ddacdfe0425.pdf 2352 NA WITH TUMOR NA NA NA NA NA Primary Tumor 01 0.4 NO YES 59 NA Ovary NA A DECEASED 2002 TCGA-59-2352-01 TCGA-59-2352-01 NA 87ec1cd8-27d3-4cde-a59b-58c82ab8cbbe NA TCGA-59-2352-01 NA TCGA-59-2352-01A-01D-0708-05 NA TCGA-59-2352-01A-21-1560-20 NA a209a8f4-9462-4ade-be57-caaec54999cb TCGA-59-2352-01A-01D-0704-01 TCGA-59-2352-01 d9066d98-0039-4956-9e7e-9931b8c28379 NA TCGA-59-2352-01A-01D-0704-01 a209a8f4-9462-4ade-be57-caaec54999cb NA a209a8f4-9462-4ade-be57-caaec54999cb TCGA-59-2352-01A-01W-0799-08 TCGA-59-2352-01 TCGA-59-2352-01 a209a8f4-9462-4ade-be57-caaec54999cb TCGA-59-2352-01A-01W-0799-08 TCGA-59-2352-01A-01R-0711-07 |
|
|
545 |
TCGA-59-2354-01 1 TCGA-59-2354-01 1046 1 days Squamous C9-OV OV-like c1 OV-like c4 NA miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-59-2354 NA NA days 1046 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Left TCGA-59-2354-F28107 TCGA-59-2354 TCGA-59-2354-01A Stage IIIC NA NA 1046 0 NA NA 462 NA NA NA 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 2.4 NA YES G3 Progression of Disease NA NA NA NA TCGA-59-2354.cbdd4d6e-0df4-4abd-af75-b3a66bdba9cc.pdf 2354 NA WITH TUMOR YES Stable Disease Imaging Study NA NA Primary Tumor 01 0.3 NA NA 59 1-10 mm Ovary NA A DECEASED 2005 TCGA-59-2354-01 TCGA-59-2354-01 NA e0e3aedf-ace3-4525-83c2-887b517837c0 NA TCGA-59-2354-01 NA TCGA-59-2354-01A-01D-0708-05 NA TCGA-59-2354-01A-21-1560-20 NA 33367eb6-4ca9-4daf-9e47-30a47a78e144 TCGA-59-2354-01A-01D-0704-01 TCGA-59-2354-01 d80db939-9815-4d8b-8d3d-927a54355003 NA TCGA-59-2354-01A-01D-0704-01 33367eb6-4ca9-4daf-9e47-30a47a78e144 NA 33367eb6-4ca9-4daf-9e47-30a47a78e144 TCGA-59-2354-01A-01W-0799-08 TCGA-59-2354-01 TCGA-59-2354-01 33367eb6-4ca9-4daf-9e47-30a47a78e144 TCGA-59-2354-01A-01W-0799-08 TCGA-59-2354-01A-01R-0711-07 |
|
|
546 |
TCGA-59-2355-01 1 TCGA-59-2355-01 65 1 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-59-2355 NA NA days 65 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 58 Right TCGA-59-2355-F28111 TCGA-59-2355 TCGA-59-2355-01A Stage IV NA NA 65 0 NA NA NA NA NA NA 2010-1-29 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.6 NA YES G3 NA NA NA NA NA TCGA-59-2355.322bedf6-e6b5-4275-a186-0075a2ec271e.pdf 2355 NA WITH TUMOR YES NA NA NA NA Primary Tumor 01 0.2 NA NA 59 >20 mm Ovary NA A DECEASED 2006 TCGA-59-2355-01 TCGA-59-2355-01 NA 9c18086a-f203-48f5-af4c-d756fe1b266b NA TCGA-59-2355-01 NA TCGA-59-2355-01A-01D-0708-05 NA NA NA 866c7355-e2ec-4816-953f-7bf791033283 TCGA-59-2355-01A-01D-0704-01 TCGA-59-2355-01 NA NA TCGA-59-2355-01A-01D-0704-01 866c7355-e2ec-4816-953f-7bf791033283 NA 866c7355-e2ec-4816-953f-7bf791033283 TCGA-59-2355-01A-01W-0799-08 TCGA-59-2355-01 TCGA-59-2355-01 866c7355-e2ec-4816-953f-7bf791033283 TCGA-59-2355-01A-01W-0799-08 TCGA-59-2355-01A-01R-0711-07 |
|
|
547 |
TCGA-59-2363-01 0 TCGA-59-2363-01 165 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 mutation cluster 5 TCGA-59-2363 NA NA days 165 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 40 Bilateral TCGA-59-2363-F28115 TCGA-59-2363 TCGA-59-2363-01A Stage IIIA NA NA NA 0 165 NA NA NA NA NA 2010-2-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NO G3 NA NA NA NA NA TCGA-59-2363.9b047485-eb2b-4fc1-a22a-d96046b63bf2.pdf 2363 NA TUMOR FREE YES Complete Remission/Response NA NO R0 Primary Tumor 01 0.4 NA NA 59 No Macroscopic disease Ovary NO A LIVING 2007 TCGA-59-2363-01 TCGA-59-2363-01 NA 0ef0c1bf-9885-4be9-85b1-ed400a1a940f NA TCGA-59-2363-01 NA TCGA-59-2363-01A-01D-0708-05 NA TCGA-59-2363-01A-21-1560-20 NA 1d3f29ac-5f19-452d-99b6-72c0abf1ce32 TCGA-59-2363-01A-01D-0704-01 TCGA-59-2363-01 abdc5a45-9e20-4c0e-b854-9a2ec535245a NA TCGA-59-2363-01A-01D-0704-01 1d3f29ac-5f19-452d-99b6-72c0abf1ce32 NA 1d3f29ac-5f19-452d-99b6-72c0abf1ce32 TCGA-59-2363-01A-01W-0799-08 TCGA-59-2363-01 TCGA-59-2363-01 1d3f29ac-5f19-452d-99b6-72c0abf1ce32 TCGA-59-2363-01A-01W-0799-08 TCGA-59-2363-01A-01R-0711-07 |
|
|
548 |
TCGA-59-2372-01 1 TCGA-59-2372-01 1363 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-59-2372 NA NA days 1363 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 73 Bilateral TCGA-59-2372-F28119 TCGA-59-2372 TCGA-59-2372-01A Stage IIIC NA NA 1363 0 NA NA NA NA NA NA 2010-2-12 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA NO G2 NA NA NA NA NA TCGA-59-2372.4411c3e9-2751-45eb-bc8f-e64ca2940a09.pdf 2372 NA NA YES NA NA NO R0 Primary Tumor 01 0.5 NA NA 59 No Macroscopic disease Ovary NO A DECEASED 2005 NA NA NA b368a37f-fa86-47ae-9a1c-d1038f19a663 NA NA NA TCGA-59-2372-01A-01D-1047-05 NA TCGA-59-2372-01A-21-1560-20 TCGA-59-2372-01A-01D-1526-09 NA TCGA-59-2372-01A-01D-1043-01 TCGA-59-2372-01 7d66df01-e224-4584-8c36-f54735a2fc53 NA TCGA-59-2372-01A-01D-1043-01 NA NA NA NA TCGA-59-2372-01 NA NA NA TCGA-59-2372-01A-01R-1050-07 |
|
|
549 |
TCGA-59-A5PD-01 1 TCGA-59-A5PD-01 624 1 days NA NA NA NA NA NA NA NA TCGA-59-A5PD NA NA days 624 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Right NA TCGA-59-A5PD TCGA-59-A5PD-01A Stage IC -20263 730 624 0 NA NA NA 0 NA NA 2013-6-25 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 130 NA NO 100 NA NA YES G3 NA NA YES false Yes, History of Synchronous/Bilateral Malignancy TCGA-59-A5PD.9A3CB382-654F-4DFD-BF41-7615710D2825.pdf A5PD Preoperative WITH TUMOR NO Complete Remission/Response NA NO NA Primary Tumor 01 NA NO YES 59 NA Ovary YES A DECEASED 2011 TCGA-59-A5PD-01 TCGA-59-A5PD-01 NA NA TCGA-59-A5PD-01A-11D-A409-05 TCGA-59-A5PD-01 NA NA NA NA NA 356a00a0-d19a-498c-8ed7-20ce89cd21eb TCGA-59-A5PD-01A-11D-A402-01 NA 8E787AAF-9659-4F93-97F9-CD58BD1FEC1D TCGA-59-A5PD-01A-11R-A406-31 TCGA-59-A5PD-01A-11D-A402-01 356a00a0-d19a-498c-8ed7-20ce89cd21eb TCGA-59-A5PD-01A-11R-A406-31 356a00a0-d19a-498c-8ed7-20ce89cd21eb NA NA TCGA-59-A5PD-01 356a00a0-d19a-498c-8ed7-20ce89cd21eb NA NA |
|
|
550 |
TCGA-5X-AA5U-01 0 TCGA-5X-AA5U-01 361 0 days NA NA NA NA NA NA NA NA TCGA-5X-AA5U 361 0 days 361 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 61 Right TCGA-5X-AA5U-F69358 TCGA-5X-AA5U TCGA-5X-AA5U-01A Stage IIC -22438 11 NA 0 361 NA NA 0 Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 FEMALE Serous Cystadenocarcinoma No C56.9 8460/3 C56.9 YES Tumor resection 230 NA NO 100 NA NO NO GX NA NA NO true Yes, History of Synchronous/Bilateral Malignancy TCGA-5X-AA5U.28F20F49-20C6-4B93-957D-8DAEF04657AE.pdf AA5U Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response NA NO R0 Primary Tumor 01 NA YES NO 5X NA Ovary NO A LIVING 2013 TCGA-5X-AA5U-01 TCGA-5X-AA5U-01 NA NA TCGA-5X-AA5U-01A-11D-A409-05 TCGA-5X-AA5U-01 NA NA NA NA NA 4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9 TCGA-5X-AA5U-01A-11D-A402-01 NA 3372257B-B9F7-42AF-8EC4-AC69618A0A35 TCGA-5X-AA5U-01A-11R-A406-31 TCGA-5X-AA5U-01A-11D-A402-01 4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9 TCGA-5X-AA5U-01A-11R-A406-31 4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9 NA NA TCGA-5X-AA5U-01 4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9 NA NA |
|
|
551 |
TCGA-61-1721-01 0 TCGA-61-1721-01 338 0 days Quiet C5-KIRC Low purity c2 OV-like c4 GBM-like c6 miRNA cluster 3 cluster 6 NA TCGA-61-1721 NA NA days 338 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 38 Bilateral TCGA-61-1721-F28123 TCGA-61-1721 TCGA-61-1721-01A Stage IV -13894 NA NA 0 338 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma Yes C56.9 8441/3 C56.9 YES Excisional Biopsy NA 0.9 NO NA 1 NA YES G1 NA NA NA NA NA TCGA-61-1721.f44d906c-f069-45e6-9cc4-49eb0da74226.pdf 1721 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 61 NA Ovary YES A LIVING 2008 TCGA-61-1721-01 TCGA-61-1721-01 NA 13cc06b1-0e57-4cfe-bfe1-b6ec96321199 NA TCGA-61-1721-01 NA TCGA-61-1721-01A-01D-0652-05 NA TCGA-61-1721-01A-21-1559-20 NA 226f9774-e22b-4b8b-8259-934edb649fc3 TCGA-61-1721-01A-01D-0648-01 TCGA-61-1721-01 0479fc63-879d-4b50-b014-20d276a2d13d NA TCGA-61-1721-01A-01D-0648-01 226f9774-e22b-4b8b-8259-934edb649fc3 NA 226f9774-e22b-4b8b-8259-934edb649fc3 NA TCGA-61-1721-01 TCGA-61-1721-01 226f9774-e22b-4b8b-8259-934edb649fc3 NA TCGA-61-1721-01A-01R-0655-07 |
|
|
552 |
TCGA-61-1722-01 0 TCGA-61-1722-01 246 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-1722 NA NA days 246 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 89 Bilateral TCGA-61-1722-F28129 TCGA-61-1722 TCGA-61-1722-01A Stage IB -32853 NA NA 0 246 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-61-1722.059421f4-442e-4e81-a726-7a8486c74cdc.pdf 1722 NA WITH TUMOR NO Stable Disease NA NO NA Primary Tumor 01 0.2 NA NA 61 No Macroscopic disease Ovary NO A LIVING 2008 NA NA NA 79b7ffda-716b-4253-a580-4b1372a8f152 NA NA NA TCGA-61-1722-01A-01D-0581-05 NA TCGA-61-1722-01A-21-1559-20 TCGA-61-1722-01A-01D-1556-09 NA TCGA-61-1722-01A-01D-0577-01 TCGA-61-1722-01 b17eace3-8ff6-4e2c-abd1-81f67343d8d1 NA TCGA-61-1722-01A-01D-0577-01 NA NA NA NA TCGA-61-1722-01 NA NA NA TCGA-61-1722-01A-01R-0584-07 |
|
|
553 |
TCGA-61-1724-01 1 TCGA-61-1724-01 637 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 3 cluster 5 NA TCGA-61-1724 NA NA days 637 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 47 Bilateral TCGA-61-1724-F28135 TCGA-61-1724 NA Stage IIIC -17168 NA 637 0 637 187 NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G3 Locoregional Disease YES NA NA NA NA 1724 NA WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 NA NA NA 61 No Macroscopic disease Ovary YES NA DECEASED 2007 TCGA-61-1724-01 TCGA-61-1724-01 NA af7c2e4b-c7c1-46d1-854e-c75365f3c967 NA TCGA-61-1724-01 NA TCGA-61-1724-01A-01D-0652-05 NA TCGA-61-1724-01A-21-1559-20 NA faab5b85-3c69-4c64-bba0-a8d5404939a2 TCGA-61-1724-01A-01D-0648-01 TCGA-61-1724-01 eb6edbbc-bc05-4627-b5af-6f91d7b6c5dd NA TCGA-61-1724-01A-01D-0648-01 faab5b85-3c69-4c64-bba0-a8d5404939a2 NA faab5b85-3c69-4c64-bba0-a8d5404939a2 NA TCGA-61-1724-01 TCGA-61-1724-01 faab5b85-3c69-4c64-bba0-a8d5404939a2 NA TCGA-61-1724-01A-01R-0655-07 |
|
|
554 |
TCGA-61-1725-01 0 TCGA-61-1725-01 956 0 days Squamous NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-61-1725 NA NA days 956 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-1725-F28143 TCGA-61-1725 TCGA-61-1725-01A Stage IIIC -14782 NA NA 0 956 NA 844 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-61-1725.8bcf7f73-abe7-43d0-a7da-ede3f5c2bb04.pdf 1725 NA WITH TUMOR YES Stable Disease Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 11-20 mm Ovary YES A LIVING 2007 TCGA-61-1725-01 TCGA-61-1725-01 NA be16e66f-a839-44c7-b700-4a95d366435f NA TCGA-61-1725-01 NA TCGA-61-1725-01A-01D-0581-05 NA NA TCGA-61-1725-01A-01W-0639-09 748ff969-cb49-4f22-994f-6debe734c38f TCGA-61-1725-01A-01D-0577-01 TCGA-61-1725-01 NA NA TCGA-61-1725-01A-01D-0577-01 748ff969-cb49-4f22-994f-6debe734c38f NA 748ff969-cb49-4f22-994f-6debe734c38f NA TCGA-61-1725-01 TCGA-61-1725-01 748ff969-cb49-4f22-994f-6debe734c38f NA TCGA-61-1725-01A-01R-0584-07 |
|
|
555 |
TCGA-61-1727-01 0 TCGA-61-1727-01 564 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-1727 NA NA days 564 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 74 Right TCGA-61-1727-F28152 TCGA-61-1727 TCGA-61-1727-01A Stage IC -27203 NA NA 0 564 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.1 NA NA G3 NA NA NA NA NA TCGA-61-1727.f8e2cbf2-911a-48a7-ad80-c23124af44fe.pdf 1727 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary NO A LIVING 2007 NA NA NA ea305cbb-1171-49bd-be79-debefe08023f NA NA NA TCGA-61-1727-01A-01D-0581-05 NA TCGA-61-1727-01A-21-1559-20 TCGA-61-1727-01A-01W-0639-09 NA TCGA-61-1727-01A-01D-0577-01 TCGA-61-1727-01 3d14831f-1ab6-43e9-bd15-0c6e930304e8 NA TCGA-61-1727-01A-01D-0577-01 NA NA NA NA TCGA-61-1727-01 NA NA NA TCGA-61-1727-01A-01R-0584-07 |
|
|
556 |
TCGA-61-1728-01 0 TCGA-61-1728-01 848 0 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-61-1728 NA NA days 848 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 59 Bilateral TCGA-61-1728-F28156 TCGA-61-1728 TCGA-61-1728-01A Stage IV -21582 NA NA 0 848 NA 533 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.1 NA NO G3 Recurrence NA NA NA NA TCGA-61-1728.7611c4d4-f58b-404e-93f1-949c865c9e12.pdf 1728 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.2 NA NA 61 1-10 mm Ovary NO A LIVING 2007 TCGA-61-1728-01 TCGA-61-1728-01 NA 54635249-84d5-466b-b956-e125a7113132 NA TCGA-61-1728-01 NA TCGA-61-1728-01A-01D-0652-05 NA NA NA bf909020-d6a1-49f1-8007-4192d39abd04 TCGA-61-1728-01A-01D-0648-01 TCGA-61-1728-01 NA NA TCGA-61-1728-01A-01D-0648-01 bf909020-d6a1-49f1-8007-4192d39abd04 NA bf909020-d6a1-49f1-8007-4192d39abd04 TCGA-61-1728-01A-01W-0699-08 TCGA-61-1728-01 TCGA-61-1728-01 bf909020-d6a1-49f1-8007-4192d39abd04 TCGA-61-1728-01A-01W-0699-08 TCGA-61-1728-01A-01R-0655-07 |
|
|
557 |
TCGA-61-1730-01 1 TCGA-61-1730-01 132 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-1730 NA NA days 132 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Left TCGA-61-1730-F28161 TCGA-61-1730 TCGA-61-1730-01A Stage IC -28508 NA 132 0 132 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.2 NA NO G3 NA NA NA NA NA TCGA-61-1730.4624968a-27c1-4f4f-b9f1-3e6997c15a21.pdf 1730 NA WITH TUMOR NO NA NA NO NA Primary Tumor 01 0.4 NA NA 61 1-10 mm Ovary NO A DECEASED 2007 NA NA NA 59246787-027e-4aea-8a7e-04521b0f96a6 NA NA NA TCGA-61-1730-01A-01D-0581-05 NA TCGA-61-1730-01A-21-1559-20 TCGA-61-1730-01A-01W-0639-09 NA TCGA-61-1730-01A-01D-0577-01 TCGA-61-1730-01 1a49f3dd-f92d-4206-bce7-05a2ff6df71e NA TCGA-61-1730-01A-01D-0577-01 NA NA NA NA TCGA-61-1730-01 NA NA NA TCGA-61-1730-01A-01R-0584-07 |
|
|
558 |
TCGA-61-1733-01 0 TCGA-61-1733-01 967 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-61-1733 NA NA days 967 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-61-1733-F28163 TCGA-61-1733 TCGA-61-1733-01A Stage IIIC -26180 NA NA 0 967 NA 175 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA YES G3 Recurrence NA NA NA NA TCGA-61-1733.bc4e6e92-d716-4ab3-8459-4f339caecffd.pdf 1733 NA WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.2 NA NA 61 No Macroscopic disease Ovary YES A LIVING 2006 TCGA-61-1733-01 TCGA-61-1733-01 NA dd206c0f-dd03-40ee-ad76-e6b3bf84ffc8 NA TCGA-61-1733-01 NA TCGA-61-1733-01A-01D-0581-05 NA TCGA-61-1733-01A-21-1559-20 TCGA-61-1733-01A-01W-0639-09 e6f856bf-0694-4c21-aecc-0d8dd54761f1 TCGA-61-1733-01A-01D-0577-01 TCGA-61-1733-01 1b2390f5-f59e-4c94-8586-35b620e0dc4d NA TCGA-61-1733-01A-01D-0577-01 e6f856bf-0694-4c21-aecc-0d8dd54761f1 NA e6f856bf-0694-4c21-aecc-0d8dd54761f1 NA TCGA-61-1733-01 TCGA-61-1733-01 e6f856bf-0694-4c21-aecc-0d8dd54761f1 NA TCGA-61-1733-01A-01R-0584-07 |
|
|
559 |
TCGA-61-1734-01 0 TCGA-61-1734-01 866 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-1734 NA NA days 866 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Bilateral TCGA-61-1734-F28171 TCGA-61-1734 TCGA-61-1734-01B Stage IC -19026 NA NA 0 866 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA YES G3 NA NA NA NA NA TCGA-61-1734.32d02aa2-1c81-417b-87a8-a5ed4035f5c0.pdf 1734 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 61 NA Ovary YES B LIVING 2006 NA NA NA b3b6480c-a96b-44c5-9590-e0659b2fc9ad NA NA NA TCGA-61-1734-01B-01D-0667-05 NA TCGA-61-1734-01B-21-1559-20 NA NA TCGA-61-1734-01B-01D-0663-01 TCGA-61-1734-01 8d84c559-ee21-4b79-a879-99d3bc6a624e NA TCGA-61-1734-01B-01D-0663-01 NA NA NA NA TCGA-61-1734-01 NA NA NA TCGA-61-1734-01B-01R-0670-07 |
|
|
560 |
TCGA-61-1736-01 1 TCGA-61-1736-01 1484 1 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-61-1736 NA NA days 1484 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Bilateral TCGA-61-1736-F28175 TCGA-61-1736 TCGA-61-1736-01B Stage IIIC -16613 NA 1484 0 1484 NA 764 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Excisional Biopsy NA 0.8 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-61-1736.c034e484-683b-463c-999d-eb1fd9741292.pdf 1736 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 NA Ovary YES B DECEASED 2005 TCGA-61-1736-01 TCGA-61-1736-01 NA 4f3d65e1-2001-48dc-bded-b8dd0a949c2c NA TCGA-61-1736-01 NA TCGA-61-1736-01B-01D-0667-05 NA TCGA-61-1736-01B-21-1559-20 NA 89f1ae39-c387-4dff-be38-e3b7265222bb TCGA-61-1736-01B-01D-0663-01 TCGA-61-1736-01 de7da1bd-3d13-495a-a931-5ae952aa5ea3 NA TCGA-61-1736-01B-01D-0663-01 89f1ae39-c387-4dff-be38-e3b7265222bb NA 89f1ae39-c387-4dff-be38-e3b7265222bb TCGA-61-1736-01B-01W-0722-08 TCGA-61-1736-01 TCGA-61-1736-01 89f1ae39-c387-4dff-be38-e3b7265222bb TCGA-61-1736-01B-01W-0722-08 TCGA-61-1736-01B-01R-0670-07 |
|
|
561 |
TCGA-61-1737-01 0 TCGA-61-1737-01 1364 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 5 NA TCGA-61-1737 NA NA days 1364 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 42 Bilateral TCGA-61-1737-F28182 TCGA-61-1737 TCGA-61-1737-01A Stage IV -15515 NA NA 0 1364 NA NA NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.3 NO NA 0.7 NA YES G3 NA NA NA NA NA TCGA-61-1737.2fa09bf8-8be5-411c-a9cf-16c12ed1390f.pdf 1737 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.2 NA NA 61 1-10 mm Ovary YES A LIVING 2005 TCGA-61-1737-01 TCGA-61-1737-01 NA 478e4825-4983-4315-aeda-12145a87f92b NA TCGA-61-1737-01 NA TCGA-61-1737-01A-01D-0581-05 NA NA TCGA-61-1737-01A-01W-0639-09 b442230a-d330-45da-adf7-76873d18645c TCGA-61-1737-01A-01D-0577-01 TCGA-61-1737-01 NA NA TCGA-61-1737-01A-01D-0577-01 b442230a-d330-45da-adf7-76873d18645c NA b442230a-d330-45da-adf7-76873d18645c NA TCGA-61-1737-01 TCGA-61-1737-01 b442230a-d330-45da-adf7-76873d18645c NA TCGA-61-1737-01A-01R-0584-07 |
|
|
562 |
TCGA-61-1738-01 1 TCGA-61-1738-01 1089 1 days High C9-OV UCEC Serous c4 BRCA basal-like c6 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-61-1738 NA NA days 1089 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 60 Right TCGA-61-1738-F28190 TCGA-61-1738 TCGA-61-1738-01A Stage IIIC -21965 NA 1089 0 1089 NA 276 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.2 NA YES G3 Recurrence NA NA NA NA TCGA-61-1738.05898c76-9832-4724-ada5-ff47eb3838b5.pdf 1738 NA WITH TUMOR YES Progressive Disease Imaging Study NO NA Primary Tumor 01 0.2 NA NA 61 1-10 mm Ovary YES A DECEASED 2005 TCGA-61-1738-01 TCGA-61-1738-01 NA 4c4af8bd-a614-4875-bdb5-4e8c64c4d134 NA TCGA-61-1738-01 NA TCGA-61-1738-01A-01D-0581-05 NA TCGA-61-1738-01A-21-1559-20 TCGA-61-1738-01A-01W-0639-09 1ca9af90-a8db-4f7e-b17a-0bf32fed98c7 TCGA-61-1738-01A-01D-0577-01 TCGA-61-1738-01 3fed489e-8243-43c5-8ca2-37979d540d22 NA TCGA-61-1738-01A-01D-0577-01 1ca9af90-a8db-4f7e-b17a-0bf32fed98c7 NA 1ca9af90-a8db-4f7e-b17a-0bf32fed98c7 NA TCGA-61-1738-01 TCGA-61-1738-01 1ca9af90-a8db-4f7e-b17a-0bf32fed98c7 NA TCGA-61-1738-01A-01R-0584-07 |
|
|
563 |
TCGA-61-1740-01 1 TCGA-61-1740-01 74 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 2 NA TCGA-61-1740 NA NA days 74 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 71 Right TCGA-61-1740-F28198 TCGA-61-1740 TCGA-61-1740-01A Stage IIIC -26169 NA 74 0 74 NA NA 3 NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.6 NA YES G3 NA NA NA NA NA TCGA-61-1740.b87690ba-0cd2-458e-938f-553cd5ab6d84.pdf 1740 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.3 NA NA 61 >20 mm Ovary YES A DECEASED 2005 TCGA-61-1740-01 TCGA-61-1740-01 NA 7e650317-6bd3-4ad9-b4ad-47178983707c NA TCGA-61-1740-01 NA TCGA-61-1740-01A-01D-0581-05 NA TCGA-61-1740-01A-21-1559-20 TCGA-61-1740-01A-01W-0639-09 e7825482-380d-4323-a4fb-d11b365c7073 TCGA-61-1740-01A-01D-0577-01 TCGA-61-1740-01 3349b819-24fe-404f-a480-0e94ed56a1cd NA TCGA-61-1740-01A-01D-0577-01 e7825482-380d-4323-a4fb-d11b365c7073 NA e7825482-380d-4323-a4fb-d11b365c7073 NA TCGA-61-1740-01 TCGA-61-1740-01 e7825482-380d-4323-a4fb-d11b365c7073 NA TCGA-61-1740-01A-01R-0584-07 |
|
|
564 |
TCGA-61-1741-01 1 TCGA-61-1741-01 1024 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 3 NA TCGA-61-1741 NA NA days 1024 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 76 Bilateral TCGA-61-1741-F28201 TCGA-61-1741 TCGA-61-1741-01A Stage IIIB -27762 NA 1024 0 1024 NA 488 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NA G3 Recurrence NA NA NA NA TCGA-61-1741.e2d0ec41-559c-48d4-8c4d-59e0f9d48823.pdf 1741 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 >20 mm Ovary NO A DECEASED 2004 TCGA-61-1741-01 TCGA-61-1741-01 NA fba783f9-28fc-41c2-b82a-1fcc55d19941 NA TCGA-61-1741-01 NA TCGA-61-1741-01A-02D-0581-05 NA TCGA-61-1741-01A-11-1563-20 TCGA-61-1741-01A-02W-0639-09 92d5764e-c576-47cd-a6bd-68ed0365c213 TCGA-61-1741-01A-02D-0577-01 TCGA-61-1741-01 4da87c92-0d8f-4475-b5c8-332329e3d7b2 NA TCGA-61-1741-01A-02D-0577-01 92d5764e-c576-47cd-a6bd-68ed0365c213 NA 92d5764e-c576-47cd-a6bd-68ed0365c213 NA TCGA-61-1741-01 TCGA-61-1741-01 92d5764e-c576-47cd-a6bd-68ed0365c213 NA TCGA-61-1741-01A-02R-0584-07 |
|
|
565 |
TCGA-61-1743-01 1 TCGA-61-1743-01 1329 1 days High C9-OV OV-like c1 BRCA basal-like c6 OV-like c16 miRNA cluster 1 cluster 1 NA TCGA-61-1743 NA NA days 1329 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NO 53 Bilateral TCGA-61-1743-F28209 TCGA-61-1743 TCGA-61-1743-01A Stage IIC -19365 NA 1329 0 1329 NA 809 NA NA NA 2009-6-2 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G2 Recurrence NA NA NA NA TCGA-61-1743.190b258b-d756-4872-b5f4-53c2d10e86b1.pdf 1743 NA WITH TUMOR YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 61 No Macroscopic disease Ovary NA A DECEASED 2004 TCGA-61-1743-01 TCGA-61-1743-01 NA 5e99b999-2c02-4a1b-97b6-176afa3edfb3 NA TCGA-61-1743-01 NA TCGA-61-1743-01A-01D-0652-05 NA TCGA-61-1743-01A-21-1559-20 NA f3277084-b0a8-43df-946e-dc792bbb8cdb TCGA-61-1743-01A-01D-0648-01 TCGA-61-1743-01 a6fffcf6-69f4-4c40-b183-a0345dacff1a NA TCGA-61-1743-01A-01D-0648-01 f3277084-b0a8-43df-946e-dc792bbb8cdb NA f3277084-b0a8-43df-946e-dc792bbb8cdb NA TCGA-61-1743-01 TCGA-61-1743-01 f3277084-b0a8-43df-946e-dc792bbb8cdb NA TCGA-61-1743-01A-01R-0655-07 |
|
|
566 |
TCGA-61-1895-01 0 TCGA-61-1895-01 44 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-61-1895 NA NA days 44 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 52 Bilateral TCGA-61-1895-F28213 TCGA-61-1895 TCGA-61-1895-01A Stage IIIB -19060 NA NA 0 44 NA NA NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.1 NA YES G3 NA NA NA NA NA TCGA-61-1895.b33d3a26-d864-4669-b06e-1335be4e9e3a.pdf 1895 NA TUMOR FREE YES Stable Disease NA NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary YES A LIVING 2009 NA TCGA-61-1895-01 NA 7ca1db65-98e8-471a-81d5-063d6c3c3a0c NA TCGA-61-1895-01 NA TCGA-61-1895-01A-01D-0581-05 NA TCGA-61-1895-01A-21-1559-20 TCGA-61-1895-01A-01W-0639-09 NA TCGA-61-1895-01A-01D-0577-01 TCGA-61-1895-01 9525c377-b25f-422f-8da7-60319fc43d79 NA TCGA-61-1895-01A-01D-0577-01 NA NA NA NA TCGA-61-1895-01 NA NA NA TCGA-61-1895-01A-01R-0584-07 |
|
|
567 |
TCGA-61-1899-01 0 TCGA-61-1899-01 256 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-61-1899 NA NA days 256 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 81 Left TCGA-61-1899-F28217 TCGA-61-1899 TCGA-61-1899-01A Stage IIIC -29692 NA NA 0 256 NA NA NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-61-1899.0b416e24-55c4-4235-b56b-9dc1507ee5ef.pdf 1899 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary NO A LIVING 2008 NA TCGA-61-1899-01 NA 06aa647b-fe58-4a63-976b-9bd171297b87 NA TCGA-61-1899-01 NA TCGA-61-1899-01A-01D-0581-05 NA TCGA-61-1899-01A-21-1559-20 TCGA-61-1899-01A-01W-0639-09 NA TCGA-61-1899-01A-01D-0577-01 TCGA-61-1899-01 fdb5929a-eedd-48b3-9938-5d08ac8ba4fc NA TCGA-61-1899-01A-01D-0577-01 NA NA NA NA TCGA-61-1899-01 NA NA NA TCGA-61-1899-01A-01R-0584-07 |
|
|
568 |
TCGA-61-1900-01 0 TCGA-61-1900-01 176 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-61-1900 NA NA days 176 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-61-1900-F28221 TCGA-61-1900 TCGA-61-1900-01A Stage IIIB -18963 NA NA 0 176 NA NA NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.9 NO NA 1.5 NA NO G3 NA NA NA NA NA TCGA-61-1900.b0dd202d-16dc-42ec-ad83-6f02b37b919f.pdf 1900 NA TUMOR FREE YES Stable Disease NA NO NA Primary Tumor 01 0.6 NA NA 61 No Macroscopic disease Ovary NO A LIVING 2008 TCGA-61-1900-01 TCGA-61-1900-01 NA c5d1eb0e-d7a4-49e1-9a07-1abe99e33881 NA TCGA-61-1900-01 NA TCGA-61-1900-01A-01D-0581-05 NA TCGA-61-1900-01A-21-1559-20 TCGA-61-1900-01A-01W-0639-09 92adf6a1-4880-4ee4-8ebe-09a943dbfe04 TCGA-61-1900-01A-01D-0577-01 TCGA-61-1900-01 c3a92cba-410a-4853-8bae-4bec74b693d7 NA TCGA-61-1900-01A-01D-0577-01 92adf6a1-4880-4ee4-8ebe-09a943dbfe04 NA 92adf6a1-4880-4ee4-8ebe-09a943dbfe04 NA TCGA-61-1900-01 TCGA-61-1900-01 92adf6a1-4880-4ee4-8ebe-09a943dbfe04 NA TCGA-61-1900-01A-01R-0584-07 |
|
|
569 |
TCGA-61-1901-01 1 TCGA-61-1901-01 347 1 days Squamous NA OV-like c1 NA NA miRNA cluster 1 cluster 6 NA TCGA-61-1901 NA NA days 347 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 65 Bilateral TCGA-61-1901-F28226 TCGA-61-1901 NA Stage IV -24042 NA 347 0 347 NA 329 NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA YES G3 Progression of Disease NA NA NA NA NA 1901 NA WITH TUMOR YES Stable Disease Imaging Study NO NA Primary Tumor 01 NA NA NA 61 NA Ovary YES NA DECEASED 2008 NA TCGA-61-1901-01 NA e34c17f8-b6a2-4c24-bba7-d9548a0cca89 NA TCGA-61-1901-01 NA TCGA-61-1901-01A-01D-0581-05 NA NA TCGA-61-1901-01A-01W-0639-09 NA TCGA-61-1901-01A-01D-0577-01 TCGA-61-1901-01 NA NA TCGA-61-1901-01A-01D-0577-01 NA NA NA NA TCGA-61-1901-01 NA NA NA TCGA-61-1901-01A-01R-0584-07 |
|
|
570 |
TCGA-61-1903-01 0 TCGA-61-1903-01 396 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-1903 NA NA days 396 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Bilateral TCGA-61-1903-F28231 TCGA-61-1903 TCGA-61-1903-01A Stage IB -20381 NA NA 0 396 NA NA NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NO G3 NA NA NA NA NA TCGA-61-1903.879ac4e3-cb0d-4fcb-a51d-8cbc6ad0c4a0.pdf 1903 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 61 NA Ovary NO A LIVING 2007 NA NA NA 9bcc6171-29ca-40b3-880a-2e3e95a95f94 NA NA NA TCGA-61-1903-01A-01D-0581-05 NA TCGA-61-1903-01A-21-1559-20 TCGA-61-1903-01A-01W-0639-09 NA TCGA-61-1903-01A-01D-0577-01 TCGA-61-1903-01 57c3b3e8-b200-43e1-9f63-f7e0f872ca8c NA TCGA-61-1903-01A-01D-0577-01 NA NA NA NA TCGA-61-1903-01 NA NA NA TCGA-61-1903-01A-01R-0584-07 |
|
|
571 |
TCGA-61-1904-01 0 TCGA-61-1904-01 276 0 days High NA OV-like c1 NA NA NA NA NA TCGA-61-1904 NA NA days 276 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Bilateral TCGA-61-1904-F28236 TCGA-61-1904 NA Stage IIIC -22009 NA NA 0 276 NA NA NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NO G3 NA NA NA NA NA NA 1904 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 61 1-10 mm Ovary NO NA LIVING 2007 NA NA NA ac3f73b4-4953-4836-8834-43729c647ac3 NA NA NA TCGA-61-1904-01A-01D-0581-05 NA NA TCGA-61-1904-01A-01W-0639-09 NA TCGA-61-1904-01A-01D-0577-01 TCGA-61-1904-01 NA NA TCGA-61-1904-01A-01D-0577-01 NA NA NA NA TCGA-61-1904-01 NA NA NA TCGA-61-1904-01A-01R-0584-07 |
|
|
572 |
TCGA-61-1906-01 1 TCGA-61-1906-01 1038 1 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 NA TCGA-61-1906 NA NA days 1038 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Bilateral TCGA-61-1906-F28240 TCGA-61-1906 TCGA-61-1906-01A Stage IIIC -20378 NA 1038 0 1038 NA 236 NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-61-1906.a540b6e3-4a34-4546-a91a-a6bcd09921bd.pdf 1906 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 61 11-20 mm Ovary YES A DECEASED 2006 NA TCGA-61-1906-01 NA 9e164e07-0887-4e9d-8e54-92e2b9621257 NA TCGA-61-1906-01 NA TCGA-61-1906-01A-01D-0581-05 NA TCGA-61-1906-01A-21-1559-20 TCGA-61-1906-01A-01W-0639-09 NA TCGA-61-1906-01A-01D-0577-01 TCGA-61-1906-01 f3b04ec3-bd80-437b-be87-aa7b75249821 NA TCGA-61-1906-01A-01D-0577-01 NA NA NA NA TCGA-61-1906-01 NA NA NA TCGA-61-1906-01A-01R-0584-07 |
|
|
573 |
TCGA-61-1907-01 0 TCGA-61-1907-01 952 0 days Squamous C9-OV OV-like c1 UCEC-like c5 OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-61-1907 NA NA days 952 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Bilateral TCGA-61-1907-F28250 TCGA-61-1907 TCGA-61-1907-01A Stage IIIC -23204 NA NA 0 952 NA 743 NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.9 NO NA 1.6 NA NA G3 Recurrence NA NA NA NA TCGA-61-1907.ae7e4795-496e-47d0-ad60-cec04e5876b0.pdf 1907 NA WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.4 NA NA 61 11-20 mm Ovary YES A LIVING 2006 TCGA-61-1907-01 TCGA-61-1907-01 NA 429e7e1a-3ded-46a3-9eee-aa048cbfade2 NA TCGA-61-1907-01 NA TCGA-61-1907-01A-01D-0581-05 NA TCGA-61-1907-01A-21-1559-20 TCGA-61-1907-01A-01W-0639-09 6d9a1fe4-7131-487c-a7ff-0cf8a53919ed TCGA-61-1907-01A-01D-0577-01 TCGA-61-1907-01 2356261e-fe60-47da-9f8e-c06bfe510a03 NA TCGA-61-1907-01A-01D-0577-01 6d9a1fe4-7131-487c-a7ff-0cf8a53919ed NA 6d9a1fe4-7131-487c-a7ff-0cf8a53919ed NA TCGA-61-1907-01 TCGA-61-1907-01 6d9a1fe4-7131-487c-a7ff-0cf8a53919ed NA TCGA-61-1907-01A-01R-0584-07 |
|
|
574 |
TCGA-61-1910-01 0 TCGA-61-1910-01 1127 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 6 NA TCGA-61-1910 NA NA days 1127 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 56 Bilateral TCGA-61-1910-F28256 TCGA-61-1910 TCGA-61-1910-01A Stage IIC -20779 NA NA 0 1127 NA NA NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.5 NA YES G3 NA NA NA NA NA TCGA-61-1910.32905714-6e41-4df8-91dd-6d3068475b40.pdf 1910 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 61 1-10 mm Ovary YES A LIVING 2006 TCGA-61-1910-01 TCGA-61-1910-01 NA e61d1b4c-7a8a-431c-bef5-1be42deda0c1 NA TCGA-61-1910-01 NA TCGA-61-1910-01A-01D-0581-05 NA TCGA-61-1910-01A-21-1559-20 TCGA-61-1910-01A-01W-0639-09 65e4e40b-f27f-4b84-9979-af659564363d TCGA-61-1910-01A-01D-0577-01 TCGA-61-1910-01 18b958a6-f51e-4fb3-a240-cfe22c05d967 NA TCGA-61-1910-01A-01D-0577-01 65e4e40b-f27f-4b84-9979-af659564363d NA 65e4e40b-f27f-4b84-9979-af659564363d NA TCGA-61-1910-01 TCGA-61-1910-01 65e4e40b-f27f-4b84-9979-af659564363d NA TCGA-61-1910-01A-01R-0584-07 |
|
|
575 |
TCGA-61-1911-01 0 TCGA-61-1911-01 1293 0 days High NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 2 NA TCGA-61-1911 NA NA days 1293 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 55 Left TCGA-61-1911-F28260 TCGA-61-1911 TCGA-61-1911-01A Stage IIA -20144 NA NA 0 1293 NA 844 NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 2 NA YES G3 Recurrence NA NA NA NA TCGA-61-1911.ba6325b4-af61-42cc-b84c-aacee9d7ecc8.pdf 1911 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 NA Ovary YES A LIVING 2005 NA TCGA-61-1911-01 NA 70685d12-f206-43bd-bc6d-1954ffa1b600 NA TCGA-61-1911-01 NA TCGA-61-1911-01A-01D-0581-05 NA TCGA-61-1911-01A-21-1559-20 TCGA-61-1911-01A-01W-0639-09 NA TCGA-61-1911-01A-01D-0577-01 TCGA-61-1911-01 18959b13-60ff-43b5-8f53-acee023d775a NA TCGA-61-1911-01A-01D-0577-01 NA NA NA NA TCGA-61-1911-01 NA NA NA TCGA-61-1911-01A-01R-0584-07 |
|
|
576 |
TCGA-61-1913-01 0 TCGA-61-1913-01 1488 0 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-61-1913 NA NA days 1488 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Right TCGA-61-1913-F28269 TCGA-61-1913 TCGA-61-1913-01A Stage IIIB -17575 NA NA 0 1488 NA NA NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.1 NA NA G3 NA NA NA NA NA TCGA-61-1913.b789ee6d-d1e2-4836-8bdc-3c59b0729ee1.pdf 1913 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 61 1-10 mm Ovary YES A LIVING 2005 NA TCGA-61-1913-01 NA 7b569b43-ae4c-4611-8852-1e8213c1d7ae NA TCGA-61-1913-01 NA TCGA-61-1913-01A-01D-0581-05 NA TCGA-61-1913-01A-21-1559-20 TCGA-61-1913-01A-01W-0639-09 NA TCGA-61-1913-01A-01D-0577-01 TCGA-61-1913-01 a97ee569-979a-4d19-bf30-61dd734ed78d NA TCGA-61-1913-01A-01D-0577-01 NA NA NA NA TCGA-61-1913-01 NA NA NA TCGA-61-1913-01A-01R-0584-07 |
|
|
577 |
TCGA-61-1914-01 0 TCGA-61-1914-01 1722 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 1 NA TCGA-61-1914 NA NA days 1722 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-61-1914-F28273 TCGA-61-1914 TCGA-61-1914-01A Stage IIIC -23850 NA NA 0 1722 NA 1674 NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA YES G3 Recurrence NA NA NA NA TCGA-61-1914.b634b2cf-9e8d-4dd4-8442-337c22522a43.pdf 1914 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 >20 mm Ovary YES A LIVING 2003 TCGA-61-1914-01 TCGA-61-1914-01 NA 32a0bd09-8cc4-46e6-a36d-67478fab51fc NA TCGA-61-1914-01 NA TCGA-61-1914-01A-01D-0581-05 NA TCGA-61-1914-01A-21-1559-20 TCGA-61-1914-01A-01W-0639-09 0d75483f-eab3-41c8-b2cc-453af29b6f44 TCGA-61-1914-01A-01D-0577-01 TCGA-61-1914-01 7497a274-7ee4-423f-a0bd-59afb02a305e NA TCGA-61-1914-01A-01D-0577-01 0d75483f-eab3-41c8-b2cc-453af29b6f44 NA 0d75483f-eab3-41c8-b2cc-453af29b6f44 NA TCGA-61-1914-01 TCGA-61-1914-01 0d75483f-eab3-41c8-b2cc-453af29b6f44 NA TCGA-61-1914-01A-01R-0584-07 |
|
|
578 |
TCGA-61-1915-01 0 TCGA-61-1915-01 2061 0 days Squamous NA OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 4 NA TCGA-61-1915 NA NA days 2061 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 50 Bilateral TCGA-61-1915-F28280 TCGA-61-1915 TCGA-61-1915-01A Stage IIC -18424 NA NA 0 2061 NA NA NA NA NA 2009-10-1 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1 NA NA G3 NA NA NA NA NA TCGA-61-1915.1c305700-d86f-449a-a556-02f32484dda1.pdf 1915 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 61 NA Ovary YES A LIVING 2003 NA TCGA-61-1915-01 NA 4c9b5377-7e2c-4a97-9663-3ff18822053c NA TCGA-61-1915-01 NA TCGA-61-1915-01A-01D-0581-05 NA TCGA-61-1915-01A-21-1559-20 TCGA-61-1915-01A-01W-0639-09 NA TCGA-61-1915-01A-01D-0577-01 TCGA-61-1915-01 407fd5a4-3e13-42c6-9f10-424562adfee5 NA TCGA-61-1915-01A-01D-0577-01 NA NA NA NA TCGA-61-1915-01 NA NA NA TCGA-61-1915-01A-01R-0584-07 |
|
|
579 |
TCGA-61-1916-01 1 TCGA-61-1916-01 475 1 days Quiet NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-1916 NA NA days 475 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 53 Bilateral TCGA-61-1916-F28284 TCGA-61-1916 NA Stage IIIC -19463 NA 475 0 475 NA 326 NA NA NA 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8461/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NA NA NA G2 Recurrence NA NA NA NA NA 1916 NA NA YES NA NA NO R1 Primary Tumor 01 NA NA NA 61 1-10 mm Ovary YES NA DECEASED 2002 NA NA NA aab4f5cd-7169-41e6-ae24-2bddbd752f62 NA NA NA TCGA-61-1916-01A-01D-0807-05 NA TCGA-61-1916-01A-21-1559-20 NA NA NA TCGA-61-1916-01 e7b8ce5d-a28b-44c9-8b3a-d52882fce319 NA NA NA NA NA NA NA NA NA NA TCGA-61-1916-01A-01R-0810-07 |
|
|
580 |
TCGA-61-1916-02 1 TCGA-61-1916-02 475 1 days NA NA OV-like c1 NA NA NA NA NA TCGA-61-1916 NA NA days 475 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 53 Bilateral TCGA-61-1916-F28284 TCGA-61-1916 TCGA-61-1916-02A Stage IIIC -19463 NA 475 0 475 NA 326 NA NA NA 2010-2-26 FEMALE Serous Cystadenocarcinoma No C56.9 8461/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.3 NO NA 1.8 NA NA G2 Recurrence NA NA NA NA TCGA-61-1916.C85D2BF7-498B-4E17-9F13-899AC8D6EC88.pdf 1916 NA NA YES NA NA NO R1 Recurrent Tumor 02 0.3 NA NA 61 1-10 mm Ovary YES A DECEASED 2002 NA NA NA 6490d8bc-620c-45d2-9314-97ec1b52e4d0 NA NA NA TCGA-61-1916-02A-01D-0807-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-61-1916-02A-01R-0810-07 |
|
|
581 |
TCGA-61-1917-01 1 TCGA-61-1917-01 1321 1 days High NA OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 NA TCGA-61-1917 NA NA days 1321 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 60 Bilateral TCGA-61-1917-F28290 TCGA-61-1917 TCGA-61-1917-01A Stage IIIB -21972 NA 1321 0 1321 NA NA NA NA NA 2009-11-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 2 NA NA G3 NA NA NA NA NA TCGA-61-1917.ebb81051-f181-4878-85ac-7e00ad6aca85.pdf 1917 NA NA YES Complete Remission/Response NA NO NA Primary Tumor 01 0.1 NA NA 61 NA Ovary NO A DECEASED 2002 TCGA-61-1917-01 TCGA-61-1917-01 NA 5005b439-42ac-4dc7-aa13-3817d6091536 NA TCGA-61-1917-01 NA TCGA-61-1917-01A-01D-0652-05 NA NA NA 519aea8b-5e08-47b2-bb98-b311f2dba540 TCGA-61-1917-01A-01D-0648-01 TCGA-61-1917-01 NA NA TCGA-61-1917-01A-01D-0648-01 519aea8b-5e08-47b2-bb98-b311f2dba540 NA 519aea8b-5e08-47b2-bb98-b311f2dba540 NA TCGA-61-1917-01 TCGA-61-1917-01 519aea8b-5e08-47b2-bb98-b311f2dba540 NA TCGA-61-1917-01A-01R-0655-07 |
|
|
582 |
TCGA-61-1918-01 1 TCGA-61-1918-01 479 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 NA TCGA-61-1918 NA NA days 479 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 45 Bilateral TCGA-61-1918-F28295 TCGA-61-1918 TCGA-61-1918-01A Stage IV -16689 NA 479 0 479 NA 413 NA NA NA 2009-11-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-61-1918.6c95bd12-e871-4e4e-961f-09a64c1fe2de.pdf 1918 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary YES A DECEASED 2002 TCGA-61-1918-01 TCGA-61-1918-01 NA 5f2955fc-dc80-4ce8-93d6-6db708af6ea4 NA TCGA-61-1918-01 NA TCGA-61-1918-01A-01D-0652-05 NA TCGA-61-1918-01A-21-1559-20 NA 62f75d97-ea9e-4694-8c83-1a0e6d137a02 TCGA-61-1918-01A-01D-0648-01 TCGA-61-1918-01 8c7cf533-1039-4e1a-9a0a-83c8d8c2e597 NA TCGA-61-1918-01A-01D-0648-01 62f75d97-ea9e-4694-8c83-1a0e6d137a02 NA 62f75d97-ea9e-4694-8c83-1a0e6d137a02 NA TCGA-61-1918-01 TCGA-61-1918-01 62f75d97-ea9e-4694-8c83-1a0e6d137a02 NA TCGA-61-1918-01A-01R-0655-07 |
|
|
583 |
TCGA-61-1919-01 1 TCGA-61-1919-01 1161 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-61-1919 NA NA days 1161 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 58 Bilateral TCGA-61-1919-F28300 TCGA-61-1919 TCGA-61-1919-01A Stage IIIC -21199 NA 1161 0 1161 NA 439 NA NA NA 2009-11-30 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.5 NA NA G2 Recurrence NA NA NA NA TCGA-61-1919.240a49a3-b611-4949-b3b9-3799d8c0dc46.pdf 1919 NA NA YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 61 NA Ovary NA A DECEASED 2001 TCGA-61-1919-01 TCGA-61-1919-01 NA e2935fb6-7c83-4691-b144-029cd17eadac NA TCGA-61-1919-01 NA TCGA-61-1919-01A-01D-0652-05 NA TCGA-61-1919-01A-21-1559-20 NA 056cca38-92df-42ff-b064-b0c243f8a82f TCGA-61-1919-01A-01D-0648-01 TCGA-61-1919-01 278e1675-c8e6-4578-b83d-4cd82de93d4b NA TCGA-61-1919-01A-01D-0648-01 056cca38-92df-42ff-b064-b0c243f8a82f NA 056cca38-92df-42ff-b064-b0c243f8a82f NA TCGA-61-1919-01 TCGA-61-1919-01 056cca38-92df-42ff-b064-b0c243f8a82f TCGA-61-1919-01A-01W-0699-08 TCGA-61-1919-01A-01R-0655-07 |
|
|
584 |
TCGA-61-1995-01 0 TCGA-61-1995-01 61 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 13 TCGA-61-1995 NA NA days 61 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 43 Bilateral TCGA-61-1995-F28302 TCGA-61-1995 TCGA-61-1995-01A Stage IIIC -16016 NA NA 0 61 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 1.1 NA YES G3 NA NA NA NA NA TCGA-61-1995.5ea6d43b-376d-43cb-873f-c33ec814a95d.pdf 1995 NA WITH TUMOR YES Stable Disease NA NO NA Primary Tumor 01 0.2 NA NA 61 1-10 mm Ovary YES A LIVING 2009 TCGA-61-1995-01 TCGA-61-1995-01 NA 180584fa-7aa6-4182-b57b-4e02365663e1 NA TCGA-61-1995-01 NA TCGA-61-1995-01A-01D-0667-05 NA TCGA-61-1995-01A-21-1559-20 NA 13b2c972-c6ef-4d1f-8ada-f831d2606023 TCGA-61-1995-01A-01D-0663-01 TCGA-61-1995-01 1bdc5555-06ec-496c-ac44-b8847ca95fb5 NA TCGA-61-1995-01A-01D-0663-01 13b2c972-c6ef-4d1f-8ada-f831d2606023 NA 13b2c972-c6ef-4d1f-8ada-f831d2606023 TCGA-61-1995-01A-01W-0722-08 TCGA-61-1995-01 TCGA-61-1995-01 13b2c972-c6ef-4d1f-8ada-f831d2606023 TCGA-61-1995-01A-01W-0722-08 TCGA-61-1995-01A-01R-0670-07 |
|
|
585 |
TCGA-61-1998-01 0 TCGA-61-1998-01 168 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-61-1998 NA NA days 168 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Bilateral TCGA-61-1998-F28306 TCGA-61-1998 TCGA-61-1998-01A Stage IIIC -17855 NA NA 0 168 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1 NA YES G3 NA NA NA NA NA TCGA-61-1998.788d25c6-75c4-4c85-be93-98dec021219a.pdf 1998 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.1 NA NA 61 1-10 mm Ovary YES A LIVING 2009 TCGA-61-1998-01 TCGA-61-1998-01 NA 03f33fd8-fd9b-46b0-8291-ba92d1d32102 NA TCGA-61-1998-01 NA TCGA-61-1998-01A-01D-0667-05 NA NA NA 0814c20e-fe77-4ff9-ab5e-a8ae2f74069d TCGA-61-1998-01A-01D-0663-01 TCGA-61-1998-01 NA NA TCGA-61-1998-01A-01D-0663-01 0814c20e-fe77-4ff9-ab5e-a8ae2f74069d NA 0814c20e-fe77-4ff9-ab5e-a8ae2f74069d TCGA-61-1998-01A-01W-0722-08 TCGA-61-1998-01 TCGA-61-1998-01 0814c20e-fe77-4ff9-ab5e-a8ae2f74069d TCGA-61-1998-01A-01W-0722-08 TCGA-61-1998-01A-01R-0670-07 |
|
|
586 |
TCGA-61-2000-01 0 TCGA-61-2000-01 441 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-61-2000 NA NA days 441 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 67 Bilateral TCGA-61-2000-F28311 TCGA-61-2000 TCGA-61-2000-01A Stage IIIC -24723 NA NA 0 441 NA 339 NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA YES G3 Recurrence NA NA NA NA TCGA-61-2000.4e13b897-c34a-4422-9c66-7ca8b2734ef2.pdf 2000 NA WITH TUMOR YES Stable Disease Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary YES A LIVING 2008 TCGA-61-2000-01 TCGA-61-2000-01 NA 4150fb96-e722-40db-a6d0-d55e60cc30f6 NA TCGA-61-2000-01 NA TCGA-61-2000-01A-01D-0667-05 NA TCGA-61-2000-01A-21-1559-20 NA f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109 TCGA-61-2000-01A-01D-0663-01 TCGA-61-2000-01 c7083eed-998f-456d-b294-5fbcf50eff88 NA TCGA-61-2000-01A-01D-0663-01 f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109 NA f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109 TCGA-61-2000-01A-01W-0722-08 TCGA-61-2000-01 TCGA-61-2000-01 f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109 TCGA-61-2000-01A-01W-0722-08 TCGA-61-2000-01A-01R-0670-07 |
|
|
587 |
TCGA-61-2002-01 0 TCGA-61-2002-01 547 0 days High NA OV-like c1 NA NA miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-61-2002 NA NA days 547 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 46 Bilateral TCGA-61-2002-F28321 TCGA-61-2002 TCGA-61-2002-01A Stage IIIC -17115 NA NA 0 547 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1.2 NA YES G3 NA NA NA NA NA TCGA-61-2002.8030b8aa-9686-45b3-bf39-1889a6b8b36f.pdf 2002 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.2 NA NA 61 11-20 mm Ovary YES A LIVING 2008 TCGA-61-2002-01 TCGA-61-2002-01 NA a31ab004-2dce-4cd6-a015-88c43ca44086 NA TCGA-61-2002-01 NA TCGA-61-2002-01A-01D-0667-05 NA NA NA 14cd154a-6ea5-4ad9-92e4-72f53ee5d60b TCGA-61-2002-01A-01D-0663-01 TCGA-61-2002-01 NA NA TCGA-61-2002-01A-01D-0663-01 14cd154a-6ea5-4ad9-92e4-72f53ee5d60b NA 14cd154a-6ea5-4ad9-92e4-72f53ee5d60b TCGA-61-2002-01A-01W-0722-08 TCGA-61-2002-01 TCGA-61-2002-01 14cd154a-6ea5-4ad9-92e4-72f53ee5d60b TCGA-61-2002-01A-01W-0722-08 TCGA-61-2002-01A-01R-0670-07 |
|
|
588 |
TCGA-61-2003-01 0 TCGA-61-2003-01 122 0 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-61-2003 NA NA days 122 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 53 Bilateral TCGA-61-2003-F28327 TCGA-61-2003 TCGA-61-2003-01A Stage IIIC -19605 NA NA 0 122 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 1.4 NO NA 1.5 NA YES G2 NA NA NA NA NA TCGA-61-2003.79c66510-6e38-470f-9e91-d774665d39a6.pdf 2003 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.2 NA NA 61 1-10 mm Ovary YES A LIVING 2008 TCGA-61-2003-01 TCGA-61-2003-01 NA a878c841-59fa-4ef2-af20-dc8937f92b9b NA TCGA-61-2003-01 NA TCGA-61-2003-01A-01D-0667-05 NA TCGA-61-2003-01A-21-1559-20 NA bc200f3a-6d31-4480-8785-987f14cfa319 TCGA-61-2003-01A-01D-0663-01 TCGA-61-2003-01 379f3f36-fb28-4eb4-8c56-24c0382bf38f NA TCGA-61-2003-01A-01D-0663-01 bc200f3a-6d31-4480-8785-987f14cfa319 NA bc200f3a-6d31-4480-8785-987f14cfa319 TCGA-61-2003-01A-01W-0722-08 TCGA-61-2003-01 TCGA-61-2003-01 bc200f3a-6d31-4480-8785-987f14cfa319 TCGA-61-2003-01A-01W-0722-08 TCGA-61-2003-01A-01R-0670-07 |
|
|
589 |
TCGA-61-2008-01 0 TCGA-61-2008-01 932 0 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 6 mutation cluster 5 TCGA-61-2008 NA NA days 932 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-2008-F28334 TCGA-61-2008 TCGA-61-2008-01A Stage IIC -14791 NA NA 0 932 NA 818 NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 1.2 NA YES G2 Recurrence NA NA NA NA TCGA-61-2008.25448427-9a2c-4c36-bc9d-40a82d6e3710.pdf 2008 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary YES A LIVING 2007 TCGA-61-2008-01 TCGA-61-2008-01 NA 5df0fa21-8263-4992-a797-44e2a1981b93 NA TCGA-61-2008-01 NA TCGA-61-2008-01A-02D-0667-05 NA NA NA 10271f7f-cce6-44fd-8754-7a4beabfb394 TCGA-61-2008-01A-02D-0663-01 TCGA-61-2008-01 53527bf6-168b-469b-bbb3-d5e7640ee38a NA TCGA-61-2008-01A-02D-0663-01 10271f7f-cce6-44fd-8754-7a4beabfb394 NA 10271f7f-cce6-44fd-8754-7a4beabfb394 TCGA-61-2008-01A-02W-0722-08 TCGA-61-2008-01 TCGA-61-2008-01 10271f7f-cce6-44fd-8754-7a4beabfb394 TCGA-61-2008-01A-02W-0722-08 TCGA-61-2008-01A-02R-0670-07 |
|
|
590 |
TCGA-61-2008-02 0 TCGA-61-2008-02 932 0 days NA C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 NA mutation cluster 5 TCGA-61-2008 NA NA days 932 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-2008-F28334 TCGA-61-2008 TCGA-61-2008-02A Stage IIC -14791 NA NA 0 932 NA 818 NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.5 NO NA 2 NA YES G2 Recurrence NA NA NA NA TCGA-61-2008.614D7B6A-B3B4-4F1B-9762-0749D559247F.pdf 2008 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Recurrent Tumor 02 0.3 NA NA 61 No Macroscopic disease Ovary YES A LIVING 2007 NA TCGA-61-2008-02 NA 0d478984-a92d-491d-88e6-4a7621463012 NA TCGA-61-2008-02 NA TCGA-61-2008-02A-01D-0807-05 NA NA NA b90a4b33-cb6f-4c75-bc26-ff316ea81cce NA NA 540b245e-be19-4b26-a9fa-a4b3dd9a2975 NA NA b90a4b33-cb6f-4c75-bc26-ff316ea81cce NA b90a4b33-cb6f-4c75-bc26-ff316ea81cce NA NA NA b90a4b33-cb6f-4c75-bc26-ff316ea81cce NA TCGA-61-2008-02A-01R-0810-07 |
|
|
591 |
TCGA-61-2009-01 0 TCGA-61-2009-01 1212 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 2 TCGA-61-2009 NA NA days 1212 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 65 Bilateral TCGA-61-2009-F28341 TCGA-61-2009 TCGA-61-2009-01A Stage IIIC -23772 NA NA 0 1212 NA 101 NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2 NO NA 2 NA YES G3 Recurrence NA NA NA NA TCGA-61-2009.39de8c59-e593-47d3-932d-575a4537b4dc.pdf 2009 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.2 NA NA 61 11-20 mm Ovary YES A LIVING 2006 TCGA-61-2009-01 TCGA-61-2009-01 NA c8e01e3b-9789-4216-b771-18ac3b062a4c NA TCGA-61-2009-01 NA TCGA-61-2009-01A-01D-0667-05 NA TCGA-61-2009-01A-21-1559-20 NA b6ed2184-0885-49ba-8b00-a3e57e4e5500 TCGA-61-2009-01A-01D-0663-01 TCGA-61-2009-01 8e12e5af-19de-4c90-a0b6-da67eeb438f4 NA TCGA-61-2009-01A-01D-0663-01 b6ed2184-0885-49ba-8b00-a3e57e4e5500 NA b6ed2184-0885-49ba-8b00-a3e57e4e5500 TCGA-61-2009-01A-01W-0722-08 TCGA-61-2009-01 TCGA-61-2009-01 b6ed2184-0885-49ba-8b00-a3e57e4e5500 TCGA-61-2009-01A-01W-0722-08 TCGA-61-2009-01A-01R-0670-07 |
|
|
592 |
TCGA-61-2012-01 0 TCGA-61-2012-01 932 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 8 TCGA-61-2012 NA NA days 932 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 81 Left TCGA-61-2012-F28352 TCGA-61-2012 TCGA-61-2012-01A Stage IIC -29830 NA NA 0 932 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.6 NA YES G2 NA NA NA NA NA TCGA-61-2012.534e3236-b9e7-4b0b-a2a3-2fc3a96fac81.pdf 2012 NA NA YES NA NA YES NA Primary Tumor 01 0.4 NA NA 61 NA Ovary YES A LIVING 2006 TCGA-61-2012-01 TCGA-61-2012-01 NA 12b5e477-31d5-4ec1-ac90-989ce781c36a NA TCGA-61-2012-01 NA TCGA-61-2012-01A-01D-0667-05 NA TCGA-61-2012-01A-21-1559-20 NA 929c2bc4-4cee-4f82-b336-918fe041a588 TCGA-61-2012-01A-01D-0663-01 TCGA-61-2012-01 6eb6997b-a982-44b0-ab5a-5faaa1b0c2be NA TCGA-61-2012-01A-01D-0663-01 929c2bc4-4cee-4f82-b336-918fe041a588 NA 929c2bc4-4cee-4f82-b336-918fe041a588 TCGA-61-2012-01A-01W-0722-08 TCGA-61-2012-01 TCGA-61-2012-01 929c2bc4-4cee-4f82-b336-918fe041a588 TCGA-61-2012-01A-01W-0722-08 TCGA-61-2012-01A-01R-0670-07 |
|
|
593 |
TCGA-61-2016-01 1 TCGA-61-2016-01 36 1 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-61-2016 NA NA days 36 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-61-2016-F28357 TCGA-61-2016 TCGA-61-2016-01A Stage IIIC -18788 NA 36 0 NA NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA YES G3 NA NA NA NA NA TCGA-61-2016.1bb87fde-9ff0-4c33-a388-b655f9647407.pdf 2016 NA WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 0.1 NA NA 61 No Macroscopic disease Ovary YES A DECEASED 2006 TCGA-61-2016-01 TCGA-61-2016-01 NA 4e470958-8a7a-4a48-a609-2d7f49b49bbf NA TCGA-61-2016-01 NA TCGA-61-2016-01A-01D-0667-05 NA NA NA a391b870-b6fb-4ca8-b425-2331fceae442 TCGA-61-2016-01A-01D-0663-01 TCGA-61-2016-01 NA NA TCGA-61-2016-01A-01D-0663-01 a391b870-b6fb-4ca8-b425-2331fceae442 NA a391b870-b6fb-4ca8-b425-2331fceae442 TCGA-61-2016-01A-01W-0722-08 TCGA-61-2016-01 TCGA-61-2016-01 a391b870-b6fb-4ca8-b425-2331fceae442 TCGA-61-2016-01A-01W-0722-08 TCGA-61-2016-01A-01R-0670-07 |
|
|
594 |
TCGA-61-2017-01 0 TCGA-61-2017-01 1398 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-2017 NA NA days 1398 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 64 Bilateral TCGA-61-2017-F28359 TCGA-61-2017 TCGA-61-2017-01A Stage IIIC -23509 NA NA 0 1398 NA 1006 NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 0.8 NA NO G1 Recurrence NA NA NA NA TCGA-61-2017.b24757fc-4585-496e-b89e-f3dafac36b8b.pdf 2017 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.3 NA NA 61 1-10 mm Ovary NO A LIVING 2005 NA NA NA 7cfe4d7d-392d-4612-a29a-80ddafdfcbd0 NA NA NA TCGA-61-2017-01A-01D-0667-05 NA TCGA-61-2017-01A-21-1559-20 NA NA TCGA-61-2017-01A-01D-0663-01 TCGA-61-2017-01 62d181c0-c0fb-44b3-9837-040f5780c2ff NA TCGA-61-2017-01A-01D-0663-01 NA NA NA NA TCGA-61-2017-01 NA NA NA TCGA-61-2017-01A-01R-0670-07 |
|
|
595 |
TCGA-61-2018-01 0 TCGA-61-2018-01 1381 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-2018 NA NA days 1381 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Bilateral TCGA-61-2018-F28366 TCGA-61-2018 TCGA-61-2018-01A Stage IC -22929 NA NA 0 1381 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.9 NA NO G3 NA NA NA NA NA TCGA-61-2018.2aec8abd-7bdc-4ca3-a404-7dce57aea7c7.pdf 2018 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 61 No Macroscopic disease Ovary NO A LIVING 2005 NA NA NA a13bb1ee-868f-4891-921f-d0005ebe1ab8 NA NA NA TCGA-61-2018-01A-01D-0667-05 NA TCGA-61-2018-01A-21-1559-20 NA NA TCGA-61-2018-01A-01D-0663-01 TCGA-61-2018-01 99bf9379-737b-4b8c-9196-2c1fa0148eae NA TCGA-61-2018-01A-01D-0663-01 NA NA NA NA TCGA-61-2018-01 NA NA NA TCGA-61-2018-01A-01R-0670-07 |
|
|
596 |
TCGA-61-2087-01 0 TCGA-61-2087-01 146 0 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-2087 NA NA days 146 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 49 Left TCGA-61-2087-F28372 TCGA-61-2087 NA Stage IC -18182 NA NA 0 146 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA NO G3 NA NA NA NA NA NA 2087 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 61 No Macroscopic disease Ovary NO NA LIVING 2009 NA NA NA a60b189b-6316-4098-adc7-fefca69b803b NA NA NA TCGA-61-2087-01A-01D-0667-05 NA TCGA-61-2087-01A-21-1560-20 NA NA TCGA-61-2087-01A-01D-0663-01 TCGA-61-2087-01 b59fdd2e-4ec7-4e64-95fd-f5777ecdc89b NA TCGA-61-2087-01A-01D-0663-01 NA NA NA NA TCGA-61-2087-01 NA NA NA TCGA-61-2087-01A-01R-0670-07 |
|
|
597 |
TCGA-61-2088-01 0 TCGA-61-2088-01 145 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-61-2088 NA NA days 145 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 51 Bilateral TCGA-61-2088-F28377 TCGA-61-2088 TCGA-61-2088-01A Stage IIIC -18770 NA NA 0 145 NA NA NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.4 NA NO G3 NA NA NA NA NA TCGA-61-2088.62624308-45b6-46f3-85a0-5a4639b44bf3.pdf 2088 NA TUMOR FREE YES NA NA NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary NO A LIVING 2009 TCGA-61-2088-01 TCGA-61-2088-01 NA 9959458a-de14-4d2d-b13f-9ab2f0c88bf1 NA TCGA-61-2088-01 NA TCGA-61-2088-01A-01D-0667-05 NA TCGA-61-2088-01A-21-1560-20 NA 62fdea50-f152-4f43-9130-a93079b5e61f TCGA-61-2088-01A-01D-0663-01 TCGA-61-2088-01 2b716c21-1692-4b95-9363-0c6a23de28d6 NA TCGA-61-2088-01A-01D-0663-01 62fdea50-f152-4f43-9130-a93079b5e61f NA 62fdea50-f152-4f43-9130-a93079b5e61f NA TCGA-61-2088-01 TCGA-61-2088-01 62fdea50-f152-4f43-9130-a93079b5e61f TCGA-61-2088-01A-01W-0722-08 TCGA-61-2088-01A-01R-0670-07 |
|
|
598 |
TCGA-61-2092-01 0 TCGA-61-2092-01 1573 0 days BRCA-LUAD+ C9-OV UCEC non-CIMP c3 OV-like c4 COADREAD-like c15 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-61-2092 NA NA days 1573 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 57 Bilateral TCGA-61-2092-F28381 TCGA-61-2092 TCGA-61-2092-01A Stage IIIC -21072 NA NA 0 1573 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.2 NO NA 1.3 NA NO G3 NA NA NA NA NA TCGA-61-2092.35b4bfa3-e6a5-4b55-a7f1-bc39953422c0.pdf 2092 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary NO A LIVING 2004 TCGA-61-2092-01 TCGA-61-2092-01 NA cf1288eb-e5c8-4c90-9f83-f3bdcbd94a96 NA TCGA-61-2092-01 NA TCGA-61-2092-01A-01D-0667-05 NA TCGA-61-2092-01A-21-1560-20 NA 0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a TCGA-61-2092-01A-01D-0663-01 TCGA-61-2092-01 94487130-5cc1-4f68-beab-57c211204449 NA TCGA-61-2092-01A-01D-0663-01 0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a NA 0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a TCGA-61-2092-01A-01W-0722-08 TCGA-61-2092-01 TCGA-61-2092-01 0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a TCGA-61-2092-01A-01W-0722-08 TCGA-61-2092-01A-01R-0670-07 |
|
|
599 |
TCGA-61-2094-01 0 TCGA-61-2094-01 2182 0 days Squamous C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 2 mutation cluster 5 TCGA-61-2094 NA NA days 2182 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 63 Bilateral TCGA-61-2094-F28385 TCGA-61-2094 TCGA-61-2094-01A Stage IIIC -23273 NA NA 0 2182 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.1 NO NA 2 NA NA G3 NA NA NA NA NA TCGA-61-2094.205b0520-854c-480e-881d-89bc8cbcff75.pdf 2094 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.3 NA NA 61 NA Ovary NA A LIVING 2003 TCGA-61-2094-01 TCGA-61-2094-01 NA 1429ef11-964e-4e8b-afbb-8f38b75ad39f NA TCGA-61-2094-01 NA TCGA-61-2094-01A-01D-0667-05 NA TCGA-61-2094-01A-21-1560-20 NA c6e1c591-3225-482a-8350-112b664a37e6 TCGA-61-2094-01A-01D-0663-01 TCGA-61-2094-01 1ac0ed16-0e91-4c45-9b9d-b68ceb9940da NA TCGA-61-2094-01A-01D-0663-01 c6e1c591-3225-482a-8350-112b664a37e6 NA c6e1c591-3225-482a-8350-112b664a37e6 TCGA-61-2094-01A-01W-0722-08 TCGA-61-2094-01 TCGA-61-2094-01 c6e1c591-3225-482a-8350-112b664a37e6 TCGA-61-2094-01A-01W-0722-08 TCGA-61-2094-01A-01R-0670-07 |
|
|
600 |
TCGA-61-2095-01 1 TCGA-61-2095-01 1875 1 days Kirc+ C9-OV OV-like c1 OV-like c4 NA miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-61-2095 NA NA days 1875 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-61-2095-F28389 TCGA-61-2095 TCGA-61-2095-01A Stage IIIC -19797 NA 1875 0 NA NA 445 NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1.2 NA NA G2 Recurrence NA NA NA NA TCGA-61-2095.3e08408b-b76a-4a32-b3f1-4590459f4af8.pdf 2095 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary YES A DECEASED 2003 TCGA-61-2095-01 TCGA-61-2095-01 NA 5229ff68-9cae-49dc-aba8-757026e6e452 NA TCGA-61-2095-01 NA TCGA-61-2095-01A-01D-0667-05 NA TCGA-61-2095-01A-21-1560-20 NA 15a11ef0-5e18-44d0-ba50-73cf356b8408 TCGA-61-2095-01A-01D-0663-01 TCGA-61-2095-01 74a1f15a-05c4-4d85-a731-9a4e5281f644 NA TCGA-61-2095-01A-01D-0663-01 15a11ef0-5e18-44d0-ba50-73cf356b8408 NA 15a11ef0-5e18-44d0-ba50-73cf356b8408 TCGA-61-2095-01A-01W-0722-08 TCGA-61-2095-01 TCGA-61-2095-01 15a11ef0-5e18-44d0-ba50-73cf356b8408 TCGA-61-2095-01A-01W-0722-08 TCGA-61-2095-01A-01R-0670-07 |
|
|
601 |
TCGA-61-2095-02 1 TCGA-61-2095-02 1875 1 days NA C9-OV OV-like c1 NA NA NA NA mutation c1uster 9 TCGA-61-2095 NA NA days 1875 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 54 Bilateral TCGA-61-2095-F28389 TCGA-61-2095 TCGA-61-2095-02A Stage IIIC -19797 NA 1875 0 NA NA 445 NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.6 NA NA G2 Recurrence NA NA NA NA TCGA-61-2095.309AA9DC-F958-45C3-B596-362ADA553B8C.pdf 2095 NA WITH TUMOR YES Complete Remission/Response Imaging Study NO NA Recurrent Tumor 02 0.3 NA NA 61 No Macroscopic disease Ovary YES A DECEASED 2003 NA NA NA 9105d49a-b3ca-4453-95c7-3bb78b3e9e80 NA NA NA TCGA-61-2095-02A-01D-0807-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-61-2095-02A-01R-0810-07 |
|
|
602 |
TCGA-61-2096-01 0 TCGA-61-2096-01 1776 0 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-2096 NA NA days 1776 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 56 Right TCGA-61-2096-F28398 TCGA-61-2096 TCGA-61-2096-01A Stage IC -20663 NA NA 0 1776 NA 421 NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA NA G2 Recurrence NA NA NA NA TCGA-61-2096.9f95fe7d-4865-4ca5-bb57-9d47c388a7ed.pdf 2096 NA TUMOR FREE YES Progressive Disease Imaging Study NO NA Primary Tumor 01 0.5 NA NA 61 No Macroscopic disease Ovary NA A LIVING 2003 NA NA NA 9497f7ac-b177-401b-a063-6297f90f009c NA NA NA TCGA-61-2096-01A-01D-0667-05 NA TCGA-61-2096-01A-21-1560-20 NA NA TCGA-61-2096-01A-01D-0663-01 TCGA-61-2096-01 91b0b079-17b3-4c29-9ebd-1781ae28c86a NA TCGA-61-2096-01A-01D-0663-01 NA NA NA NA TCGA-61-2096-01 NA NA NA TCGA-61-2096-01A-01R-0670-07 |
|
|
603 |
TCGA-61-2097-01 0 TCGA-61-2097-01 1844 0 days High C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-61-2097 NA NA days 1844 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 71 Bilateral TCGA-61-2097-F28413 TCGA-61-2097 NA Stage IIC -25961 NA NA 0 1844 NA NA NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA NA NA NA NA NA YES G2 NA NA NA NA NA NA 2097 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 NA NA NA 61 1-10 mm Ovary YES NA LIVING 2003 TCGA-61-2097-01 TCGA-61-2097-01 NA c1da73c7-9f61-41b6-90a1-fdc7bbf4ecd3 NA TCGA-61-2097-01 NA TCGA-61-2097-01A-02D-0667-05 NA NA NA d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1 TCGA-61-2097-01A-02D-0663-01 TCGA-61-2097-01 NA NA TCGA-61-2097-01A-02D-0663-01 d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1 NA d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1 TCGA-61-2097-01A-02W-0722-08 TCGA-61-2097-01 TCGA-61-2097-01 d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1 TCGA-61-2097-01A-02W-0722-08 TCGA-61-2097-01A-02R-0670-07 |
|
|
604 |
TCGA-61-2098-01 0 TCGA-61-2098-01 1993 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 NA TCGA-61-2098 NA NA days 1993 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 62 Bilateral TCGA-61-2098-F28418 TCGA-61-2098 TCGA-61-2098-01A Stage IIIC -22876 NA NA 0 1993 NA NA NA NA NA 2009-12-8 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.7 NO NA 2 NA NA G2 NA NA NA NA NA TCGA-61-2098.d1c8ab49-5ba0-46c3-8205-53b4e39808b3.pdf 2098 NA TUMOR FREE YES Complete Remission/Response NA NO NA Primary Tumor 01 0.5 NA NA 61 11-20 mm Ovary NO A LIVING 2003 TCGA-61-2098-01 TCGA-61-2098-01 NA 0a007e29-e769-44ca-b0a8-465df5d46f4e NA TCGA-61-2098-01 NA TCGA-61-2098-01A-01D-0667-05 NA TCGA-61-2098-01A-21-1560-20 NA d855f86a-f302-47fb-aa9f-5977632c695a TCGA-61-2098-01A-01D-0663-01 TCGA-61-2098-01 f69ce3d8-2a32-4048-a786-50d7e153c051 NA TCGA-61-2098-01A-01D-0663-01 d855f86a-f302-47fb-aa9f-5977632c695a NA d855f86a-f302-47fb-aa9f-5977632c695a NA TCGA-61-2098-01 TCGA-61-2098-01 d855f86a-f302-47fb-aa9f-5977632c695a NA TCGA-61-2098-01A-01R-0670-07 |
|
|
605 |
TCGA-61-2101-01 1 TCGA-61-2101-01 1688 1 days High C9-OV OV-like c1 OV-like c4 NA miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-61-2101 NA NA days 1688 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Bilateral TCGA-61-2101-F28422 TCGA-61-2101 TCGA-61-2101-01A Stage IIIC -20287 NA 1688 0 NA NA NA 0 NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO 100 1.5 NA NA G2 NA NA NA NA NA TCGA-61-2101.b9d85995-85dd-4b00-b93f-3387cd018475.pdf 2101 Post-Adjuvant Therapy WITH TUMOR YES Partial Remission/Response NA NO NA Primary Tumor 01 0.4 NA NA 61 11-20 mm Ovary NA A DECEASED 1999 TCGA-61-2101-01 TCGA-61-2101-01 NA 504e1539-a518-4ef6-90b0-4ec6cd2ffbe8 NA TCGA-61-2101-01 NA TCGA-61-2101-01A-01D-0667-05 NA TCGA-61-2101-01A-21-1560-20 NA 95970bdb-e1f2-49dc-903b-c30088cef71d TCGA-61-2101-01A-01D-0663-01 TCGA-61-2101-01 c33bc4d6-607a-425b-bffd-e818b69949f8 NA TCGA-61-2101-01A-01D-0663-01 95970bdb-e1f2-49dc-903b-c30088cef71d NA 95970bdb-e1f2-49dc-903b-c30088cef71d TCGA-61-2101-01A-01W-0722-08 TCGA-61-2101-01 TCGA-61-2101-01 95970bdb-e1f2-49dc-903b-c30088cef71d TCGA-61-2101-01A-01W-0722-08 TCGA-61-2101-01A-01R-0670-07 |
|
|
606 |
TCGA-61-2102-01 1 TCGA-61-2102-01 197 1 days High C9-OV OV-like c1 KIRC-like c1 OV-like c16 miRNA cluster 2 cluster 3 mutation cluster 5 TCGA-61-2102 NA NA days 197 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 74 Right TCGA-61-2102-F28438 TCGA-61-2102 TCGA-61-2102-01A Stage IIIC -27256 NA 197 0 197 NA NA NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.5 NA NA G3 NA NA NA NA NA TCGA-61-2102.f0521e47-1cc3-4f72-9efd-3d128f57e614.pdf 2102 NA WITH TUMOR YES NA NA NO NA Primary Tumor 01 0.3 NA NA 61 NA Ovary NA A DECEASED 1999 TCGA-61-2102-01 TCGA-61-2102-01 NA 5b4f1e0c-f04d-4aa1-a794-5936189506d7 NA TCGA-61-2102-01 NA TCGA-61-2102-01A-01D-0667-05 NA TCGA-61-2102-01A-21-1560-20 NA 7ac6af79-c14a-4026-84aa-a288afcb96da TCGA-61-2102-01A-01D-0663-01 TCGA-61-2102-01 0f492d79-0174-4e9f-8693-2827ba83fd7c NA TCGA-61-2102-01A-01D-0663-01 7ac6af79-c14a-4026-84aa-a288afcb96da NA 7ac6af79-c14a-4026-84aa-a288afcb96da TCGA-61-2102-01A-01W-0722-08 TCGA-61-2102-01 TCGA-61-2102-01 7ac6af79-c14a-4026-84aa-a288afcb96da TCGA-61-2102-01A-01W-0722-08 TCGA-61-2102-01A-01R-0670-07 |
|
|
607 |
TCGA-61-2104-01 0 TCGA-61-2104-01 2338 0 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 4 mutation cluster 5 TCGA-61-2104 NA NA days 2338 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Bilateral TCGA-61-2104-F28442 TCGA-61-2104 TCGA-61-2104-01A Stage IIC -19432 NA NA 0 2338 NA 1680 NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.6 NO NA 1.5 NA NA G2 Recurrence NA NA NA NA TCGA-61-2104.38d2e115-ec9a-40e5-bfa0-30fb1db60691.pdf 2104 NA NA YES Complete Remission/Response Imaging Study NO NA Primary Tumor 01 0.4 NA NA 61 No Macroscopic disease Ovary NO A LIVING 2003 TCGA-61-2104-01 TCGA-61-2104-01 NA 28510e09-fb60-4595-802a-48b0aafc09b9 NA TCGA-61-2104-01 NA TCGA-61-2104-01A-01D-0667-05 NA TCGA-61-2104-01A-21-1560-20 NA 721a8fc8-bb54-4ec3-a19c-340c35f05280 TCGA-61-2104-01A-01D-0663-01 TCGA-61-2104-01 14d97fdf-fcf4-4471-8595-4b6b5401caf6 NA TCGA-61-2104-01A-01D-0663-01 721a8fc8-bb54-4ec3-a19c-340c35f05280 NA 721a8fc8-bb54-4ec3-a19c-340c35f05280 TCGA-61-2104-01A-01W-0722-08 TCGA-61-2104-01 TCGA-61-2104-01 721a8fc8-bb54-4ec3-a19c-340c35f05280 TCGA-61-2104-01A-01W-0722-08 TCGA-61-2104-01A-01R-0670-07 |
|
|
608 |
TCGA-61-2109-01 1 TCGA-61-2109-01 629 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 1 cluster 5 mutation cluster 5 TCGA-61-2109 NA NA days 629 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-2109-F28450 TCGA-61-2109 TCGA-61-2109-01A Stage IIIC -14900 NA 629 0 629 NA 465 NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.8 NO NA 1.7 NA NO G3 Recurrence NA NA NA NA TCGA-61-2109.c16bfe93-016f-49d4-8895-05b9055344c9.pdf 2109 NA WITH TUMOR YES NA Molecular Markers NO NA Primary Tumor 01 0.2 NA NA 61 >20 mm Ovary NO A DECEASED 1999 TCGA-61-2109-01 TCGA-61-2109-01 NA 37fc46df-f46d-462f-8761-d82c66b8a3a1 NA TCGA-61-2109-01 NA TCGA-61-2109-01A-01D-0667-05 NA TCGA-61-2109-01A-21-1560-20 NA c87ddfc3-d7a4-4704-b3cc-a19edfb63452 TCGA-61-2109-01A-01D-0663-01 TCGA-61-2109-01 d3e2505d-0838-4a9c-a626-ad04f9254dd1 NA TCGA-61-2109-01A-01D-0663-01 c87ddfc3-d7a4-4704-b3cc-a19edfb63452 NA c87ddfc3-d7a4-4704-b3cc-a19edfb63452 TCGA-61-2109-01A-01W-0722-08 TCGA-61-2109-01 TCGA-61-2109-01 c87ddfc3-d7a4-4704-b3cc-a19edfb63452 TCGA-61-2109-01A-01W-0722-08 TCGA-61-2109-01A-01R-0670-07 |
|
|
609 |
TCGA-61-2110-01 1 TCGA-61-2110-01 1354 1 days Squamous C9-OV OV-like c1 NA OV-like c16 miRNA cluster 1 cluster 3 mutation cluster 5 TCGA-61-2110 NA NA days 1354 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 56 Bilateral TCGA-61-2110-F28456 TCGA-61-2110 TCGA-61-2110-01A Stage IIIC -20718 NA 1354 0 1354 NA 213 NA NA NA 2009-12-4 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 0.4 NA NA NA Recurrence NA NA NA NA TCGA-61-2110.d7a597dc-d607-4e20-90a9-a181d6c11d17.pdf 2110 NA WITH TUMOR YES Progressive Disease First Seen At Further Surgery NO NA Primary Tumor 01 0.1 NA NA 61 No Macroscopic disease Ovary NA A DECEASED 1998 TCGA-61-2110-01 TCGA-61-2110-01 NA 8f17192c-1ecb-4f31-8df0-a6dde0b8ce96 NA TCGA-61-2110-01 NA TCGA-61-2110-01A-01D-0667-05 NA NA NA 6561cdb8-8499-41a6-8a79-ef0119e34c66 TCGA-61-2110-01A-01D-0663-01 TCGA-61-2110-01 NA NA TCGA-61-2110-01A-01D-0663-01 6561cdb8-8499-41a6-8a79-ef0119e34c66 NA 6561cdb8-8499-41a6-8a79-ef0119e34c66 TCGA-61-2110-01A-01W-0722-08 TCGA-61-2110-01 TCGA-61-2110-01 6561cdb8-8499-41a6-8a79-ef0119e34c66 TCGA-61-2110-01A-01W-0722-08 TCGA-61-2110-01A-01R-0670-07 |
|
|
610 |
TCGA-61-2111-01 0 TCGA-61-2111-01 3825 0 days Squamous C9-OV UCEC Serous c4 OV-like c4 OV-like c16 miRNA c1uster 10 cluster 5 mutation cluster 5 TCGA-61-2111 NA NA days 3825 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 61 Left TCGA-61-2111-F28467 TCGA-61-2111 TCGA-61-2111-01A Stage IV -22517 NA NA 0 3825 NA 2205 NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1.4 NO NA 1.5 NA NA G3 Recurrence NA NA NA NA TCGA-61-2111.351930bc-ac4d-468e-9fe2-ba6f16c01444.pdf 2111 NA WITH TUMOR YES Complete Remission/Response Other Method NO NA Primary Tumor 01 0.3 NA NA 61 NA Ovary NA A LIVING 1998 TCGA-61-2111-01 TCGA-61-2111-01 NA 3ee05aa8-a556-4d87-8aab-a76491d30640 NA TCGA-61-2111-01 NA TCGA-61-2111-01A-01D-0667-05 NA TCGA-61-2111-01A-21-1560-20 NA 25c0888a-25b9-4cc0-a02f-6d363a341e8f TCGA-61-2111-01A-01D-0663-01 TCGA-61-2111-01 975fb889-32f1-46e2-a558-b32d8a1b353f NA TCGA-61-2111-01A-01D-0663-01 25c0888a-25b9-4cc0-a02f-6d363a341e8f NA 25c0888a-25b9-4cc0-a02f-6d363a341e8f TCGA-61-2111-01A-01W-0722-08 TCGA-61-2111-01 TCGA-61-2111-01 25c0888a-25b9-4cc0-a02f-6d363a341e8f TCGA-61-2111-01A-01W-0722-08 TCGA-61-2111-01A-01R-0670-07 |
|
|
611 |
TCGA-61-2113-01 1 TCGA-61-2113-01 676 1 days High C9-OV OV-like c1 OV-like c4 OV-like c16 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-61-2113 NA NA days 676 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 53 Right TCGA-61-2113-F28479 TCGA-61-2113 TCGA-61-2113-01A Stage IIC -19722 NA 676 0 676 NA 291 NA NA NA 2009-12-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.8 NO NA 1.6 NA YES G3 Recurrence NA NA NA NA TCGA-61-2113.d10e1b61-73c4-4ab7-bc4b-8c7827856602.pdf 2113 NA NA YES NA NA NO NA Primary Tumor 01 0.4 NA NA 61 NA Ovary YES A DECEASED 1999 TCGA-61-2113-01 TCGA-61-2113-01 NA 9467c678-f573-4a50-83d9-ae3a0880354b NA TCGA-61-2113-01 NA TCGA-61-2113-01A-01D-0667-05 NA TCGA-61-2113-01A-21-1562-20 NA d5752594-1a2c-47c8-a40b-bffd5b6b7e71 TCGA-61-2113-01A-01D-0663-01 TCGA-61-2113-01 a8827db2-9eab-4285-bf50-ab2b9e19be57 NA TCGA-61-2113-01A-01D-0663-01 d5752594-1a2c-47c8-a40b-bffd5b6b7e71 NA d5752594-1a2c-47c8-a40b-bffd5b6b7e71 TCGA-61-2113-01A-01W-0722-08 TCGA-61-2113-01 TCGA-61-2113-01 d5752594-1a2c-47c8-a40b-bffd5b6b7e71 TCGA-61-2113-01A-01W-0722-08 TCGA-61-2113-01A-01R-0670-07 |
|
|
612 |
TCGA-61-2610-01 1 TCGA-61-2610-01 1579 1 days NA NA NA OV-like c4 NA NA NA NA TCGA-61-2610 NA NA days 1579 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Left TCGA-61-2610-F28484 TCGA-61-2610 TCGA-61-2610-01A Stage IIIC -22481 NA 1579 0 1579 NA 524 NA NA NA 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 1 NO NA 1 NA NA G3 Recurrence NA NA NA NA TCGA-61-2610.a5914371-94ab-4079-a6ea-11c79e9db4a1.pdf 2610 NA WITH TUMOR YES Stable Disease Imaging Study NO R1 Primary Tumor 01 0.4 NA NA 61 11-20 mm Ovary NA A DECEASED 1998 NA NA NA NA NA NA NA NA NA TCGA-61-2610-01A-21-20 NA NA NA NA a3cbaeb1-63e7-4818-aa6b-ce817827231b NA NA NA NA NA NA NA NA NA NA NA |
|
|
613 |
TCGA-61-2610-02 1 TCGA-61-2610-02 1579 1 days NA NA OV-like c1 NA NA NA NA NA TCGA-61-2610 NA NA days 1579 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES YES 61 Left TCGA-61-2610-F28484 TCGA-61-2610 TCGA-61-2610-02A Stage IIIC -22481 NA 1579 0 1579 NA 524 NA NA NA 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 0.6 NA NA G3 Recurrence NA NA NA NA TCGA-61-2610.361A67F5-2116-457D-988A-5B1E5D1A689B.pdf 2610 NA WITH TUMOR YES Stable Disease Imaging Study NO R1 Recurrent Tumor 02 0.3 NA NA 61 11-20 mm Ovary NA A DECEASED 1998 NA NA NA 30ed8178-1e57-4d4e-af54-ea8097a33bbe NA NA NA TCGA-61-2610-02A-01D-1138-05 NA NA TCGA-61-2610-02A-01W-1092-09 NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-61-2610-02A-01R-1141-07 |
|
|
614 |
TCGA-61-2611-02 1 TCGA-61-2611-02 483 1 days NA NA Low purity c2 NA NA NA NA NA TCGA-61-2611 NA NA days 483 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 40 Bilateral TCGA-61-2611-F28491 TCGA-61-2611 TCGA-61-2611-02A Stage IIIC -14782 NA 483 0 483 NA 383 NA NA NA 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Cytology (e.g. Peritoneal or pleural fluid) NA 0.6 NO NA 0.7 NA NA G3 Recurrence NA NA NA NA TCGA-61-2611.29965B48-14CA-467F-B825-8BC99A99544B.pdf 2611 NA WITH TUMOR YES Complete Remission/Response First Seen At Further Surgery NO R1 Recurrent Tumor 02 0.3 NA NA 61 1-10 mm Ovary YES A DECEASED 2008 NA NA NA 2983d372-ea74-4ceb-a26e-7b4e6a8acf8f NA NA NA TCGA-61-2611-02A-01D-1138-05 NA NA TCGA-61-2611-02A-01W-1092-09 NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-61-2611-02A-01R-1141-07 |
|
|
615 |
TCGA-61-2612-01 1 TCGA-61-2612-01 193 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-2612 NA NA days 193 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 63 Bilateral TCGA-61-2612-F28496 TCGA-61-2612 TCGA-61-2612-01A Stage IIIC -23074 NA 193 0 193 NA 179 NA NA NA 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 2 NO NA 2.5 NA YES G3 Recurrence NA NA NA NA TCGA-61-2612.48d32d40-9eef-43d2-beb6-75fcc071c52b.pdf 2612 NA WITH TUMOR YES Stable Disease First Seen At Further Surgery NO R1 Primary Tumor 01 0.4 NA NA 61 1-10 mm Ovary YES A DECEASED 2002 NA NA NA 9b739900-7aff-4e27-aa8b-5feaaaa77247 NA NA NA TCGA-61-2612-01A-01D-1138-05 NA TCGA-61-2612-01A-21-20 TCGA-61-2612-01A-01W-1092-09 NA TCGA-61-2612-01A-01D-1134-01 TCGA-61-2612-01 7055e7b7-38bb-4fe4-841b-1419a6273bad NA TCGA-61-2612-01A-01D-1134-01 NA NA NA NA TCGA-61-2612-01 NA NA NA TCGA-61-2612-01A-01R-1141-07 |
|
|
616 |
TCGA-61-2613-01 1 TCGA-61-2613-01 945 1 days Squamous NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-2613 NA NA days 945 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 73 Bilateral TCGA-61-2613-F28500 TCGA-61-2613 TCGA-61-2613-01A Stage IIIC -26779 NA 945 0 945 NA 358 NA NA NA 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.5 NO NA 1.1 NA NA G3 Recurrence NA NA NA NA TCGA-61-2613.6d7a40b1-02f0-4d7e-b3e2-e467e404a241.pdf 2613 NA WITH TUMOR YES Stable Disease Imaging Study NO R1 Primary Tumor 01 0.3 NA NA 61 11-20 mm Ovary NA A DECEASED 1998 NA NA NA 4f3e6b8b-2c5b-4c59-aca0-d3a6b7ee46b5 NA NA NA TCGA-61-2613-01A-01D-1138-05 NA TCGA-61-2613-01A-21-20 TCGA-61-2613-01A-01W-1092-09 NA TCGA-61-2613-01A-01D-1134-01 TCGA-61-2613-01 fce6b5fb-7b97-4af7-a919-0215363156f0 NA TCGA-61-2613-01A-01D-1134-01 NA NA NA NA TCGA-61-2613-01 NA NA NA TCGA-61-2613-01A-01R-1141-07 |
|
|
617 |
TCGA-61-2614-01 1 TCGA-61-2614-01 262 1 days High NA OV-like c1 OV-like c4 NA NA NA NA TCGA-61-2614 NA NA days 262 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary YES NO 71 Bilateral TCGA-61-2614-F28505 TCGA-61-2614 TCGA-61-2614-01A Stage IIIC -26142 NA 262 0 262 NA 38 NA NA NA 2010-9-7 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection NA 0.4 NO NA 1.6 NA YES G3 Recurrence NA NA NA NA TCGA-61-2614.d0ffe1e5-5b41-4dfb-b82d-da937b5b345b.pdf 2614 NA WITH TUMOR NO Stable Disease Imaging Study NO R1 Primary Tumor 01 0.3 NA NA 61 1-10 mm Ovary YES A DECEASED 2007 NA NA NA 59193352-8a67-49d4-9ca0-430c36fe0d12 NA NA NA TCGA-61-2614-01A-01D-1138-05 NA TCGA-61-2614-01A-21-20 TCGA-61-2614-01A-01W-1092-09 NA TCGA-61-2614-01A-01D-1134-01 TCGA-61-2614-01 81ab2618-ccb2-4a64-bab2-83e69633defe NA TCGA-61-2614-01A-01D-1134-01 NA NA NA NA TCGA-61-2614-01 NA NA NA TCGA-61-2614-01A-01R-1141-07 |
|
|
618 |
TCGA-72-4231-01 NA TCGA-72-4231-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4231 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4231-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.3 NO NA 0.5 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4231-01A-01D-1011-05 NA NA NA NA TCGA-72-4231-01A-01D-1017-01 NA NA NA TCGA-72-4231-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
619 |
TCGA-72-4232-01 NA TCGA-72-4232-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4232 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4232-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.5 NO NA 0.6 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4232-01A-01D-1011-05 NA NA NA NA TCGA-72-4232-01A-01D-1017-01 NA NA NA TCGA-72-4232-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
620 |
TCGA-72-4233-01 NA TCGA-72-4233-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4233 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4233-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.3 NO NA 0.5 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4233-01A-01D-1011-05 NA NA NA NA TCGA-72-4233-01A-01D-1017-01 NA NA NA TCGA-72-4233-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
621 |
TCGA-72-4234-01 NA TCGA-72-4234-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4234 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4234-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.2 NO NA 1.2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4234-01A-01D-1011-05 NA NA NA NA TCGA-72-4234-01A-01D-1017-01 NA NA NA TCGA-72-4234-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
622 |
TCGA-72-4235-01 NA TCGA-72-4235-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4235 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4235-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.6 NO NA 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4235-01A-01D-1011-05 NA NA NA NA TCGA-72-4235-01A-01D-1017-01 NA NA NA TCGA-72-4235-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
623 |
TCGA-72-4236-01 NA TCGA-72-4236-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4236 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4236-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.2 NO NA 0.4 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4236-01A-01D-1011-05 NA NA NA NA TCGA-72-4236-01A-01D-1017-01 NA NA NA TCGA-72-4236-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
624 |
TCGA-72-4237-01 NA TCGA-72-4237-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4237 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4237-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.3 NO NA 1.5 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4237-01A-01D-1011-05 NA NA NA NA TCGA-72-4237-01A-01D-1017-01 NA NA NA TCGA-72-4237-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
625 |
TCGA-72-4238-01 NA TCGA-72-4238-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4238 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4238-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.4 NO NA 1.5 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4238-01A-01D-1011-05 NA NA NA NA TCGA-72-4238-01A-01D-1017-01 NA NA NA TCGA-72-4238-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
626 |
TCGA-72-4240-01 NA TCGA-72-4240-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4240 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4240-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NO NA 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4240-01A-01D-1011-05 NA NA NA NA TCGA-72-4240-01A-01D-1017-01 NA NA NA TCGA-72-4240-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
627 |
TCGA-72-4241-01 NA TCGA-72-4241-01 NA NA days NA NA OV-like c1 NA NA NA NA NA TCGA-72-4241 NA NA days NA days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA NA NA NA NA TCGA-72-4241-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.3 NO NA 2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 0.1 NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA TCGA-72-4241-01A-01D-1011-05 NA NA NA NA TCGA-72-4241-01A-01D-1017-01 NA NA NA TCGA-72-4241-01A-01D-1017-01 NA NA NA NA NA NA NA NA NA |
|
|
628 |
TCGA-OY-A56P-01 0 TCGA-OY-A56P-01 1207 0 days NA NA NA NA NA NA NA NA TCGA-OY-A56P NA NA days 1207 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 48 Right TCGA-OY-A56P-F56664 TCGA-OY-A56P TCGA-OY-A56P-01A Stage IIIB -17580 796 NA 0 1207 NA NA NA Scheduled Follow-up Submission Stable Disease 2014-2-17 FEMALE Serous Cystadenocarcinoma No C56.9 8460/3 C56.9 YES Tumor resection 390 NA NO NA NA NO NO G3 NA NA YES false No TCGA-OY-A56P.D916ED58-54D5-43FC-A5B0-6E4844A7F677.pdf A56P NA WITH TUMOR YES Complete Remission/Response NA NO R2 Primary Tumor 01 NA YES NO OY 1-10 mm Ovary NO A LIVING 2010 TCGA-OY-A56P-01 TCGA-OY-A56P-01 NA NA TCGA-OY-A56P-01A-12D-A409-05 TCGA-OY-A56P-01 NA NA NA NA NA 05689fed-96dd-4c52-b51d-5dc799422b9a TCGA-OY-A56P-01A-12D-A402-01 NA 31FB79CF-D6E4-48CF-8EFD-45A81701E359 TCGA-OY-A56P-01A-12R-A406-31 TCGA-OY-A56P-01A-12D-A402-01 05689fed-96dd-4c52-b51d-5dc799422b9a TCGA-OY-A56P-01A-12R-A406-31 05689fed-96dd-4c52-b51d-5dc799422b9a NA NA TCGA-OY-A56P-01 05689fed-96dd-4c52-b51d-5dc799422b9a NA NA |
|
|
629 |
TCGA-OY-A56Q-01 0 TCGA-OY-A56Q-01 576 0 days NA NA NA NA NA NA NA NA TCGA-OY-A56Q 576 0 days 576 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 78 Left TCGA-OY-A56Q-F57585 TCGA-OY-A56Q TCGA-OY-A56Q-01A Stage IIA -28623 120 NA 0 576 NA NA NA Scheduled Follow-up Submission Complete Remission/Response 2014-3-17 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 370 NA NO NA NA NO NO G3 NA NA NO false No TCGA-OY-A56Q.3EF6F66B-8B6E-48E6-9CF4-F8A6B236856D.pdf A56Q NA TUMOR FREE YES Complete Remission/Response NA NO RX Primary Tumor 01 NA YES NO OY No Macroscopic disease Ovary NO A LIVING 2012 TCGA-OY-A56Q-01 TCGA-OY-A56Q-01 NA NA TCGA-OY-A56Q-01A-11D-A409-05 TCGA-OY-A56Q-01 NA NA NA NA NA 3a1867ff-7c1e-47c1-854f-90c0af4b2d03 TCGA-OY-A56Q-01A-11D-A402-01 NA 7029EE0E-6B69-4B6F-8648-FA831B7B70A5 TCGA-OY-A56Q-01A-11R-A406-31 TCGA-OY-A56Q-01A-11D-A402-01 3a1867ff-7c1e-47c1-854f-90c0af4b2d03 TCGA-OY-A56Q-01A-11R-A406-31 3a1867ff-7c1e-47c1-854f-90c0af4b2d03 NA NA TCGA-OY-A56Q-01 3a1867ff-7c1e-47c1-854f-90c0af4b2d03 NA NA |
|
|
630 |
TCGA-VG-A8LO-01 1 TCGA-VG-A8LO-01 24 1 days NA NA NA NA NA NA NA NA TCGA-VG-A8LO 24 0 days 24 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 55 Right NA TCGA-VG-A8LO TCGA-VG-A8LO-01A Stage IV -20274 122 24 0 NA NA NA 4 NA NA 2014-3-25 FEMALE Serous Cystadenocarcinoma No C56.9 8460/3 C56.9 YES Excisional Biopsy 260 NA NO 50 NA NA NA GB NA NA NO false No TCGA-VG-A8LO.6FF4C359-F127-44E6-A1A2-641D60A3665F.pdf A8LO Other WITH TUMOR YES NA NA NO R2 Primary Tumor 01 NA YES NO VG >20 mm Ovary NA A DECEASED 2013 TCGA-VG-A8LO-01 TCGA-VG-A8LO-01 NA NA TCGA-VG-A8LO-01A-11D-A409-05 TCGA-VG-A8LO-01 NA NA NA NA NA fbad0ba1-131d-48af-9957-e9ca56f54e84 TCGA-VG-A8LO-01A-11D-A402-01 NA 0AA665F9-6A46-4A4C-B2E1-11D8EE17B447 TCGA-VG-A8LO-01A-11R-A406-31 TCGA-VG-A8LO-01A-11D-A402-01 fbad0ba1-131d-48af-9957-e9ca56f54e84 TCGA-VG-A8LO-01A-11R-A406-31 fbad0ba1-131d-48af-9957-e9ca56f54e84 NA NA TCGA-VG-A8LO-01 fbad0ba1-131d-48af-9957-e9ca56f54e84 NA NA |
|
|
631 |
TCGA-WR-A838-01 1 TCGA-WR-A838-01 304 1 days NA NA NA NA NA NA NA NA TCGA-WR-A838 304 0 days 304 days TCGA Ovarian Cancer (OV) ovarian serous cystadenocarcinoma Ovary NA NA 72 Right TCGA-WR-A838-F66184 TCGA-WR-A838 TCGA-WR-A838-01A Stage IIIC -26418 110 304 0 245 NA 245 1 Scheduled Follow-up Submission Progressive Disease 2014-10-3 FEMALE Serous Cystadenocarcinoma No C56.9 8441/3 C56.9 YES Tumor resection 200 NA NO NA NA NO YES G3 Progression of Disease NA NO false No TCGA-WR-A838.8F364931-727D-4099-A1D2-E96C61461479.pdf A838 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NA NO NA Primary Tumor 01 NA NO YES WR NA Ovary YES A DECEASED 2013 TCGA-WR-A838-01 TCGA-WR-A838-01 NA NA TCGA-WR-A838-01A-12D-A409-05 TCGA-WR-A838-01 NA NA NA NA NA 010e9bf0-b7a0-4c68-b028-90299840fbaf TCGA-WR-A838-01A-12D-A402-01 NA 95C1EF06-FB7C-4817-86A5-1E608DDA7102 TCGA-WR-A838-01A-12R-A406-31 TCGA-WR-A838-01A-12D-A402-01 010e9bf0-b7a0-4c68-b028-90299840fbaf TCGA-WR-A838-01A-12R-A406-31 010e9bf0-b7a0-4c68-b028-90299840fbaf NA NA TCGA-WR-A838-01 010e9bf0-b7a0-4c68-b028-90299840fbaf NA NA |